file_name	file_id	cases.0.samples.0.portions.0.analytes.0.aliquots.0.submitter_id	cases.0.samples.0.portions.0.analytes.0.submitter_id	cases.0.samples.0.portions.0.slides.0.submitter_id	cases.0.samples.0.portions.0.slides.1.submitter_id	cases.0.samples.0.portions.0.submitter_id	cases.0.samples.0.portions.1.slides.0.submitter_id	cases.0.samples.0.submitter_id	cases.0.submitter_id	cases.0.case_id	cases.0.disease_type	cases.0.primary_site	cases.0.project.project_id	cases.0.samples.0.days_to_collection	cases.0.samples.0.days_to_sample_procurement	cases.0.samples.0.initial_weight	cases.0.samples.0.intermediate_dimension	cases.0.samples.0.is_ffpe	cases.0.samples.0.longest_dimension	cases.0.samples.0.oct_embedded	cases.0.samples.0.pathology_report_uuid	cases.0.samples.0.portions.0.analytes.0.a260_a280_ratio	cases.0.samples.0.portions.0.analytes.0.aliquots.0.aliquot_id	cases.0.samples.0.portions.0.analytes.0.aliquots.0.aliquot_quantity	cases.0.samples.0.portions.0.analytes.0.aliquots.0.aliquot_volume	cases.0.samples.0.portions.0.analytes.0.aliquots.0.concentration	cases.0.samples.0.portions.0.analytes.0.aliquots.0.source_center	cases.0.samples.0.portions.0.analytes.0.aliquots.0.state	cases.0.samples.0.portions.0.analytes.0.analyte_id	cases.0.samples.0.portions.0.analytes.0.analyte_type	cases.0.samples.0.portions.0.analytes.0.analyte_type_id	cases.0.samples.0.portions.0.analytes.0.concentration	cases.0.samples.0.portions.0.analytes.0.spectrophotometer_method	cases.0.samples.0.portions.0.analytes.0.state	cases.0.samples.0.portions.0.is_ffpe	cases.0.samples.0.portions.0.portion_id	cases.0.samples.0.portions.0.portion_number	cases.0.samples.0.portions.0.slides.0.percent_lymphocyte_infiltration	cases.0.samples.0.portions.0.slides.0.percent_monocyte_infiltration	cases.0.samples.0.portions.0.slides.0.percent_necrosis	cases.0.samples.0.portions.0.slides.0.percent_neutrophil_infiltration	cases.0.samples.0.portions.0.slides.0.percent_normal_cells	cases.0.samples.0.portions.0.slides.0.percent_stromal_cells	cases.0.samples.0.portions.0.slides.0.percent_tumor_cells	cases.0.samples.0.portions.0.slides.0.percent_tumor_nuclei	cases.0.samples.0.portions.0.slides.0.section_location	cases.0.samples.0.portions.0.slides.0.slide_id	cases.0.samples.0.portions.0.slides.0.state	cases.0.samples.0.portions.0.slides.1.percent_lymphocyte_infiltration	cases.0.samples.0.portions.0.slides.1.percent_monocyte_infiltration	cases.0.samples.0.portions.0.slides.1.percent_necrosis	cases.0.samples.0.portions.0.slides.1.percent_neutrophil_infiltration	cases.0.samples.0.portions.0.slides.1.percent_normal_cells	cases.0.samples.0.portions.0.slides.1.percent_stromal_cells	cases.0.samples.0.portions.0.slides.1.percent_tumor_cells	cases.0.samples.0.portions.0.slides.1.percent_tumor_nuclei	cases.0.samples.0.portions.0.slides.1.section_location	cases.0.samples.0.portions.0.slides.1.slide_id	cases.0.samples.0.portions.0.slides.1.state	cases.0.samples.0.portions.0.state	cases.0.samples.0.portions.0.weight	cases.0.samples.0.portions.1.portion_id	cases.0.samples.0.portions.1.slides.0.section_location	cases.0.samples.0.portions.1.slides.0.slide_id	cases.0.samples.0.portions.1.slides.0.state	cases.0.samples.0.preservation_method	cases.0.samples.0.sample_id	cases.0.samples.0.sample_type	cases.0.samples.0.sample_type_id	cases.0.samples.0.shortest_dimension	cases.0.samples.0.state	cases.0.samples.0.tissue_type	cases.0.state	cases.0.demographic.submitter_id	cases.0.demographic.age_at_index	cases.0.demographic.days_to_birth	cases.0.demographic.days_to_death	cases.0.demographic.demographic_id	cases.0.demographic.ethnicity	cases.0.demographic.gender	cases.0.demographic.race	cases.0.demographic.state	cases.0.demographic.vital_status	cases.0.demographic.year_of_birth	cases.0.demographic.year_of_death	cases.0.exposures.0.submitter_id	cases.0.exposures.0.alcohol_history	cases.0.exposures.0.exposure_id	cases.0.exposures.0.state	cases.0.diagnoses.0.submitter_id	cases.0.diagnoses.0.age_at_diagnosis	cases.0.diagnoses.0.classification_of_tumor	cases.0.diagnoses.0.days_to_diagnosis	cases.0.diagnoses.0.days_to_last_follow_up	cases.0.diagnoses.0.diagnosis_id	cases.0.diagnoses.0.figo_stage	cases.0.diagnoses.0.icd_10_code	cases.0.diagnoses.0.last_known_disease_status	cases.0.diagnoses.0.morphology	cases.0.diagnoses.0.primary_diagnosis	cases.0.diagnoses.0.prior_malignancy	cases.0.diagnoses.0.prior_treatment	cases.0.diagnoses.0.progression_or_recurrence	cases.0.diagnoses.0.site_of_resection_or_biopsy	cases.0.diagnoses.0.state	cases.0.diagnoses.0.synchronous_malignancy	cases.0.diagnoses.0.tissue_or_organ_of_origin	cases.0.diagnoses.0.tumor_grade	cases.0.diagnoses.0.tumor_stage	cases.0.diagnoses.0.year_of_diagnosis	cases.0.diagnoses.0.treatments.0.submitter_id	cases.0.diagnoses.0.treatments.1.submitter_id	cases.0.diagnoses.0.treatments.0.state	cases.0.diagnoses.0.treatments.0.treatment_id	cases.0.diagnoses.0.treatments.0.treatment_or_therapy	cases.0.diagnoses.0.treatments.0.treatment_type	cases.0.diagnoses.0.treatments.1.state	cases.0.diagnoses.0.treatments.1.treatment_id	cases.0.diagnoses.0.treatments.1.treatment_or_therapy	cases.0.diagnoses.0.treatments.1.treatment_type	id
4722ba18-27f6-480d-975b-59742f9f0f89.htseq.counts.gz	a1bacdbd-60f6-472f-b4a8-bcfec0250279	TCGA-5X-AA5U-01A-11R-A406-31	TCGA-5X-AA5U-01A-11R	TCGA-5X-AA5U-01A-01-TSA		TCGA-5X-AA5U-01A-11		TCGA-5X-AA5U-01A	TCGA-5X-AA5U	bc84c5c5-1785-4edd-b732-8987f862063e	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV	11		230.0		False		true	28F20F49-20C6-4B93-957D-8DAEF04657AE	1.9	4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9			0.16	23	released	f9f30961-2625-492e-8bae-819431b2209c	RNA	R	0.16	UV Spec	released	False	b85cb060-6a51-443a-9557-24f6c912e428	11	2.0	0.0	0.0	0.0	5.0	20.0	75.0	75.0	TOP	9d54b87f-491d-4482-a0dd-194417619d7a	released												released	30.0						e2d8b59b-b044-4aad-9e1b-f88c3208df3a	Primary Tumor	01		released	Not Reported	released	TCGA-5X-AA5U_demographic	61	-22438		168d1029-2d5f-5f1c-8258-18c881e52862	not reported	female	black or african american	released	Alive	1952		TCGA-5X-AA5U_exposure	Not Reported	32609c74-35f3-59d0-956f-1f082d609d97	released	TCGA-5X-AA5U_diagnosis	22438	not reported	0	361	14b248c8-51a1-5f37-9c1f-5b310254bd02	Stage IIC	C56.9	not reported	8460/3	Papillary serous cystadenocarcinoma	no	No	not reported	Ovary	released	Yes	Ovary	not reported	not reported	2013	TCGA-5X-AA5U_treatment_1	TCGA-5X-AA5U_treatment	released	a0485491-7a12-5247-b71f-7d9bd2fc880b	yes	Pharmaceutical Therapy, NOS	released	2fec166a-281f-55ed-97e9-c3513e22fb44	no	Radiation Therapy, NOS	a1bacdbd-60f6-472f-b4a8-bcfec0250279
3e00e8aa-31bc-454e-b558-7bcbad5f47ad.htseq.counts.gz	4958b9d4-59fa-49e4-a849-1b777452f6d2	TCGA-25-2400-01A-01R-1569-13	TCGA-25-2400-01A-01R	TCGA-25-2400-01A-01-TS1	TCGA-25-2400-01A-01-BS1	TCGA-25-2400-01A-01		TCGA-25-2400-01A	TCGA-25-2400	5c127332-5ca0-45f1-a5ac-4876ad94e491	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.1		0C87DA7B-EBA1-4998-88D5-6DF2B0E6A40C	1.8	5c98c2c5-806f-4562-ad57-e152ea8388ab			0.15	22	released	1a2568ed-a431-4105-afd9-f60d06560476	RNA	R	0.15	UV Spec	released	False	7efea88f-0952-4088-9998-dff35aa7ccf2	01			1.0		0.0	10.0	89.0	90.0	TOP	881b0e48-63ea-433e-86f2-361f288cfd94	released			1.0		0.0	10.0	89.0	90.0	BOTTOM	bff6af4f-f392-43f9-bb3f-955ee0871789	released	released	135.0						b5e8849b-9002-4b65-a2ea-6a46c04aba4a	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-25-2400_demographic	76	-27789	1278	3c33fcef-becb-52f1-8639-ed1171c7abf6	not hispanic or latino	female	white	released	Dead	1928	2007	TCGA-25-2400_exposure	Not Reported	5629bc6a-8447-5850-9e03-3f7fdc39a215	released	TCGA-25-2400_diagnosis	27789	not reported	0	1278	f39bd60a-a005-5137-a928-fc58efb4c5d7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-25-2400_treatment_1	TCGA-25-2400_treatment	released	e9c97035-3529-5c2b-89a6-70fd124fd6f2	yes	Pharmaceutical Therapy, NOS	released	42214af6-e6c0-52d7-8f63-48cb7d376457	no	Radiation Therapy, NOS	4958b9d4-59fa-49e4-a849-1b777452f6d2
0991973f-cd4d-4fcc-bf95-ee735422abb6.htseq.counts.gz	86e97a45-76bb-4c76-8799-d705242c29d5	TCGA-24-2290-01A-01R-1568-13	TCGA-24-2290-01A-01R	TCGA-24-2290-01A-01-TS1	TCGA-24-2290-01A-01-BS1	TCGA-24-2290-01A-01		TCGA-24-2290-01A	TCGA-24-2290	2b14123b-8fcd-402c-9399-4e7c47f20252	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		71036f77-0d99-427a-883c-75624453890d	1.8	a3173b33-aa16-48a2-b733-0345aad49755			0.15	22	released	a653c306-05aa-4064-a547-3b753ff555b3	RNA	R	0.15	UV Spec	released	False	4fefd336-d14e-4e1e-8bf1-16e3c64b6495	01			15.0		0.0	15.0	70.0	85.0	TOP	298bd41d-f2e2-4db3-9582-62d0be13aa8c	released			5.0		0.0	5.0	90.0	95.0	BOTTOM	f5d185e3-f27f-4ad4-9f81-8721b109da1d	released	released	144.0						bbfed693-79e1-4dc7-896e-15b98fc7dbac	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-2290_demographic	56	-20530	1102	c59bc65d-24b8-5f31-a7bf-24ec7a57a5c3	not reported	female	white	released	Dead	1941	2000	TCGA-24-2290_exposure	Not Reported	707b1326-faa7-5565-9aa5-ec5f9f8d0801	released	TCGA-24-2290_diagnosis	20530	not reported	0	1102	608d39b1-f3d7-5c83-a83a-61248eacbd74	Stage IIIC	C48.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Specified parts of peritoneum	released	Not Reported	Ovary	not reported	not reported	1997	TCGA-24-2290_treatment_1	TCGA-24-2290_treatment	released	f04d9b4f-fec4-5246-8514-374ddeeb745c	yes	Pharmaceutical Therapy, NOS	released	85bbe000-218f-5fdd-a9e9-3873e195ba2f	no	Radiation Therapy, NOS	86e97a45-76bb-4c76-8799-d705242c29d5
e8bd5099-de91-4c44-8573-f5eaba611dfe.htseq.counts.gz	65bad43d-4b38-439b-a126-19cb19a6671b	TCGA-09-2054-01A-01R-1568-13	TCGA-09-2054-01A-01R	TCGA-09-2054-01A-01-TS1	TCGA-09-2054-01A-01-BS1	TCGA-09-2054-01A-01		TCGA-09-2054-01A	TCGA-09-2054	cbd87697-7708-4b69-9e50-9ee474feabe1	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	2		4f0eb2a1-996c-4816-a956-835ce5085438	1.8	5cd7faa0-323a-4ea3-a658-859d0336e0ac	3.2	20	0.16	22	released	c82bb4a9-a0dd-43a8-a9b9-bf8a79795b8f	RNA	R	0.16	UV Spec	released	False	c747b71f-bf22-4c46-810e-6ad17f1d5283	01	0	0	0	0	0	10	90	90	TOP	ca88b75f-1c48-4cce-84e9-97e78412a275	released	0	0	0	0	0	10	90	90	BOTTOM	e68f41e6-572a-40f8-9263-cfdd4fe62e8a	released	released	112						e2a7621d-3c1d-4b7c-9494-0c02df363ecb	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-09-2054_demographic	58	-21285	637	8be5e1f5-91eb-53cd-9cfe-8cc67176093b	not hispanic or latino	female	black or african american	released	Dead	1947	2006	TCGA-09-2054_exposure	Not Reported	652755bf-83bb-5dd2-be52-b44d306a657d	released	TCGA-09-2054_diagnosis	21285	not reported	0	637	90364ee6-2b18-5172-a7f4-b50c4343e0f4	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-09-2054_treatment_1	TCGA-09-2054_treatment	released	a825d1b8-d033-5837-8185-6409d3d7e84d	yes	Pharmaceutical Therapy, NOS	released	0d318cfb-b4dd-5b02-aac5-d0e3fe6aa09d	no	Radiation Therapy, NOS	65bad43d-4b38-439b-a126-19cb19a6671b
d0744791-f4c0-45c7-b233-c6512f3c766b.htseq.counts.gz	fb02a814-f9e0-42ee-b3a1-7d9beee939be	TCGA-13-1489-01A-01R-1565-13	TCGA-13-1489-01A-01R	TCGA-13-1489-01A-01-BS1	TCGA-13-1489-01A-01-TS1	TCGA-13-1489-01A-01		TCGA-13-1489-01A	TCGA-13-1489	7248cd60-be22-44bc-bc58-f644db0940a2	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.7		C65BE57D-0015-49BB-A4BE-81D7B302F464	1.8	dcb03592-9f67-49bf-bc78-d89d69de14a8			0.15	22	released	e735fa2a-87a9-496e-8292-c62bf0700e66	RNA	R	0.15	UV Spec	released	False	a9c02458-5ed0-422e-ad6e-bb875d94c09b	01			10.0		5.0	0.0	85.0	95.0	BOTTOM	89a1069f-7323-4169-9dbd-3dd204338851	released	50.0		2.0	50.0	5.0	0.0	95.0	98.0	TOP	afac158d-0de2-4e56-a1e8-1970763d8563	released	released	170.0						4b2b6e5e-248c-46f6-938a-95571577e02d	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1489_demographic	70	-25768	2553	39bca6ab-f7fe-59fd-b376-b16f300c341d	not hispanic or latino	female	white	released	Dead	1932		TCGA-13-1489_exposure	Not Reported	888ccf70-daf2-573f-986b-b9a6a79b4635	released	TCGA-13-1489_diagnosis	25768	not reported	0	2521	f903544f-b690-54a3-b3e5-faa412f474d7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-13-1489_treatment_1	TCGA-13-1489_treatment	released	4d28d2af-7102-5e8b-bb3a-2861f9a5d09b	yes	Pharmaceutical Therapy, NOS	released	ad9e7582-766f-591a-8ef5-78df3f6d07be	no	Radiation Therapy, NOS	fb02a814-f9e0-42ee-b3a1-7d9beee939be
9d80d1a6-3a9c-42ca-8139-c88659088638.htseq.counts.gz	238992db-6a59-4110-aebe-e8083109554a	TCGA-61-2088-01A-01R-1568-13	TCGA-61-2088-01A-01R	TCGA-61-2088-01A-01-TS1	TCGA-61-2088-01A-01-BS1	TCGA-61-2088-01A-01		TCGA-61-2088-01A	TCGA-61-2088	242943fe-1fa0-4a12-8f7e-9c6c4af1194d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1	False	1.4		62624308-45b6-46f3-85a0-5a4639b44bf3	1.8	62fdea50-f152-4f43-9130-a93079b5e61f	2.8	20	0.14	22	released	97ce9df4-911e-427d-a187-f7d5f5bd3cea	RNA	R	0.14	UV Spec	released	False	0bf84d3a-befa-4285-a973-900c2a27befa	01			1		0	5	94	95	TOP	aed842d4-ca7b-483e-85f5-2843f4dc7005	released			1		0	5	94	95	BOTTOM	3e099147-d41d-42a2-b979-5847180209b4	released	released	111						29d36fc7-e849-42aa-bcc8-2fd9f7c9e24e	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-2088_demographic	51	-18770		f10f87ea-db88-50ac-8b62-e269aa16ba67	not hispanic or latino	female	white	released	Alive	1958		TCGA-61-2088_exposure	Not Reported	bf654f43-19d0-5282-b9e7-0ddad2b335fb	released	TCGA-61-2088_diagnosis	18770	not reported	0	145	6e4a13d0-dffc-5780-9f24-ee952362f22d	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-61-2088_treatment_1	TCGA-61-2088_treatment	released	538520d8-736c-5717-ade8-39085b6adf71	yes	Pharmaceutical Therapy, NOS	released	ef2a5e93-9f0f-53c1-96d5-da124011ce36	no	Radiation Therapy, NOS	238992db-6a59-4110-aebe-e8083109554a
5327762f-5add-4008-ac5f-beca30ee5b4d.htseq.counts.gz	b02459dd-1f1d-4a66-a5d0-e8fd2d0dbc68	TCGA-24-1923-01A-01R-1567-13	TCGA-24-1923-01A-01R	TCGA-24-1923-01A-01-BS1	TCGA-24-1923-01A-01-TS1	TCGA-24-1923-01A-01		TCGA-24-1923-01A	TCGA-24-1923	8449955f-42d9-46f6-919a-5cc5d59e6284	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.3		6ae8158a-e236-4cc0-88d2-50756216f0e7	1.8	d34ae25d-8073-4129-a1b8-3f43e19af73b			0.13	22	released	44d176bd-a939-4839-88a5-f8d18d7a1525	RNA	R	0.13	UV Spec	released	False	2d4a29e0-efc5-4a2e-a7ed-36e08cdac283	01	0.0	0.0	5.0	5.0	0.0	5.0	90.0	90.0	BOTTOM	2f93d2e1-4288-44cf-b6c0-1b8e4d964e75	released	0.0	0.0	15.0	10.0	0.0	15.0	70.0	70.0	TOP	efa7fe61-eeee-4f33-a76e-def9e1e4347b	released	released	100.0						84d06f56-6611-4fa1-89fd-df8780f7f446	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-24-1923_demographic	51	-18628	690	96d5e3f2-4a30-5a3a-ba6f-eecd943d1046	not reported	female	white	released	Dead	1950	2002	TCGA-24-1923_exposure	Not Reported	8829ffd1-1226-5fae-9eb0-90c166e2a5e4	released	TCGA-24-1923_diagnosis	18628	not reported	0	690	ee2e4650-934a-5367-946a-baa0ebb000e2	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-24-1923_treatment_1	TCGA-24-1923_treatment	released	b160099e-570d-5b9c-b290-7d99fcdc01f6	yes	Pharmaceutical Therapy, NOS	released	aa018f9d-8c45-57dd-9697-3f2fe2e0e89d	no	Radiation Therapy, NOS	b02459dd-1f1d-4a66-a5d0-e8fd2d0dbc68
f920e615-9b0a-4767-821b-201c407730c4.htseq.counts.gz	b18de6ad-4e03-4cdf-98c4-c469f1c646b2	TCGA-13-0726-01A-01R-1564-13	TCGA-13-0726-01A-01R	TCGA-13-0726-01A-01-BS1	TCGA-13-0726-01A-01-TS1	TCGA-13-0726-01A-01		TCGA-13-0726-01A	TCGA-13-0726	32960bc7-839a-42c5-9460-3917fa578ffc	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		7165A995-69AE-4D74-9437-02C4730701C1	1.8	3dd100f9-9261-4e1c-9bbb-95a2c56abfb6			0.17	22	released	97116276-2869-4411-8c04-15f3723c9f10	RNA	R	0.17	UV Spec	released	False	4983a34b-1877-47b1-95ef-59d896a54e74	01			0.0		0.0	40.0	60.0	80.0	BOTTOM	a58bbed2-b315-4182-8965-023c55e37725	released	50.0		0.0	50.0	0.0	30.0	70.0	90.0	TOP	2a8707fc-2d7b-459a-9707-96c5b4e11f43	released	released	131.0						391c5d58-68fd-4e17-a095-ebb94d32bf58	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0726_demographic	55	-20134	949	056db782-ad0b-5cfe-9fe5-55f48edf37d0	not hispanic or latino	female	white	released	Dead	1947	2004	TCGA-13-0726_exposure	Not Reported	a2927499-22fb-56fe-9c9e-f8bc995b9b61	released	TCGA-13-0726_diagnosis	20134	not reported	0	946	ed0b214c-e415-5615-bfad-27541c16d7bd	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-13-0726_treatment_1	TCGA-13-0726_treatment	released	7f4d8d1b-fa63-5a3c-96e0-b14ade55e8f4	yes	Pharmaceutical Therapy, NOS	released	a659d0d0-4cd3-5dfa-82bf-b1f1d7eae1bb	no	Radiation Therapy, NOS	b18de6ad-4e03-4cdf-98c4-c469f1c646b2
40b41560-b08b-47a7-8149-b73c9d00d25c.htseq.counts.gz	60853163-f939-4a8c-b300-e0d3c24b2eb7	TCGA-23-1022-01A-01R-1564-13	TCGA-23-1022-01A-01R	TCGA-23-1022-01A-01-BS1	TCGA-23-1022-01A-01-TS1	TCGA-23-1022-01A-01		TCGA-23-1022-01A	TCGA-23-1022	d0673efd-3315-4dd5-8ab6-912bfa07dceb	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	0.7		1A674838-E992-4E9B-82AE-FAFA0AD3BF56	1.8	2eeb258f-bbc2-4412-9673-cc39915da304			0.15	22	released	11a8ea90-bd92-4f69-9d09-37367c0b95ef	RNA	R	0.15	UV Spec	released	False	08b67a5f-a236-467a-8150-6f138ed3d57c	01			0.0		5.0	5.0	90.0	90.0	TOP	b230a1dc-5e45-4d8a-9668-91a9e105d1a1	released			0.0		5.0	5.0	90.0	90.0	TOP	8e55f9a0-4044-4413-a4f8-e30004575fc3	released	released	96.0						65e5e0dc-01e3-43b1-80b5-09762432309e	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-23-1022_demographic	67	-24798	1511	c4eab79f-a23b-5be3-abcc-b2e64f7626dc	not hispanic or latino	female	white	released	Dead	1936	2007	TCGA-23-1022_exposure	Not Reported	aef251e9-49c9-5f8d-948b-7aef061f6b39	released	TCGA-23-1022_diagnosis	24798	not reported	0		0cb11846-7903-535a-926e-9347464dcdd3	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-23-1022_treatment	TCGA-23-1022_treatment_1	released	5eee8d7b-7f8d-591a-8674-7896ce4867ff	no	Radiation Therapy, NOS	released	afa79747-1c52-5997-90cb-17ac54c1eb25	yes	Pharmaceutical Therapy, NOS	60853163-f939-4a8c-b300-e0d3c24b2eb7
fed23e32-490a-4849-b335-d6cc8f0187fa.htseq.counts.gz	b4533fab-5f7b-417a-8455-99fcb6f277b1	TCGA-31-1956-01A-01R-1568-13	TCGA-31-1956-01A-01R	TCGA-31-1956-01A-01-BS1	TCGA-31-1956-01A-01-TS1	TCGA-31-1956-01A-01		TCGA-31-1956-01A	TCGA-31-1956	e1158102-06f2-47bb-9fe0-49b57f070755	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.3		3646c24b-c4b7-400b-bc93-7ef485c6892c	1.8	24cfcfd9-ce30-4e24-9470-60265efd6721			0.16	22	released	17356abe-8ee8-4e1d-bfec-92bc98d78d73	RNA	R	0.16	UV Spec	released	False	92ede993-4acc-4e5a-be66-718d422b4839	01			2.0		0.0	18.0	80.0	90.0	BOTTOM	5fafa924-13b2-4b34-9930-1810a3ac5022	released	5.0	3.0	5.0		0.0	45.0	50.0	85.0	TOP	e3853ccf-184c-48d1-aeca-6a62e93e3d84	released	released	113.0						3218e049-6d6a-471c-8453-d8ac52cf9d14	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-31-1956_demographic	60	-22100		567cb496-8b1d-54e3-bfa7-401b51d6b3fd	not hispanic or latino	female	white	released	Alive	1945		TCGA-31-1956_exposure	Not Reported	f6ba8f4a-d9ec-574f-ae6d-c0c469e85e13	released	TCGA-31-1956_diagnosis	22100	not reported	0	1342	cfbadd21-1fd9-5470-bec1-e14b76ad9ae8	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-31-1956_treatment_1	TCGA-31-1956_treatment	released	751d736d-346c-58b0-8b98-5d60c60474c9	yes	Pharmaceutical Therapy, NOS	released	01a71b58-c55c-5270-b629-f123096449bb	no	Radiation Therapy, NOS	b4533fab-5f7b-417a-8455-99fcb6f277b1
7b6e2a12-c537-4f1f-911f-d430bd864d2d.htseq.counts.gz	5523cb49-46a9-48f0-9fe3-90d34d2fac3e	TCGA-13-0800-01A-01R-1564-13	TCGA-13-0800-01A-01R	TCGA-13-0800-01A-01-TS1	TCGA-13-0800-01A-01-BS1	TCGA-13-0800-01A-01		TCGA-13-0800-01A	TCGA-13-0800	390eed6b-50af-48a9-9fd6-3a68a2bbb7f9	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.5		E3206F00-3BC6-44B4-848E-F2ED70E094BD	1.8	cd93531b-4d92-4be3-95e5-032636dd1ad8			0.16	22	released	9d48368c-951d-4d00-a3f8-21c19caf4029	RNA	R	0.16	UV Spec	released	False	63bc8343-32b3-40bb-ab70-bf15f41b8a7d	01			0.0		0.0	15.0	85.0	95.0	TOP	b12d32bb-aeed-4d6d-8ee6-f76bc9fb8d76	released			5.0		0.0	35.0	60.0	80.0	BOTTOM	9a6d87aa-4ea6-4ae9-a1e4-c64f5e9713bf	released	released	141.0						a99995e3-8d0b-453a-b604-206218279b71	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-0800_demographic	52	-19087		5f1fb8da-be94-5c96-95df-d92366f4f2cd	not hispanic or latino	female	white	released	Alive	1956		TCGA-13-0800_exposure	Not Reported	1fb1d957-e131-5f48-a3a6-a8f76a64f951	released	TCGA-13-0800_diagnosis	19087	not reported	0	2661	876d6193-704f-5a99-a4cc-eff9b4e4f2d5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-0800_treatment_1	TCGA-13-0800_treatment	released	a59a6193-4095-5b48-b560-1a4477dba95c	yes	Pharmaceutical Therapy, NOS	released	97066293-e221-5df0-9097-d6eb462e5791	no	Radiation Therapy, NOS	5523cb49-46a9-48f0-9fe3-90d34d2fac3e
0045a228-1dad-4ced-9bc6-5067aeee0518.htseq.counts.gz	7525f3b0-b416-49d5-b839-40eaee3a42e4	TCGA-25-1326-01A-01R-1565-13	TCGA-25-1326-01A-01R	TCGA-25-1326-01A-01-BS1	TCGA-25-1326-01A-01-TS1	TCGA-25-1326-01A-01		TCGA-25-1326-01A	TCGA-25-1326	07a859fc-6f78-4905-9035-90e2403dbe8d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				2.5	False	3.0		B17E5B27-48DB-4E64-A1C3-CAE4921C14DF	1.8	b29bd766-95b1-46fa-a070-d2206cd5722a			0.16	22	released	1582b110-76e8-43e1-bbca-38a8d720d2ce	RNA	R	0.16	UV Spec	released	False	e4b95817-fd4c-4bce-bdaa-6013d6e29fe6	01			20.0			20.0	60.0	85.0	BOTTOM	04f4d76d-fa58-4f40-97d0-c67616253bfb	released			5.0			20.0	75.0	85.0	TOP	0fbff408-12f4-429e-9d63-c51e858c6971	released	released	175.0						655bee4a-887e-495e-9afe-586b75516e7d	Primary Tumor	01	1.2	released	Not Reported	released	TCGA-25-1326_demographic	61	-22339	1249	64e2c7b4-6061-5765-b200-5ae4c9836b78	not hispanic or latino	female	white	released	Dead	1941	2005	TCGA-25-1326_exposure	Not Reported	14234a0a-da47-5d89-a87a-eb875e6200d4	released	TCGA-25-1326_diagnosis	22339	not reported	0	945	ea06b490-4522-5521-8124-5f077e608a8a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-25-1326_treatment_1	TCGA-25-1326_treatment	released	fc2da38e-c81e-59f4-98af-621f1329dbc4	yes	Pharmaceutical Therapy, NOS	released	611953da-651f-5fa7-b92a-89fdd2c73eb3	no	Radiation Therapy, NOS	7525f3b0-b416-49d5-b839-40eaee3a42e4
871da002-8649-42bc-8ce4-9d2a8ff66213.htseq.counts.gz	69984aa4-8e6b-4f1c-9e6e-af774a4cbfd3	TCGA-13-1403-01A-01R-1565-13	TCGA-13-1403-01A-01R	TCGA-13-1403-01A-01-TS1	TCGA-13-1403-01A-01-BS1	TCGA-13-1403-01A-01		TCGA-13-1403-01A	TCGA-13-1403	0d5e232d-5aa2-4f6f-be58-ffd5f15ee0b8	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.2		435619AB-01F5-4AC3-8D28-A8CC0054699F	1.8	3217dd54-d41c-4c63-8bab-ff2c4baaee10			0.17	22	released	f2e8f2b2-85f8-44da-9d17-db980ca34dbe	RNA	R	0.17	UV Spec	released	False	ba5b371b-b766-4d1e-aedf-cb0d3e28eb55	01			5.0		0.0	10.0	85.0	90.0	TOP	d9d6de3c-5c5c-4966-b028-b914002e89c6	released			1.0		0.0	5.0	94.0	95.0	BOTTOM	ac764ada-e3f7-4b8e-9ba5-6a15e4d53224	released	released	134.0						62043d1b-2c38-4c45-abd0-97ff2f77176b	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1403_demographic	48	-17697	2345	cd835f8d-6b5c-5b52-b9f3-6392a04c6f1e	not hispanic or latino	female	white	released	Dead	1960		TCGA-13-1403_exposure	Not Reported	d513531f-1601-5c54-a6c3-fd27dd7ad2ec	released	TCGA-13-1403_diagnosis	17697	not reported	0	331	2bb5937a-3659-5c77-a650-35e461810f1f	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1403_treatment_1	TCGA-13-1403_treatment	released	2827735c-1bc1-5e2a-b8d0-9e7cd99829c7	yes	Pharmaceutical Therapy, NOS	released	71a4ee5b-ad87-5777-a700-f569bd948d39	no	Radiation Therapy, NOS	69984aa4-8e6b-4f1c-9e6e-af774a4cbfd3
60da3a1a-65ee-48fa-a08f-88b6d52a18c2.htseq.counts.gz	bed9afc1-0329-499f-a159-fb7bc0c61b55	TCGA-25-1322-01A-01R-1565-13	TCGA-25-1322-01A-01R	TCGA-25-1322-01A-01-TS1	TCGA-25-1322-01A-01-BS1	TCGA-25-1322-01A-01		TCGA-25-1322-01A	TCGA-25-1322	b520aae5-65a6-4b27-bc2a-10b02c7b1aeb	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.8	False	2.6		6EAF4358-51F9-4999-A219-39178418CC9C	1.8	bce04e1e-a90c-4e81-bd16-415cccc9d7e2			0.15	22	released	4c881e32-be86-4dee-8400-81993776dd24	RNA	R	0.15	UV Spec	released	False	fb9346c0-edd4-46dd-bbf1-9568a9a6177b	01			15.0			10.0	75.0	95.0	TOP	5678ec6d-331d-43fc-9a9a-0ef43c274f73	released			15.0			10.0	75.0	95.0	BOTTOM	df752342-0132-40ea-96a4-91c9f7f23eb2	released	released	125.0						9bc6ca0e-c74a-49f7-be04-6546e56e8ba2	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-25-1322_demographic	62	-22646	91	895829cd-984f-5029-ac7d-de8de3feb97f	not hispanic or latino	female	white	released	Dead	1939	2001	TCGA-25-1322_exposure	Not Reported	6d9285d5-91ae-537c-827b-2614bdd0139a	released	TCGA-25-1322_diagnosis	22646	not reported	0	91	d7d5faf4-cb8e-5db8-9a9c-7894070b7ead	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-25-1322_treatment_1	TCGA-25-1322_treatment	released	5da4453d-06d8-5b91-8979-84b33445ea7d	yes	Pharmaceutical Therapy, NOS	released	0552af02-bfa2-562e-a1c2-e127329c9904	no	Radiation Therapy, NOS	bed9afc1-0329-499f-a159-fb7bc0c61b55
bd727430-2539-4897-a754-2c8d8de59f9e.htseq.counts.gz	4809258e-9835-49f4-92c1-09f97fcecebd	TCGA-24-1558-01A-01R-1566-13	TCGA-24-1558-01A-01R	TCGA-24-1558-01A-01-BS1	TCGA-24-1558-01A-01-TS1	TCGA-24-1558-01A-01		TCGA-24-1558-01A	TCGA-24-1558	ba68f2cf-9271-41fd-9655-1fac7681f588	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.9		62143e5f-4452-47ca-a67c-cd87036424b1	1.8	1b8d5b5e-f671-419a-844a-6640fe5a896d			0.13	22	released	578fab37-8783-4c98-9278-eabc33cec19f	RNA	R	0.13	UV Spec	released	False	9d933b67-1f83-4a95-aff5-d59ee2ab355a	01			0.0		0.0	2.0	98.0	95.0	BOTTOM	64a012b1-90d0-4df7-8b7b-9c3f0ca584b9	released			0.0		0.0	2.0	98.0	95.0	TOP	88c2fa99-388d-4924-93a4-44e541bfc064	released	released	147.0						3e8bd387-4fda-4623-924e-314267c55eea	Primary Tumor	01	0.9	released	Not Reported	released	TCGA-24-1558_demographic	73	-27004	594	58103f7a-0d5a-5c6b-b9cb-6214466a0c34	not reported	female	white	released	Dead	1927	2001	TCGA-24-1558_exposure	Not Reported	153b7059-443b-5d85-91de-3f494d33bed8	released	TCGA-24-1558_diagnosis	27004	not reported	0	594	2c050cd3-82f7-5809-b295-340ecf3cb89c	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-24-1558_treatment	TCGA-24-1558_treatment_1	released	5e803842-33be-5620-ac0b-2cfd048621d8	no	Radiation Therapy, NOS	released	76b7b05d-f627-57e1-b9c9-39dfb07bb153	yes	Pharmaceutical Therapy, NOS	4809258e-9835-49f4-92c1-09f97fcecebd
1865f7a2-31da-4e7a-8cd5-a4c15372ffaf.htseq.counts.gz	eaf9ae41-e243-4c70-a59d-8303f2d42c38	TCGA-24-2288-01A-01R-1568-13	TCGA-24-2288-01A-01R	TCGA-24-2288-01A-01-TS1	TCGA-24-2288-01A-01-BS1	TCGA-24-2288-01A-01		TCGA-24-2288-01A	TCGA-24-2288	28ed2d42-5b4c-4bca-b2b2-6b2a6d3c42cf	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.2		a8d48a3e-3f22-44ec-8cbd-2ad8bb43bb45	1.8	dbc2cfac-df65-4750-af39-37760bad1057			0.16	22	released	32d0d144-c528-484f-9e3c-9a800f943238	RNA	R	0.16	UV Spec	released	False	bc83e978-7b52-4c8a-be6f-b231eac6fce3	01			5.0		0.0	10.0	85.0	90.0	TOP	553695fa-d194-441a-a0b8-05528b9ccb12	released			5.0		0.0	10.0	85.0	90.0	BOTTOM	a45d4cd8-d5c7-4d1c-9911-335e306097da	released	released	148.0						8f515078-38de-44c1-81ce-e40d8a942fc7	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-2288_demographic	70	-25831	25	04990ab9-c2a6-52e5-be59-8e9024d7e18c	not reported	female	white	released	Dead	1929	1999	TCGA-24-2288_exposure	Not Reported	4e89d0a6-a4eb-5dab-aa61-76e633d86256	released	TCGA-24-2288_diagnosis	25831	not reported	0	25	54c4860f-11d8-5cff-be3e-d4405cc30f73	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-24-2288_treatment	TCGA-24-2288_treatment_1	released	a514274f-a2ac-5f8f-9a8b-c8b32dec1aee	no	Radiation Therapy, NOS	released	0d106823-1ea9-5d8e-931f-5f40ab0c2dda	yes	Pharmaceutical Therapy, NOS	eaf9ae41-e243-4c70-a59d-8303f2d42c38
86cb28d4-5dcd-4e7e-a4c9-c5a5b16a9739.htseq.counts.gz	70603898-1188-4ee8-9b85-2cb1bdc23fe7	TCGA-25-1626-01A-01R-1566-13	TCGA-25-1626-01A-01R	TCGA-25-1626-01A-01-BS1	TCGA-25-1626-01A-01-TS1	TCGA-25-1626-01A-01		TCGA-25-1626-01A	TCGA-25-1626	662d77d1-1a43-427a-813b-e11edd30868e	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.4		4B54A1C9-6F08-435B-B85F-736D4278EA82	1.8	daaba89d-acd3-4670-a618-89e5973b03f4			0.15	22	released	b337168c-f0fc-47a1-bfa5-974be2c59248	RNA	R	0.15	UV Spec	released	False	e2b5f773-736b-46d7-b60b-63d98692759b	01			5.0		0.0	30.0	65.0	75.0	BOTTOM	a288053e-86fd-4189-8dba-641155072fc7	released			5.0		0.0	40.0	55.0	70.0	TOP	84f55106-8f41-49e6-b9e5-2c70a99aaeef	released	released	117.0						1b396d98-af47-49c3-bf45-9f26ed32d71c	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-25-1626_demographic	65	-23932	518	7a6939c1-85fa-5b74-b9c5-60e18347c35a	not hispanic or latino	female	white	released	Dead	1941	2007	TCGA-25-1626_exposure	Not Reported	8cc51124-e4e5-54c5-9c33-5902d489749d	released	TCGA-25-1626_diagnosis	23932	not reported	0	481	f5f5f800-6d60-522d-a538-95bf6adaa275	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-25-1626_treatment	TCGA-25-1626_treatment_1	released	2a73c773-6a90-5db2-b0d0-3a7ef3e20122	no	Radiation Therapy, NOS	released	6756ac62-fc9a-535e-a49d-6d5daa7996bc	yes	Pharmaceutical Therapy, NOS	70603898-1188-4ee8-9b85-2cb1bdc23fe7
eb329194-22d5-4675-a982-0c2dd8e5a324.htseq.counts.gz	27e07fa1-44f5-4956-9518-a61b29ee93b1	TCGA-24-2035-01A-01R-1568-13	TCGA-24-2035-01A-01R	TCGA-24-2035-01A-01-TS1	TCGA-24-2035-01A-01-BS1	TCGA-24-2035-01A-01		TCGA-24-2035-01A	TCGA-24-2035	062982f8-9f49-425a-99e9-008af5ed9040	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.0		025d4b31-5832-451a-9f70-e0281f698aa6	1.8	e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0			0.14	22	released	bb306488-b47f-401d-96c9-a5afda87a866	RNA	R	0.14	UV Spec	released	False	433a4bc6-3f6b-40a5-adb0-5cdae48f8a29	01	0.0	0.0	0.0	0.0	0.0	50.0	50.0	90.0	TOP	219f3d14-d927-4732-acfe-9fb918296c53	released	5.0	0.0	0.0	0.0	0.0	90.0	10.0	90.0	BOTTOM	1ea4d2d3-feff-446e-a198-cd91ce4d56b7	released	released	127.0						e4ccc95d-79ca-49e3-8cd0-c8452c5f9aa2	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-2035_demographic	65	-23855	857	07018a25-f50f-5622-ac08-b364ea38ff12	not reported	female	white	released	Dead	1931	1998	TCGA-24-2035_exposure	Not Reported	ecdc841a-404a-5c34-af8a-0c8856e767f7	released	TCGA-24-2035_diagnosis	23855	not reported	0	857	0e6482de-13e4-5907-b7c0-18515ebd9c3d	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1996	TCGA-24-2035_treatment	TCGA-24-2035_treatment_1	released	d183dbca-1016-5ed6-8e50-f554c32c5b76	no	Radiation Therapy, NOS	released	3565816c-8774-5bb5-b47a-477a20eb1010	yes	Pharmaceutical Therapy, NOS	27e07fa1-44f5-4956-9518-a61b29ee93b1
f76c1066-d6e9-4d27-a0ac-0a493d8e85f4.htseq.counts.gz	1d534ab0-4e5f-4463-b2b5-96ae2e4b9ce1	TCGA-57-1584-01A-01R-1566-13	TCGA-57-1584-01A-01R	TCGA-57-1584-01A-01-TS1	TCGA-57-1584-01A-01-BS1	TCGA-57-1584-01A-01		TCGA-57-1584-01A	TCGA-57-1584	ed21615c-0de3-421c-9e8d-8996026c4431	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	2.3		3e4b484e-4727-444f-b2bc-c32d5d1ad815	1.8	e92b95df-bacb-4083-b2de-78e540ec0e68			0.14	22	released	4429c3a8-508a-485f-9bd6-8e1d055f0bbf	RNA	R	0.14	UV Spec	released	False	3db9d93f-0752-4cc9-b00d-aaba1b4ea3c8	01			0.0		0.0	10.0	90.0	90.0	TOP	b57410ca-d6e6-484d-96ad-5ed4d8294995	released			0.0		0.0	10.0	90.0	90.0	BOTTOM	f3dcde68-506f-4250-909b-18833b596180	released	released	147.0						99287cbc-e4d4-4d24-b373-7865b7905727	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-57-1584_demographic	47	-17263		7330b127-a51c-583d-a55b-d390f16ea0c2	not hispanic or latino	female	white	released	Alive	1960		TCGA-57-1584_exposure	Not Reported	bef717db-3695-50af-8887-85f135932d37	released	TCGA-57-1584_diagnosis	17263	not reported	0	643	6d0c4029-6165-5461-9759-8581bfb6c538	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-57-1584_treatment_1	TCGA-57-1584_treatment	released	8de626a9-5501-58e4-8145-4c83f7dbc3ba	yes	Pharmaceutical Therapy, NOS	released	ff36a589-56d2-535a-9593-1cd26c63b156	no	Radiation Therapy, NOS	1d534ab0-4e5f-4463-b2b5-96ae2e4b9ce1
74318679-8eae-42ee-8721-fd38de88938a.htseq.counts.gz	1c841b7f-f124-4882-b91d-f26e041ad944	TCGA-61-2012-01A-01R-1568-13	TCGA-61-2012-01A-01R	TCGA-61-2012-01A-01-TS1	TCGA-61-2012-01A-01-BS1	TCGA-61-2012-01A-01		TCGA-61-2012-01A	TCGA-61-2012	20c6be4d-7baf-4ea0-93e2-a5212f2e9b9c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.6		534e3236-b9e7-4b0b-a2a3-2fc3a96fac81	1.8	929c2bc4-4cee-4f82-b336-918fe041a588			0.13	22	released	9ee4786e-b524-4c48-8d8e-a39ca3651337	RNA	R	0.13	UV Spec	released	False	f6ad2d94-29f1-44ab-8602-e4bb9b07f4c1	01			10.0		0.0	10.0	80.0	90.0	TOP	d68a617d-bd93-4048-895f-46279334d114	released			10.0		0.0	10.0	80.0	90.0	BOTTOM	0360d47c-f42a-4f5f-b317-ff0f55799425	released	released	135.0						0befd656-457c-4fa2-81c0-6c5a56f70196	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-2012_demographic	81	-29830		8498c00e-74f7-5fcf-b735-19fa805babfc	not hispanic or latino	female	white	released	Alive	1925		TCGA-61-2012_exposure	Not Reported	c12297fa-146b-579e-b1c6-6b6a1a248e3c	released	TCGA-61-2012_diagnosis	29830	not reported	0	932	c2f4be9a-f3ef-5c78-b92f-88a7763041f2	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-61-2012_treatment	TCGA-61-2012_treatment_1	released	da579c57-8052-52c0-90de-1bb0c90d7898	yes	Radiation Therapy, NOS	released	a2b69fd4-35c9-5e20-8091-caea60422f12	yes	Pharmaceutical Therapy, NOS	1c841b7f-f124-4882-b91d-f26e041ad944
8eb0f5ac-1196-4cc5-b25b-f9e76301772e.htseq.counts.gz	65eb41ea-b829-49d4-8c68-5db21c758755	TCGA-24-1847-01A-01R-1566-13	TCGA-24-1847-01A-01R	TCGA-24-1847-01A-01-TS1	TCGA-24-1847-01A-01-BS1	TCGA-24-1847-01A-01		TCGA-24-1847-01A	TCGA-24-1847	21966708-4e66-4211-add0-f1515b09e362	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.0		20d96d45-40d3-44ad-a9e8-fdc7e545ed5d	1.8	83354694-078e-411e-89d2-029649708528			0.15	22	released	66749a52-3b1a-43bb-98b2-ab99e76789d0	RNA	R	0.15	UV Spec	released	False	85a36ad5-734f-43c6-9e55-9e34b851593b	01	0.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	TOP	feb1ba92-5e6b-473e-a1e3-b8660512a989	released	0.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	BOTTOM	801bcc7d-3382-42fa-aff1-076ebcc5bdf4	released	released	108.0						f1989bf4-c884-430d-a075-679f7b4a4b07	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-1847_demographic	45	-16529		7dff2c76-7f44-5910-806b-2355bc702bbf	not reported	female	white	released	Alive	1964		TCGA-24-1847_exposure	Not Reported	4fe078cd-5e95-5084-b35a-8e56efe30c7c	released	TCGA-24-1847_diagnosis	16529	not reported	0	343	3384bda3-487e-5148-92d7-620f7ed61f10	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-24-1847_treatment_1	TCGA-24-1847_treatment	released	cf2fc135-2747-5c5e-a7fd-4ad6181bfb0b	yes	Pharmaceutical Therapy, NOS	released	bdef78fe-9ed5-575c-9c8f-1337cd8ecdd5	no	Radiation Therapy, NOS	65eb41ea-b829-49d4-8c68-5db21c758755
64430665-49d5-49d4-9ef8-7559cbfcabf8.htseq.counts.gz	8d0f8abc-c04b-4962-b2f9-1c40d1c4c713	TCGA-61-2111-01A-01R-1568-13	TCGA-61-2111-01A-01R	TCGA-61-2111-01A-01-BS1	TCGA-61-2111-01A-01-TS1	TCGA-61-2111-01A-01		TCGA-61-2111-01A	TCGA-61-2111	91a17d40-c8cb-4cce-b306-966382a8fe4a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.4	False	1.5		351930bc-ac4d-468e-9fe2-ba6f16c01444	1.8	25c0888a-25b9-4cc0-a02f-6d363a341e8f			0.15	22	released	62bb5571-e230-42a3-9cf3-c3e0f12f43bd	RNA	R	0.15	UV Spec	released	False	0a53f31e-370e-4c6c-897b-406a5b7ed3ce	01			10.0		0.0	5.0	85.0	80.0	BOTTOM	1dbf80e0-c681-41e6-a309-a61787c3ffa2	released			14.0		3.0	3.0	80.0	75.0	TOP	f5cf5d70-ae84-4039-a9b7-bc4af6d21516	released	released	129.0						b469134f-2528-456e-bf69-c5b5a9268145	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-61-2111_demographic	61	-22517		207b7d58-3bbf-5097-98dd-b566c44fa826	not hispanic or latino	female	white	released	Alive	1937		TCGA-61-2111_exposure	Not Reported	8d5e32d6-0f70-51d4-ac5d-cc838904a191	released	TCGA-61-2111_diagnosis	22517	not reported	0	3825	cfac89b4-e306-5fa3-8441-559631390575	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-61-2111_treatment_1	TCGA-61-2111_treatment	released	757ca363-6397-5f48-aab5-c59fadd01c14	yes	Pharmaceutical Therapy, NOS	released	dffd8615-b8f5-5ae6-a72a-d6641b0a4c28	no	Radiation Therapy, NOS	8d0f8abc-c04b-4962-b2f9-1c40d1c4c713
5d0bb715-68ef-4688-9d58-0f18478e6a5c.htseq.counts.gz	6ca72b27-692e-44da-a045-e9d47319f46d	TCGA-20-0987-01A-02R-1564-13	TCGA-20-0987-01A-02R	TCGA-20-0987-01A-02-BS2	TCGA-20-0987-01A-01-BS1	TCGA-20-0987-01A-02		TCGA-20-0987-01A	TCGA-20-0987	34f285ab-6c31-4865-a0a7-a57af3567df0	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.5		EB7C0C99-8A43-4023-B165-4EFFC1FC5800	1.8	40dafb8b-7311-4ee3-b5bc-9c9c7ffb8cce			0.15	22	released	5735d18e-a5c0-472a-95e2-f17564dd7b1d	RNA	R	0.15	UV Spec	released	False	3782947c-38f2-4aa5-ab58-35ef29d7dedf	02			20.0		15.0	0.0	65.0	90.0	BOTTOM	580a22f9-d1d6-4638-bde8-e2ca93062bf1	released			2.0		18.0	2.0	78.0	80.0	TOP	5bd6ee19-dc60-48ab-bdb1-b28ed0c70f4c	released	released	113.0						27a6b2d1-ad0f-4193-b54c-646560930289	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-20-0987_demographic	61	-22287	701	320febbb-04db-59be-aced-d111a47c27ba	not hispanic or latino	female	white	released	Dead	1943	2005	TCGA-20-0987_exposure	Not Reported	61b5ac7c-4d36-5484-b9c9-e5278f67b706	released	TCGA-20-0987_diagnosis	22287	not reported	0		d704293e-b3ad-5c64-946f-4bacf3517263	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-20-0987_treatment	TCGA-20-0987_treatment_1	released	2bfaa920-0463-5a3d-aab2-bb32658cfbd7	no	Radiation Therapy, NOS	released	7ba7fd1a-b3ca-57fb-87cd-5c2dd11e3e2d	yes	Pharmaceutical Therapy, NOS	6ca72b27-692e-44da-a045-e9d47319f46d
b4760c72-6405-4b0c-b13b-dbef127b7ffb.htseq.counts.gz	1560ba5a-c252-43aa-a5e3-cac2764469cc	TCGA-09-2056-01B-01R-1568-13	TCGA-09-2056-01B-01R	TCGA-09-2056-01B-01-TS1	TCGA-09-2056-01B-01-BS1	TCGA-09-2056-01B-01		TCGA-09-2056-01B	TCGA-09-2056	ea6405c4-0fe4-4f37-bef2-275072f91e39	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.6		67bdb457-cfb8-4052-bd33-bff86c736910	1.8	67670628-ad07-41ef-8977-890080616900	3	20	0.15	22	released	923154b3-a270-44f5-a101-833e19fb1c21	RNA	R	0.15	UV Spec	released	False	f578774b-fe46-4d47-a3bd-31faadb0b9e6	01	0	0	0	0	0	20	80	80	TOP	c06a79f0-b3e3-4099-b892-3ac829ebb42d	released	0	0	0	0	0	20	80	80	BOTTOM	209a5c45-ac0b-4411-9cb1-7ec50c5f37ff	released	released	153						c6045243-4072-4342-8fb1-f2bbea55fe7b	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-09-2056_demographic	62	-22864		639a1216-bb98-5a39-8290-2bc82db55e29	hispanic or latino	female	white	released	Alive	1946		TCGA-09-2056_exposure	Not Reported	9cdf85ae-1322-54f1-8e37-3ddabf716f4d	released	TCGA-09-2056_diagnosis	22864	not reported	0	379	70e65ccc-6f17-52fe-a1e7-1f828967cdaf	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-09-2056_treatment	TCGA-09-2056_treatment_1	released	58e398e1-041f-5ea9-b2bc-71395883c72d	no	Radiation Therapy, NOS	released	8b9ba11a-e76c-57c6-9e44-ea2eef5b8873	yes	Pharmaceutical Therapy, NOS	1560ba5a-c252-43aa-a5e3-cac2764469cc
41c1021b-1086-470b-9907-afe11444ed3f.htseq.counts.gz	d952565a-b10c-460e-ae19-099da5f3ce0c	TCGA-24-1546-01A-01R-1566-13	TCGA-24-1546-01A-01R	TCGA-24-1546-01A-01-TS1	TCGA-24-1546-01A-01-BS1	TCGA-24-1546-01A-01		TCGA-24-1546-01A	TCGA-24-1546	9e7d3dea-5d81-4f10-819c-1c2a68ddd150	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	1.5		d6eec9a6-7bfd-40e2-891e-0a3cd7759ace	1.8	9984be2d-c37f-44cd-9eb8-61b65efcf8cb			0.15	22	released	0ac93c62-85b5-47b5-b41f-34aa170aa730	RNA	R	0.15	UV Spec	released	False	f2e4232e-fb30-4e33-8512-d5dc0ba89646	01			0.0		0.0	40.0	60.0	70.0	TOP	fce4f2d8-a91c-4dd0-a99a-b75361492286	released			0.0		0.0	40.0	60.0	70.0	BOTTOM	5c73ae2f-2e1b-4666-a9cb-c02eddcd874d	released	released	121.0						db9720f0-d7ef-469c-ae11-e8f17488126b	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-1546_demographic	46	-17130	1955	8bff82fb-9ffa-5794-8922-4b2771f31589	not reported	female	white	released	Dead	1951	2002	TCGA-24-1546_exposure	Not Reported	0f415104-491c-5bda-a5aa-4ded7bdc6cb1	released	TCGA-24-1546_diagnosis	17130	not reported	0	1955	4ec47e19-8ac8-5799-995f-ed82d4ebef47	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1997	TCGA-24-1546_treatment	TCGA-24-1546_treatment_1	released	287d5b25-e1ee-5e5b-a4a2-d403b4e54836	not reported	Radiation Therapy, NOS	released	2631b34d-33a7-5fd3-8fdf-323c11ddf540	yes	Pharmaceutical Therapy, NOS	d952565a-b10c-460e-ae19-099da5f3ce0c
01770ca7-0c13-4078-b956-a35dc68fbe28.htseq.counts.gz	fc5e0141-13d5-4e22-8d0e-06807da55fb5	TCGA-30-1891-01A-01R-1568-13	TCGA-30-1891-01A-01R	TCGA-30-1891-01A-01-TS1	TCGA-30-1891-01A-01-BS1	TCGA-30-1891-01A-01		TCGA-30-1891-01A	TCGA-30-1891	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.2		F2E0C289-3ED3-4876-8BFA-A447AB1DBB2B	1.8	690d1437-2a05-4263-8fa7-8f4481893b83			0.15	22	released	a085780c-f121-43c3-814e-6a07d178232d	RNA	R	0.15	UV Spec	released	False	bc4548ab-c38f-4398-bb8f-958cbfdb0724	01			10.0		0.0	20.0	70.0	80.0	TOP	621013a7-cdb9-4be7-aae2-fe8291645d1c	released			15.0		0.0	20.0	65.0	80.0	BOTTOM	038ab98b-6a36-43b4-b37b-11775670647a	released	released	122.0						8e66ac32-4df0-45b2-915e-37eacd1040a2	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-30-1891_demographic	61	-22344	914	1270303a-3e2c-5099-b188-7454f3ec9414	not hispanic or latino	female	white	released	Dead	1943	2006	TCGA-30-1891_exposure	Not Reported	e088b6b0-8034-560b-a0d6-423c532191dc	released	TCGA-30-1891_diagnosis	22344	not reported	0	914	dcbdfdd3-dfe8-51f7-969c-02ea3474bc0a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-30-1891_treatment_1	TCGA-30-1891_treatment	released	95afd62c-0de4-5c1c-a240-a3285be9c625	yes	Pharmaceutical Therapy, NOS	released	b51582d6-b9b9-50c0-af2a-db58b79a9638	no	Radiation Therapy, NOS	fc5e0141-13d5-4e22-8d0e-06807da55fb5
a085cea5-b7ca-449c-b218-07c7715ca736.htseq.counts.gz	d1eb06e4-aea6-474f-9e01-52bb9fe7ff27	TCGA-09-1662-01A-01R-1566-13	TCGA-09-1662-01A-01R	TCGA-09-1662-01A-01-BS1	TCGA-09-1662-01A-01-TS1	TCGA-09-1662-01A-01		TCGA-09-1662-01A	TCGA-09-1662	867f9563-16c9-45a8-b519-6df61ba1b6b7	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.5		8e2676a4-2ac3-42af-be7d-cf74b6d82f2f	1.8	759060d9-af2e-4098-b4ee-7aa2214acba8			0.16	22	released	8b90471f-de03-46c1-a5e2-09ac18de7193	RNA	R	0.16	UV Spec	released	False	47364d4b-dbed-4978-a38b-a1b6671d6935	01			3.0		10.0	0.0	87.0	95.0	BOTTOM	47ad6cd0-c2f1-4aae-aa2a-ff9dae3583db	released			5.0		8.0	0.0	87.0	85.0	TOP	991a3778-5f86-4d75-93d3-93b24310153c	released	released	127.0						510f8684-3686-4192-b2a3-dd2499365f78	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-09-1662_demographic	58	-21246	2717	b1157df0-4b67-57c6-a41d-2425cbc0a707	not hispanic or latino	female	white	released	Dead	1943	2008	TCGA-09-1662_exposure	Not Reported	56dbe702-1653-55fc-9bca-2b2ad5d36a61	released	TCGA-09-1662_diagnosis	21246	not reported	0		5b81cf5b-651e-5c5e-a09f-53be4eca5931	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-09-1662_treatment	TCGA-09-1662_treatment_1	released	081f9cc1-d2cf-528e-8029-566cc8be67e1	no	Radiation Therapy, NOS	released	b00f0d40-ded0-5264-99ee-8778389f14d6	yes	Pharmaceutical Therapy, NOS	d1eb06e4-aea6-474f-9e01-52bb9fe7ff27
1db081ff-e475-412c-9f55-fc5face40558.htseq.counts.gz	4cdb5722-3759-4337-9f8c-f0ad35542157	TCGA-31-1951-01A-01R-1568-13	TCGA-31-1951-01A-01R	TCGA-31-1951-01A-01-BS1	TCGA-31-1951-01A-01-TS1	TCGA-31-1951-01A-01		TCGA-31-1951-01A	TCGA-31-1951	b0839f46-8c82-4619-be3d-c857a1759463	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	0.7		b10efe75-1420-47d2-9c5b-202b09099357	1.8	197ea6b5-5716-4e5c-9c7f-92ed4521682a	3.4	20	0.17	22	released	14b537f4-0115-4e25-9da5-6bc2f9184ce7	RNA	R	0.17	UV Spec	released	False	9fe09e22-da6f-44d1-9a4f-4ad31b42d13c	01			2		0	18	90	90	BOTTOM	e4569bfa-757f-4f1e-85a2-8b17bfad7876	released			1		0	19	80	95	TOP	5fe1fa05-31a4-478f-9008-bdb07e1b677f	released	released	120						cc6a73f6-9dee-4eeb-85c3-c81f02d1adef	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-31-1951_demographic	58	-21352		1f9b5de4-e9f0-5e4d-8959-ccfe046d49a5	not hispanic or latino	female	white	released	Alive	1949		TCGA-31-1951_exposure	Not Reported	47185f16-293d-58dc-add1-c4cae3035926	released	TCGA-31-1951_diagnosis	21352	not reported	0	684	201d89c4-e6e6-5f26-9ffc-249c94991d25	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-31-1951_treatment_1	TCGA-31-1951_treatment	released	3aa0ff80-4ddb-5327-9c8c-5c28865bcfac	yes	Pharmaceutical Therapy, NOS	released	26eb5580-5888-5b83-8256-0e83babb4ed7	no	Radiation Therapy, NOS	4cdb5722-3759-4337-9f8c-f0ad35542157
7024891a-6a74-45d1-813d-7199707c45c5.htseq.counts.gz	5844b51c-a8d9-4d2e-9b95-74d71e089291	TCGA-24-1427-01A-01R-1565-13	TCGA-24-1427-01A-01R	TCGA-24-1427-01A-01-TS1	TCGA-24-1427-01A-01-BS1	TCGA-24-1427-01A-01		TCGA-24-1427-01A	TCGA-24-1427	02d9aa2e-b16a-48ea-a420-5daed9fd51a6	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.7		af63c4e2-2f77-4311-bfe2-ee45cfd200bb	1.8	5a505632-422c-4083-b867-82a7a503b314			0.16	22	released	0ba6bb69-9144-46fe-8da3-6a2ba8f00200	RNA	R	0.16	UV Spec	released	False	f0b9796a-f82e-4d83-97c3-22968950d0b5	01			1.0		0.0	20.0	79.0	80.0	TOP	b23b731e-4150-4c0c-b015-e6bbe8933b0b	released			1.0		0.0	10.0	89.0	90.0	BOTTOM	03d4bcec-43c8-4b9e-a91f-0aae325fc711	released	released	155.0						93827307-1efa-43b5-aea5-380c6ce5feed	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-24-1427_demographic	58	-21423		ec306cf2-62ba-5e6a-b350-fab228fd3b76	not reported	female	not reported	released	Alive	1950		TCGA-24-1427_exposure	Not Reported	7744d13b-9617-51b7-bb92-23681a7132d4	released	TCGA-24-1427_diagnosis	21423	not reported	0	147	6adf251d-ef48-5413-8547-40f40921f744	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1427_treatment	TCGA-24-1427_treatment_1	released	61d7052b-b5bb-5959-991d-9fab45e4ff79	no	Radiation Therapy, NOS	released	35452b02-1918-5e8f-98af-25d53f8c5366	yes	Pharmaceutical Therapy, NOS	5844b51c-a8d9-4d2e-9b95-74d71e089291
d143ba0b-3878-428d-9432-2a179a9abf8c.htseq.counts.gz	2bb52f35-936f-4ade-a288-0c85101314b3	TCGA-20-1687-01A-01R-1566-13	TCGA-20-1687-01A-01R	TCGA-20-1687-01A-01-TS1	TCGA-20-1687-01A-01-BS1	TCGA-20-1687-01A-01		TCGA-20-1687-01A	TCGA-20-1687	9bf16a89-2fc7-4c08-93bc-3105eec5c3cc	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.8		e966d90f-0e5f-42e6-b487-1f10fbef204f	1.8	ad7529aa-47f7-4207-b0a9-8684ff1e6e80			0.17	22	released	d8414027-a74e-4679-91fb-4d713842264c	RNA	R	0.17	UV Spec	released	False	45746f80-6ac4-454f-a751-8bda6df6f046	01			0.0		0.0	35.0	65.0	85.0	TOP	5f56bb43-6913-4695-a791-568daa718090	released			0.0		0.0	15.0	85.0	90.0	BOTTOM	1dd87cf9-da7f-4f8c-a47b-ae0a1905c2e1	released	released	110.0						bcd16bf3-0877-4e4b-b70b-7d6a497af7ac	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-20-1687_demographic	46	-16961		c5058873-7e86-55ab-83ec-68f37f816ab9	not hispanic or latino	female	white	released	Alive	1962		TCGA-20-1687_exposure	Not Reported	8b6855f9-9319-57fb-9d93-d857d9a94fc1	released	TCGA-20-1687_diagnosis	16961	not reported	0	81	9729bb87-a1cc-5e8d-9e77-b68ef5b45a33	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-20-1687_treatment	TCGA-20-1687_treatment_1	released	d9afbb9d-5ca7-5a29-80ac-efbbff19f83b	no	Radiation Therapy, NOS	released	7c536fbc-2cac-5c4b-99d5-98223327da01	yes	Pharmaceutical Therapy, NOS	2bb52f35-936f-4ade-a288-0c85101314b3
f10f8b8e-c6e7-46e1-a97d-08f90c76b539.htseq.counts.gz	972bc42b-75ee-4707-8b48-f37d10c5043c	TCGA-13-1483-01A-01R-1565-13	TCGA-13-1483-01A-01R	TCGA-13-1483-01A-01-TS1	TCGA-13-1483-01A-01-BS1	TCGA-13-1483-01A-01		TCGA-13-1483-01A	TCGA-13-1483	611600a6-43ec-4029-9682-cd6d6a3312ec	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.4	False	1.8		c5f81fb7-5cdc-4c0a-8d5a-74e93a11b7db	1.8	1120f746-aeb6-457a-946e-46ed665a9211			0.15	22	released	02aa300d-75e3-4c82-b780-4c636e177757	RNA	R	0.15	UV Spec	released	False	e157ea22-ddef-4d00-81f9-9774ea04c2a4	01	40.0	10.0	10.0	50.0	0.0	40.0	50.0	70.0	TOP	da3bd09a-1930-49c2-a2c0-592f45fa3859	released	40.0	10.0	5.0	50.0	0.0	45.0	50.0	75.0	BOTTOM	ddf45f15-dac1-461f-8937-3ac159a33d50	released	released	118.0						ee7d5c16-fb34-4500-87f4-c920f797d9f5	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1483_demographic	61	-22342	895	1b6e413d-3075-5578-96e1-c7441bed86cd	not hispanic or latino	female	white	released	Dead	1939	2002	TCGA-13-1483_exposure	Not Reported	82786649-99d9-5b2b-ac2c-f52ef3c2984d	released	TCGA-13-1483_diagnosis	22342	not reported	0	895	7c0462b7-dd23-5dc0-855f-2377dab52877	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-13-1483_treatment	TCGA-13-1483_treatment_1	released	d1b07c9f-3521-5664-b0e8-f9a4cb10a15f	no	Radiation Therapy, NOS	released	e827b861-5b10-5aa6-aac5-8fb4f32950fe	yes	Pharmaceutical Therapy, NOS	972bc42b-75ee-4707-8b48-f37d10c5043c
c9e12ef8-5bf6-496d-8c8a-e0596c2f1d7c.htseq.counts.gz	43a5f50f-5e71-4e6f-b0b6-9a20b754ecb5	TCGA-29-1705-01A-01R-1567-13	TCGA-29-1705-01A-01R	TCGA-29-1705-01A-01-TS1	TCGA-29-1705-01A-01-BS1	TCGA-29-1705-01A-01		TCGA-29-1705-01A	TCGA-29-1705	f9c835db-2ab6-4bf5-826f-48723493c0ec	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.8		e7a899e9-2c61-4bda-874c-0f1b456e5dfc	1.8	d1603029-2b45-4c5c-b313-8846d0ebdbdb			0.15	22	released	6f80f52b-cd1b-4998-8872-8231f968813f	RNA	R	0.15	UV Spec	released	False	29080803-f621-4ddd-98e3-539042ec7b1c	01			2.0		0.0	0.0	98.0	85.0	TOP	b4cec7c6-267d-4b63-bb60-1e9b618ea03e	released			15.0		0.0	0.0	85.0	80.0	BOTTOM	febc5de5-d46e-4d34-a597-501782af363a	released	released	97.0						fd3e7ba8-21a5-438b-82ee-482ed6905310	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-29-1705_demographic	47	-17530	555	3d81138a-577c-5983-a1ce-b5d08a9a5faa	not reported	female	white	released	Dead	1958	2006	TCGA-29-1705_exposure	Not Reported	3e9341aa-6e61-513d-9856-9cb2257de028	released	TCGA-29-1705_diagnosis	17530	not reported	0	555	cdcf923e-15c6-5ee7-9cac-bda5bcaad9b7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-29-1705_treatment	TCGA-29-1705_treatment_1	released	41aa04ab-c1bc-57e4-99c3-5de2f16cf42a	no	Radiation Therapy, NOS	released	8ced112e-a2c7-50f0-af55-aeb917751ad1	yes	Pharmaceutical Therapy, NOS	43a5f50f-5e71-4e6f-b0b6-9a20b754ecb5
2ad2adf3-212d-42e5-87df-a4025e900584.htseq.counts.gz	ed125963-e1e8-4ce4-b73d-1e49a3a2c9fa	TCGA-24-2024-01A-02R-1568-13	TCGA-24-2024-01A-02R	TCGA-24-2024-01A-02-BS2	TCGA-24-2024-01A-01-BS1	TCGA-24-2024-01A-02		TCGA-24-2024-01A	TCGA-24-2024	0a48873a-092a-4b25-822b-b0b3c18c08a8	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1	False	1.1		4189cfa0-00c3-42fb-91b9-d2f4b4887061	1.8	bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	3.2	20	0.16	22	released	cd096a1b-cd16-4536-a498-0b946ebc7c5a	RNA	R	0.16	UV Spec	released	False	5fef661c-4dc0-4f82-8a73-48ab58399977	02	0	0	0	0	0	5	95	80	BOTTOM	bb2cc430-c917-437d-b85e-f8fb69028121	released	0	0	0	0	0	5	95	80	TOP	0467ab38-1f2d-4fbb-a6c4-0e38d2e0de33	released	released	150						a3f8dcad-c42a-4070-80c4-782627bbaca2	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-2024_demographic	72	-26476	1769	7d734828-adb9-5d7e-966d-8e0043300194	not reported	female	black or african american	released	Dead	1922	1998	TCGA-24-2024_exposure	Not Reported	0e20bc82-7865-5e12-b4c6-7dd726514a2a	released	TCGA-24-2024_diagnosis	26476	not reported	0	1769	f6efd774-9d62-56da-95f2-00366dfc8c27	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1994	TCGA-24-2024_treatment_1	TCGA-24-2024_treatment	released	ebab23d0-25ab-51dc-b2ed-b39cb7b260b9	yes	Pharmaceutical Therapy, NOS	released	823f6596-b65d-5519-86f6-a5c4e5181b3b	no	Radiation Therapy, NOS	ed125963-e1e8-4ce4-b73d-1e49a3a2c9fa
9d904376-a13a-4827-a3f5-3772f579e5dd.htseq.counts.gz	75551f95-070b-4a63-b45e-f906f612b8fb	TCGA-24-1843-01A-01R-1567-13	TCGA-24-1843-01A-01R	TCGA-24-1843-01A-01-TS1	TCGA-24-1843-01A-01-BS1	TCGA-24-1843-01A-01		TCGA-24-1843-01A	TCGA-24-1843	9ec86cbd-8c74-4697-90da-529ab91ab835	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.4		d2625c77-0f03-42ea-b5ea-df45769f0fbb	1.8	c50cf5af-3375-4748-9894-1f9521f746da			0.14	22	released	a93a8a89-cb0e-4b29-9ee4-263c79bd82bc	RNA	R	0.14	UV Spec	released	False	d7087367-20fa-4b50-b1c3-65a703834738	01	0.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	572a0abb-4f27-4520-982f-ef4fa9183652	released	0.0	0.0	0.0	0.0	0.0	20.0	80.0	80.0	BOTTOM	67b22c44-f74a-4da1-b048-b733fa840f44	released	released	100.0						737481f9-845a-4c7a-b12f-881d9da3998a	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-1843_demographic	66	-24469		63120061-1f2d-5054-ae2e-359fc077acae	not reported	female	white	released	Alive	1943		TCGA-24-1843_exposure	Not Reported	bd8ee4e1-b757-521d-a5cb-7e990c0404d1	released	TCGA-24-1843_diagnosis	24469	not reported	0	106	59f8614c-8ad2-570a-9e9e-134adc1741a0	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-24-1843_treatment	TCGA-24-1843_treatment_1	released	25d0621f-3c4b-56a8-92c5-7b9192816479	no	Radiation Therapy, NOS	released	74fa4874-6b83-5b27-86a2-769ea7d49d14	yes	Pharmaceutical Therapy, NOS	75551f95-070b-4a63-b45e-f906f612b8fb
1fbaa35c-4ff8-49e4-8aed-4a20b408f840.htseq.counts.gz	b57b0e7e-36bc-4aa3-9ddb-356adf541747	TCGA-61-2008-02A-01R-1568-13	TCGA-61-2008-02A-01R	TCGA-61-2008-02A-01-BS1	TCGA-61-2008-02A-01-TS1	TCGA-61-2008-02A-01		TCGA-61-2008-02A	TCGA-61-2008	3ac45a71-c463-4f0f-b030-58c475a34418	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.5	False	2.0		614D7B6A-B3B4-4F1B-9762-0749D559247F	1.8	b90a4b33-cb6f-4c75-bc26-ff316ea81cce			0.15	22	released	1f57d960-8019-4aa5-a498-11c034287817	RNA	R	0.15	UV Spec	released	False	0b8474a8-cd56-48ab-b369-cc576237de66	01			10.0		0.0	5.0	75.0	85.0	BOTTOM	80e74f58-026f-4665-bbe4-95b89bc2f6c7	released			5.0		0.0	5.0	80.0	85.0	TOP	f04bb94a-6caf-4ba5-a918-08db1b26b964	released	released	106.0						9983a90e-9f72-4fe0-9d3b-62d25d3356ee	Recurrent Tumor	02	0.3	released	Not Reported	released	TCGA-61-2008_demographic	40	-14791		32601890-a62f-5eac-821d-10d86af7637f	not hispanic or latino	female	asian	released	Alive	1967		TCGA-61-2008_exposure	Not Reported	18c2dbfc-00ed-54a7-8607-a39c4b69bc3e	released	TCGA-61-2008_diagnosis	14791	not reported	0	932	4233e6db-8d18-5461-b504-3aa62d11e73f	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-61-2008_treatment	TCGA-61-2008_treatment_1	released	8e378e12-53e5-58b2-b236-5632aa905b06	no	Radiation Therapy, NOS	released	7391ef61-cc98-5a52-889b-cb6f107d19a1	yes	Pharmaceutical Therapy, NOS	b57b0e7e-36bc-4aa3-9ddb-356adf541747
9f223240-1020-4450-a6ec-a6168a9211e5.htseq.counts.gz	8fb9e8df-469b-4340-8cfe-81715cabc493	TCGA-23-1122-01A-01R-1565-13	TCGA-23-1122-01A-01R	TCGA-23-1122-01A-01-TS1	TCGA-23-1122-01A-01-BS1	TCGA-23-1122-01A-01		TCGA-23-1122-01A	TCGA-23-1122	d2c0d320-d1c5-4eed-af4f-15540e60db0b	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.1		9507d553-b1c7-4b71-90c1-064fd8ef15ba	1.8	54b75801-ad36-49a1-b0c2-edc0053b897e			0.17	22	released	f346d7b7-c225-4b49-a7d0-5ebf1d8eb4fe	RNA	R	0.17	UV Spec	released	False	f355ea3d-0f49-45bc-b6fe-b1577194ca52	01			1.0		0.0			90.0	TOP	3856005c-5450-450c-944e-a104156e84ec	released			1.0		0.0			80.0	BOTTOM	e47c346e-2941-41b9-910b-713b18c0113d	released	released	132.0						ff14c071-ccce-4d44-8d0b-c4cbdfb59c8c	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-23-1122_demographic	53	-19537	1189	35fba336-e795-5600-a892-a3899a3d9fe3	not reported	female	white	released	Dead	1945	2001	TCGA-23-1122_exposure	Not Reported	8556d095-09eb-5e30-b9ca-a221adaa26c7	released	TCGA-23-1122_diagnosis	19537	not reported	0		0bf0b7d6-59fd-5d2e-b753-857c4b618889	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-23-1122_treatment_1	TCGA-23-1122_treatment	released	c21bf9b1-fefa-525f-88c2-d2779bf1e064	yes	Pharmaceutical Therapy, NOS	released	9d7b0051-95b8-5e5f-850a-505f56d62842	yes	Radiation Therapy, NOS	8fb9e8df-469b-4340-8cfe-81715cabc493
211b9b7e-5a5b-4da7-b75c-4a0a738cdaed.htseq.counts.gz	964aae89-2112-4793-bc60-b31dc21ab70d	TCGA-13-0886-01A-01R-1569-13	TCGA-13-0886-01A-01R	TCGA-13-0886-01A-01-BS1	TCGA-13-0886-01A-01-TS1	TCGA-13-0886-01A-01		TCGA-13-0886-01A	TCGA-13-0886	91de8a74-a1e6-46b6-a06e-70aedf2c3eaf	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		2FB5824C-F30B-4E0B-B787-CBF93A6A48AE	1.8	eac4bb8e-83fe-4fdf-822d-8fb126b1da1e			0.14	22	released	782116c6-8d36-4e87-b5b4-dc592e987556	RNA	R	0.14	UV Spec	released	False	fd62e4e7-4c9b-485c-8de9-0b2e200471a7	01			2.0		30.0	0.0	68.0	70.0	BOTTOM	d21154a8-2994-4f78-b12c-bd53414d2570	released			5.0		30.0	0.0	65.0	70.0	TOP	87d770e2-fb08-4fbe-8091-53a12ef5413a	released	released	70.0						91054520-9955-4d9b-bb06-e0bdd253c687	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-13-0886_demographic	67	-24724		144fbbef-2227-5cdd-8e21-22114001fe47	not hispanic or latino	female	white	released	Alive	1935		TCGA-13-0886_exposure	Not Reported	2570eb00-47ec-54a3-8e01-f6cfd9c3a895	released	TCGA-13-0886_diagnosis	24724	not reported	0	4665	e3734193-eac9-5df2-9f6d-dfa735dee27b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-13-0886_treatment	TCGA-13-0886_treatment_1	released	0692cbb4-fb9a-5464-9bb4-3ca610e4a304	no	Radiation Therapy, NOS	released	538a298e-d057-55a5-b806-65eae0d766db	yes	Pharmaceutical Therapy, NOS	964aae89-2112-4793-bc60-b31dc21ab70d
d0e4aa5d-e918-4156-99ba-14b14a2a9975.htseq.counts.gz	2d721dd7-07cc-4b25-ba34-7a4ec0968f16	TCGA-24-1464-01A-01R-1566-13	TCGA-24-1464-01A-01R	TCGA-24-1464-01A-01-BS1	TCGA-24-1464-01A-01-TS1	TCGA-24-1464-01A-01		TCGA-24-1464-01A	TCGA-24-1464	4160e048-f0b0-40f5-805b-e277a5893a3b	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.5		242047B0-E0E3-4BA3-A0DF-95887392602E	1.8	6eb0fbff-f1b8-4544-91e2-cd593b631ead			0.15	22	released	c864f99c-3a2d-43d4-95c5-be700101c6eb	RNA	R	0.15	UV Spec	released	False	40cd8a8c-85c6-48f1-9916-e8a7459f0ea0	01			1.0		0.0	19.0	80.0	80.0	BOTTOM	4629f765-e185-4cee-b30e-2024f6fad17d	released			1.0		0.0	9.0	90.0	90.0	TOP	33baf922-5467-4b79-8191-fbba9f70c972	released	released	130.0						cd43784d-8829-4cac-819f-d2960c5409cb	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-24-1464_demographic	70	-25874	379	12069954-6818-59be-9f0a-bea245e7b149	not reported	female	white	released	Dead	1928	1999	TCGA-24-1464_exposure	Not Reported	fb35ab81-ee9e-59be-ae26-85cebc3e5658	released	TCGA-24-1464_diagnosis	25874	not reported	0	379	3092467a-bee4-5eb1-bd74-5efa87d5836e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-24-1464_treatment_1	TCGA-24-1464_treatment	released	46421369-f983-5395-ab50-48852e7aa8c2	yes	Pharmaceutical Therapy, NOS	released	ab42f598-17c8-5847-ae16-a068190bd6f0	yes	Radiation Therapy, NOS	2d721dd7-07cc-4b25-ba34-7a4ec0968f16
995b85f1-d46f-4989-a4a0-2a73b5df69bf.htseq.counts.gz	ebffd3cf-6699-487a-a3cb-cd31221b2a5d	TCGA-13-0906-01A-01R-1564-13	TCGA-13-0906-01A-01R	TCGA-13-0906-01A-01-TS1	TCGA-13-0906-01A-01-BS1	TCGA-13-0906-01A-01		TCGA-13-0906-01A	TCGA-13-0906	e43d3769-e25f-4fb7-9080-ea26defaf094	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.1		D75790B2-C93F-4723-B691-84EE94656FF1	1.8	7fa0eba3-8a33-425d-a7fb-2fa169e5f8e6			0.15	22	released	762f9a80-23bd-454b-b066-938480be7a7e	RNA	R	0.15	UV Spec	released	False	908c128c-736e-43ac-b3b9-79b7d6e14632	01			20.0		30.0	0.0	50.0	70.0	TOP	7be7e649-9db2-4a60-b120-e912df932701	released			20.0		19.0	0.0	60.0	80.0	BOTTOM	e8aa0544-cc48-4941-9d7f-bbd41aafaa30	released	released	150.0						a0c48680-3caf-49bd-b495-c9fd3a9cbe76	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0906_demographic	50	-18383		2669e329-d864-59c4-b6a0-2629d82ac5ee	not hispanic or latino	female	white	released	Alive	1955		TCGA-13-0906_exposure	Not Reported	c134e16e-967a-5b14-8eee-81a0d6f00f99	released	TCGA-13-0906_diagnosis	18383	not reported	0	3619	74976cb2-5ac3-5764-a813-40be781e4353	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-13-0906_treatment	TCGA-13-0906_treatment_1	released	53bebc61-4550-5f45-bb1b-f109e2496117	no	Radiation Therapy, NOS	released	66a741bb-e244-5c37-ba84-42c7ef5c3262	yes	Pharmaceutical Therapy, NOS	ebffd3cf-6699-487a-a3cb-cd31221b2a5d
effcab37-0ee4-422d-9d51-5cdbb78d2db9.htseq.counts.gz	2443c89f-0c03-4194-9c2d-e98e79191ae0	TCGA-24-2254-01A-01R-1568-13	TCGA-24-2254-01A-01R	TCGA-24-2254-01A-01-TS1	TCGA-24-2254-01A-01-BS1	TCGA-24-2254-01A-01		TCGA-24-2254-01A	TCGA-24-2254	9af2248a-d86a-4277-93b4-8eba5a39bd3c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.0		3788629f-17da-4075-af61-cf124bdfb48e	1.8	e496319b-df71-44a0-bfa6-90f50ae54654			0.16	22	released	eaf3a99b-20ec-444c-8beb-53408023e340	RNA	R	0.16	UV Spec	released	False	3c0b4ee7-ae8a-4e2c-baf2-9c1142bfcd7e	01			0.0		0.0	10.0	90.0	90.0	TOP	de52a9bb-d52a-465e-860a-4fdfacb8f9e2	released			0.0		0.0	10.0	90.0	90.0	BOTTOM	8693850b-af0f-47b9-8113-44ab1cde89cb	released	released	150.0						c2699551-32d9-46ad-9c41-04730ef6a8a4	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-2254_demographic	66	-24407	1736	430d063a-f24e-5702-a4b9-2a5bef151ce1	not reported	female	white	released	Dead	1937	2007	TCGA-24-2254_exposure	Not Reported	cfe838d2-1295-567f-abcb-9a137bf760bc	released	TCGA-24-2254_diagnosis	24407	not reported	0	1736	a00f2045-a1f8-5198-8f98-26c7090ec6c5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-24-2254_treatment	TCGA-24-2254_treatment_1	released	4c61d397-260b-583f-bb65-98f9b8feb433	no	Radiation Therapy, NOS	released	780644c3-035c-587d-b49d-13806e4dd069	yes	Pharmaceutical Therapy, NOS	2443c89f-0c03-4194-9c2d-e98e79191ae0
5cf0bf40-6b9a-4bcb-a88f-7256a298c5ef.htseq.counts.gz	998315d3-a800-463d-a25f-23679485642c	TCGA-29-2414-01A-02R-1569-13	TCGA-29-2414-01A-02R	TCGA-29-2414-01A-01-BS1	TCGA-29-2414-01A-02-BS2	TCGA-29-2414-01A-02		TCGA-29-2414-01A	TCGA-29-2414	a2319490-b85d-4219-a1b0-fa1ec432d5c8	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.0		1A4882EA-818E-4A23-8584-2881D0DE8406	1.8	ecbadb01-01ec-4d9f-877c-75709d6f5914			0.14	22	released	9e975fa6-5e54-4b42-89c5-a0324e199fc2	RNA	R	0.14	UV Spec	released	False	0b069ab9-6c2d-48b7-9f49-b9e22019747b	02			5.0		35.0	0.0	60.0	76.0	TOP	c86cba2a-8d47-4657-84ad-1a66647440e9	released			6.0		45.0	0.0	49.0	70.0	BOTTOM	5006bae6-462f-4310-b8ab-8d7d8809cc0f	released	released	123.0						c8de9eaf-cda6-4680-a710-93fd9e9a8903	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-29-2414_demographic	75	-27417	2621	7b9aeb08-3b4c-5661-bec0-b3b74dc9ec8a	not reported	female	white	released	Dead	1923	2005	TCGA-29-2414_exposure	Not Reported	9ddfa6c8-882b-5014-b95c-e996183632d0	released	TCGA-29-2414_diagnosis	27417	not reported	0	2621	1911c0e4-d523-5681-9cc6-332707c4c25e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-29-2414_treatment	TCGA-29-2414_treatment_1	released	6a5666f9-cc38-5f1c-a8b6-ec1953ac9ff2	yes	Radiation Therapy, NOS	released	05378657-f28b-596e-9c75-e01314d078f2	yes	Pharmaceutical Therapy, NOS	998315d3-a800-463d-a25f-23679485642c
701b8c71-6c05-4e5b-ac10-396d245d62ea.htseq.counts.gz	8bc92137-5cc8-4b7e-9882-91300a662648	TCGA-13-1487-01A-01R-1565-13	TCGA-13-1487-01A-01R	TCGA-13-1487-01A-01-TS1	TCGA-13-1487-01A-01-BS1	TCGA-13-1487-01A-01		TCGA-13-1487-01A	TCGA-13-1487	c9e28934-8379-4511-817c-d787f2c4ca3a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.4		30C193A0-7AB5-445D-AD37-3661A89DC06A	1.8	55704c3f-7261-4ab1-bb1e-d8957bfd8952			0.14	22	released	8f62af2a-0578-421b-817e-b8c798da6070	RNA	R	0.14	UV Spec	released	False	613060cd-276d-46a0-91ad-45588e7b225a	01			5.0		0.0	15.0	80.0	90.0	TOP	b14479d4-1994-4b5b-9d2e-ef20b92f57a5	released			0.0		0.0	30.0	70.0	80.0	BOTTOM	a695ac28-7c81-420e-9940-f4cc99483200	released	released	124.0						bff12f06-dabc-4424-ac53-65ca01d0a406	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1487_demographic	74	-27176	681	d660ec1a-93b8-5ce7-9a60-49c9ec945ce8	not hispanic or latino	female	white	released	Dead	1928	2003	TCGA-13-1487_exposure	Not Reported	a77fb142-9a0f-5817-aa6d-24f62640e2cf	released	TCGA-13-1487_diagnosis	27176	not reported	0	681	f2bef3a1-e2c5-5c6f-8f16-e34d476c1a86	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-13-1487_treatment	TCGA-13-1487_treatment_1	released	f3bec8f1-1367-5073-a080-dae1f9d758dd	no	Radiation Therapy, NOS	released	7d0d3dad-334b-5e3a-b4b7-633bc769d8f3	yes	Pharmaceutical Therapy, NOS	8bc92137-5cc8-4b7e-9882-91300a662648
a26fe084-f208-423b-ab61-6d34598c9cad.htseq.counts.gz	d6123f3e-38e2-4da4-8739-883c46108eff	TCGA-24-2281-01A-01R-1568-13	TCGA-24-2281-01A-01R	TCGA-24-2281-01A-01-TS1	TCGA-24-2281-01A-01-BS1	TCGA-24-2281-01A-01		TCGA-24-2281-01A	TCGA-24-2281	59b3fbfe-0b7c-41e5-b756-ee7e23730df5	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.5		363dc00f-480d-4a3f-8950-80a6bc0b7dd8	1.8	44948279-405d-42f6-ad29-465150ee6d85			0.14	22	released	076ae210-4b7f-4137-b888-cc1f6df9f765	RNA	R	0.14	UV Spec	released	False	67c03d2b-64a0-4f5c-ae70-bc9b9703a46c	01			5.0		0.0	25.0	70.0	70.0	TOP	1f2b1446-69d7-4e61-a21b-4ddbd68a092f	released			5.0		0.0	35.0	60.0	70.0	BOTTOM	0d68fc45-8e3a-4161-b2e8-34dd9094b284	released	released	131.0						fcd83e7f-2210-465d-8362-3b5e2c368625	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-24-2281_demographic	68	-25019		31c47fb8-f9c9-5bd3-a2e0-1416b999df2b	not reported	female	white	released	Alive	1938		TCGA-24-2281_exposure	Not Reported	2376f600-f890-5dfe-8951-c29f22d4bb12	released	TCGA-24-2281_diagnosis	25019	not reported	0	1357	c9b6188c-636e-5f19-9261-7b9a70e42044	Stage IIA	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-24-2281_treatment_1	TCGA-24-2281_treatment	released	dd44a969-fbe8-529d-a65b-86c5a97249e8	yes	Pharmaceutical Therapy, NOS	released	7f1743f0-eb08-56bc-88cc-14c67bb223f5	no	Radiation Therapy, NOS	d6123f3e-38e2-4da4-8739-883c46108eff
e9841cd8-c4a9-49ac-9d53-6b808d82ca8a.htseq.counts.gz	85fbab0e-e8d3-4471-aa33-31d5833ec240	TCGA-24-1422-01A-01R-1565-13	TCGA-24-1422-01A-01R	TCGA-24-1422-01A-01-TS1	TCGA-24-1422-01A-01-BS1	TCGA-24-1422-01A-01		TCGA-24-1422-01A	TCGA-24-1422	05ba5839-e00a-4a9e-8ba3-ecb490781e62	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.8		8bcb6cf4-84ea-41a1-9113-061a7523c19f	1.8	99a9d9af-2e42-4a4f-8ad7-3f8b6e145a55			0.16	22	released	e3fc854b-65fe-4f54-9c56-f2c15db14d35	RNA	R	0.16	UV Spec	released	False	17e10f56-4afe-407b-8f40-688b03a6a458	01			10.0		40.0	0.0	50.0	90.0	TOP	aafeef2d-1616-480b-a3c6-4b9567c5e2ab	released			8.0		10.0	0.0	82.0	75.0	BOTTOM	53e4f6dd-f37e-4292-aac7-083bf40da8b5	released	released	106.0						b6568556-a2fb-4eec-a953-b8b81d2fd6dd	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1422_demographic	82	-30234	23	838591b6-cdae-547d-adfe-1dfcc60db703	not reported	female	black or african american	released	Dead	1926	2008	TCGA-24-1422_exposure	Not Reported	bbcc2b2e-8863-58be-a155-4bcc3a3479bf	released	TCGA-24-1422_diagnosis	30234	not reported	0	23	f2ffb8cb-705b-5752-84dd-53e3f9fab12b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1422_treatment	TCGA-24-1422_treatment_1	released	a9ea5705-2622-5dc2-b25c-5610263acf81	no	Radiation Therapy, NOS	released	d58a0a81-18d9-5f45-bbe2-8e55cff2c6a5	no	Pharmaceutical Therapy, NOS	85fbab0e-e8d3-4471-aa33-31d5833ec240
de855db4-12d8-47bc-855b-96f61d306541.htseq.counts.gz	28b17bd0-672a-4a73-a821-1b5ed7b79fcc	TCGA-30-1853-01A-02R-1567-13	TCGA-30-1853-01A-02R	TCGA-30-1853-01A-01-BS1	TCGA-30-1853-01A-02-BS2	TCGA-30-1853-01A-02		TCGA-30-1853-01A	TCGA-30-1853	5d603bba-62e6-48fb-b8fc-401109abcaee	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		ded9ba4c-8d3d-450b-a345-772a3e3ae288	1.8	fc32468d-de77-4e0e-b1a2-203ac119cb02			0.14	22	released	71f3c368-3988-480b-9b90-62232d5a49a8	RNA	R	0.14	UV Spec	released	False	a53e6cad-652e-4911-a849-69a0c88f193b	02			1.0		0.0	1.0	98.0	99.0	TOP	97d7d1f1-3b08-47ed-84d2-9c7439d1720c	released			1.0		0.0	1.0	98.0	99.0	BOTTOM	59402746-32fc-4ce7-ac6f-235da20da619	released	released	131.0						35817ec6-5c0c-44d7-b5a8-b6de3ab24fdd	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-30-1853_demographic	58	-21404	1103	9649f5ae-33a3-5b79-b29f-c90792bbbc57	not hispanic or latino	female	white	released	Dead	1942	2003	TCGA-30-1853_exposure	Not Reported	f0fdac4e-a099-546d-8444-e2214869a76c	released	TCGA-30-1853_diagnosis	21404	not reported	0	1103	0de0b75a-d428-5237-ac4d-c3078e11272d	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-30-1853_treatment	TCGA-30-1853_treatment_1	released	92fcd1cb-811d-50be-9e36-8cfd9f8c6788	no	Radiation Therapy, NOS	released	35624fe3-16df-5fcd-bbb9-1649c782ba14	yes	Pharmaceutical Therapy, NOS	28b17bd0-672a-4a73-a821-1b5ed7b79fcc
678a3fad-2c4a-450f-ae1e-8258fc8a618a.htseq.counts.gz	5d4f90e8-24df-4db3-a3b7-1c4972d36459	TCGA-25-1627-01A-01R-1566-13	TCGA-25-1627-01A-01R	TCGA-25-1627-01A-01-TS1	TCGA-25-1627-01A-01-BS1	TCGA-25-1627-01A-01		TCGA-25-1627-01A	TCGA-25-1627	cbe3309e-9b7b-4f62-87b5-0f5ed4218ada	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		FB36B0F9-6519-4CF5-9A74-F7015FD405FF	1.8	0fc68715-c7fc-4481-a5bf-68a281f5ec64			0.15	22	released	6f75c8a2-1356-4980-9344-1a6a03f3aacd	RNA	R	0.15	UV Spec	released	False	183422c9-24c3-46a8-a8d0-d93c86b042b9	01			2.0		0.0	8.0	90.0	95.0	TOP	7d635326-16a2-4ed8-a60f-297b62e42fc0	released			0.0		0.0	10.0	90.0	95.0	BOTTOM	42532801-bad3-4503-8e89-c92084458b14	released	released	128.0						c405e873-8ef5-43f6-8065-830fdb99825d	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-25-1627_demographic	73	-26784	394	f17d6310-6505-5f0f-a62b-1a1f807f9e50	not hispanic or latino	female	white	released	Dead	1930	2004	TCGA-25-1627_exposure	Not Reported	38235f2e-f005-56e8-8583-e22be02a1bf6	released	TCGA-25-1627_diagnosis	26784	not reported	0	11	b0bdaa93-0778-58a1-a5ab-dd9f0efa3171	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-25-1627_treatment_1	TCGA-25-1627_treatment	released	e14cd4a2-a463-5e87-9616-d9b91c41b007	yes	Pharmaceutical Therapy, NOS	released	7f8fd9a1-9d68-5d75-850b-b199877c0d1d	no	Radiation Therapy, NOS	5d4f90e8-24df-4db3-a3b7-1c4972d36459
24a15ca8-0811-4131-baa1-94f904973ecd.htseq.counts.gz	995f39e1-207a-4ae2-b044-27a708c61a2f	TCGA-25-1635-01A-01R-1566-13	TCGA-25-1635-01A-01R	TCGA-25-1635-01A-01-BS1	TCGA-25-1635-01A-01-TS1	TCGA-25-1635-01A-01		TCGA-25-1635-01A	TCGA-25-1635	bc2591b0-65d7-48c3-a5cc-783f67b65869	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.7		28168C52-FD75-4B43-918B-C48CC8DA9C66	1.8	877d96a2-6e5c-472c-b190-59fcfd1febb4			0.15	22	released	9494afb0-d523-4e93-a25a-89ddf27bdd86	RNA	R	0.15	UV Spec	released	False	4b3bff31-a3a0-49f1-998b-7f40829a3ecd	01			5.0		0.0	15.0	80.0	85.0	BOTTOM	bf595f95-9e5f-4b08-8d7e-0b7b08a7c6ee	released			5.0		0.0	15.0	80.0	85.0	TOP	e3fb13c5-3313-4116-9aff-2dd97b81cace	released	released	128.0						8eab6a91-e73b-4555-9915-8ac4b91d9de3	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-25-1635_demographic	71	-26200	1583	79dac28f-6891-5ca1-9a1b-b6b946171961	not hispanic or latino	female	white	released	Dead	1931	2006	TCGA-25-1635_exposure	Not Reported	f08969fe-44c3-54e8-9b5d-ce234754e1fd	released	TCGA-25-1635_diagnosis	26200	not reported	0	1558	1b49c382-da56-568d-823a-34afc1fd6a96	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-25-1635_treatment_1	TCGA-25-1635_treatment	released	f530f9b6-1048-5f63-af78-726a2e0006cc	yes	Pharmaceutical Therapy, NOS	released	73649ab7-ae3a-5923-8c7b-d9afbaf187f4	no	Radiation Therapy, NOS	995f39e1-207a-4ae2-b044-27a708c61a2f
660a745a-f0a2-4439-b3f3-51a60132b97d.htseq.counts.gz	9550d42d-da72-4868-af21-092068d6fc6d	TCGA-24-2297-01A-01R-1568-13	TCGA-24-2297-01A-01R	TCGA-24-2297-01A-01-BS1	TCGA-24-2297-01A-01-TS1	TCGA-24-2297-01A-01		TCGA-24-2297-01A	TCGA-24-2297	2ab32e11-80d6-4ed0-a42e-da612219bbdd	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		12b02227-4050-4d02-bdb8-939d348a4c19	1.8	2b0089bc-b493-4179-bf5c-e58550e1ee5b			0.14	22	released	b9711060-225c-415f-a377-c8c7addfde3f	RNA	R	0.14	UV Spec	released	False	f5bd762b-8f57-46a8-81b4-445cc667c6a8	01			10.0		30.0	0.0	60.0	81.0	BOTTOM	7addcb34-e944-4d8d-84e7-03fb2c107745	released			2.0		8.0	0.0	90.0	97.0	TOP	ef97e135-54be-4846-9f87-c9fe3ab2ddf4	released	released	101.0						e1855137-b479-4d9c-b729-ff84263abd89	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-2297_demographic	56	-20487	1699	5e77a0b3-6cd4-5602-bdb2-874b275291f9	not reported	female	white	released	Dead	1937	1997	TCGA-24-2297_exposure	Not Reported	342787b3-9179-5570-95d0-afb338ca2644	released	TCGA-24-2297_diagnosis	20487	not reported	0	1699	036f498f-caec-57c3-8ca1-8d83d027149d	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1993	TCGA-24-2297_treatment	TCGA-24-2297_treatment_1	released	dc3124f9-3068-5934-890b-d005d0885181	no	Radiation Therapy, NOS	released	a008ddf4-31ec-5965-a54e-18ee11e543a5	yes	Pharmaceutical Therapy, NOS	9550d42d-da72-4868-af21-092068d6fc6d
75fdcd7e-f701-4c93-b3cc-22ff09b770ad.htseq.counts.gz	63b9e55c-6ece-4c96-b22e-8f439197b1be	TCGA-04-1356-01A-01R-1569-13	TCGA-04-1356-01A-01R	TCGA-04-1356-01A-01-BS1	TCGA-04-1356-01A-01-TS1	TCGA-04-1356-01A-01		TCGA-04-1356-01A	TCGA-04-1356	8652ddee-98f4-4584-b450-e6f2f5c9d7ec	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		7D26B212-1DE7-43CC-A0DC-A9071C3A534F	1.8	dc4a5c2f-8b96-4d3b-9553-a02510ba445f			0.16	22	released	5d507d61-03b8-4c36-9c8e-63cd99b8d77d	RNA	R	0.16	UV Spec	released	False	0584b714-53fa-41ac-a17a-6cefc7443ccc	01			5.0		0.0	10.0	85.0	95.0	BOTTOM	5269e379-7422-4dfd-87fe-65f585209d21	released			10.0		0.0	5.0	85.0	99.0	TOP	1874f2aa-ad0f-47e3-8e23-367b0d246260	released	released	114.0						3d1f80f8-1033-48d9-9b97-36f025486b0a	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-04-1356_demographic	62	-22855	1499	6f4e3146-4cfe-55b8-8427-ff6397b2269e	hispanic or latino	female	white	released	Dead	1942	2008	TCGA-04-1356_exposure	Not Reported	9834c924-f3c2-59f7-a562-fa189c92125b	released	TCGA-04-1356_diagnosis	22855	not reported	0		9c12fc68-20a6-5db7-aa57-9cc51005f642	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-04-1356_treatment_1	TCGA-04-1356_treatment	released	2af9677f-01fc-578b-9378-518f25104c45	yes	Pharmaceutical Therapy, NOS	released	dee40d08-8480-526a-a9d8-342a0fd44479	no	Radiation Therapy, NOS	63b9e55c-6ece-4c96-b22e-8f439197b1be
ab8603dd-2f94-4c83-9927-455958be0007.htseq.counts.gz	b7c1da28-59e1-4867-b5af-93ad1f8f72a0	TCGA-13-0891-01A-01R-1564-13	TCGA-13-0891-01A-01R	TCGA-13-0891-01A-01-BS1	TCGA-13-0891-01A-01-TS1	TCGA-13-0891-01A-01		TCGA-13-0891-01A	TCGA-13-0891	0740321b-f8a5-4e1d-b390-ca6187598fac	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.4		7DF79B3C-8CD7-446D-A13A-BBB69DFE2394	1.8	c6666bbe-77cd-497e-88b4-ff73dcf6f399			0.15	22	released	424dcc28-060f-4188-a8e9-767da176de06	RNA	R	0.15	UV Spec	released	False	3219705f-bdc7-4ddb-a83c-21c4411ca20b	01			1.0		5.0	0.0	94.0	95.0	BOTTOM	8d1ded3e-bb87-402e-8103-f421b6ee27dd	released			1.0		10.0	0.0	89.0	90.0	TOP	720d6bab-786c-4ec2-a692-c70414ced567	released	released	86.0						6ff303cc-7d1d-41e5-a839-9f163ba04989	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0891_demographic	73	-26886	3128	2fbefc9e-1e10-5799-9005-b6fe7e10fd13	not hispanic or latino	female	white	released	Dead	1930		TCGA-13-0891_exposure	Not Reported	93ad84a9-4ce2-5924-8a83-920c60d0e83a	released	TCGA-13-0891_diagnosis	26886	not reported	0	2099	3d1dbced-2a51-54ba-b21b-6492adf26960	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-13-0891_treatment_1	TCGA-13-0891_treatment	released	d23956c7-6439-52d7-af0a-d43364d3594f	yes	Pharmaceutical Therapy, NOS	released	ba25d659-2194-544e-8781-bbbc25a11f2a	no	Radiation Therapy, NOS	b7c1da28-59e1-4867-b5af-93ad1f8f72a0
1d6a0834-0561-4d45-813d-1ea499b613c0.htseq.counts.gz	39aa4fef-1f7e-4855-87a3-c000f744d45c	TCGA-25-2409-01A-01R-1569-13	TCGA-25-2409-01A-01R	TCGA-25-2409-01A-01-BS1	TCGA-25-2409-01A-01-TS1	TCGA-25-2409-01A-01		TCGA-25-2409-01A	TCGA-25-2409	dce71741-ccbe-40b7-a0b8-2048d07187a4	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.5	False	1.5		89A631C6-5000-4A96-B752-879EAA7231CB	1.8	4e5f3a15-68fd-4be0-b368-e0bd04eaf872			0.14	22	released	0415d430-4e99-4adf-9ff6-a78068af1cc2	RNA	R	0.14	UV Spec	released	False	d1feca38-9d25-457f-bcdf-497eb7c4b4d5	01			1.0		1.0	4.0	94.0	95.0	BOTTOM	91c79a10-fdff-4095-929c-b1b1e1c3b9a0	released			1.0		1.0	4.0	94.0	95.0	TOP	a28f0475-589d-4831-9186-6b955153f5bb	released	released	159.0						3d0f2483-ae45-4b2f-bba3-76a0eaecff4f	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-25-2409_demographic	71	-26267	821	5897f462-2f0f-5340-b4d1-bff091eb649b	not hispanic or latino	female	white	released	Dead	1934	2007	TCGA-25-2409_exposure	Not Reported	c953c546-0d79-5f83-aace-a4e927efe6bf	released	TCGA-25-2409_diagnosis	26267	not reported	0	821	c8d48465-069c-5154-9bae-9ce289ab10d4	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-25-2409_treatment_1	TCGA-25-2409_treatment	released	21ff28fd-052a-5de9-b03d-5af335d58ff1	yes	Pharmaceutical Therapy, NOS	released	45822b90-dc03-52ff-8615-95d34501c53e	no	Radiation Therapy, NOS	39aa4fef-1f7e-4855-87a3-c000f744d45c
16e1bba3-6db0-429c-bfc8-82f27c8a3252.htseq.counts.gz	2fcc3c22-92d9-4844-aa02-d50d8f273b1e	TCGA-61-2008-01A-02R-1568-13	TCGA-61-2008-01A-02R	TCGA-61-2008-01A-02-BS2	TCGA-61-2008-01A-01-BS1	TCGA-61-2008-01A-02		TCGA-61-2008-01A	TCGA-61-2008	3ac45a71-c463-4f0f-b030-58c475a34418	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.2		25448427-9a2c-4c36-bc9d-40a82d6e3710	1.8	10271f7f-cce6-44fd-8754-7a4beabfb394			0.14	22	released	3fe43ef1-3e89-4df8-a7fa-7ad5a2904d7c	RNA	R	0.14	UV Spec	released	False	0cdd3869-bac6-4abf-9c15-81569b985211	02			1.0		0.0	30.0	69.0	70.0	BOTTOM	3e834d4a-0868-4f2e-bf72-03aa2c766449	released			1.0		1.0	29.0	69.0	70.0	TOP	ebbf8459-bf7b-4836-a990-3b6d50fae361	released	released	146.0						69d76e7a-e0cb-4a8d-b6cd-67d8702d2af9	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-2008_demographic	40	-14791		32601890-a62f-5eac-821d-10d86af7637f	not hispanic or latino	female	asian	released	Alive	1967		TCGA-61-2008_exposure	Not Reported	18c2dbfc-00ed-54a7-8607-a39c4b69bc3e	released	TCGA-61-2008_diagnosis	14791	not reported	0	932	4233e6db-8d18-5461-b504-3aa62d11e73f	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-61-2008_treatment	TCGA-61-2008_treatment_1	released	8e378e12-53e5-58b2-b236-5632aa905b06	no	Radiation Therapy, NOS	released	7391ef61-cc98-5a52-889b-cb6f107d19a1	yes	Pharmaceutical Therapy, NOS	2fcc3c22-92d9-4844-aa02-d50d8f273b1e
1902f5f0-8474-4f4c-a17b-f813fe02ca58.htseq.counts.gz	6726428c-c4ac-4228-8a46-83a4aafc0685	TCGA-59-2348-01A-01R-1569-13	TCGA-59-2348-01A-01R	TCGA-59-2348-01A-01-BS1	TCGA-59-2348-01A-01-TS1	TCGA-59-2348-01A-01		TCGA-59-2348-01A	TCGA-59-2348	20cf00ea-d7da-42bb-bce7-f005f0b952eb	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	2.0		ffb300e9-cb06-4162-a751-f079fec57153	1.8	7162d809-ff1a-4346-bb00-c8086386ec46			0.14	22	released	796fbc4f-6c96-499b-a55c-879fc1be514a	RNA	R	0.14	UV Spec	released	False	9da4bbad-1b7e-4a86-9ba8-f7e9599f1d59	01			5.0		0.0	10.0	85.0	90.0	BOTTOM	2dd39e8f-db2f-4d2c-9799-c289a6d6d505	released			5.0		0.0	10.0	85.0	90.0	TOP	3d166d77-0129-481e-b769-22faa586c38e	released	released	143.0						cbdafa49-7dd7-4a42-b0a5-891aad11a802	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-59-2348_demographic	59			6a7ef2cd-8b8c-57fc-af3d-74c34a357885	not hispanic or latino	female	white	released	Alive	1935		TCGA-59-2348_exposure	Not Reported	98e021f3-1c89-5a14-bbb9-e9df13c305fd	released	TCGA-59-2348_diagnosis		not reported	0	5481	7fbc9ad4-d3ae-5f9c-bb13-bdfa201dec51	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1994	TCGA-59-2348_treatment_1	TCGA-59-2348_treatment	released	f7e811d7-ab8b-5cd8-9c51-f6da7abe0dbe	not reported	Pharmaceutical Therapy, NOS	released	87a7a46d-b73f-5b7b-a184-4bac979edb5f	not reported	Radiation Therapy, NOS	6726428c-c4ac-4228-8a46-83a4aafc0685
f27920c4-1504-45ef-8933-65f42ec9ab98.htseq.counts.gz	37947dd8-72b2-493a-bc4b-d45699c04389	TCGA-09-1673-01A-01R-1566-13	TCGA-09-1673-01A-01R	TCGA-09-1673-01A-01-BS1	TCGA-09-1673-01A-01-TS1	TCGA-09-1673-01A-01		TCGA-09-1673-01A	TCGA-09-1673	4e6f88de-7624-4719-8234-4c9e5b2e2988	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	3.0		d4f7aa96-11e8-4d66-a1be-595ec22de450	1.8	37037dcf-fa69-4cd3-b83d-e474d69059b4			0.14	22	released	f637e3b8-a9f9-4e9a-9acd-5eb71a8b719f	RNA	R	0.14	UV Spec	released	False	eb47601f-b4bb-4712-8c15-d97c55cca2cd	01			8.0		0.0	5.0	87.0	99.0	BOTTOM	6984ccd0-0e27-4549-98fe-c8b864b7c087	released			10.0		0.0	5.0	85.0	99.0	TOP	6c3902a7-444c-4d7d-97c2-4d1dd7c9e19c	released	released	97.0						95522925-79b0-4ce7-8323-dce56cbf15cd	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-09-1673_demographic	50	-18599		52ee8dcb-6b70-54da-9a9b-846e68a0b566	not hispanic or latino	female	white	released	Alive	1958		TCGA-09-1673_exposure	Not Reported	97abcf42-3e7c-5826-abd7-b5c56dd790da	released	TCGA-09-1673_diagnosis	18599	not reported	0	92	18cf8d27-34a1-592b-b795-f9dd1ad5ee52	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-09-1673_treatment_1	TCGA-09-1673_treatment	released	b922a952-7a31-55d2-a4f2-63ff444026f8	yes	Pharmaceutical Therapy, NOS	released	8a696dc3-800d-55d6-ad6e-a0a36d15bc7c	no	Radiation Therapy, NOS	37947dd8-72b2-493a-bc4b-d45699c04389
fedd52be-18a8-423f-ba8a-4f9416f11ff5.htseq.counts.gz	cd32019f-e6e5-4cf9-a4b4-d38dfdfc0f0a	TCGA-24-1418-01A-01R-1565-13	TCGA-24-1418-01A-01R	TCGA-24-1418-01A-01-BS1	TCGA-24-1418-01A-01-TS1	TCGA-24-1418-01A-01		TCGA-24-1418-01A	TCGA-24-1418	195ecf43-06bd-4ffe-8d8b-a766f3f7179b	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.2		14fdb291-ba79-4852-9242-02dc191ca8c5	1.8	4e701e9f-9127-4d61-8a72-7e440b969fbe			0.15	22	released	41bd0036-fc58-433d-b081-90eae4e6f0c3	RNA	R	0.15	UV Spec	released	False	f685a0da-d011-4e2d-b40b-7aaabf4185fd	01			5.0		10.0	0.0	85.0	70.0	BOTTOM	8c2fa6a6-86f7-486b-8dda-3c8c0bab4811	released			5.0		20.0	0.0	75.0	70.0	TOP	384345b7-9a47-4c10-ab17-31a6f1e9a544	released	released	135.0						b40f7345-8f0c-4db7-90ba-424ae5ee22ed	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-1418_demographic	68	-24842		f7482f5e-2a1e-5563-bd07-0041884d5457	not reported	female	white	released	Alive	1940		TCGA-24-1418_exposure	Not Reported	c32f845a-0d2f-581c-8178-a22c88c384ae	released	TCGA-24-1418_diagnosis	24842	not reported	0	243	624e0ef7-bfb4-547e-83f8-3468edfbae97	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1418_treatment_1	TCGA-24-1418_treatment	released	09786e27-6ae5-56c6-bbc9-e16a5bd47d27	yes	Pharmaceutical Therapy, NOS	released	726efb55-eb75-5dfe-a418-915bce72ca08	no	Radiation Therapy, NOS	cd32019f-e6e5-4cf9-a4b4-d38dfdfc0f0a
9c330249-5ea7-4795-98c1-9c8f2cea6ac3.htseq.counts.gz	e9ff3df6-7c3a-4da8-b65d-cb432d7ef680	TCGA-24-0970-01B-01R-1565-13	TCGA-24-0970-01B-01R	TCGA-24-0970-01B-01-TS1	TCGA-24-0970-01B-01-BS1	TCGA-24-0970-01B-01		TCGA-24-0970-01B	TCGA-24-0970	95e58015-a7c0-4bdc-bf64-7617d24d0784	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	2.0		50AB91D8-AEC6-46B6-95C1-8F008EE0ED8F	1.8	b8ca62bf-dd6f-4984-b2c5-4d077d46d783			0.16	22	released	6ec2e7c7-59af-4082-9575-2c1ac9799015	RNA	R	0.16	UV Spec	released	False	4a48e55d-fe8f-4222-b5d4-4b39d56f8a64	01			5.0		0.0	0.0		95.0	TOP	97d1c7d0-939c-4b4d-900a-32bde4406a8b	released			5.0		0.0	0.0		95.0	BOTTOM	afff57a2-9f27-479f-bf64-47390dc616d9	released	released	115.0						c352a6f8-dee5-473c-a1a4-d85250ac8ddf	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-24-0970_demographic	63	-23276	354	9338f958-a412-5c8f-8b5e-944eec93124c	not reported	female	white	released	Dead	1942	2005	TCGA-24-0970_exposure	Not Reported	291120ac-e797-564e-8f8b-45b60395efbf	released	TCGA-24-0970_diagnosis	23276	not reported	0	354	7d9442c7-a63d-5d58-9578-78601010e061	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-24-0970_treatment	TCGA-24-0970_treatment_1	released	338e74f4-bc2c-58ab-aad9-ba361960dc59	no	Radiation Therapy, NOS	released	3eae73dc-b63e-5f75-8430-206b73139354	yes	Pharmaceutical Therapy, NOS	e9ff3df6-7c3a-4da8-b65d-cb432d7ef680
38721491-84e5-4eee-92d4-fa8f8cf463f1.htseq.counts.gz	89dc013b-099f-4167-88bf-a2a4d97236fd	TCGA-09-2048-01A-01R-1568-13	TCGA-09-2048-01A-01R	TCGA-09-2048-01A-01-BS1	TCGA-09-2048-01A-01-TS1	TCGA-09-2048-01A-01		TCGA-09-2048-01A	TCGA-09-2048	184aac07-44c1-47f1-8adf-50acbcc1762c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.0		0755D708-ADF5-4219-ABC6-BCD9C2BCA089	1.8	d3220bce-1bf3-47c4-951f-937dac7581be			0.14	22	released	ca81d5aa-4ae6-4f25-b706-a8661466e6b3	RNA	R	0.14	UV Spec	released	False	b89981ed-9095-42bd-8262-a5f7f9c7871e	01			1.0		0.0	5.0	94.0	95.0	BOTTOM	185260f3-68dc-4e18-993c-7ac8bab6fe3c	released			5.0		0.0	5.0	90.0	95.0	TOP	a6b08202-bed9-476e-8919-8a4300021f11	released	released	111.0						fe693f25-efb5-46d5-8bab-de5b87eef1ad	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-09-2048_demographic	63	-23043	138	43dd4513-5e1d-57ed-8b5a-5bf9175bb209	not hispanic or latino	female	white	released	Dead	1936	1999	TCGA-09-2048_exposure	Not Reported	5f92e6b4-a572-54f0-a1df-bcd3de90ed75	released	TCGA-09-2048_diagnosis	23043	not reported	0		e84e8a2c-231c-56f6-97e2-983b9bb2e049	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-09-2048_treatment_1	TCGA-09-2048_treatment	released	48ad431e-f196-56e4-aa23-f8a6567d3f98	yes	Pharmaceutical Therapy, NOS	released	6742f88d-c93f-565f-8b51-0f565f6845e8	no	Radiation Therapy, NOS	89dc013b-099f-4167-88bf-a2a4d97236fd
68975d5d-407b-4ceb-96d3-8e2a37ca3c1e.htseq.counts.gz	946d33d9-8cb0-4d7e-9fd3-0a8648518e37	TCGA-24-1845-01A-01R-1567-13	TCGA-24-1845-01A-01R	TCGA-24-1845-01A-01-BS1	TCGA-24-1845-01A-01-TS1	TCGA-24-1845-01A-01		TCGA-24-1845-01A	TCGA-24-1845	a782352e-c4bb-4c3e-ba82-456a47c3689a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.8		1fda446a-e0d2-422a-a023-57ec5bfae62b	1.8	78b612c0-5323-46e9-962e-497ad3c877c1			0.14	22	released	48420409-efd3-4fec-91c2-8d8bdfa202a3	RNA	R	0.14	UV Spec	released	False	bc78f3b6-2463-4321-a9d0-c69493af2814	01	0.0	0.0	10.0	10.0	0.0	0.0	90.0	90.0	BOTTOM	fbc4f1c3-ac59-4dab-b77f-61da0511bcad	released	0.0	0.0	0.0	0.0	0.0	5.0	95.0	95.0	TOP	c7917780-aa0a-4784-8a61-222bb9edf646	released	released	136.0						c6987abb-e8cb-4701-bee2-416627c1f970	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1845_demographic	42	-15599		4992063f-c38e-540f-852c-da0c5b9e027b	not reported	female	white	released	Alive	1967		TCGA-24-1845_exposure	Not Reported	c8ff9270-2ab7-5998-8768-70627c680393	released	TCGA-24-1845_diagnosis	15599	not reported	0	116	77f2d86e-3e74-5e0b-a3b4-dc55a7d1702e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-24-1845_treatment	TCGA-24-1845_treatment_1	released	7d9db0d7-056f-553a-9d8a-fbfb7f7b2e67	no	Radiation Therapy, NOS	released	74d50d30-0591-503d-a7fd-14f17b8544a2	yes	Pharmaceutical Therapy, NOS	946d33d9-8cb0-4d7e-9fd3-0a8648518e37
45b64a61-30d8-4ecc-909a-803be9c3ff2f.htseq.counts.gz	7a38fc20-11bf-4347-bc2f-bf597957d6e0	TCGA-23-1119-01A-02R-1565-13	TCGA-23-1119-01A-02R	TCGA-23-1119-01A-02-BS2	TCGA-23-1119-01A-01-BS1	TCGA-23-1119-01A-02		TCGA-23-1119-01A	TCGA-23-1119	2dfd8a0e-e642-49b3-abd7-f0334927eebb	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	0.8		86389912-6945-49e6-9255-e7a41fde197a	1.8	a0e6000c-2e04-4e12-bce6-ef9c29f04252			0.16	22	released	6b1add57-a096-4048-bc25-b052a67b992d	RNA	R	0.16	UV Spec	released	False	028b5d24-f4fe-4674-9d70-b97f2b01c9b7	02			1.0		0.0	0.0	0.0	95.0	BOTTOM	22ec8a4f-c913-4531-a71a-c6daaa6ad4f2	released			1.0		0.0	0.0	0.0	90.0	TOP	69056588-dd6a-4365-9780-e3344697ae99	released	released	161.0						072ba366-b5ad-46bd-ad87-e85057ca6bf7	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-23-1119_demographic	64	-23686		f3da4ea8-cbc9-5519-9037-d701e149a8f6	not hispanic or latino	female	white	released	Alive	1933		TCGA-23-1119_exposure	Not Reported	27739612-c539-5c16-af98-30d9a0a1cd32	released	TCGA-23-1119_diagnosis	23686	not reported	0	3953	cfa1e23f-420a-51df-9119-d916745ddbb1	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1997	TCGA-23-1119_treatment	TCGA-23-1119_treatment_1	released	f6fee3e9-e14b-5301-96fe-88ab01895f94	no	Radiation Therapy, NOS	released	53d6def8-ba8f-5feb-899f-715100c88dd9	yes	Pharmaceutical Therapy, NOS	7a38fc20-11bf-4347-bc2f-bf597957d6e0
45c99019-ad30-473d-af3b-2fa0ccb819b9.htseq.counts.gz	e054a3b7-04e9-473e-a1d8-1c8358aade6b	TCGA-36-1570-01A-01R-1566-13	TCGA-36-1570-01A-01R	TCGA-36-1570-01A-01-TS1	TCGA-36-1570-01A-01-BS1	TCGA-36-1570-01A-01		TCGA-36-1570-01A	TCGA-36-1570	0f530b3e-5b6d-4892-9ebd-9138d76fdca7	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.3		f83833f4-a820-4fb9-a040-c238084976c3	1.8	cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7			0.14	22	released	daa42c88-29bd-4bc7-834d-816c26578e3d	RNA	R	0.14	UV Spec	released	False	ddb0dcde-e2e5-48bf-8f62-7655376de451	01			1.0		0.0	5.0	94.0	95.0	TOP	6fa53e8d-c4e9-4a35-8000-7c1706f46eb6	released			1.0		0.0	5.0	94.0	95.0	BOTTOM	b44d5ee7-7e05-4e8c-b2f3-03761aa43052	released	released	104.0						22b7e0e2-334c-419c-a243-358ba22e479a	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-36-1570_demographic	49	-17956		8bf011e8-2516-55b4-b40b-332a899f5710	not reported	female	white	released	Alive	1958		TCGA-36-1570_exposure	Not Reported	ffd31bdc-f119-5b30-a33f-75c193af34c4	released	TCGA-36-1570_diagnosis	17956	not reported	0	655	2a9bd40c-59be-5757-894c-c0b7f1100b5f	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-36-1570_treatment	TCGA-36-1570_treatment_1	released	4cdec97d-42bf-5508-a2e3-f9c2755ab3ed	no	Radiation Therapy, NOS	released	e4642003-a794-5ab6-9450-0f4e7a405cd1	yes	Pharmaceutical Therapy, NOS	e054a3b7-04e9-473e-a1d8-1c8358aade6b
7394d96b-2719-4eb4-b776-439171584f2a.htseq.counts.gz	d7b702c1-de1f-4341-9329-7931e1384da8	TCGA-24-0966-01A-01R-1564-13	TCGA-24-0966-01A-01R	TCGA-24-0966-01A-01-TS1	TCGA-24-0966-01A-01-BS1	TCGA-24-0966-01A-01		TCGA-24-0966-01A	TCGA-24-0966	fef1696c-a8f4-4db6-8615-e486522baaaa	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.3		99D5CA9E-3E3F-4037-96B9-9D4A34C614B3	1.8	63a8de0c-927c-4faf-a596-841871ceb8f9			0.13	22	released	4c16f7f3-2328-4bf9-bc25-1cb1bb2033af	RNA	R	0.13	UV Spec	released	False	e293c072-11cc-448d-bde3-01b629ef3fc0	01			0.0		0.0	5.0	95.0	98.0	TOP	c31b0a81-6484-4f31-a765-008b25eb5f1e	released			0.0		0.0	10.0	90.0	95.0	BOTTOM	a6800fb7-6124-452d-84d7-29222262792c	released	released	132.0						67c7b4cb-5fe3-49cf-9aa3-df23717553bb	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-24-0966_demographic	78	-28529		385531c7-4f02-5ce6-97f6-56ec690678d5	not hispanic or latino	female	black or african american	released	Alive	1930		TCGA-24-0966_exposure	Not Reported	6890ce1e-8c0c-5ea2-9384-45fcaa82cb1e	released	TCGA-24-0966_diagnosis	28529	not reported	0	232	6068ff26-e91d-597d-ae69-4436a0c104bb	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-0966_treatment	TCGA-24-0966_treatment_1	released	ce67b43c-ed64-51ef-999f-c4ee5733ecb5	no	Radiation Therapy, NOS	released	4e05b9d9-8ae2-50c4-8be1-976b9d3320e3	yes	Pharmaceutical Therapy, NOS	d7b702c1-de1f-4341-9329-7931e1384da8
654acb8d-c1bb-42b1-91af-4f0b37abf02c.htseq.counts.gz	6c9ecca1-a836-4d3c-9229-6baf15817289	TCGA-57-1994-01A-01R-1568-13	TCGA-57-1994-01A-01R	TCGA-57-1994-01A-01-TS1	TCGA-57-1994-01A-01-BS1	TCGA-57-1994-01A-01		TCGA-57-1994-01A	TCGA-57-1994	602e2934-223a-44db-8c33-06eb05d72f94	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	0.5		54c3dd01-b473-424f-987a-c5d6e972e9bb	1.8	2cf309ea-0c2e-4f28-a94b-342dc9a1aae8			0.15	22	released	f7ff5f3c-05f5-447e-aa4c-f493ebf817ac	RNA	R	0.15	UV Spec	released	False	7838fa3d-cd82-47fd-ba3f-01dc86625e23	01			10.0		0.0	10.0	80.0	90.0	TOP	739ef125-4790-490d-bf6b-7e7fbe966335	released	1.0		5.0		0.0	5.0	90.0	95.0	BOTTOM	1c54ff54-4fce-4f01-b009-5c75dbbf525e	released	released	96.0						a2667408-6465-4258-9e68-f88ec3cd7b7d	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-57-1994_demographic	63	-23062		bd5457d3-56e5-5b22-9a6c-7e0490fffb31	not reported	female	white	released	Alive	1941		TCGA-57-1994_exposure	Not Reported	74feb4b4-35aa-55e5-bbbb-e1c165065bba	released	TCGA-57-1994_diagnosis	23062	not reported	0	761	f930091a-6f43-5cce-960e-931dad13eb66		C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-57-1994_treatment_1	TCGA-57-1994_treatment	released	6fc5b85b-6a81-51ae-a9b4-f9734ce725c6	no	Pharmaceutical Therapy, NOS	released	11b280e8-d263-5ead-afac-b43658b894c3	no	Radiation Therapy, NOS	6c9ecca1-a836-4d3c-9229-6baf15817289
9bca614a-922a-4bef-8a96-c2b71dcaf17f.htseq.counts.gz	3405c4ca-2a4d-46df-87ce-bc23a0c79d64	TCGA-09-1667-01C-01R-1566-13	TCGA-09-1667-01C-01R	TCGA-09-1667-01C-01-TS1	TCGA-09-1667-01C-01-BS1	TCGA-09-1667-01C-01		TCGA-09-1667-01C	TCGA-09-1667	32d4d200-1fdf-44ed-b81f-1954a9c93926	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.0		0f3fbc34-6dce-467f-a837-442815ebc159	1.8	9b7a1eb0-014f-4cd6-bde8-fd96131fac3e			0.16	22	released	bbf6b49c-d014-42ab-8bab-b8e8725e7107	RNA	R	0.16	UV Spec	released	False	ad4d286b-f0e0-475d-af62-263c9eefbcd1	01			5.0		5.0	7.0	83.0	90.0	TOP	0a437844-e107-4238-9bf7-3200ff7da548	released			3.0		0.0	7.0	90.0	90.0	BOTTOM	162cb788-9ff3-4ebb-a5e3-8e476026a4db	released	released	106.0						111f607f-5b87-4595-9aa7-df9381717bee	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-09-1667_demographic	61	-22306		74bea85c-1cac-5272-9bd3-f20fe9ca3b0d	not hispanic or latino	female	white	released	Alive	1943		TCGA-09-1667_exposure	Not Reported	921d5cd3-9c33-5b6a-8cde-75bb5d780b39	released	TCGA-09-1667_diagnosis	22306	not reported	0	1882	a6b591a1-0fe2-54bb-b79b-392e1358cdb7	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-09-1667_treatment	TCGA-09-1667_treatment_1	released	dd668383-cf24-5d47-9ef7-1cc2f70f508a	yes	Radiation Therapy, NOS	released	879836f9-0ed7-546e-9e6c-9d49581d8457	yes	Pharmaceutical Therapy, NOS	3405c4ca-2a4d-46df-87ce-bc23a0c79d64
b322d383-64cb-4033-9b44-872ad37acc4a.htseq.counts.gz	e134072f-d381-4be0-9456-6aa576e669a3	TCGA-20-1683-01A-01R-1566-13	TCGA-20-1683-01A-01R	TCGA-20-1683-01A-01-BS1	TCGA-20-1683-01A-01-TS1	TCGA-20-1683-01A-01		TCGA-20-1683-01A	TCGA-20-1683	ac2e88ff-8b1e-4691-9a96-5a581f98d827	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.0		5a83e4b3-8be2-4628-bd4b-93d040b43856	1.8	e78c6cd7-67f2-4ac8-9dd9-c46392459835			0.14	22	released	5b59e1f7-acce-434a-8772-b3c96c2f2111	RNA	R	0.14	UV Spec	released	False	2f8d71a3-4ea8-4dcb-ae77-76ecd12a0f3d	01	2.0		5.0		0.0	30.0	65.0	95.0	BOTTOM	4fa77b3e-e254-44a5-8dbe-ac9089746160	released	3.0		3.0		0.0	20.0	72.0	90.0	TOP	d6e3a27b-344e-4566-ad53-33189f1cbe02	released	released	104.0						a0300830-9dd9-46bc-94c0-23b2e8703e25	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-20-1683_demographic	65	-24006		7ca939fc-90ab-59cf-bf58-f423d134465e	not hispanic or latino	female	white	released	Alive	1942		TCGA-20-1683_exposure	Not Reported	4af87322-3221-53ff-9ef3-8323165da992	released	TCGA-20-1683_diagnosis	24006	not reported	0	772	b3cd76a3-af1c-573b-b5fc-42c3ee779e66	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-20-1683_treatment_1	TCGA-20-1683_treatment	released	89644d84-f416-5fbb-90ea-f105b7483a61	yes	Pharmaceutical Therapy, NOS	released	c145f10f-6028-5b8b-9b46-43b0d9d01105	no	Radiation Therapy, NOS	e134072f-d381-4be0-9456-6aa576e669a3
bd0abda0-f330-40f3-b06b-1f6c8f5c667a.htseq.counts.gz	00bc9dff-d999-46ab-8d32-d6fb794d527f	TCGA-13-1507-01A-01R-1565-13	TCGA-13-1507-01A-01R	TCGA-13-1507-01A-01-TS1	TCGA-13-1507-01A-01-BS1	TCGA-13-1507-01A-01		TCGA-13-1507-01A	TCGA-13-1507	502e8d02-2953-4514-a2e1-6179dd94da73	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	2.0		0B6D1513-8119-459C-8D5A-8942B8C31179	1.8	41a5fa6b-4594-4ef8-b841-fe75c17a13c2			0.15	22	released	43e011da-1c4d-4d96-964c-6ab49995c822	RNA	R	0.15	UV Spec	released	False	ecc6bd1f-24f1-4d2d-810d-f65f45160716	01			5.0		0.0	5.0	90.0	95.0	TOP	d693a034-776b-4726-b248-fa02fce6680e	released			5.0		0.0	5.0	90.0	95.0	BOTTOM	b4f68dd8-44d6-4b1f-afdc-2655cf3246df	released	released	160.0						fce7a055-f6ea-4dc3-a42f-51b8ed236ca7	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1507_demographic	77	-28445	1993	4b3ee618-9be0-5230-9ca5-33cab6e8a02f	not hispanic or latino	female	white	released	Dead	1931		TCGA-13-1507_exposure	Not Reported	201b82f0-3fc8-52ef-8bca-34eca6f94893	released	TCGA-13-1507_diagnosis	28445	not reported	0	145	3b1937d2-acf2-5a70-ac4c-0df7f5e295f7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1507_treatment_1	TCGA-13-1507_treatment	released	08e35b76-480f-59a8-ac01-3488c0de4eb4	yes	Pharmaceutical Therapy, NOS	released	ba370601-81b6-599a-b4bb-9ae81c595161	no	Radiation Therapy, NOS	00bc9dff-d999-46ab-8d32-d6fb794d527f
58f06031-8e8c-4865-8cea-ba65d28317a9.htseq.counts.gz	390042c0-b512-444c-a86d-ab441205b370	TCGA-24-2033-01A-01R-1568-13	TCGA-24-2033-01A-01R	TCGA-24-2033-01A-01-BS1	TCGA-24-2033-01A-01-TS1	TCGA-24-2033-01A-01		TCGA-24-2033-01A	TCGA-24-2033	872d2922-7292-4681-adb7-d3b267eccbe7	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1		c804dedf-5495-4051-b87f-974afe4d5718	1.8	b03b75e2-d1d0-4fd7-b66e-891f7b0acb76	3.2	20	0.16	22	released	dd71759b-1a5b-4b79-bb6a-63639a015215	RNA	R	0.16	UV Spec	released	False	4131ce66-68c1-42f3-a80d-0b5291dc2b6b	01	5	0	0	0	0	35	65	85	BOTTOM	c452734b-3ab3-4067-b7d3-fce4e584a18e	released	0	0	0	0	0	5	95	85	TOP	88804778-148e-4bc9-9ea2-958f6e212d0c	released	released	131						88152ab3-4bbc-4d80-9e1e-34c96de3d604	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-24-2033_demographic	87	-31977	562	7726c9f9-3852-5bc5-99d6-00a44e1d0173	not reported	female	white	released	Dead	1908	1996	TCGA-24-2033_exposure	Not Reported	1a838110-04e1-50c5-9d1f-625e18682fb0	released	TCGA-24-2033_diagnosis	31977	not reported	0	562	54f526da-dd2d-5ca2-ba04-32fa91ce3f46	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1995	TCGA-24-2033_treatment	TCGA-24-2033_treatment_1	released	2b692939-01eb-5f0f-9fb5-c6bb2f44a78f	no	Radiation Therapy, NOS	released	6f81eaf9-5543-524a-826a-d7ebeca21c25	yes	Pharmaceutical Therapy, NOS	390042c0-b512-444c-a86d-ab441205b370
4c8d97ab-39ad-41b9-b7f9-3aa56f373c2a.htseq.counts.gz	eda10edd-5495-48db-b2c0-54849ba9e8b1	TCGA-24-1553-01A-01R-1566-13	TCGA-24-1553-01A-01R	TCGA-24-1553-01A-01-BS1	TCGA-24-1553-01A-01-TS1	TCGA-24-1553-01A-01		TCGA-24-1553-01A	TCGA-24-1553	08c64000-d320-4e4d-974b-da503d48890c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.3		5abe7782-ca53-4add-9a9a-01955859420b	1.8	7c607e77-a353-4995-855b-36ccaaf3bde6			0.13	22	released	19eacc97-9db1-45c1-87a7-d6609a843120	RNA	R	0.13	UV Spec	released	False	98c06ac4-6186-444a-815a-552a1fbd4d78	01			0.0		0.0	15.0	85.0	95.0	BOTTOM	ff75b56d-efb0-48ab-9ae2-ea6013bd6b85	released			0.0		0.0	5.0	95.0	99.0	TOP	335b5d27-d22e-4631-a772-ad33e0e3fc49	released	released	146.0						aefe6c18-3891-4c17-99d3-16931151d96e	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-1553_demographic	53	-19393	1767	f6ba61ac-3f98-557c-ac57-f0a30a3dc22b	not reported	female	white	released	Dead	1944	2001	TCGA-24-1553_exposure	Not Reported	ce400643-26ff-5ee3-8f94-8b8f4471e13c	released	TCGA-24-1553_diagnosis	19393	not reported	0	1767	0f6394e0-ad6b-55a6-bb34-cb34cbc020ef	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1997	TCGA-24-1553_treatment_1	TCGA-24-1553_treatment	released	edb71145-589c-5553-86f3-1b003bf3e8a5	yes	Pharmaceutical Therapy, NOS	released	2013ed67-c225-52e5-91aa-e926eaa05f58	no	Radiation Therapy, NOS	eda10edd-5495-48db-b2c0-54849ba9e8b1
69134f9d-2738-4fc7-820d-0fb80b699480.htseq.counts.gz	fbb62773-9d22-428a-aea0-9c3da6c0f1e3	TCGA-24-2271-01A-01R-1568-13	TCGA-24-2271-01A-01R	TCGA-24-2271-01A-01-BS1	TCGA-24-2271-01A-01-TS1	TCGA-24-2271-01A-01		TCGA-24-2271-01A	TCGA-24-2271	a8c4a333-6b67-44c8-9000-516f8ccea788	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.6		87d64a93-9b08-48a5-a26e-1cc4b5ac8bde	1.8	f3581696-e1db-4d0f-9ce7-5fb0f5c08906			0.15	22	released	e8406b8d-b1d6-4f96-8a43-8f48c5f1d898	RNA	R	0.15	UV Spec	released	False	83da0e24-3b0e-4cf9-a4ad-34ef419f2316	01			0.0		0.0	15.0	85.0	80.0	BOTTOM	bed2de0b-65ae-49a2-8fc6-a1ad85be2972	released			0.0		0.0	20.0	80.0	80.0	TOP	b6591fc7-87de-4c84-968f-5a07d4cb9dcc	released	released	143.0						de9d08f5-24f5-4cdc-8f30-d05a2bea5301	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-2271_demographic	55	-20399	962	ade57b50-0f6f-525d-b4d9-895575ae7a36	not reported	female	asian	released	Dead	1944	2001	TCGA-24-2271_exposure	Not Reported	4d82013f-496e-5dcb-8d7f-3f151ed1c999	released	TCGA-24-2271_diagnosis	20399	not reported	0	962	ae67d486-7f72-5338-90a8-592460e5a8d4	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-24-2271_treatment_1	TCGA-24-2271_treatment	released	0047a20e-65f6-58f4-89e8-d39d593a91b4	yes	Pharmaceutical Therapy, NOS	released	82203de9-9821-59e2-80b1-afd36bf7da68	no	Radiation Therapy, NOS	fbb62773-9d22-428a-aea0-9c3da6c0f1e3
34e382cd-6fef-4386-8a30-cd1c8f889f30.htseq.counts.gz	78ca2bc4-e7af-4625-8b0f-276b95f4a4c4	TCGA-36-1568-01A-01R-1566-13	TCGA-36-1568-01A-01R	TCGA-36-1568-01A-01-BS1	TCGA-36-1568-01A-01-TS1	TCGA-36-1568-01A-01		TCGA-36-1568-01A	TCGA-36-1568	de548bdd-14ca-486b-bd16-a6fbdd5b50d2	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.6		dad4bbdc-0156-48c2-a975-27ccfb9152a3	1.8	4e539c62-454a-4b1c-bde1-6951ee12d109			0.15	22	released	98d419ff-25e6-44b8-86d6-9d699ab48aa3	RNA	R	0.15	UV Spec	released	False	f32135ee-7587-4664-a4dc-90d905c43873	01			0.0		0.0	5.0	95.0	95.0	BOTTOM	4356f10e-d4de-400b-8954-eb2e30b693fb	released			0.0		0.0	5.0	95.0	95.0	TOP	1a9c6c51-2b6b-4fa9-ab42-ddf6f921adfb	released	released	100.0						0c2b931b-813b-450f-a911-d25fd7465e18	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-36-1568_demographic	52	-19311		357b0c19-bb6c-588d-a652-1d4bf67cc0c4	not reported	female	not reported	released	Alive	1955		TCGA-36-1568_exposure	Not Reported	242aeb0c-4420-551d-8c97-e63304088649	released	TCGA-36-1568_diagnosis	19311	not reported	0	875	f0ac6623-6d2a-5f87-a515-fe563d907b98	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-36-1568_treatment_1	TCGA-36-1568_treatment	released	72060aa3-9d6a-5aee-9b1e-fa53a5d338eb	yes	Pharmaceutical Therapy, NOS	released	2a0802da-d09e-5156-bca8-f7f3f8d78cb7	no	Radiation Therapy, NOS	78ca2bc4-e7af-4625-8b0f-276b95f4a4c4
0ab0f22f-bfeb-4a5e-bd8f-f0fb30eac992.htseq.counts.gz	bc2cade8-7717-4469-a5fa-3d3a8907d1bf	TCGA-61-1737-01A-01R-1567-13	TCGA-61-1737-01A-01R	TCGA-61-1737-01A-01-TS1	TCGA-61-1737-01A-01-BS1	TCGA-61-1737-01A-01		TCGA-61-1737-01A	TCGA-61-1737	0aa020cb-69d2-4235-a609-c279a133d8bb	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.3	False	0.7		2fa09bf8-8be5-411c-a9cf-16c12ed1390f	1.8	b442230a-d330-45da-adf7-76873d18645c			0.15	22	released	1ec149d1-5a04-4501-b4cc-0fbabfe3ef7f	RNA	R	0.15	UV Spec	released	False	a3d8d731-8fdb-4967-ae4a-9839e43fb20d	01			10.0		0.0	0.0	90.0	90.0	TOP	bea088b8-a989-4ea3-9f43-3ea4138a8c40	released	5.0		5.0		0.0	0.0	95.0	85.0	BOTTOM	495692fd-b4aa-44fd-8373-fd64d0a04e02	released	released	84.0						782164d9-0804-48f7-bb97-a35ebfb0c372	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-61-1737_demographic	42	-15515		7a541ca2-8c30-58c9-ad7e-ff1f0d75aa14	not hispanic or latino	female	white	released	Alive	1963		TCGA-61-1737_exposure	Not Reported	1c1e55cc-254c-5c83-be98-1e92417e7aac	released	TCGA-61-1737_diagnosis	15515	not reported	0	1364	12f72a04-d096-517f-b4d6-c4369f4a1bf6	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-61-1737_treatment	TCGA-61-1737_treatment_1	released	bf28a79c-0327-5f7a-9371-c7dcce64526c	no	Radiation Therapy, NOS	released	566844d6-fa41-5229-be97-6f752022b1c1	yes	Pharmaceutical Therapy, NOS	bc2cade8-7717-4469-a5fa-3d3a8907d1bf
af6e5654-e755-4c15-b3e5-807da2642e25.htseq.counts.gz	5bc23348-57f9-4929-a90b-a557696ca955	TCGA-24-2262-01A-01R-1568-13	TCGA-24-2262-01A-01R	TCGA-24-2262-01A-01-BS1	TCGA-24-2262-01A-01-TS1	TCGA-24-2262-01A-01		TCGA-24-2262-01A	TCGA-24-2262	1d0225b5-f515-4197-bba7-3dc17e502b88	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.5		d58b58ac-365c-43d0-a893-0becfb6e9fff	1.8	efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe			0.15	22	released	b168cbf5-8ee1-44b3-85af-7aebc1753af4	RNA	R	0.15	UV Spec	released	False	f1b99ae7-2de9-4f35-9144-75ba7640b23b	01			10.0		1.0	9.0	80.0	90.0	BOTTOM	4f040506-3126-4be0-9bd2-91ef4ff0c00f	released			15.0		1.0	9.0	75.0	90.0	TOP	2458cc8d-8541-420a-a725-db4e4d1e3e6f	released	released	111.0						c8767fb2-1e4a-42de-b648-847d4a5df78b	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-2262_demographic	57	-20861	11	354360d8-cfa6-5226-8582-8db9bf3e8ee9	not reported	female	white	released	Dead	1935	1992	TCGA-24-2262_exposure	Not Reported	f275ca4e-1ebf-5e5a-bedb-8b6883f56a72	released	TCGA-24-2262_diagnosis	20861	not reported	0	11	d5a8ef4a-e9fb-5014-939c-b0fcf9d6a2e5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1992	TCGA-24-2262_treatment_1	TCGA-24-2262_treatment	released	cc1974c5-3ed2-5421-841f-d28a140f3cd7	no	Pharmaceutical Therapy, NOS	released	e6ec155b-d287-5959-b056-11401a70ba01	no	Radiation Therapy, NOS	5bc23348-57f9-4929-a90b-a557696ca955
12c8b289-b9d0-4697-b3a6-db8eed617937.htseq.counts.gz	570518e9-12de-4cde-87db-9b7eb3c0858b	TCGA-09-1669-01A-01R-1566-13	TCGA-09-1669-01A-01R	TCGA-09-1669-01A-01-BS1	TCGA-09-1669-01A-01-TS1	TCGA-09-1669-01A-01		TCGA-09-1669-01A	TCGA-09-1669	b1c90c69-6149-4105-8182-ab9212f196be	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	0.9		7870b5a7-a96c-4e55-b56f-8eca45918251	1.8	a56ccd4c-1959-44a9-968d-57e6c5bc0cf8			0.16	22	released	dc18d6de-70e9-4b40-95a6-a0c288c8a1f2	RNA	R	0.16	UV Spec	released	False	486497a8-c746-44c7-a85d-3857d5c08b92	01			5.0		0.0	40.0	55.0	70.0	BOTTOM	f8a5a978-1bfe-40d2-849e-ac225005e7f2	released			5.0		0.0	30.0	65.0	80.0	TOP	389e7206-51cf-433f-937e-dab344cbc88a	released	released	86.0						646165d1-4eb0-4dbd-8e05-90cdb30e1d22	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-09-1669_demographic	54	-20052		85394400-da7b-574f-8346-6d5fc26b3df5	not hispanic or latino	female	white	released	Alive	1950		TCGA-09-1669_exposure	Not Reported	4905a932-d253-5b54-ae93-d1b3ae64f7d3	released	TCGA-09-1669_diagnosis	20052	not reported	0	928	a5bcf80f-e5db-5ab5-8c04-57c2093acb89	Stage IIIA	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-09-1669_treatment	TCGA-09-1669_treatment_1	released	15a724f5-1a73-51fb-83ad-81dbf48cc564	no	Radiation Therapy, NOS	released	bec98a55-9373-580e-85a9-68307ab6e343	yes	Pharmaceutical Therapy, NOS	570518e9-12de-4cde-87db-9b7eb3c0858b
be626971-cdea-495d-88cd-1323e7c23fe7.htseq.counts.gz	de92051d-c3f8-49ad-bce9-ca748c6fdd09	TCGA-24-2020-01A-01R-1567-13	TCGA-24-2020-01A-01R	TCGA-24-2020-01A-01-TS1	TCGA-24-2020-01A-01-BS1	TCGA-24-2020-01A-01		TCGA-24-2020-01A	TCGA-24-2020	e20ea417-7296-4da8-9fdb-71cd1f45153a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.1		4f529d42-acb0-4c02-bd0f-d4a650655df8	1.8	19765b4f-458e-4f02-bf96-01498d80ac83	3.4	20	0.17	22	released	ab297fcf-0cbb-4c04-9986-247ee15f5c38	RNA	R	0.17	UV Spec	released	False	b90d709a-38ee-4582-bf44-b1d6e42603b6	01	0	0	0	0	0	0	100	95	TOP	e210ebcd-ea37-4fe7-9531-1c526757d70a	released	0	0	5	0	0	5	90	95	BOTTOM	a863f994-8289-43c8-b1de-2263f5d3bc28	released	released	134						871fc478-cf3f-43c2-8aea-0db7c777abe1	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-2020_demographic	67	-24682	4624	bc3036a7-e795-5db4-9293-f25c1dd954ff	not reported	female	white	released	Dead	1927	2006	TCGA-24-2020_exposure	Not Reported	18a80ee7-ffab-56c5-8892-0a8b819ac0e0	released	TCGA-24-2020_diagnosis	24682	not reported	0	4624	2a7a1bf4-1fe5-5d1d-ad8f-a06bdfbe0774	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1994	TCGA-24-2020_treatment	TCGA-24-2020_treatment_1	released	5170fed0-6c99-5fee-a14e-53b3d62e774d	no	Radiation Therapy, NOS	released	095d4a19-33b6-599d-be76-c81e3cd54f49	yes	Pharmaceutical Therapy, NOS	de92051d-c3f8-49ad-bce9-ca748c6fdd09
78362a69-6a41-4c14-8e08-4fd7773ce03a.htseq.counts.gz	82e1c15b-77f7-47c6-ad9f-d8d3cc980ffd	TCGA-25-1870-01A-01R-1567-13	TCGA-25-1870-01A-01R	TCGA-25-1870-01A-01-BS1	TCGA-25-1870-01A-01-TS1	TCGA-25-1870-01A-01		TCGA-25-1870-01A	TCGA-25-1870	15f1a992-0724-4d76-a71a-702ac7753a41	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.8		5F2EF344-7BE6-4D1A-90F8-8CA796C232B3	1.8	c446d667-ea88-40fe-ad97-fd3fcceb7dd1			0.15	22	released	e63c81ae-bc06-4d84-bc85-a652ccbf29dc	RNA	R	0.15	UV Spec	released	False	f1b0c0d5-5d7c-4ef2-a19a-06b11658862a	01	0.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	BOTTOM	d4ab8919-bcf7-440f-af7b-f66bc835ccfa	released	0.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	TOP	e29642cc-97ec-4d8b-b09d-ba85be57dd44	released	released	82.0						b6eb7ad6-2676-416e-b165-0cf683116793	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-25-1870_demographic	59	-21550	455	c0bb7234-e6e9-5243-a3ab-3e33ef23ba66	not hispanic or latino	female	white	released	Dead	1935	1995	TCGA-25-1870_exposure	Not Reported	2be83342-3483-5a89-9457-be91e405fa42	released	TCGA-25-1870_diagnosis	21550	not reported	0	455	7a970436-b1ad-5ed4-bc9d-c7e4870207ec	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1994	TCGA-25-1870_treatment_1	TCGA-25-1870_treatment	released	2a4b0f5d-4aeb-5957-9177-c6b7aa268f99	yes	Pharmaceutical Therapy, NOS	released	fc63c78d-4a19-561f-83e9-7c619a14021d	no	Radiation Therapy, NOS	82e1c15b-77f7-47c6-ad9f-d8d3cc980ffd
4c6f3410-7bb6-4be3-a4d1-b3717279b212.htseq.counts.gz	0d4a061d-25f1-4715-9b9e-5ee879a2465a	TCGA-61-1741-01A-02R-1567-13	TCGA-61-1741-01A-02R	TCGA-61-1741-01A-01-BS1	TCGA-61-1741-01A-02-BS2	TCGA-61-1741-01A-02		TCGA-61-1741-01A	TCGA-61-1741	16ced1b8-64d5-4498-82df-4d37bfe5b310	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		e2d0ec41-559c-48d4-8c4d-59e0f9d48823	1.8	92d5764e-c576-47cd-a6bd-68ed0365c213			0.14	22	released	ac85afc6-d9bf-4385-b5af-fe05d2478628	RNA	R	0.14	UV Spec	released	False	40b04779-cbdd-40cb-bd5d-1dd102126046	02	3.0	2.0	15.0		0.0	0.0	85.0	90.0	TOP	816f2ee6-2268-4214-8cb3-36bc58a5a060	released	5.0		5.0		0.0	0.0	95.0	90.0	BOTTOM	609dafe9-9590-45dd-b689-f49bee6a58ec	released	released	149.0						e5e22755-8759-4349-a6ba-87fff441183c	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-1741_demographic	76	-27762	1024	058fb30f-2085-5770-b4f2-6a6cf64072f7	not hispanic or latino	female	white	released	Dead	1928	2006	TCGA-61-1741_exposure	Not Reported	fd20e5cb-4ad5-5411-9ec2-c210ccd889b8	released	TCGA-61-1741_diagnosis	27762	not reported	0	1024	4338074a-9988-5342-ae53-3406d24b6758	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-61-1741_treatment_1	TCGA-61-1741_treatment	released	eefa6bba-5ae1-573f-a1fb-c740647e9b44	yes	Pharmaceutical Therapy, NOS	released	56160cfd-0619-58a1-bbb8-d6d31502c502	no	Radiation Therapy, NOS	0d4a061d-25f1-4715-9b9e-5ee879a2465a
178c423a-3ae9-4343-aa81-02292024e421.htseq.counts.gz	9390eaf2-e059-4481-94c1-1b752e619975	TCGA-61-1911-01A-01R-1567-13	TCGA-61-1911-01A-01R	TCGA-61-1911-01A-01-TS1	TCGA-61-1911-01A-01-BS1	TCGA-61-1911-01A-01		TCGA-61-1911-01A	TCGA-61-1911	93095c36-2263-438f-a619-a4a4d6ae13c7	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	2.0		ba6325b4-af61-42cc-b84c-aacee9d7ecc8	1.8	1ec9cbc3-fd76-4d44-be24-8ff296d3c4c9			0.14	22	released	365101b3-ec2e-4a41-9948-62824c538ef4	RNA	R	0.14	UV Spec	released	False	0166ad2a-aece-4167-8a33-6a7e43e8e311	01			0.0		0.0	5.0	95.0	95.0	TOP	ea4d8814-16d0-4475-b259-f228f8803b76	released			1.0		0.0	5.0	94.0	95.0	BOTTOM	668ba554-cdf9-422c-8bdb-3faeccefa07c	released	released	118.0						7f7b442a-3985-4f4a-98b1-da82670c957c	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-1911_demographic	55	-20144		da682e41-52c5-5a4f-b12c-62a7252a9929	not hispanic or latino	female	white	released	Alive	1950		TCGA-61-1911_exposure	Not Reported	b81730ab-d11e-5660-bfcf-c57888213686	released	TCGA-61-1911_diagnosis	20144	not reported	0	1293	2fe15ad8-1c35-5513-a742-928b7ffa9166	Stage IIA	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-61-1911_treatment_1	TCGA-61-1911_treatment	released	0001a9be-5714-5349-b729-c7f04f15f96e	yes	Pharmaceutical Therapy, NOS	released	1bdabded-cf7f-5dda-a880-89807b805126	no	Radiation Therapy, NOS	9390eaf2-e059-4481-94c1-1b752e619975
829fbe64-5c02-4a8f-96e6-9e251c776107.htseq.counts.gz	d0994a08-f214-4306-a88c-4bd12fd8e721	TCGA-13-0730-01A-01R-1564-13	TCGA-13-0730-01A-01R	TCGA-13-0730-01A-01-TS1	TCGA-13-0730-01A-01-BS1	TCGA-13-0730-01A-01		TCGA-13-0730-01A	TCGA-13-0730	2ebb738c-4829-4720-931a-96c0fd117e2a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.1		2AF2844E-F1DC-4938-85D3-08B07BB9DCFF	1.8	754dfe07-22f4-4070-bbcb-10bfbb649def			0.17	22	released	c10d066e-3ea1-48f5-926b-e75052441108	RNA	R	0.17	UV Spec	released	False	043bee4f-3d2f-41dc-9dcd-bce9eac3bd48	01	50.0		5.0	50.0	0.0	15.0	80.0	95.0	TOP	fde90bcb-ed7b-45b6-954f-fbf94f6aa317	released	50.0		5.0	50.0	0.0	5.0	90.0	95.0	BOTTOM	0d18e57d-ba4f-4185-84a0-dc9b489ed29f	released	released	101.0						bbe4ea81-6f31-4589-8797-b140bcb35d2b	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0730_demographic	71	-26086	542	1049f24d-d521-549d-bda2-361501386994	not hispanic or latino	female	white	released	Dead	1932	2004	TCGA-13-0730_exposure	Not Reported	96d095c2-7a39-5f4d-9372-7f01af4742c7	released	TCGA-13-0730_diagnosis	26086	not reported	0		fc0019a4-0e6b-5e7d-b8f7-e7a1d85c90e6	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-13-0730_treatment	TCGA-13-0730_treatment_1	released	e37bbf48-7ace-5775-9bee-668d8cd94a3a	not reported	Radiation Therapy, NOS	released	36d5d5b7-d79b-5672-b899-ddfc44f4dd30	not reported	Pharmaceutical Therapy, NOS	d0994a08-f214-4306-a88c-4bd12fd8e721
43622957-7bed-4d24-a31e-5fadf41216e1.htseq.counts.gz	749e9e26-eb75-4681-b039-6966e911ae7a	TCGA-25-1328-01A-01R-1565-13	TCGA-25-1328-01A-01R	TCGA-25-1328-01A-01-TS1	TCGA-25-1328-01A-01-BS1	TCGA-25-1328-01A-01		TCGA-25-1328-01A	TCGA-25-1328	79fd602b-3e8e-4353-aa78-4f5f170b607d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.8	False	2.8		A2DA7EB3-8E42-4E86-9352-99673F51AEFF	1.8	9ba8d6bf-1541-4127-bc60-73091d2d81c7			0.16	22	released	20fb9f66-3332-49fb-85cc-426099998b0a	RNA	R	0.16	UV Spec	released	False	ac96ba4f-f4e5-4a96-b39e-9e3ebf913fa3	01			5.0			5.0	90.0	95.0	TOP	7302303f-6917-4ca2-9547-8a657c7274e5	released			20.0			10.0	70.0	95.0	BOTTOM	8d6019d0-3250-41ee-9af3-cb18b44ee0ea	released	released	117.0						1ff50970-b13c-4aef-bfb7-fb1b516ff079	Primary Tumor	01	1.0	released	Not Reported	released	TCGA-25-1328_demographic	38	-13911	2009	04824ef8-fadb-546a-bfc0-957cf62e574e	not hispanic or latino	female	white	released	Dead	1963	2006	TCGA-25-1328_exposure	Not Reported	4994cee7-bacc-57c1-a7f9-3d26ef92e4be	released	TCGA-25-1328_diagnosis	13911	not reported	0	1979	b7fddc9e-b9ea-58bc-8db5-3e808b1953a1	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-25-1328_treatment	TCGA-25-1328_treatment_1	released	53a24073-31e5-5429-81ae-5e46520bfad4	no	Radiation Therapy, NOS	released	a09951be-ca58-5440-8210-58748964f36a	yes	Pharmaceutical Therapy, NOS	749e9e26-eb75-4681-b039-6966e911ae7a
9a111391-cea9-47b0-bb5e-2bd19ff09a5a.htseq.counts.gz	936ff453-f781-467a-a53e-97e10f5c46d6	TCGA-24-2293-01A-01R-1568-13	TCGA-24-2293-01A-01R	TCGA-24-2293-01A-01-BS1	TCGA-24-2293-01A-01-TS1	TCGA-24-2293-01A-01		TCGA-24-2293-01A	TCGA-24-2293	bdd792e7-d75f-4aa3-b38e-f0708e112075	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.3		caf7dd79-d1f9-4061-8b50-aa8e5a4f18b7	1.8	d554a1f1-3e8a-4b8c-a458-36e6550905dd			0.14	22	released	2e29f752-96c8-4f49-8366-0711541f2587	RNA	R	0.14	UV Spec	released	False	8e8db6a9-d98b-4113-a874-c56a61ea67ac	01			2.0		58.0	0.0	40.0	66.0	BOTTOM	96b19260-6a66-40bb-b472-749fb3caea6e	released			2.0		43.0	0.0	55.0	74.0	TOP	bbb53d55-4e3b-46a6-aa7a-98b79d7b6591	released	released	112.0						542c8797-ff2c-49c6-955b-ef8222194b6d	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-2293_demographic	47	-17235	506	8d3d202d-b300-5de9-9226-3338350a13e7	not reported	female	white	released	Dead	1948	1996	TCGA-24-2293_exposure	Not Reported	05e9f203-4690-5079-9d1e-81872ce0edb7	released	TCGA-24-2293_diagnosis	17235	not reported	0	506	9b15e2a6-35c6-5b7c-a120-c89694cdd36a		C48.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Specified parts of peritoneum	released	Not Reported	Ovary	not reported	not reported	1995	TCGA-24-2293_treatment	TCGA-24-2293_treatment_1	released	ae907019-965d-5ddf-9959-8803fadc8401	no	Radiation Therapy, NOS	released	ead3c222-0fe9-5136-afad-40bb94996274	yes	Pharmaceutical Therapy, NOS	936ff453-f781-467a-a53e-97e10f5c46d6
3db0253d-7bc6-4d7c-8c8f-fbfefc3556a6.htseq.counts.gz	b3de7d12-4dd1-43b7-9423-ba92d1494772	TCGA-13-2060-01A-01R-1568-13	TCGA-13-2060-01A-01R	TCGA-13-2060-01A-01-TS1	TCGA-13-2060-01A-01-BS1	TCGA-13-2060-01A-01		TCGA-13-2060-01A	TCGA-13-2060	196f4600-b6c9-4652-9f77-65c92883f8c1	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.5	False	2.5		F6986C14-4627-424E-81C5-74E1CE38D52D	1.8	32de1e4d-198a-4616-8227-4d633c80124b			0.14	22	released	8eb50374-84f0-4d88-8d13-cdbf64e21cfa	RNA	R	0.14	UV Spec	released	False	66095e77-a7e7-41e0-a61d-8debcedb1105	01	15.0	0.0	5.0	0.0	0.0	10.0	85.0	80.0	TOP	029d23ee-2d6c-4172-9908-837eeb844719	released	20.0	0.0	5.0	0.0	0.0	10.0	85.0	70.0	BOTTOM	dfa4bfe4-24cf-4410-b813-45a7ba514053	released	released	144.0						bffd965b-885f-4914-b25b-a993338acaad	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-13-2060_demographic	51	-18635		b78eb8ff-ab78-5321-aa85-a563f3b4d1fb	not reported	female	white	released	Alive	1958		TCGA-13-2060_exposure	Not Reported	8a209447-d77c-52c1-a892-8808caea5394	released	TCGA-13-2060_diagnosis	18635	not reported	0	2369	31073de8-aadc-57d6-99a1-0a6b4d438bb9	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-13-2060_treatment	TCGA-13-2060_treatment_1	released	3b289c5a-3774-50a6-8cda-424d24af7b96	no	Radiation Therapy, NOS	released	4bbfe0b4-8214-5674-b980-8c6f4a0923a8	yes	Pharmaceutical Therapy, NOS	b3de7d12-4dd1-43b7-9423-ba92d1494772
5ee01776-d2f8-433e-8dca-761151099491.htseq.counts.gz	7b4eb1bc-48a4-403f-8b11-1fd8019aa829	TCGA-24-1565-01A-01R-1566-13	TCGA-24-1565-01A-01R	TCGA-24-1565-01A-01-BS1	TCGA-24-1565-01A-01-TS1	TCGA-24-1565-01A-01		TCGA-24-1565-01A	TCGA-24-1565	cf1e86ec-4bcb-403c-831b-d67bddef14eb	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	0.8		f424905e-3dc2-4e37-b6c4-8a77c7ce817b	1.8	0d80226b-8c70-44ab-a6d9-f054d89330f3			0.15	22	released	41bbfcb1-aa15-4cc5-8d98-be98c87f1ca2	RNA	R	0.15	UV Spec	released	False	29e70280-67fb-4c83-a9b1-7a23815da44d	01			0.0		0.0	5.0	95.0	95.0	BOTTOM	1dd6e7fb-cbd7-4da0-923d-d43435834cf0	released			0.0		0.0	5.0	95.0	95.0	TOP	2f178ae2-c7f7-444e-902a-212be3f0433d	released	released	102.0						6feb1257-da6f-4a70-bbd1-f3aa843ef72a	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-1565_demographic	74	-27048	312	ff23d451-c438-5f18-9951-f4adc6b0744f	not reported	female	white	released	Dead	1923	1997	TCGA-24-1565_exposure	Not Reported	b8936a1d-1971-58c9-842a-0f16463cda74	released	TCGA-24-1565_diagnosis	27048	not reported	0	312	e36db772-f900-5281-9362-18c0fa204e9a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1997	TCGA-24-1565_treatment	TCGA-24-1565_treatment_1	released	461f56c9-ffc0-5212-a78d-f465658fd2ad	no	Radiation Therapy, NOS	released	3f39479a-6e2b-5864-b56d-b1281fa7b728	yes	Pharmaceutical Therapy, NOS	7b4eb1bc-48a4-403f-8b11-1fd8019aa829
01eac123-1e21-440d-9495-8b7a4166249f.htseq.counts.gz	7ce010cb-4875-4206-8e87-38fe4f554917	TCGA-13-1495-01A-01R-1565-13	TCGA-13-1495-01A-01R	TCGA-13-1495-01A-01-TS1	TCGA-13-1495-01A-01-BS1	TCGA-13-1495-01A-01		TCGA-13-1495-01A	TCGA-13-1495	74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.5	False	2.1		51F0A8BF-0E86-402D-BE9F-D41771ED98A3	1.8	845d11ec-7fc7-4498-a0f4-1187413c5914			0.16	22	released	ed7bfbb4-4c2f-4c25-b856-63d9fcc60371	RNA	R	0.16	UV Spec	released	False	3a018c7b-3334-4c02-88cc-70e40ec30235	01			1.0		0.0	20.0	79.0	80.0	TOP	beca9d8a-6867-45d1-a81e-03dc4e7989b0	released			1.0		0.0	20.0	79.0	80.0	BOTTOM	ae354aba-3dfc-4e7c-a02b-bfa4d5562264	released	released	128.0						98675894-f21c-4dc4-b822-a6e52634d470	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1495_demographic	60	-22046	2749	1cb753ba-3ecc-572a-8d29-c4ed3c9a35f4	not hispanic or latino	female	white	released	Dead	1944		TCGA-13-1495_exposure	Not Reported	778322fe-6700-5ffc-a9cc-ed84f0709999	released	TCGA-13-1495_diagnosis	22046	not reported	0	1498	4f419b0f-ece4-5df0-9ea1-9d12e5078189	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-13-1495_treatment	TCGA-13-1495_treatment_1	released	cf47d22a-a147-5264-9647-4afc0f4be049	no	Radiation Therapy, NOS	released	0400b1d1-71f2-5395-8527-bbb656163048	yes	Pharmaceutical Therapy, NOS	7ce010cb-4875-4206-8e87-38fe4f554917
eb4572b5-43a0-4d92-ab9c-1c5853710297.htseq.counts.gz	a8b95cad-f709-4e4f-9923-8d23daeb5b30	TCGA-23-2084-01A-02R-1568-13	TCGA-23-2084-01A-02R	TCGA-23-2084-01A-01-BS1	TCGA-23-2084-01A-02-BS2	TCGA-23-2084-01A-02		TCGA-23-2084-01A	TCGA-23-2084	2cb82948-7cbe-4b6c-8414-c02f662de2d0	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.4		00fd3d04-b48e-434e-8d25-0f0949e796cc	1.8	858a382c-49dc-4990-8c0f-017fedd9a6db	3.2	20	0.16	22	released	fc1cc22f-8d1b-4b22-bdf3-3dcd839f7c3d	RNA	R	0.16	UV Spec	released	False	978b1d8a-5a2b-4142-ae22-d55ea0c7632e	02			0		1	9	90	90	TOP	55a32aa7-50fb-4a0a-ac8a-6c62173174ab	released			0		1	14	85	85	BOTTOM	8ea25871-38c9-45a4-b7ac-ec3095f2b9ae	released	released	105						6ea4f0e4-f241-4d14-af35-a9bbcb8f4a9d	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-23-2084_demographic	45	-16493	1516	0344269b-0441-5bd3-9846-3c0415320ab6	not hispanic or latino	female	white	released	Dead	1955	2004	TCGA-23-2084_exposure	Not Reported	955470fb-ff5f-5156-b8c2-e421835132f1	released	TCGA-23-2084_diagnosis	16493	not reported	0		2aaa9e6d-1157-5f86-b34f-9c9abf6e82f8	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-23-2084_treatment_1	TCGA-23-2084_treatment	released	f40361c7-947d-5498-b457-87a92ebe4423	yes	Pharmaceutical Therapy, NOS	released	7a3b9a37-c86c-5a54-a1c3-5bc54d09979c	no	Radiation Therapy, NOS	a8b95cad-f709-4e4f-9923-8d23daeb5b30
72bb9902-d411-494f-98ca-0e273967b96a.htseq.counts.gz	2022fda5-3d7c-45c5-a5e6-3519073219e5	TCGA-24-1435-01A-01R-1566-13	TCGA-24-1435-01A-01R	TCGA-24-1435-01A-01-TS1	TCGA-24-1435-01A-01-BS1	TCGA-24-1435-01A-01		TCGA-24-1435-01A	TCGA-24-1435	49d2c0cf-a3f3-4519-a755-0a5f769df2ea	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.5		d1574b6c-6cc1-45bc-86d0-97585d8a5c93	1.8	c20ba763-e310-448a-9c85-0b4f680e6196			0.14	22	released	cf334d2a-3614-4876-bf7f-7792888bb4d0	RNA	R	0.14	UV Spec	released	False	05bbb1d0-8116-48a8-9240-dc9b01b2a20a	01			1.0		0.0	5.0	94.0	95.0	TOP	d678e541-f8bc-4a7e-87ca-e1df06b156ec	released			1.0		0.0	5.0	94.0	95.0	BOTTOM	3429e07b-d614-4c41-bf6e-9bfb4fc1e325	released	released	179.0						a36ab3e1-b5fb-4557-af54-88d4ada2aaaf	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1435_demographic	57	-21107	1324	1a799775-3d93-5950-9ea0-0ac519e37476	not reported	female	white	released	Dead	1942	2002	TCGA-24-1435_exposure	Not Reported	210f65e9-4dd3-58c2-9023-df79fc175006	released	TCGA-24-1435_diagnosis	21107	not reported	0	1324	020510a4-78b5-5290-a377-54a07c066478	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-24-1435_treatment	TCGA-24-1435_treatment_1	released	9504fd23-5eba-5a30-b910-8975b0786281	no	Radiation Therapy, NOS	released	0aef8495-8e2d-595d-a0b1-3dfe52cf79de	yes	Pharmaceutical Therapy, NOS	2022fda5-3d7c-45c5-a5e6-3519073219e5
7c4769c1-1907-47ea-98f7-26cd438d022e.htseq.counts.gz	0fe70a8a-da0e-443e-a430-718c304b2541	TCGA-23-1116-01A-01R-1564-13	TCGA-23-1116-01A-01R	TCGA-23-1116-01A-01-TS1	TCGA-23-1116-01A-01-BS1	TCGA-23-1116-01A-01		TCGA-23-1116-01A	TCGA-23-1116	70fe08bd-a0b4-4a88-b82e-813b176f8e40	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.0		d39c8f94-c4f0-4166-864b-912d7535f2b6	1.8	ab28a926-0266-4602-8e90-529934cf43ab			0.16	22	released	65b49803-c9eb-49f0-a2d4-dd8941f2542e	RNA	R	0.16	UV Spec	released	False	ecd1760f-ab95-4a1d-922c-e6801da984db	01			0.0		0.0			80.0	TOP	e0a68198-f101-4469-9dbf-f9b0c9c8ca63	released			5.0		0.0			90.0	BOTTOM	a02dca17-bfe8-419b-b790-944bff16fcf2	released	released	106.0						91fbc26e-c049-49af-8307-22c7980079df	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-23-1116_demographic	83	-30464	592	4b9f2013-cf47-571e-8a15-8f1207cd8a5a	not hispanic or latino	female	white	released	Dead	1925		TCGA-23-1116_exposure	Not Reported	6969a1ad-9414-5040-9585-d51d51e0fa6b	released	TCGA-23-1116_diagnosis	30464	not reported	0	139	d0a829b8-ce2d-5f29-8ac9-e83d900af073	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-23-1116_treatment_1	TCGA-23-1116_treatment	released	07e72c2c-509d-53a3-b931-318fd9db1d0e	yes	Pharmaceutical Therapy, NOS	released	2841e495-9897-5d46-ae74-44b8a692f808	no	Radiation Therapy, NOS	0fe70a8a-da0e-443e-a430-718c304b2541
a528840a-20b9-40ed-acfa-46b8b52ffef6.htseq.counts.gz	311ec972-11c4-407c-bcda-9c27c9e287f3	TCGA-25-1315-01A-01R-1565-13	TCGA-25-1315-01A-01R	TCGA-25-1315-01A-01-TS1	TCGA-25-1315-01A-01-BS1	TCGA-25-1315-01A-01		TCGA-25-1315-01A	TCGA-25-1315	635f5335-b008-428e-b005-615776a6643f	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				2.0	False	3.5		486E22A0-A224-4471-BA52-9F52E021B131	1.8	b6908d33-80c8-4fc0-bd1d-829ec3161527			0.16	22	released	48c5b79c-4b1a-4083-898e-4201afe70bd3	RNA	R	0.16	UV Spec	released	False	468d2550-2808-420f-acd4-57e56e5a6d2b	01			0.0		0.0	5.0	95.0	95.0	TOP	617ad1a6-305c-4ca3-b86c-b1de86429a0a	released			0.0		0.0	5.0	95.0	95.0	BOTTOM	2ea40aad-f13d-46af-89a6-0e04116a5d54	released	released	156.0						d1a2fb08-a7b9-4920-af5a-33118478a429	Primary Tumor	01	0.9	released	Not Reported	released	TCGA-25-1315_demographic	50	-18263	1583	37be6983-075c-55d9-a482-fc41dcc71bb0	not hispanic or latino	female	white	released	Dead	1950	2004	TCGA-25-1315_exposure	Not Reported	523f6260-7445-5207-9cfa-624d18a0f551	released	TCGA-25-1315_diagnosis	18263	not reported	0	1553	b068f29c-7d2b-5d20-8748-67a56d85ac72	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-25-1315_treatment_1	TCGA-25-1315_treatment	released	e4a79b5e-ac25-5aa6-8556-d1e42edb3472	yes	Pharmaceutical Therapy, NOS	released	faca2e40-1fb3-5d24-81c3-6a26cd0dd2d5	no	Radiation Therapy, NOS	311ec972-11c4-407c-bcda-9c27c9e287f3
320a6126-c3fc-483f-b79d-b15700a51997.htseq.counts.gz	225d939f-fe81-4075-930f-5265dd75ef85	TCGA-36-1581-01A-01R-1566-13	TCGA-36-1581-01A-01R	TCGA-36-1581-01A-01-TS1	TCGA-36-1581-01A-01-BS1	TCGA-36-1581-01A-01		TCGA-36-1581-01A	TCGA-36-1581	ef5e85cf-2d82-4d52-a02c-fed5c76e4cec	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.7		6512ef01-a2fb-4fd8-9e1a-b59855c256de	1.8	d84c76a9-dbee-4720-8639-91382101b27a			0.14	22	released	defc4c39-849c-471f-a625-5abdc2a83bfe	RNA	R	0.14	UV Spec	released	False	6da1522e-8974-4f57-a96d-89609a0acf90	01			2.0		0.0	3.0	95.0	95.0	TOP	eb8eab2e-7062-48bb-bc87-44ca7b8a1cd9	released			5.0		0.0	2.0	93.0	95.0	BOTTOM	1673dba9-dd32-4927-9f51-3525f0d62786	released	released	120.0						3d547b69-ceaa-49c1-8ea9-03a32b3fac90	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-36-1581_demographic	63	-23272		45b3ff78-a16c-5228-a88f-e0777a316c9f	not reported	female	white	released	Alive	1944		TCGA-36-1581_exposure	Not Reported	badd0bdf-bf24-5f9c-b14f-b744c060e468	released	TCGA-36-1581_diagnosis	23272	not reported	0	751	241ae640-2769-5065-97aa-05298c7b1b9b	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-36-1581_treatment	TCGA-36-1581_treatment_1	released	0adc4703-4ee1-52fa-b1ca-e461ad689029	no	Radiation Therapy, NOS	released	080cd847-28d9-5da0-ae71-4139402cb92b	yes	Pharmaceutical Therapy, NOS	225d939f-fe81-4075-930f-5265dd75ef85
42d8c04e-0355-455c-b982-581727f75665.htseq.counts.gz	03d68b4f-8418-494c-a886-a5e849bb1348	TCGA-24-2298-01A-01R-1569-13	TCGA-24-2298-01A-01R	TCGA-24-2298-01A-01-TS1	TCGA-24-2298-01A-01-BS1	TCGA-24-2298-01A-01		TCGA-24-2298-01A	TCGA-24-2298	7e4e7914-ec23-4c55-98d6-3c5eecffa8e4	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	1.0		fe9d7bf4-a278-4842-b911-018d0127ef20	1.8	7b39cb0a-7152-4037-9989-57545a1df980			0.14	22	released	2e19fa49-b036-45c0-a9ab-16f2b4fc8042	RNA	R	0.14	UV Spec	released	False	09989586-a5ec-4bdd-afa9-e2deebbb8db6	01			1.0		25.0	0.0	74.0	89.0	TOP	17f016db-5fb5-4bdb-a5b3-5d3ae85e69fb	released			3.0		27.0	0.0	70.0	88.0	BOTTOM	3257628a-82df-49ba-ba4c-5ab509434c97	released	released	161.0						96e08856-06cc-463d-b2c5-5ed29204f66e	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-2298_demographic	55	-20453	1620	38d463fa-52e1-5bde-ba99-892ae69ef237	not reported	female	white	released	Dead	1938	1997	TCGA-24-2298_exposure	Not Reported	673853f3-879e-5bf1-9131-c4a93a1cef1e	released	TCGA-24-2298_diagnosis	20453	not reported	0	1620	13e8bf35-e57d-57bc-a649-ba968b92dd9d	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1993	TCGA-24-2298_treatment_1	TCGA-24-2298_treatment	released	d2a85d6d-dc63-5c29-9265-5f31484109a6	yes	Pharmaceutical Therapy, NOS	released	5d8058bd-49e3-5610-b7f5-2c424cb4966d	no	Radiation Therapy, NOS	03d68b4f-8418-494c-a886-a5e849bb1348
d7e6e15d-d26c-43f3-b0a9-d5a4dc861e9d.htseq.counts.gz	54868d06-58d9-4afe-8b34-f249eefeba76	TCGA-61-2113-01A-01R-1568-13	TCGA-61-2113-01A-01R	TCGA-61-2113-01A-01-BS1	TCGA-61-2113-01A-01-TS1	TCGA-61-2113-01A-01		TCGA-61-2113-01A	TCGA-61-2113	71faa2c1-0d5b-4dcc-bdf9-f2405f29907c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.6		d10e1b61-73c4-4ab7-bc4b-8c7827856602	1.8	d5752594-1a2c-47c8-a40b-bffd5b6b7e71			0.14	22	released	ac4fd38d-5875-4341-a8e1-ad8ea9148631	RNA	R	0.14	UV Spec	released	False	a4c1bf5e-5fe6-49fb-acf4-f8e0c80ea5c6	01			0.0		0.0	30.0	70.0	70.0	BOTTOM	25ef0623-cbe2-44b4-a956-5934342adc0d	released			0.0		0.0	30.0	70.0	70.0	TOP	91aa5d6b-d95f-4465-b1a5-d7697dab7d29	released	released	127.0						9ba8451e-7ffc-43f2-b602-8ce8764dfc14	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-2113_demographic	53	-19722	676	74216962-1bf9-5e6b-8285-3865c6655eac	not hispanic or latino	female	white	released	Dead	1946	2000	TCGA-61-2113_exposure	Not Reported	3b3e3fc4-5510-5e5e-b655-8397e71ae569	released	TCGA-61-2113_diagnosis	19722	not reported	0	676	6b483d36-30fc-5513-8cba-f768ad1d62e3	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-61-2113_treatment_1	TCGA-61-2113_treatment	released	677835d3-6702-5fcd-a762-48b5fda6122d	yes	Pharmaceutical Therapy, NOS	released	f215980e-01ac-56cb-906b-bf98d6d20a30	no	Radiation Therapy, NOS	54868d06-58d9-4afe-8b34-f249eefeba76
0f878485-4f73-45ec-8d2d-b89850813aa5.htseq.counts.gz	103d151d-2c67-4b4f-aade-8afbd106146f	TCGA-61-1918-01A-01R-1568-13	TCGA-61-1918-01A-01R	TCGA-61-1918-01A-01-BS1	TCGA-61-1918-01A-01-TS1	TCGA-61-1918-01A-01		TCGA-61-1918-01A	TCGA-61-1918	3491d67a-4f83-4f67-8085-bbb9fe942be5	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	1.0		6c95bd12-e871-4e4e-961f-09a64c1fe2de	1.8	62f75d97-ea9e-4694-8c83-1a0e6d137a02			0.14	22	released	0515430a-06ed-49ea-9e7c-6aa62f5016c2	RNA	R	0.14	UV Spec	released	False	ffcc32bc-d62f-465f-b479-b609dc7b4589	01			15.0		0.0	15.0	70.0	85.0	BOTTOM	2839dfd5-d116-494f-b31e-512aad6fc514	released			10.0		0.0	10.0	80.0	90.0	TOP	1f691318-7bee-4a1f-a5ef-09a24185d119	released	released	135.0						f17ca1b8-f58c-4b17-bc4d-3bd33d9aec5f	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-1918_demographic	45	-16689	479	3e70c222-a83b-5da9-9917-afab5c944561	not hispanic or latino	female	white	released	Dead	1957	2003	TCGA-61-1918_exposure	Not Reported	5f347db9-226a-5220-a4a8-19a998b53226	released	TCGA-61-1918_diagnosis	16689	not reported	0	479	333c3c88-a293-5542-b167-ffd3a6a82a8d	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-61-1918_treatment_1	TCGA-61-1918_treatment	released	5256a284-7276-5af2-a0e7-6f197cd00854	yes	Pharmaceutical Therapy, NOS	released	92769dda-b04b-5014-a5a0-0fb807673dfe	no	Radiation Therapy, NOS	103d151d-2c67-4b4f-aade-8afbd106146f
e78cab9d-1b43-4416-8dbc-78d51558d895.htseq.counts.gz	d65480c7-8ef0-4535-bd00-1f86a1d5deac	TCGA-24-1544-01A-01R-1566-13	TCGA-24-1544-01A-01R	TCGA-24-1544-01A-01-TS1	TCGA-24-1544-01A-01-BS1	TCGA-24-1544-01A-01		TCGA-24-1544-01A	TCGA-24-1544	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.4		2fd78a14-cc3f-4920-9c50-6051579b6ad4	1.8	83333a5a-de0b-4d72-b886-e5488c619827			0.16	22	released	7d1f8818-cfc3-4716-8cac-d0b2fb48f865	RNA	R	0.16	UV Spec	released	False	a87fc66d-5ec9-438b-99d1-b4943e512461	01			5.0		0.0	20.0	75.0	80.0	TOP	5c0e797d-fd2e-4368-8b27-b77ad0cd4601	released			10.0		0.0	20.0	70.0	80.0	BOTTOM	8b67402c-67b0-4909-b96c-f8a7f9e85ced	released	released	149.0						cf7b9151-6479-41af-986c-d9db10e33ca6	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1544_demographic	71	-26141	820	d6576dc5-1505-5552-85bd-65620144f49e	not reported	female	black or african american	released	Dead	1929	2002	TCGA-24-1544_exposure	Not Reported	9b6b99bf-0c84-53fb-973c-f344c0718729	released	TCGA-24-1544_diagnosis	26141	not reported	0	820	b05e9689-4d0c-5974-965f-d8c1411d17ef	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-24-1544_treatment	TCGA-24-1544_treatment_1	released	7e5eea55-c677-5c45-8463-f4efa49ca963	no	Radiation Therapy, NOS	released	ab4e0819-e35d-5af5-a778-8107f982d7ea	yes	Pharmaceutical Therapy, NOS	d65480c7-8ef0-4535-bd00-1f86a1d5deac
aea568b9-f9d8-4458-89fd-894c9e9ecb57.htseq.counts.gz	46330b58-7097-4e16-89a6-de61277e2ff4	TCGA-13-1509-01A-01R-1565-13	TCGA-13-1509-01A-01R	TCGA-13-1509-01A-01-BS1	TCGA-13-1509-01A-01-TS1	TCGA-13-1509-01A-01		TCGA-13-1509-01A	TCGA-13-1509	fe402983-70da-44db-b7b1-c32702ddde26	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.5	False	1.7		5FB47FA9-299B-4466-A324-20D44C788F8B	1.8	6e57a2e1-2894-421d-bdeb-7e532a78bdeb			0.16	22	released	75941df7-c517-4f24-84dd-5f55e919e2a4	RNA	R	0.16	UV Spec	released	False	635eb50e-6d68-4f01-aca7-57cc01c4ac11	01			5.0		0.0	10.0	85.0	90.0	BOTTOM	031e3f43-6049-4cef-9b2b-b856aa268557	released			5.0		0.0	10.0	85.0	90.0	TOP	c55b2176-151c-4d47-a9ce-e219fcf78418	released	released	153.0						832fbf68-76dc-47f7-b0ac-257d77d69bdf	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1509_demographic	64	-23481		1c90a4f4-86be-5c63-81d0-0a48ef654c51	not hispanic or latino	female	white	released	Alive	1944		TCGA-13-1509_exposure	Not Reported	1442997e-cc50-595a-a61f-f319d4580fca	released	TCGA-13-1509_diagnosis	23481	not reported	0	2438	67fe78ea-3168-5753-80bf-85495328d780	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1509_treatment	TCGA-13-1509_treatment_1	released	87c1a7a8-25cc-545d-977d-350a3fdf0993	no	Radiation Therapy, NOS	released	465ac160-8456-56e5-8b89-2f7fdf924c80	yes	Pharmaceutical Therapy, NOS	46330b58-7097-4e16-89a6-de61277e2ff4
ba8ce34a-28bc-485c-af2e-1c835c351997.htseq.counts.gz	035a4b53-84b3-4c27-9bb3-a880e112207b	TCGA-25-2042-01A-01R-1568-13	TCGA-25-2042-01A-01R	TCGA-25-2042-01A-01-BS1	TCGA-25-2042-01A-01-TS1	TCGA-25-2042-01A-01		TCGA-25-2042-01A	TCGA-25-2042	818dc159-aba4-46bc-a4ed-68ee0f8c4461	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.4		4D14A408-E3F6-47EB-A67C-0606450DB0C5	1.8	ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c			0.15	22	released	12e5f40d-b2c3-43da-8795-f8dabfd905d1	RNA	R	0.15	UV Spec	released	False	9fb74096-c9db-4415-b630-1a77cdacb130	01			2.0		0.0	68.0	30.0	85.0	BOTTOM	682d08f1-28cd-4f93-a65b-7d735574c7db	released			2.0		0.0	68.0	30.0	85.0	TOP	a7d0928a-7742-4678-8183-b9f192787900	released	released	111.0						71484ed8-3496-48b2-81b8-888d04f10f0a	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-25-2042_demographic	60	-22127	396	6b47a6c1-f0cd-5fa9-9205-69c8f3ec37e7	not hispanic or latino	female	american indian or alaska native	released	Dead	1946	2007	TCGA-25-2042_exposure	Not Reported	f89baac8-8e53-5e4d-a982-c84f1e062f66	released	TCGA-25-2042_diagnosis	22127	not reported	0	396	2a402414-8c80-5260-9406-443e0dadda66	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-25-2042_treatment	TCGA-25-2042_treatment_1	released	cd4c75d9-43a1-5f3a-bf7d-81632cf8e2a7	no	Radiation Therapy, NOS	released	ad1542bc-adcb-5c67-ae5b-cf1274cf8b94	yes	Pharmaceutical Therapy, NOS	035a4b53-84b3-4c27-9bb3-a880e112207b
043993e1-370b-4bdc-8783-be65b97ed886.htseq.counts.gz	07994c98-bf61-40d8-93d8-cb24250e408b	TCGA-13-1405-01A-01R-1565-13	TCGA-13-1405-01A-01R	TCGA-13-1405-01A-01-TS1	TCGA-13-1405-01A-01-BS1	TCGA-13-1405-01A-01		TCGA-13-1405-01A	TCGA-13-1405	29dccd25-4c4a-463b-a353-38a193337f38	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.3		DFB9F8B2-986C-4963-B2D2-837E54174CF0	1.8	044d949f-0eb4-44c9-8327-90226936fc7c			0.17	22	released	515f0052-170d-431a-a7d0-715a3bfc0d40	RNA	R	0.17	UV Spec	released	False	659f0e5a-1d50-4e3b-a588-cbf534841e31	01			1.0		0.0	15.0	84.0	85.0	TOP	97fd5c92-85f1-4cb2-9ed6-289072e137bb	released			1.0		0.0	15.0	84.0	85.0	BOTTOM	75a754e9-5c31-4b53-b8a9-fe6deec738ab	released	released	133.0						d900cebf-8795-4385-8f57-77209178ff43	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-13-1405_demographic	49	-18218	868	baec593a-b625-575d-9c78-53c435b457e4	not hispanic or latino	female	white	released	Dead	1959		TCGA-13-1405_exposure	Not Reported	b2a583cf-c40d-593e-b479-65f986bc2205	released	TCGA-13-1405_diagnosis	18218	not reported	0	224	84bc8778-a967-5764-8dc6-e7fb3efed07f	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1405_treatment_1	TCGA-13-1405_treatment	released	cc46c924-dab0-55e5-b271-19f8e199368a	yes	Pharmaceutical Therapy, NOS	released	c7850771-7a41-51a9-bb1d-2c5902c69931	no	Radiation Therapy, NOS	07994c98-bf61-40d8-93d8-cb24250e408b
df06bca2-4481-455f-98b2-4c1981698f56.htseq.counts.gz	67270205-5ba8-414f-b5d8-b162e5b27db8	TCGA-13-0901-01B-01R-1565-13	TCGA-13-0901-01B-01R	TCGA-13-0901-01B-01-TS1	TCGA-13-0901-01B-01-BS1	TCGA-13-0901-01B-01		TCGA-13-0901-01B	TCGA-13-0901	27920e1e-b9ab-4587-970a-0cba7025becb	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.3		5613318C-D3D4-436D-B22F-BE8FC36D9686	1.8	4320fb38-5508-4ba7-87f1-43c4dc70854c			0.16	22	released	796c50fd-c41c-478f-8916-140b5a45867e	RNA	R	0.16	UV Spec	released	False	337b223d-c8a9-4c4c-88d7-100483cfad24	01			1.0		0.0	10.0	89.0	90.0	TOP	68cbcd84-0e37-48aa-8e6f-c48b43b93e7b	released			1.0		0.0	10.0	89.0	90.0	BOTTOM	a01b26f4-7a4c-4529-a400-e6ad62f1a956	released	released	123.0						04cc5fca-1b0e-408b-bc12-b0987c561d53	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0901_demographic	41	-15333		039bb7cc-4731-57bd-bbe7-dfce13b11b2e	not hispanic or latino	female	asian	released	Alive	1963		TCGA-13-0901_exposure	Not Reported	305002b0-0755-5587-a2f4-61fe18ddc86d	released	TCGA-13-0901_diagnosis	15333	not reported	0	589	8285c0fe-f59c-574b-87d7-0bb866d8ac59	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-13-0901_treatment	TCGA-13-0901_treatment_1	released	469999a3-4b66-5c0e-a9df-78a39a510a99	no	Radiation Therapy, NOS	released	d2a3de26-3e43-5187-8a28-4f1db7bda178	yes	Pharmaceutical Therapy, NOS	67270205-5ba8-414f-b5d8-b162e5b27db8
b90ceb09-1097-4c53-ae4d-0e7acd0ea8df.htseq.counts.gz	c2bbd6b8-02be-49ff-a5e5-6e5dd2cd2af6	TCGA-36-1571-01A-01R-1566-13	TCGA-36-1571-01A-01R	TCGA-36-1571-01A-01-TS1	TCGA-36-1571-01A-01-BS1	TCGA-36-1571-01A-01		TCGA-36-1571-01A	TCGA-36-1571	12581634-eebb-4841-8498-71dc9d78c546	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.3		cee6fb75-8fcc-4347-824e-b00b96e6e481	1.8	55c68aef-938c-4f68-a74d-f408673fff9c			0.14	22	released	b783d8c9-2a75-4a3e-84ef-a56ee35aa0a1	RNA	R	0.14	UV Spec	released	False	dcec160c-2969-4959-a77a-bc73ea787b61	01			1.0		0.0	5.0	94.0	95.0	TOP	481fbd5a-885c-415d-8462-550e3b4d54b6	released			0.0		0.0	5.0	95.0	95.0	BOTTOM	456cf689-c3f2-47ad-8b8c-8990e20dc816	released	released	100.0						a1d026c2-4d7a-4454-a8e3-30e5c243aba0	Primary Tumor	01	0.9	released	Not Reported	released	TCGA-36-1571_demographic	53	-19608	695	45064610-c261-5514-8632-f45474cd4857	not reported	female	white	released	Dead	1954	2008	TCGA-36-1571_exposure	Not Reported	5a5eab17-b41c-52d6-9274-6fbab24cc7ce	released	TCGA-36-1571_diagnosis	19608	not reported	0	695	5cdad4c0-aa9e-59d2-b9d8-59157a7f2f7e	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-36-1571_treatment	TCGA-36-1571_treatment_1	released	6af5f8d5-278b-5da9-b503-b63a549cf3a8	no	Radiation Therapy, NOS	released	51ca4e0d-af26-50b7-acc3-a79aca6b37df	yes	Pharmaceutical Therapy, NOS	c2bbd6b8-02be-49ff-a5e5-6e5dd2cd2af6
7163f82e-33ef-4a92-946d-7dd07a9657af.htseq.counts.gz	06a54225-762c-4371-a94e-7836cbde6613	TCGA-36-1580-01A-01R-1566-13	TCGA-36-1580-01A-01R	TCGA-36-1580-01A-01-TS1	TCGA-36-1580-01A-01-BS1	TCGA-36-1580-01A-01		TCGA-36-1580-01A	TCGA-36-1580	533f5ff9-466c-4cdb-9c46-b841c2626775	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	2.0		a647e4da-8579-4848-b545-bc857db85d98	1.8	6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3			0.14	22	released	d8f3a035-0317-45cc-955d-540bf652d06c	RNA	R	0.14	UV Spec	released	False	5a23ef3d-566b-4060-b5a1-f6f9cf9a6a8e	01			5.0		0.0	40.0	55.0	70.0	TOP	b317174e-d87f-4853-bb63-edcaa569f579	released			10.0		0.0	45.0	45.0	70.0	BOTTOM	2d7f0952-5f56-477d-9dde-9526e5a71b6e	released	released	119.0						e134063e-745d-4c97-8d48-6f3e238daefc	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-36-1580_demographic	82	-29992	737	8a7b50d7-9032-55a0-b9b9-293f589052cc	not reported	female	not reported	released	Dead	1925	2009	TCGA-36-1580_exposure	Not Reported	5350fa43-1e64-57a6-8290-0ea093f3ff4d	released	TCGA-36-1580_diagnosis	29992	not reported	0	737	b6c3e3e6-e354-5dd8-a77d-95a47bd63099	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-36-1580_treatment	TCGA-36-1580_treatment_1	released	66904e0f-853e-5754-88cb-e9402250bd98	no	Radiation Therapy, NOS	released	5f4eb912-4cc6-5612-b796-2f3df4868509	yes	Pharmaceutical Therapy, NOS	06a54225-762c-4371-a94e-7836cbde6613
7b707153-0a5f-4923-a3d3-a53a798d4259.htseq.counts.gz	5cd1c12c-bbb8-4425-9f3c-5fd210e5aa11	TCGA-24-1104-01A-01R-1565-13	TCGA-24-1104-01A-01R	TCGA-24-1104-01A-01-TS1	TCGA-24-1104-01A-01-BS1	TCGA-24-1104-01A-01		TCGA-24-1104-01A	TCGA-24-1104	f9f44f86-10c7-4473-b156-5afbfa9a2ad0	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		4991D5F7-0259-430F-AFF7-1307DF563E41	1.8	3947333f-7cc5-4044-bc18-01a8f4426017			0.14	22	released	42b4c310-e383-4920-9d76-b9aee23f4255	RNA	R	0.14	UV Spec	released	False	ee53731b-c0da-4c04-a86d-6f2844668fcc	01			1.0					80.0	TOP	5f113d14-b733-4f7d-ad0d-3d2a0771bb8b	released			1.0					90.0	BOTTOM	c0b24512-3855-4e5f-9214-1823828394ef	released	released	157.0						fce206e4-6f50-466b-800c-7e295ea56124	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-24-1104_demographic	56	-20527	1933	2ab1be5c-ffea-5f82-b277-6ac057112641	not reported	female	white	released	Dead	1945	2006	TCGA-24-1104_exposure	Not Reported	e7a49ffe-8c98-53e2-a0a1-db7c8904fcad	released	TCGA-24-1104_diagnosis	20527	not reported	0	1933	ac7b7a1d-8dbb-502b-bd62-6f2ca7f711c4	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-24-1104_treatment	TCGA-24-1104_treatment_1	released	4b77d291-8bc5-5c6b-8245-beef617493f5	yes	Radiation Therapy, NOS	released	e2b11c9e-50cd-522d-a9e1-6186193fab42	yes	Pharmaceutical Therapy, NOS	5cd1c12c-bbb8-4425-9f3c-5fd210e5aa11
d7be2882-fa19-4a0f-937e-286066dd0642.htseq.counts.gz	1688f4c9-ec1a-48f5-8fe3-ad8e90bb21b7	TCGA-13-1408-01A-01R-1565-13	TCGA-13-1408-01A-01R	TCGA-13-1408-01A-01-BS1	TCGA-13-1408-01A-01-TS1	TCGA-13-1408-01A-01		TCGA-13-1408-01A	TCGA-13-1408	8fac8e40-beac-4059-9d54-7ee530598cfd	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.8		39435FCB-699F-4A2F-9005-E67C9A41C766	1.8	cacecdfe-9e01-409c-b45b-5076281b9da8			0.16	22	released	370e6b3f-f96e-4d08-bd34-7ea71459bc3e	RNA	R	0.16	UV Spec	released	False	2df889d4-f7e3-4d1e-9250-c4cac83edd18	01			1.0		0.0	20.0	79.0	80.0	BOTTOM	daf88d62-ca7c-4479-b027-16e04a5c66e4	released			0.0		0.0	20.0	80.0	80.0	TOP	8ba1c97e-931d-4dab-8ee6-438648815551	released	released	100.0						1e5e8214-4132-461d-ae3e-bd1f87faa61d	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-1408_demographic	59	-21635	1680	45f8a427-8d1d-5aae-b1f3-7f698c460b17	not hispanic or latino	female	white	released	Dead	1949		TCGA-13-1408_exposure	Not Reported	e7691733-0d2b-5198-9e50-3ba9f1cc8663	released	TCGA-13-1408_diagnosis	21635	not reported	0	180	8ea974b6-785e-5566-a7c3-61fc6c0fd914	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1408_treatment_1	TCGA-13-1408_treatment	released	9bb74924-c327-5393-bacf-b0968f0cfeba	yes	Pharmaceutical Therapy, NOS	released	d62233c1-db6f-5c67-8080-81da1707a968	no	Radiation Therapy, NOS	1688f4c9-ec1a-48f5-8fe3-ad8e90bb21b7
8cfe4a4f-7ca0-49fa-8820-99321c22176d.htseq.counts.gz	65517e82-3d69-4e81-87c2-69bef989c1c7	TCGA-31-1950-01A-01R-1568-13	TCGA-31-1950-01A-01R	TCGA-31-1950-01A-01-TS1	TCGA-31-1950-01A-01-BS1	TCGA-31-1950-01A-01		TCGA-31-1950-01A	TCGA-31-1950	4ca9c0e8-75a7-4665-9d88-6dd2bb44b1e1	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.2		4ed80cbd-e56d-4d09-b8ac-2b6535346b73	1.8	a32eba80-dbe9-464e-8102-5f77a3c7e177			0.16	22	released	0039da56-450d-44a5-824e-f1e080e8e60e	RNA	R	0.16	UV Spec	released	False	7625c2c5-050a-4451-a462-c7c83130133c	01			5.0		0.0	15.0	80.0	85.0	TOP	42495a8a-15e3-4fc2-aaeb-37f45493e9a5	released			2.0		0.0	85.0	13.0	85.0	BOTTOM	d428155b-53a5-486a-b938-824b3a3f438f	released	released	106.0						5ce49570-ce22-4370-9d38-6cf43f808e81	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-31-1950_demographic	76	-28100		2e01658c-ae7d-592e-8f7b-a56b8851c913	not hispanic or latino	female	white	released	Alive	1931		TCGA-31-1950_exposure	Not Reported	8e178f78-d95b-58f1-9adc-60c31647f493	released	TCGA-31-1950_diagnosis	28100	not reported	0	571	c87e9e32-50c5-54fd-8808-7ca57c0c7543	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-31-1950_treatment_1	TCGA-31-1950_treatment	released	9f214c4d-3e30-572c-9076-4128ed89d2b9	yes	Pharmaceutical Therapy, NOS	released	0b4b1ab2-75a9-5a17-aa6e-00429fdae651	no	Radiation Therapy, NOS	65517e82-3d69-4e81-87c2-69bef989c1c7
f9dc7237-e186-40e8-ab4c-d142dba7cf3d.htseq.counts.gz	dd9bc896-11ad-4156-9fd2-e85be97507e4	TCGA-09-1670-01A-01R-1566-13	TCGA-09-1670-01A-01R	TCGA-09-1670-01A-01-BS1	TCGA-09-1670-01A-01-TS1	TCGA-09-1670-01A-01		TCGA-09-1670-01A	TCGA-09-1670	60014a6e-6a13-4f92-bbfd-eeeee9632f98	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.6		5cc85cd9-99c4-4087-bdc5-8039b0369538	1.8	eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4			0.16	22	released	89007f69-a97a-4123-9b44-11e38df9d244	RNA	R	0.16	UV Spec	released	False	99db2200-966d-41b4-8268-1da18e4fdfb8	01			0.0		0.0	5.0	95.0	99.0	BOTTOM	add0cb07-6946-4e37-ac37-5bf786c99bc8	released			0.0		0.0	5.0	95.0	99.0	TOP	e32f1bda-c2b1-4475-a544-b4cc03320371	released	released	96.0						1ad76860-b19e-45ac-b81a-bb0bdac2b5ab	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-09-1670_demographic	57	-21147		6b43a657-6688-5c19-a029-98a9960eb782	not reported	female	white	released	Alive	1948		TCGA-09-1670_exposure	Not Reported	c15fb269-5358-580b-be4e-fd7afa02568b	released	TCGA-09-1670_diagnosis	21147	not reported	0	547	35db92e7-eaa8-5d22-ba3a-cde96978732d	Stage IIIA	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-09-1670_treatment	TCGA-09-1670_treatment_1	released	ed415d17-e6ec-504f-a7da-248bb4055e92	no	Radiation Therapy, NOS	released	29e36edc-b7f5-5f7b-8407-9f7160a82ff3	yes	Pharmaceutical Therapy, NOS	dd9bc896-11ad-4156-9fd2-e85be97507e4
a46fc22b-4074-4184-b471-c372139f9486.htseq.counts.gz	6795735e-e8ff-4c8a-9149-7e25e24f7cce	TCGA-29-1776-01A-01R-1567-13	TCGA-29-1776-01A-01R	TCGA-29-1776-01A-01-TS1	TCGA-29-1776-01A-01-BS1	TCGA-29-1776-01A-01		TCGA-29-1776-01A	TCGA-29-1776	7472b3ba-9b15-4d97-8708-a2dd82ca0f45	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	0.9		eb6df66e-c6ee-4c63-889d-9f4b6ca170c7	1.8	50867fed-2fda-4c45-aa08-042087e7daa9			0.15	22	released	3d66b44d-3c68-48c3-88a6-4682f8be095c	RNA	R	0.15	UV Spec	released	False	147309dc-6b56-46db-afc7-f271de4f8d47	01	5.0		0.0		0.0	25.0	75.0	90.0	TOP	03055f59-cdd6-4ca9-8418-1736106b21df	released	5.0		0.0		0.0	15.0	85.0	90.0	BOTTOM	0b7528ff-07cf-4940-88be-d12a3191aaef	released	released	134.0						5b6791a5-2fec-41c8-87fb-9d83a3bed4bc	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1776_demographic	63	-23016		ab7de0f2-baa5-58ec-bd27-60f24523a32a	not reported	female	black or african american	released	Alive	1945		TCGA-29-1776_exposure	Not Reported	05d982f8-545e-5432-8d63-63aea9c666e8	released	TCGA-29-1776_diagnosis	23016	not reported	0	360	0716ed12-2ffb-546f-a3c1-8a2cefdfaab5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-29-1776_treatment_1	TCGA-29-1776_treatment	released	8e2a441e-02ff-56d1-8e1b-fadcb639fd00	yes	Pharmaceutical Therapy, NOS	released	cccdf89e-7a68-5630-b208-ecb71e11900a	no	Radiation Therapy, NOS	6795735e-e8ff-4c8a-9149-7e25e24f7cce
d26ea6e6-8770-486f-9d79-249e5b039606.htseq.counts.gz	5a968ee8-0c54-47ec-8da7-0a615951a0c7	TCGA-13-0887-01A-01R-1564-13	TCGA-13-0887-01A-01R	TCGA-13-0887-01A-01-BS1	TCGA-13-0887-01A-01-TS1	TCGA-13-0887-01A-01		TCGA-13-0887-01A	TCGA-13-0887	14c58def-60ee-48e0-a74b-da4eb77ef344	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.3		AAEBFF3C-EA12-4D58-A424-2463307484A3	1.8	def55de4-e4eb-4693-aa54-889cd0f88051			0.16	22	released	777c75d8-3664-4549-877c-82b96ed112e4	RNA	R	0.16	UV Spec	released	False	420c3ca2-01e9-4513-9648-66df967dc4a3	01			10.0		5.0	0.0	85.0	95.0	BOTTOM	8936aa9f-f77e-419d-ae3f-8b88933225ef	released			1.0		10.0	0.0	89.0	90.0	TOP	03c9ff20-0795-4bd1-8be1-3d7fcd15b7e9	released	released	124.0						1713ce6c-f182-41df-a356-b073002ca1f7	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0887_demographic	42	-15669	2028	05ddf2a8-4ba3-5158-ad54-369b93b80bf4	not hispanic or latino	female	white	released	Dead	1960	2007	TCGA-13-0887_exposure	Not Reported	e05d7633-6f0e-5535-97c6-2da5c2b172b1	released	TCGA-13-0887_diagnosis	15669	not reported	0	2028	5e9e3f81-ce0d-57fd-824c-1c7d28ccdbfe	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-13-0887_treatment_1	TCGA-13-0887_treatment	released	f9f306c6-ee8b-52cd-b459-c2ba80b5bbbb	yes	Pharmaceutical Therapy, NOS	released	a96bd863-5a58-5e3b-a71d-a2cf736e0240	no	Radiation Therapy, NOS	5a968ee8-0c54-47ec-8da7-0a615951a0c7
f1b52b3a-9748-4862-ba4a-a8f8e8a0166c.htseq.counts.gz	3267ca00-0daf-4ae8-94f2-830745e6d036	TCGA-13-0725-01A-01R-1564-13	TCGA-13-0725-01A-01R	TCGA-13-0725-01A-01-TS1	TCGA-13-0725-01A-01-BS1	TCGA-13-0725-01A-01		TCGA-13-0725-01A	TCGA-13-0725	446ce2a3-d328-443c-a419-3344baad0e16	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		A6CD74F2-47A0-4790-BB81-6C636DA16ADC	1.8	5551b356-0f0f-4e21-a2f5-cf539b5a490b			0.18	22	released	41389261-5ee2-4fe9-b4f6-2f211dcc1e4b	RNA	R	0.18	UV Spec	released	False	ac35ba6b-0012-4b02-b8e2-183e7d23b02c	01	50.0		0.0		0.0	10.0	90.0	95.0	TOP	93a2c5e6-57fa-4784-b8cf-29d898406640	released	50.0		0.0	50.0	40.0		60.0	90.0	BOTTOM	6cd2a2f7-689b-4674-a98e-a7ab00beaa84	released	released	117.0						4a52777f-e23f-49f8-b853-be84b9a74bda	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-13-0725_demographic	44	-16086	377	7e7cc471-edf6-5cd4-aee4-062c81eadd47	hispanic or latino	female	white	released	Dead	1958	2003	TCGA-13-0725_exposure	Not Reported	2c2993c0-fb12-52d0-a6c7-57dcec0b4c81	released	TCGA-13-0725_diagnosis	16086	not reported	0	377	5f3845f7-ab3b-5c4b-94b1-84a7afef4150	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-13-0725_treatment_1	TCGA-13-0725_treatment	released	0d64d45c-a200-5401-906c-141048d524e6	yes	Pharmaceutical Therapy, NOS	released	f02227b1-3a4c-5751-86f1-a116d2791b03	no	Radiation Therapy, NOS	3267ca00-0daf-4ae8-94f2-830745e6d036
528fc2fd-fded-426d-a62c-af4ba50e9645.htseq.counts.gz	c2c4a273-40e1-42eb-b610-8eec20dee7db	TCGA-09-1668-01B-01R-1566-13	TCGA-09-1668-01B-01R	TCGA-09-1668-01B-01-TS1	TCGA-09-1668-01B-01-BS1	TCGA-09-1668-01B-01		TCGA-09-1668-01B	TCGA-09-1668	0e475b3d-be3c-431a-ab12-5a867ea8f6cd	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	0.7		7740b3ec-1d81-4408-be9e-45ccd7e91b3a	1.8	66894abe-8af5-4fd9-9a59-cf24e57fc07f			0.17	22	released	f358ac3e-5dad-4685-8fb8-98f223800f0b	RNA	R	0.17	UV Spec	released	False	e72e2726-dac4-4624-ab20-3bf25da55669	01			5.0		0.0	10.0	85.0	95.0	TOP	a922c1f1-847e-4396-b785-63799e47fc94	released			5.0		0.0	5.0	90.0	95.0	BOTTOM	299ef5ea-edf2-4a0e-81b2-b8c28d985121	released	released	68.0						3db1f968-6db6-40c7-aacd-44921f0bf709	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-09-1668_demographic	57	-20972		750dae51-7957-57e9-9cf2-2054e1f5840a	not hispanic or latino	female	white	released	Alive	1947		TCGA-09-1668_exposure	Not Reported	50a4389b-e604-5ef9-afcb-cd720f5a1b50	released	TCGA-09-1668_diagnosis	20972	not reported	0	1684	0fbdc72e-a36b-5c66-9042-67e6732464ab	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-09-1668_treatment_1	TCGA-09-1668_treatment	released	84c8ab13-eb88-52bd-a08a-81da279571e2	yes	Pharmaceutical Therapy, NOS	released	a2ef7309-4ade-5a6a-949f-d52fe5347193	no	Radiation Therapy, NOS	c2c4a273-40e1-42eb-b610-8eec20dee7db
6c962389-a73a-4627-8a2c-41e4a1cc8df3.htseq.counts.gz	e3ff91e0-fb0b-4dc5-85f2-8771c773405d	TCGA-24-1552-01A-01R-1566-13	TCGA-24-1552-01A-01R	TCGA-24-1552-01A-01-BS1	TCGA-24-1552-01A-01-TS1	TCGA-24-1552-01A-01		TCGA-24-1552-01A	TCGA-24-1552	62379be5-13f0-474b-94d3-6f944ec4ee96	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	0.9		FF7B6D0B-D13B-473E-A924-C63CB0B46511	1.8	990bcb1f-7269-4020-8ea5-8ba338b390b8			0.14	22	released	772f2ed2-7be2-4063-91ea-112bdcd3e927	RNA	R	0.14	UV Spec	released	False	a58861b9-cde9-48dd-a2de-010a9c047710	01			5.0		0.0	5.0	90.0	99.0	BOTTOM	7af35fc5-d9df-4cce-a0c6-30dde43ad0a2	released			2.0		0.0	3.0	95.0	99.0	TOP	295ebff0-1ee5-4fe1-a6e1-35951c014456	released	released	135.0						411b4c26-fcc4-438a-8731-d0cf5dd6c74f	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-24-1552_demographic	77	-28129	1259	74a423cc-a9ec-5dd0-b5aa-5054a39621ef	not reported	female	white	released	Dead	1920	2000	TCGA-24-1552_exposure	Not Reported	66de3699-aecc-541d-96c5-f999f181a7c6	released	TCGA-24-1552_diagnosis	28129	not reported	0	1259	88f98d56-7d93-59ed-92e9-0c71546a7a92	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1997	TCGA-24-1552_treatment	TCGA-24-1552_treatment_1	released	b46cd276-b012-5291-9186-339e1ef23cd4	no	Radiation Therapy, NOS	released	9120948b-629d-5483-a7a1-4f09162e09f2	yes	Pharmaceutical Therapy, NOS	e3ff91e0-fb0b-4dc5-85f2-8771c773405d
882d61db-f3ae-4c4c-8d2d-32c18b597624.htseq.counts.gz	6975eca1-fe2a-49ff-963f-14adfcd74fed	TCGA-13-0768-01A-01R-1569-13	TCGA-13-0768-01A-01R	TCGA-13-0768-01A-01-BS1	TCGA-13-0768-01A-01-TS1	TCGA-13-0768-01A-01		TCGA-13-0768-01A	TCGA-13-0768	e732f81c-9b7d-44bd-a905-ff53fbed5009	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	0.8		7D67D0D3-105C-4A00-B104-106BE26FEE2D	1.8	f6907b8b-95a3-47a8-abe0-239c6ae60482			0.17	22	released	0b33334d-b1f5-4369-9195-6ba034c60559	RNA	R	0.17	UV Spec	released	False	5df97230-56c0-4149-8ca2-fee265c3855f	01			9.0		5.0	1.0	85.0	94.0	BOTTOM	a3e6fc49-57bd-4ae6-ab13-bf5e86f13ccf	released			1.0		10.0		89.0	90.0	TOP	209a6162-13a3-4fd1-8395-83488491ab9b	released	released	61.0						f2b9f258-092d-4f46-a6c3-f5dc86188746	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0768_demographic	73	-26999	1784	966cbbef-f952-52c3-b48d-c694642a69ee	not hispanic or latino	female	white	released	Dead	1935		TCGA-13-0768_exposure	Not Reported	b25fb536-8207-5d75-ae91-e3cbafa93c22	released	TCGA-13-0768_diagnosis	26999	not reported	0	257	d5398208-3c8b-5148-b69e-9f403cbb7786	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-0768_treatment_1	TCGA-13-0768_treatment	released	77f188f4-9908-59f8-b0ea-dc1820895137	yes	Pharmaceutical Therapy, NOS	released	b31b0776-fe73-5a8b-ae73-4dc7822bd957	no	Radiation Therapy, NOS	6975eca1-fe2a-49ff-963f-14adfcd74fed
538a1fe4-8e69-4a29-a789-da52c075e75f.htseq.counts.gz	1c07df73-e470-4755-a183-30eed2d08ea3	TCGA-13-0924-01A-01R-1564-13	TCGA-13-0924-01A-01R	TCGA-13-0924-01A-01-TS1	TCGA-13-0924-01A-01-BS1	TCGA-13-0924-01A-01		TCGA-13-0924-01A	TCGA-13-0924	fbb45305-de8d-4baf-8bd0-047b29c2e9d9	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV					False			2EA17F21-1594-430A-97E3-29C5F49CB3BC	1.7	85a4c41b-9829-48f8-9c7a-a9de870332b6			0.14	22	released	38682764-e412-4260-b8d6-74cd8b038351	RNA	R	0.14	UV Spec	released	False	2b7faaee-8756-4558-b9ab-56c937f30f0f	01			0.0		0.0	25.0	75.0	80.0	TOP	c61ffb1a-c4d3-463d-93ec-1ea5bb9ace24	released			0.0		0.0	35.0	65.0	70.0	BOTTOM	24f68578-f603-437a-894e-a74abecbb93c	released	released							5be2767c-8f8e-4b30-a3fa-bfbcce461c5c	Primary Tumor	01		released	Not Reported	released	TCGA-13-0924_demographic	45	-16670		2bf5429c-69b5-528e-ba15-0b4626f97010	not hispanic or latino	female	white	released	Alive	1963		TCGA-13-0924_exposure	Not Reported	b1891f21-0d2e-574c-a78d-4b3642c43de0	released	TCGA-13-0924_diagnosis	16670	not reported	0	2614	5fece8ec-73b8-509c-8a0c-0f513822d210	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-0924_treatment_1	TCGA-13-0924_treatment	released	98f65e04-2b74-50b6-a2e6-3190eab3571e	yes	Pharmaceutical Therapy, NOS	released	2faff6a9-9bea-53eb-9127-0273d6838332	no	Radiation Therapy, NOS	1c07df73-e470-4755-a183-30eed2d08ea3
b1808878-10a4-4024-9359-70d7ef17a439.htseq.counts.gz	45cdd029-59c8-4470-a9de-9f7955c4c340	TCGA-24-2026-01A-01R-1567-13	TCGA-24-2026-01A-01R	TCGA-24-2026-01A-01-TS1	TCGA-24-2026-01A-01-BS1	TCGA-24-2026-01A-01		TCGA-24-2026-01A	TCGA-24-2026	2517ca7a-6057-4c19-b7e1-f6d078e9881a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1	False	1		7fc3cf2f-b132-4dce-b16a-2b4a1162da14	1.8	ce0fd762-e18f-4cca-a4c4-c064dca62e60	3	20	0.15	22	released	fae45d31-ca46-4b87-85b3-48e2e1f56fc5	RNA	R	0.15	UV Spec	released	False	d7187c85-3cc8-4859-a53a-e17e46a0e377	01	0	0	0	0	0	15	85	80	TOP	9da284eb-d410-4006-9a8a-503b1e731363	released	0	2	0	0	0	10	90	90	BOTTOM	b2af0e7d-797b-40c0-bd33-71426c55f66f	released	released	122						fe8b3cb8-15ce-4d0c-b168-d8d3db4be176	Primary Tumor	01	1	released	Not Reported	released	TCGA-24-2026_demographic	79	-29050	1059	108043f3-cc98-5a3e-9410-f2aea4bf95ec	not reported	female	white	released	Dead	1916	1997	TCGA-24-2026_exposure	Not Reported	0257df96-5378-534c-9e7a-71d345cbdba4	released	TCGA-24-2026_diagnosis	29050	not reported	0	1059	d2d82e4b-87db-5610-a968-930933e83fb7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1995	TCGA-24-2026_treatment	TCGA-24-2026_treatment_1	released	68f6ac27-3f36-54a2-b22a-4c15522f35dc	no	Radiation Therapy, NOS	released	94eb2298-3e69-5f77-aaea-1247bd639a78	yes	Pharmaceutical Therapy, NOS	45cdd029-59c8-4470-a9de-9f7955c4c340
094dbc70-aa59-40b1-8ceb-1ce6e5e6bf01.htseq.counts.gz	96091213-41a1-40b9-8e7b-297ed5742a60	TCGA-13-0893-01B-01R-1565-13	TCGA-13-0893-01B-01R	TCGA-13-0893-01B-01-TS1	TCGA-13-0893-01B-01-BS1	TCGA-13-0893-01B-01		TCGA-13-0893-01B	TCGA-13-0893	15170c7f-5880-4fb6-82ce-68d3df0dfb68	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		0648E74B-766C-4AB7-BEEE-D45895413E5E	1.8	2b2d5fc7-b109-4d11-a632-db8016268840			0.14	22	released	3bda2735-b9aa-4ada-b0fa-c1ef9630f71e	RNA	R	0.14	UV Spec	released	False	87eaef24-c85f-4a0e-b77b-6f42985d701d	01			1.0		0.0	10.0	89.0	90.0	TOP	c090cde5-476a-4ba5-a3eb-9ed8e0a04085	released			1.0		0.0	10.0	89.0	90.0	BOTTOM	8fa39d98-59e4-4957-857e-06d9db47e419	released	released	113.0						8f4f9492-0d28-4747-b4bb-25ddc99e4327	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-0893_demographic	48	-17573	1319	6c86e5a1-4fa3-5421-8580-641c2765baa8	not hispanic or latino	female	black or african american	released	Dead	1955	2006	TCGA-13-0893_exposure	Not Reported	29df26eb-d840-5347-b0ec-95dd8fe19a56	released	TCGA-13-0893_diagnosis	17573	not reported	0	1319	74c32721-9793-5e47-9563-559b08a6f618	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-13-0893_treatment	TCGA-13-0893_treatment_1	released	186be6ea-fe78-538d-aeb7-be248980c0ae	no	Radiation Therapy, NOS	released	53d9c99f-8ec3-52a5-b0f0-34d79c411663	yes	Pharmaceutical Therapy, NOS	96091213-41a1-40b9-8e7b-297ed5742a60
f8cef5ad-7841-4f50-ba42-55e11ed1fc36.htseq.counts.gz	af770e08-ef4f-42be-93aa-538848e8a8ac	TCGA-04-1362-01A-01R-1565-13	TCGA-04-1362-01A-01R	TCGA-04-1362-01A-01-BS1	TCGA-04-1362-01A-01-TS1	TCGA-04-1362-01A-01		TCGA-04-1362-01A	TCGA-04-1362	1d192835-524e-429d-bf74-3c4727acb446	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		D3757F96-E669-4D0E-BBCB-41696AB72004	1.8	802ea3c6-e07f-49a1-a1c2-8f90e3197e62			0.16	22	released	256eb858-fef5-49fc-a719-a05f0a475407	RNA	R	0.16	UV Spec	released	False	03a3051e-1b8b-437d-baf0-b18ab8ddd508	01			1.0		0.0	10.0	89.0	99.0	BOTTOM	852e1e87-7168-4688-9188-4de1d318423e	released			1.0		0.0	15.0	84.0	99.0	TOP	4ebe1dd9-f87e-4fbc-bcba-25cf3d39d737	released	released	122.0						2cd492fc-4e79-4483-a8d6-31c0156c50c9	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-04-1362_demographic	59	-21745	1348	508c36c3-7b48-5032-937e-d91e566e31a6	not reported	female	white	released	Dead	1943	2005	TCGA-04-1362_exposure	Not Reported	ac873f52-dda4-51cc-be88-ce0490c32222	released	TCGA-04-1362_diagnosis	21745	not reported	0		6c650e4b-ae78-596e-8ff7-657d4f6db775	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-04-1362_treatment_1	TCGA-04-1362_treatment	released	af6f7cdf-e756-596a-a351-520cc7cf30fd	yes	Pharmaceutical Therapy, NOS	released	e4570351-8389-5e5a-a13c-13883ddf03a2	no	Radiation Therapy, NOS	af770e08-ef4f-42be-93aa-538848e8a8ac
cf3d8158-3e8d-47ba-8569-e976c8e8e1a6.htseq.counts.gz	f3c624c2-1e98-4dec-b219-3e0ff500a065	TCGA-13-0897-01A-01R-1564-13	TCGA-13-0897-01A-01R	TCGA-13-0897-01A-01-BS1	TCGA-13-0897-01A-01-TS1	TCGA-13-0897-01A-01		TCGA-13-0897-01A	TCGA-13-0897	79e6e31c-22a1-481c-903b-ab5499cbd450	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.1		058A5354-D36C-4398-AC2C-12447FDB0966	1.8	479b74bf-5003-45e1-9505-687146a5fc45			0.16	22	released	83eeecce-43b3-4131-8d7c-31f19716d157	RNA	R	0.16	UV Spec	released	False	814120ca-3d11-4fc7-913e-fadf27a37650	01			2.0		10.0	0.0	88.0	90.0	BOTTOM	dcac13fe-5762-4440-8ef6-f20f7add987c	released			1.0		10.0	0.0	89.0	90.0	TOP	06f71559-c811-4995-9983-f16452175b36	released	released	94.0						daabfedb-ac0a-4bc9-b145-9bef04bdd66f	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-13-0897_demographic	54	-19894	2182	98f76dc4-21fd-5024-915b-f6c36aa533ae	not hispanic or latino	female	white	released	Dead	1950		TCGA-13-0897_exposure	Not Reported	a3a3afcc-01f3-59b9-be80-84b073f498a6	released	TCGA-13-0897_diagnosis	19894	not reported	0	1748	2867623c-36a9-589a-b65a-25518a378ba0	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-13-0897_treatment	TCGA-13-0897_treatment_1	released	ffb36efb-aef4-5ef0-9837-15590806facc	no	Radiation Therapy, NOS	released	4e6258c2-379a-5680-855e-4fd9fdb2f683	yes	Pharmaceutical Therapy, NOS	f3c624c2-1e98-4dec-b219-3e0ff500a065
85c382ef-b9c1-4c1a-8ef1-5a2fbbb5f72a.htseq.counts.gz	9c19f0e6-c9ee-4516-8333-fbe4e5eb4eb7	TCGA-25-2399-01A-01R-1569-13	TCGA-25-2399-01A-01R	TCGA-25-2399-01A-01-BS1	TCGA-25-2399-01A-01-TS1	TCGA-25-2399-01A-01		TCGA-25-2399-01A	TCGA-25-2399	ad2b1a0a-153f-483d-b228-5763eba3f6cc	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.6		38AEA3BF-A853-4719-B308-63884A6F8F13	1.8	28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1			0.15	22	released	6b7021e6-8ae5-4446-8455-759e552e6eb8	RNA	R	0.15	UV Spec	released	False	b474ddc6-6185-4469-b2f1-65584a0a3e5f	01			5.0		0.0	5.0	90.0	95.0	BOTTOM	55932ba7-125d-49c0-bb6d-b1c4b9d2622f	released			5.0		0.0	5.0	90.0	95.0	TOP	cf0cf6b0-d4ab-45d5-a7f1-16823526f35e	released	released	104.0						c9aa6cf0-f536-4640-8290-3e745ae2a36b	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-25-2399_demographic	80	-29373	608	bf26361b-e6d4-5693-b15f-d91ed2a71b5f	not hispanic or latino	female	white	released	Dead	1924	2005	TCGA-25-2399_exposure	Not Reported	38afbc7b-da23-5e37-b5e3-6aefc0737154	released	TCGA-25-2399_diagnosis	29373	not reported	0	608	e1731d67-eada-531d-baa0-f203daa3117c	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-25-2399_treatment	TCGA-25-2399_treatment_1	released	b0e7aa92-8bc0-5c75-b202-cda6572df638	no	Radiation Therapy, NOS	released	abf47353-a2ca-5444-9260-891b689bd767	yes	Pharmaceutical Therapy, NOS	9c19f0e6-c9ee-4516-8333-fbe4e5eb4eb7
623e04e4-491d-4381-8c11-b64ece9a4c31.htseq.counts.gz	9f8f10ec-5cbb-4284-a41d-46b158e9ff3e	TCGA-24-1470-01A-01R-1566-13	TCGA-24-1470-01A-01R	TCGA-24-1470-01A-01-TS1	TCGA-24-1470-01A-01-BS1	TCGA-24-1470-01A-01		TCGA-24-1470-01A	TCGA-24-1470	a3898640-0d85-441d-a000-b5b8ff857399	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		f47eefcf-f15d-42cb-8bd2-d0c252ecafb3	1.8	f2066443-2f17-4279-a993-f07961259108			0.16	22	released	5a7e32dd-3b74-419e-b536-a77367edfe97	RNA	R	0.16	UV Spec	released	False	7ec05bd6-a496-440c-b0ec-fc2c468526ab	01			1.0		0.0	4.0	95.0	95.0	TOP	b8c86d30-2ff5-4a29-b5c9-deb324c8427a	released			1.0		0.0	29.0	70.0	70.0	BOTTOM	b1fce053-0934-489a-b25c-2d05505e4bce	released	released	131.0						5287e961-91f0-4fb0-a00a-d570377cee62	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1470_demographic	54	-20007		db352bc7-95c7-59df-a9fe-4655e1c409df	not reported	female	white	released	Alive	1955		TCGA-24-1470_exposure	Not Reported	d576c7a4-6b92-5735-a833-b247dfb35493	released	TCGA-24-1470_diagnosis	20007	not reported	0	105	7baca1af-8043-51b5-ab12-d87b025a8ded	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-24-1470_treatment	TCGA-24-1470_treatment_1	released	f4a5e8c4-7ce4-5a44-9abd-6942c0721e86	no	Radiation Therapy, NOS	released	6b41f8ea-8ce6-5578-b09f-c515ad89cbd7	yes	Pharmaceutical Therapy, NOS	9f8f10ec-5cbb-4284-a41d-46b158e9ff3e
f6a67523-d202-4ce7-af2e-b2cc4d8db20a.htseq.counts.gz	49e52b73-9259-410c-8bb8-9541aa34f9b3	TCGA-10-0933-01A-01R-1569-13	TCGA-10-0933-01A-01R	TCGA-10-0933-01A-01-TS1	TCGA-10-0933-01A-01-BS1	TCGA-10-0933-01A-01		TCGA-10-0933-01A	TCGA-10-0933	9446e349-71e6-455a-aa8f-53ec96597146	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	1.0		f973309d-55dd-489b-a7ca-9348666a9129	1.8	484100a8-fa3b-4d8a-9051-de0ba8035cb4			0.15	22	released	d5f967ae-d7f5-4b62-8e28-1e698ebe2f67	RNA	R	0.15	UV Spec	released	False	e69a9138-7249-492a-acc4-b61b7c73dbf0	01	0.0		0.0	0.0	5.0	5.0	90.0	90.0	TOP	4193c207-aac8-400e-be84-1ff6ebccd090	released			0.0		5.0	10.0	85.0	90.0	BOTTOM	56e3863d-bfc6-4a9c-95e0-e6ee735e134f	released	released	153.0						1d568bd2-d658-40fa-a341-daa4d2a5bb22	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-10-0933_demographic	77	-28433	446	5dcb5210-ad8c-5ee3-806a-4305cfba74e6	not hispanic or latino	female	white	released	Dead	1926	2004	TCGA-10-0933_exposure	Not Reported	87991217-6530-55c0-9bda-b46d229953e3	released	TCGA-10-0933_diagnosis	28433	not reported	0	356	c1a0ef23-5337-5624-91ed-fca9c7b85f47	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-10-0933_treatment	TCGA-10-0933_treatment_1	released	23a22951-5b42-5c90-ba99-ce22fc046fbc	no	Radiation Therapy, NOS	released	1fbe4de0-2ae1-5b22-9257-f035d632e091	yes	Pharmaceutical Therapy, NOS	49e52b73-9259-410c-8bb8-9541aa34f9b3
273c58d9-1f2a-491c-8487-408f751a7a3b.htseq.counts.gz	a12332f0-a812-4379-b46c-e714b63f43bc	TCGA-24-2289-01A-01R-1568-13	TCGA-24-2289-01A-01R	TCGA-24-2289-01A-01-TS1	TCGA-24-2289-01A-01-BS1	TCGA-24-2289-01A-01		TCGA-24-2289-01A	TCGA-24-2289	b867e933-e3e3-4491-9bb6-b18c48d6f173	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		3c9bb67a-702f-4e9b-bd0f-c0ef8a5d237d	1.8	bdc4400c-c552-450b-a806-2ae10f61cca8			0.14	22	released	0f99983f-913e-44d4-b6db-6962acbf7327	RNA	R	0.14	UV Spec	released	False	e4c845a5-946a-4723-854d-7b6ad1212418	01			1.0		0.0	10.0	89.0	90.0	TOP	4f5337c4-78ae-449f-8452-71be5ba1dd69	released			1.0		0.0	10.0	89.0	90.0	BOTTOM	9a729ef3-7079-43be-a05c-14bba09008f5	released	released	139.0						f39ab685-fda1-43e8-aa70-fa3ed1566061	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-2289_demographic	68	-25191	2049	c9b134f1-5648-5775-8531-9769fbda3073	not reported	female	white	released	Dead	1929	2002	TCGA-24-2289_exposure	Not Reported	94c9a000-21e6-532e-a1f0-0b373eafa3a8	released	TCGA-24-2289_diagnosis	25191	not reported	0	2049	566061b0-53fa-5c9b-aba1-fe01ff343b32	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1997	TCGA-24-2289_treatment	TCGA-24-2289_treatment_1	released	13ec1c2a-b48f-5fce-a7c0-e091a367564f	no	Radiation Therapy, NOS	released	59cb9582-25ba-5d4f-a455-5762716dfe22	yes	Pharmaceutical Therapy, NOS	a12332f0-a812-4379-b46c-e714b63f43bc
9a420e2d-15c8-41f3-859f-25872765f75e.htseq.counts.gz	a2d8e28d-0371-4421-8ca4-4629a8cc7b72	TCGA-24-1557-01A-01R-1566-13	TCGA-24-1557-01A-01R	TCGA-24-1557-01A-01-TS1	TCGA-24-1557-01A-01-BS1	TCGA-24-1557-01A-01		TCGA-24-1557-01A	TCGA-24-1557	7dcc809b-e33a-4453-b92a-c00786f48cb0	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.5		ec04339c-f1ae-4519-bddf-e60cc1f30d52	1.8	bca48aa6-25bc-49e4-8bb5-edf38362b4a8			0.15	22	released	c3cb4f02-5939-4861-8779-3549c858200f	RNA	R	0.15	UV Spec	released	False	c3c6697d-2ddc-4a7f-9123-14e430ee2766	01			2.0		0.0	8.0	90.0	90.0	TOP	37ecb22e-99d5-46d8-b90f-34c35bb96139	released			5.0		0.0	10.0	85.0	85.0	BOTTOM	d09c8628-1498-4b56-8be4-82531a96b579	released	released	121.0						fa79b363-380e-48ae-bb82-db395085353c	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1557_demographic	49	-17943	1213	c20d3b88-776c-5d07-aa24-9bff0c574c2b	not reported	female	white	released	Dead	1951	2003	TCGA-24-1557_exposure	Not Reported	b0dcd669-0f99-571d-88b7-d19045df4b98	released	TCGA-24-1557_diagnosis	17943	not reported	0	1213	017a1126-1b80-5060-b971-d27b20147a99	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-24-1557_treatment_1	TCGA-24-1557_treatment	released	058d5944-be12-5d69-8f6a-1dd93e1ab488	yes	Pharmaceutical Therapy, NOS	released	e67a217f-812e-5248-be04-40dd2c35c244	no	Radiation Therapy, NOS	a2d8e28d-0371-4421-8ca4-4629a8cc7b72
765c9c00-fbd8-4dac-89da-a4cee971e8bd.htseq.counts.gz	a4425c8c-63bf-489c-9d2c-4e951e3181a9	TCGA-23-1026-01B-01R-1569-13	TCGA-23-1026-01B-01R	TCGA-23-1026-01B-01-BS1	TCGA-23-1026-01B-01-TS1	TCGA-23-1026-01B-01		TCGA-23-1026-01B	TCGA-23-1026	c6ede8ae-881c-47a0-a0ef-745ed4b7764a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	0.8		E41E1018-422B-4B4A-8732-C9389847830D	1.8	973907c7-f259-4d1a-b9df-68db1837af91			0.16	22	released	99f7299e-9a2f-45c7-8757-819b4142e54f	RNA	R	0.16	UV Spec	released	False	093e7505-61c6-4e9a-8477-0502a772efa8	01			5.0		0.0			80.0	BOTTOM	6f43fabb-d511-4b5f-bd09-37d885a34ddd	released			5.0		0.0			80.0	TOP	6d8886c6-37c0-4fd8-b847-b5b40d84742f	released	released	107.0						30d07f1e-0899-4d8f-9bd9-abe572affc8c	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-23-1026_demographic	45	-16442		c1602427-bdf1-51ea-b682-09a7e2a740c1	not hispanic or latino	female	white	released	Alive	1959		TCGA-23-1026_exposure	Not Reported	766ab0bd-a20b-598b-b596-4daa9f5bf337	released	TCGA-23-1026_diagnosis	16442	not reported	0	816	0a5bc544-d5cc-57d6-85e2-fd38deb2fccb	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-23-1026_treatment_1	TCGA-23-1026_treatment	released	19d2db56-2541-59ff-b73c-1521c07620c1	yes	Pharmaceutical Therapy, NOS	released	abcd3aa9-29eb-52a2-a30b-9378a2110059	no	Radiation Therapy, NOS	a4425c8c-63bf-489c-9d2c-4e951e3181a9
9e198dfe-9fc6-48e2-ba06-90c49ddf48aa.htseq.counts.gz	769c5f60-fdf1-49b1-bba3-7f4a3ef1f9a8	TCGA-29-1701-01A-01R-1567-13	TCGA-29-1701-01A-01R	TCGA-29-1701-01A-01-TS1	TCGA-29-1701-01A-01-BS1	TCGA-29-1701-01A-01		TCGA-29-1701-01A	TCGA-29-1701	86b513ba-df09-485d-92d4-fb9e888f7350	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.3		f7568046-b77a-4654-9f94-8978bd3e22c4	1.8	e5e6f25b-d641-4598-8bb1-0850750ef048			0.16	22	released	c9c89c72-dbea-42fa-a0d3-ae48915fdb73	RNA	R	0.16	UV Spec	released	False	3be60d94-02c6-4ebf-967c-e842877627be	01			2.0		0.0	0.0	98.0	90.0	TOP	1e5a96c0-8c8b-49fe-8083-4e9b2248d324	released			2.0		0.0	0.0	98.0	90.0	BOTTOM	d847a62d-bdbf-4972-b4f1-4d817ced7de5	released	released	97.0						eae870be-bbc8-4ffe-bffc-86d87414ff4b	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-29-1701_demographic	56	-20737	515	5a7b3dcd-6dc2-5969-88a3-e6623cb00004	not reported	female	white	released	Dead	1948	2005	TCGA-29-1701_exposure	Not Reported	51ff74bd-eb63-5ebf-81a2-207d7b074690	released	TCGA-29-1701_diagnosis	20737	not reported	0	514	7970b8af-897d-58cd-9c10-f467a239f1d1	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-29-1701_treatment	TCGA-29-1701_treatment_1	released	2411538c-6d01-5b61-969d-ff4d50ed1969	no	Radiation Therapy, NOS	released	d7bcaf35-79b6-5dee-a905-83f6bf1d8dc3	yes	Pharmaceutical Therapy, NOS	769c5f60-fdf1-49b1-bba3-7f4a3ef1f9a8
d73c0f69-ab9b-4408-bf89-aa34bf829351.htseq.counts.gz	7c8ea118-fbce-4dc9-803d-1b6e30d06704	TCGA-10-0931-01A-01R-1564-13	TCGA-10-0931-01A-01R	TCGA-10-0931-01A-01-BS1	TCGA-10-0931-01A-01-TS1	TCGA-10-0931-01A-01		TCGA-10-0931-01A	TCGA-10-0931	e07a61e2-bcd2-4a96-80df-97e04aafbd32	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	0.5		45d8f828-6dfb-4e68-8282-f2ee74671461	1.8	3dbc3349-abcf-4e54-879e-1de74ee2b334			0.16	22	released	543f46ee-d47b-481f-b8df-a617bcf2bf85	RNA	R	0.16	UV Spec	released	False	4326d7e3-06e4-483d-b6b7-f0f8bfa6ec16	01			0.0		0.0	5.0	95.0	98.0	BOTTOM	0d63b5df-9fa6-4bdf-bd67-69e60e710137	released			0.0		5.0	10.0	85.0	85.0	TOP	f6dbb223-2348-40fe-8da2-e93c3071d823	released	released	102.0						f46d6e67-40ef-4a8c-99fc-700d8e598131	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-10-0931_demographic	44	-16262	1000	9d30f62d-cadc-5d3f-8505-00561713c897	not reported	female	white	released	Dead	1958	2004	TCGA-10-0931_exposure	Not Reported	46c49118-7b30-53bc-b837-3a74c2d4212c	released	TCGA-10-0931_diagnosis	16262	not reported	0	982	da8e8e22-7514-538e-8029-9f2dd1dbf55e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-10-0931_treatment_1	TCGA-10-0931_treatment	released	7c82253d-04be-558d-b5b1-56dc5140ce4d	yes	Pharmaceutical Therapy, NOS	released	9f28ef7c-ec38-53e3-9538-b454efcde173	no	Radiation Therapy, NOS	7c8ea118-fbce-4dc9-803d-1b6e30d06704
825ebcdf-3e59-4d89-9f6d-b27c7dc896d1.htseq.counts.gz	404db5ef-a2b5-4c2c-b238-854588e7083a	TCGA-24-1563-01A-01R-1566-13	TCGA-24-1563-01A-01R	TCGA-24-1563-01A-01-BS1	TCGA-24-1563-01A-01-TS1	TCGA-24-1563-01A-01		TCGA-24-1563-01A	TCGA-24-1563	52386f66-2877-4c75-894e-5c1dc03e6ef4	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.1		6fdeb714-439d-49d7-aae0-99166a3e8eba	1.8	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a			0.15	22	released	4ce1bd1f-d4f6-4acc-b956-6ed570fbb92d	RNA	R	0.15	UV Spec	released	False	91b36320-3d8e-4081-84db-4e90c7cf112e	01			1.0		0.0	30.0	69.0	70.0	BOTTOM	77a77ca5-d792-4b25-9b37-f9f5ba572e04	released			5.0		0.0	10.0	85.0	90.0	TOP	3f251140-d701-4deb-b82e-4924e4667a14	released	released	133.0						9347d927-3747-4f06-ab2a-672aefdf48ea	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-1563_demographic	66	-24274	1451	f6f97e46-62a4-5b7b-bd32-9be8b0952a2c	not reported	female	black or african american	released	Dead	1933	2002	TCGA-24-1563_exposure	Not Reported	a5ba4d34-56c4-5c87-8e28-1902f343dca3	released	TCGA-24-1563_diagnosis	24274	not reported	0	1451	c88a4db0-50d4-5c23-969b-c211f9b47565	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-24-1563_treatment_1	TCGA-24-1563_treatment	released	12a872ab-0daf-503c-888b-1305ff3ab70c	yes	Pharmaceutical Therapy, NOS	released	27512de5-2152-56f1-9d7a-00e7b5484dbc	no	Radiation Therapy, NOS	404db5ef-a2b5-4c2c-b238-854588e7083a
e360132f-9b30-4d44-ba1c-68941706d9ee.htseq.counts.gz	be8e6614-d088-48a0-8875-deb6ce6bb293	TCGA-25-1320-01A-01R-1565-13	TCGA-25-1320-01A-01R	TCGA-25-1320-01A-01-BS1	TCGA-25-1320-01A-01-TS1	TCGA-25-1320-01A-01		TCGA-25-1320-01A	TCGA-25-1320	46395c3d-5e51-477f-946e-e58b87cc7baa	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				3.0	False	3.4		AF68EF8D-A31D-453B-8083-CF6B9EE4E838	1.8	52697815-ede2-4ce3-a6d0-2680f6b9bb73			0.17	22	released	b1e2e405-3b0f-49e8-b225-cce836277aab	RNA	R	0.17	UV Spec	released	False	db678e66-b2d5-42d1-8ba4-4ad77903b90e	01			0.0		0.0	30.0	70.0	95.0	BOTTOM	61670b41-a75a-42e1-a67e-17b3c9e5d31c	released			5.0		0.0	25.0	70.0	85.0	TOP	7baccc6e-48b9-4f66-b04a-5a550b77dfce	released	released	112.0						97a91868-8a8d-4b2d-bba2-8bd187f572ac	Primary Tumor	01	1.0	released	Not Reported	released	TCGA-25-1320_demographic	65	-24018	1155	1720ccc7-09c1-5f51-9513-6a8de9c133e6	not hispanic or latino	female	white	released	Dead	1936	2004	TCGA-25-1320_exposure	Not Reported	d25630cb-de47-51dc-be38-ab27f7fff50d	released	TCGA-25-1320_diagnosis	24018	not reported	0	1124	1786b36d-9344-51a7-bf6a-5abd3ce5549b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-25-1320_treatment	TCGA-25-1320_treatment_1	released	5c815fd4-2587-570d-8b77-cdb0cac1612d	no	Radiation Therapy, NOS	released	4baf7418-3b59-5bea-b36b-4cf01e48c072	yes	Pharmaceutical Therapy, NOS	be8e6614-d088-48a0-8875-deb6ce6bb293
608f7a0f-75a7-425d-9a82-6bf7e2023138.htseq.counts.gz	9a50e40d-2803-46cb-9887-d54d3a09f1a6	TCGA-13-0900-01B-01R-1565-13	TCGA-13-0900-01B-01R	TCGA-13-0900-01B-01-TS1	TCGA-13-0900-01B-01-BS1	TCGA-13-0900-01B-01		TCGA-13-0900-01B	TCGA-13-0900	9e48a4b1-6917-4625-9d78-e4832eb816a5	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.5		27A4B579-9123-431C-95B6-FBC5CB5142C9	1.8	48c027ac-0580-43aa-9356-f56b3d897127			0.15	22	released	644e9281-6062-48c2-a14c-4dc992e504ad	RNA	R	0.15	UV Spec	released	False	85aafcad-c9a1-4fd5-932f-1e326d93b9b2	01			1.0		0.0	15.0	84.0	85.0	TOP	bd003171-83a0-4ad5-a012-58abfa9d00de	released			5.0		0.0	20.0	75.0	80.0	BOTTOM	a7ab33bd-827e-4ab7-b7c5-7163a3518e93	released	released	125.0						f9cd355d-0a69-4479-bacd-b281c5056385	Primary Tumor	01	0.1	released	Not Reported	released	TCGA-13-0900_demographic	59	-21698		5d5bb297-6177-5d8a-8562-cbfa5c0f119a	not hispanic or latino	female	white	released	Alive	1945		TCGA-13-0900_exposure	Not Reported	6fd63f19-3039-587d-88d9-92c485f9f2b5	released	TCGA-13-0900_diagnosis	21698	not reported	0	4077	0637c309-0ed0-5cbf-a47b-4d33baea8096	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-13-0900_treatment	TCGA-13-0900_treatment_1	released	6fc269ae-92bb-54f9-b556-34237de627ea	no	Radiation Therapy, NOS	released	3442e105-3c66-537c-b442-7e35ffd2e27e	yes	Pharmaceutical Therapy, NOS	9a50e40d-2803-46cb-9887-d54d3a09f1a6
a2082ad4-279e-422f-b5a7-cb7fbeb7a6df.htseq.counts.gz	1480554d-8579-4146-93ba-a7b23b8c9a5b	TCGA-24-2027-01A-01R-1567-13	TCGA-24-2027-01A-01R	TCGA-24-2027-01A-01-TS1	TCGA-24-2027-01A-01-BS1	TCGA-24-2027-01A-01		TCGA-24-2027-01A	TCGA-24-2027	219f54ef-4235-482d-b799-f2fa9930105c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.6		8a4d0373-9d57-4cf7-ac78-d8b558d43df6	1.8	fc1f34ba-12e1-46d8-85ef-15b9486b37c2			0.15	22	released	7c51887a-114f-4223-8bd3-4fbbaa73cacd	RNA	R	0.15	UV Spec	released	False	378430bb-b6ce-469c-9c6a-66a6843b382e	01	0.0	0.0	0.0	0.0	0.0	5.0	95.0	85.0	TOP	d6d55952-e8db-460f-aaff-9cc1b9044610	released	0.0	0.0	3.0	0.0	0.0	7.0	90.0	85.0	BOTTOM	84920977-5b25-4424-a913-41bc08ac0250	released	released	157.0						d458ab44-bd23-410d-9ffa-4d469d16c62b	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-24-2027_demographic	51	-18835	3337	5baa23ff-1696-5388-a54c-c4fbd711013e	not reported	female	white	released	Dead	1944	2004	TCGA-24-2027_exposure	Not Reported	990b979c-f8e0-5820-abf1-0df4a7a925e9	released	TCGA-24-2027_diagnosis	18835	not reported	0	3337	7e4bfb50-f7b9-5a44-a69e-28e275a0517e	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1995	TCGA-24-2027_treatment	TCGA-24-2027_treatment_1	released	3f913450-7829-55de-a999-e5e30b983e2e	no	Radiation Therapy, NOS	released	cdd6ad1d-5e70-50ef-8287-688eaa0cf705	yes	Pharmaceutical Therapy, NOS	1480554d-8579-4146-93ba-a7b23b8c9a5b
15241763-4cf7-452e-bc24-b3d877348b2d.htseq.counts.gz	cce1ef9f-8f6e-48a9-985a-6c65ec81a072	TCGA-61-1725-01A-01R-1567-13	TCGA-61-1725-01A-01R	TCGA-61-1725-01A-01-TS1	TCGA-61-1725-01A-01-BS1	TCGA-61-1725-01A-01		TCGA-61-1725-01A	TCGA-61-1725	a6eb0cd0-fe57-41b0-8593-776208684293	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.0		8bcf7f73-abe7-43d0-a7da-ede3f5c2bb04	1.8	748ff969-cb49-4f22-994f-6debe734c38f			0.15	22	released	e2608fdf-7c1f-4a21-a11a-1d7da53e147b	RNA	R	0.15	UV Spec	released	False	6a29c6f2-ee27-475b-b791-8d4c775b47a6	01			20.0		0.0	0.0	80.0	90.0	TOP	99fc6def-5952-425f-ac0f-393aac908d99	released			10.0		0.0	0.0	90.0	95.0	BOTTOM	19559478-b60e-4af8-b6f0-a6773f29175a	released	released	137.0						6ecade07-4c2f-4587-9c8b-589943f1c9e6	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-1725_demographic	40	-14782		1567ed8d-6ce0-5fab-b6a3-901c244c2235	not hispanic or latino	female	white	released	Alive	1967		TCGA-61-1725_exposure	Not Reported	0afb41eb-ce05-50e8-8958-76ecfbc77d77	released	TCGA-61-1725_diagnosis	14782	not reported	0	956	9ff03257-e85c-5449-95be-ea2f7d51e27d	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-61-1725_treatment	TCGA-61-1725_treatment_1	released	d5198be0-1414-55b3-98ae-cbb0ea820f6a	no	Radiation Therapy, NOS	released	dee5760d-256d-5621-ada4-aed762c20c1b	yes	Pharmaceutical Therapy, NOS	cce1ef9f-8f6e-48a9-985a-6c65ec81a072
aac2baeb-b9e2-4e94-82c5-8d591d90cf91.htseq.counts.gz	5c82be6c-b892-4dea-8b79-5a220f244af7	TCGA-04-1343-01A-01R-1564-13	TCGA-04-1343-01A-01R	TCGA-04-1343-01A-01-BS1	TCGA-04-1343-01A-01-TS1	TCGA-04-1343-01A-01		TCGA-04-1343-01A	TCGA-04-1343	b7715ff6-57a6-4513-9447-aa8bc93f16d4	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		E62828D9-A46C-498F-9976-CC430D16057E	1.7	e7aeb2b8-2a2d-4175-94f4-0192bd467fed			0.15	22	released	b014326b-ee98-4e0a-92eb-9d323f79e5c0	RNA	R	0.15	UV Spec	released	False	833c21be-ce02-4030-8483-0c095df89b4a	01			4.0		0.0	16.0	80.0	88.0	BOTTOM	ffc80a0b-db70-456c-8e52-4f59b621a8be	released			1.0		0.0	4.0	95.0	93.0	TOP	75e55c68-3906-434a-8f27-6e0592e859ba	released	released	108.0						1d8b4c59-7500-4951-80bc-bfd7a035b876	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-04-1343_demographic	72	-26428	361	f71d969e-38e8-523e-8db7-d8b2e3f0ae0c	not hispanic or latino	female	white	released	Dead	1930	2002	TCGA-04-1343_exposure	Not Reported	1e3460de-aa51-5598-9ba7-c25bf5a4b864	released	TCGA-04-1343_diagnosis	26428	not reported	0		bd744f83-779b-5ca5-af2b-45670de8fcec	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-04-1343_treatment	TCGA-04-1343_treatment_1	released	3a42b4ee-f935-5ed4-a090-fd63bb17beb5	no	Radiation Therapy, NOS	released	121b2f05-a0c1-5039-80af-45256c12a3d1	yes	Pharmaceutical Therapy, NOS	5c82be6c-b892-4dea-8b79-5a220f244af7
87fd11ca-f797-4336-8e23-c8c0ccef6b0c.htseq.counts.gz	fe231cb1-4529-455c-93ea-50240194a8bb	TCGA-61-1998-01A-01R-1568-13	TCGA-61-1998-01A-01R	TCGA-61-1998-01A-01-TS1	TCGA-61-1998-01A-01-BS1	TCGA-61-1998-01A-01		TCGA-61-1998-01A	TCGA-61-1998	565d06a1-3640-4274-8fb3-8cad7e578876	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.0		788d25c6-75c4-4c85-be93-98dec021219a	1.8	0814c20e-fe77-4ff9-ab5e-a8ae2f74069d			0.13	22	released	b78bf7f3-25ae-4e77-8715-f9e719c7baea	RNA	R	0.13	UV Spec	released	False	4c40be97-c972-47f7-bb31-6e331fa52610	01			15.0		15.0	40.0	30.0	90.0	TOP	594237ab-2edf-49de-b4ab-b59f95a07052	released			5.0		15.0	72.0	8.0	90.0	BOTTOM	16a1dc45-c69e-46ef-b90c-e3434676491d	released	released	119.0						981e7677-6bde-4617-8c24-732d606b81e4	Primary Tumor	01	0.1	released	Not Reported	released	TCGA-61-1998_demographic	48	-17855		dcf3372c-5c88-5b4b-96fe-6f38ca251168	not hispanic or latino	female	white	released	Alive	1961		TCGA-61-1998_exposure	Not Reported	8ade61dd-42cb-5e69-99ac-3f1d5e6f3214	released	TCGA-61-1998_diagnosis	17855	not reported	0	168	720e8667-af0a-5909-9705-68bab71ed9f5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-61-1998_treatment	TCGA-61-1998_treatment_1	released	e3fafe10-5118-51b1-8db6-d84c45daec73	no	Radiation Therapy, NOS	released	9075722f-7088-5346-8f74-d8d3d32535b9	yes	Pharmaceutical Therapy, NOS	fe231cb1-4529-455c-93ea-50240194a8bb
8fc333b1-b2ee-4eff-afa9-8606b282a341.htseq.counts.gz	23dfce3d-1352-489b-b8dc-99acf159f92b	TCGA-23-1123-01A-01R-1565-13	TCGA-23-1123-01A-01R	TCGA-23-1123-01A-01-TS1	TCGA-23-1123-01A-01-BS1	TCGA-23-1123-01A-01		TCGA-23-1123-01A	TCGA-23-1123	60cce7ac-d27d-44a6-9873-ecf91da5e906	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	0.8		28f9189b-24eb-4540-8551-4eaacc296c20	1.8	71543abc-9f15-48d9-994d-e7b963a4d8f3			0.15	22	released	37806515-25d9-4b0f-b556-fe6239f12cb9	RNA	R	0.15	UV Spec	released	False	ededaff5-f223-4e4d-89c5-b8f3eb6ba74e	01			0.0		0.0	0.0	0.0	95.0	TOP	9d6036ea-f3bb-4e32-b1b1-51d0a4363b3a	released			5.0		0.0	0.0	0.0	95.0	BOTTOM	cd3395cb-5e52-4549-8e3d-731ad55c5534	released	released	131.0						ed537d83-388b-4125-8c8c-204a0bcbcde8	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-23-1123_demographic	59	-21552	1018	ce764708-fee9-5782-b207-acbf274a2c5e	not hispanic or latino	female	white	released	Dead	1939	2000	TCGA-23-1123_exposure	Not Reported	c12c61b4-81df-5b38-87ec-b153a7ee4938	released	TCGA-23-1123_diagnosis	21552	not reported	0		394df501-4b80-527f-91ba-621c945330b6	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-23-1123_treatment_1	TCGA-23-1123_treatment	released	f2622ffb-0a1f-57a4-b3ce-1fb6c92b1873	yes	Pharmaceutical Therapy, NOS	released	fdde878a-f1e1-5022-90a0-86319fee955a	no	Radiation Therapy, NOS	23dfce3d-1352-489b-b8dc-99acf159f92b
ffa465fc-7af9-401f-af3c-bca394a1ab25.htseq.counts.gz	9ec661a4-5c62-49e5-836d-4fd07bc37015	TCGA-61-1995-01A-01R-1568-13	TCGA-61-1995-01A-01R	TCGA-61-1995-01A-01-TS1	TCGA-61-1995-01A-01-BS1	TCGA-61-1995-01A-01		TCGA-61-1995-01A	TCGA-61-1995	931738a7-4b5b-46dc-b69f-72600862d8af	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.1		5ea6d43b-376d-43cb-873f-c33ec814a95d	1.8	13b2c972-c6ef-4d1f-8ada-f831d2606023			0.15	22	released	57e1a300-44f6-468c-b0d2-6adbf4911d98	RNA	R	0.15	UV Spec	released	False	09b9747e-7699-410f-8f8e-c373975eea0f	01			12.0		10.0	10.0	68.0	75.0	TOP	28ee27c5-9f6c-475f-8943-62896f6d3239	released			10.0		8.0	8.0	74.0	75.0	BOTTOM	e7dbda48-4123-45ac-aa6d-22b0d1567285	released	released	109.0						2e1fa816-2b90-4c40-8ab5-617d19736cb0	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-61-1995_demographic	43	-16016		53fc8603-b3cd-55a5-9034-1c63bbb7089d	not hispanic or latino	female	white	released	Alive	1966		TCGA-61-1995_exposure	Not Reported	f3366249-77e0-514f-b7c8-e922997c646f	released	TCGA-61-1995_diagnosis	16016	not reported	0	61	5a7c82bd-5460-53e5-8b52-19d8586a011c	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-61-1995_treatment_1	TCGA-61-1995_treatment	released	cdd79cc5-e55a-5e3b-87a7-468ce94f8563	yes	Pharmaceutical Therapy, NOS	released	44ecbbb3-e9b5-519e-b19b-991a0d510db2	no	Radiation Therapy, NOS	9ec661a4-5c62-49e5-836d-4fd07bc37015
67bee95c-2a85-443b-b662-28103dfefdd4.htseq.counts.gz	e0e2ad9d-357f-4f7d-8b5d-ca58ac76bf0b	TCGA-13-1407-01A-01R-1565-13	TCGA-13-1407-01A-01R	TCGA-13-1407-01A-01-TS1	TCGA-13-1407-01A-01-BS1	TCGA-13-1407-01A-01		TCGA-13-1407-01A	TCGA-13-1407	f2dcf4cc-609d-4532-a90d-6ae2bbb53365	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.5		CCAF94A8-AA26-46FE-B3D3-22C9B750344A	1.8	2afc4437-8c6b-4f79-804c-b37ed04c4c77			0.17	22	released	cd2f3447-2c4a-41ee-ada1-de3f528fc9a4	RNA	R	0.17	UV Spec	released	False	fb8f5368-01f6-4097-ae16-5a75e4330371	01			0.0		0.0	5.0	95.0	95.0	TOP	a6dbdc72-d387-4fc3-a469-57ea6084908b	released			0.0		0.0	5.0	95.0	95.0	BOTTOM	05372268-5e6e-416e-a3e3-1047cee97d57	released	released	135.0						f7011673-3a61-4450-b6b9-043ef33ac682	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1407_demographic	51	-18896		ce1b2666-1364-5381-ae68-062a3cc7e5d5	not hispanic or latino	female	white	released	Alive	1957		TCGA-13-1407_exposure	Not Reported	5bb83df8-a4fc-533e-b75d-f49e7671759a	released	TCGA-13-1407_diagnosis	18896	not reported	0	2534	3b851cf3-1472-5cb5-8f7a-4543fadcd62d	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1407_treatment_1	TCGA-13-1407_treatment	released	20146071-236b-57dc-bbe6-53020d5a8bc3	yes	Pharmaceutical Therapy, NOS	released	c01352be-2ef4-5b20-9594-a127ad0d4767	no	Radiation Therapy, NOS	e0e2ad9d-357f-4f7d-8b5d-ca58ac76bf0b
2df4d9b2-5c9f-4952-bd5b-62f1a244f5f1.htseq.counts.gz	2c4a6c98-bbc3-49e0-8d79-9bba6a01072b	TCGA-13-1510-01A-02R-1565-13	TCGA-13-1510-01A-02R	TCGA-13-1510-01A-01-BS1	TCGA-13-1510-01A-02-BS2	TCGA-13-1510-01A-02		TCGA-13-1510-01A	TCGA-13-1510	dac96910-0cb2-44ea-b108-2d6d51b07112	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	2.0		D6FA84A0-0DE4-42F8-9D15-9EDA4115AE4D	1.8	b75db551-4254-4736-a089-0a38890e7778			0.17	22	released	bb6c4555-645b-489e-847b-1aea460eb2f8	RNA	R	0.17	UV Spec	released	False	d1932478-9264-40e4-9107-c8a8f2c7120e	02			20.0		0.0	5.0	75.0	95.0	TOP	a9adcc98-382e-48ca-bd92-c7fdd1007305	released			20.0		0.0	5.0	75.0	95.0	BOTTOM	870506d6-ca79-4aa2-b3b0-86f7f49f6427	released	released	157.0						557f7cab-8204-4295-831e-9a8cacf72231	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1510_demographic	62	-22708	1359	d5a00182-83dc-5ef7-9d6a-3caf42ebc893	not hispanic or latino	female	white	released	Dead	1946		TCGA-13-1510_exposure	Not Reported	f6e9bec3-d9a5-5091-8691-64890e77a539	released	TCGA-13-1510_diagnosis	22708	not reported	0	78	f0fc4512-b8f5-52b9-848e-eb15cdedcf49	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1510_treatment_1	TCGA-13-1510_treatment	released	6416a722-0c6b-5a5a-b612-4873be3faa2f	not reported	Pharmaceutical Therapy, NOS	released	fe1299cf-07a6-5314-b980-6d27541634b1	no	Radiation Therapy, NOS	2c4a6c98-bbc3-49e0-8d79-9bba6a01072b
4f715b36-328a-4d62-8cf8-28cf65f73841.htseq.counts.gz	9b44a053-e6cb-443d-92c4-1514c64f2ab3	TCGA-13-1505-01A-01R-1565-13	TCGA-13-1505-01A-01R	TCGA-13-1505-01A-01-BS1	TCGA-13-1505-01A-01-TS1	TCGA-13-1505-01A-01		TCGA-13-1505-01A	TCGA-13-1505	914f84bf-578b-4f4d-93cb-378228ea58f6	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		ACD1E3CC-53FC-4615-B31B-0AFDF4B259BF	1.8	7774b7d4-2935-4b9b-bf76-312a625629e1			0.15	22	released	9a790ed4-64e4-43f4-9eef-d294dd24d612	RNA	R	0.15	UV Spec	released	False	2743b09b-d517-4e7e-b0e3-457c8672afb4	01			0.0		0.0	20.0	80.0	80.0	BOTTOM	77c5a936-fbd0-44ea-bdca-a1756f1edff1	released			0.0		0.0	10.0	90.0	90.0	TOP	8eca8e28-c530-40b1-840b-2c50c23758fa	released	released	100.0						4fb10554-1573-44d5-99dd-d7abef42e373	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-1505_demographic	63	-23238		b7362858-0e48-5035-9da1-763716901ea0	not hispanic or latino	female	white	released	Alive	1945		TCGA-13-1505_exposure	Not Reported	825d2f9f-c2ba-5484-81d9-4bc253050337	released	TCGA-13-1505_diagnosis	23238	not reported	0	1998	efcf95ec-a94c-5a40-9a69-0f895651d4f8	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1505_treatment	TCGA-13-1505_treatment_1	released	4bdc11e9-5d64-5fb2-bfc2-28406c6a80de	no	Radiation Therapy, NOS	released	924d44fe-1a7d-5cef-9314-6f03b74b0333	yes	Pharmaceutical Therapy, NOS	9b44a053-e6cb-443d-92c4-1514c64f2ab3
a7ce619c-20e3-4a20-adee-1b1d0c367e76.htseq.counts.gz	7269ee11-c643-4b55-b1a4-e682037a0b54	TCGA-25-1317-01A-01R-1565-13	TCGA-25-1317-01A-01R	TCGA-25-1317-01A-01-TS1	TCGA-25-1317-01A-01-BS1	TCGA-25-1317-01A-01		TCGA-25-1317-01A	TCGA-25-1317	78777a80-cc6c-46c9-a14a-837ac7943719	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.4	False	1.5		5DC53520-0991-42B6-B10D-0D62C3F92BAD	1.8	423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf			0.15	22	released	304d494e-2f41-4a65-aa5a-f7641e3369f6	RNA	R	0.15	UV Spec	released	False	d01f67d9-bbbd-473c-bcd6-63861fa5e36a	01			10.0		0.0	40.0	50.0	85.0	TOP	c33273aa-4977-48d6-ac62-00d1f61260c8	released			0.0		0.0	30.0	70.0	90.0	BOTTOM	7237ad91-a258-4544-a2c4-1fb411af658a	released	released	108.0						12be4fe0-391e-4bdd-9af9-33fa7a135975	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-25-1317_demographic	66	-24199	61	f8742fb7-df55-59c6-9428-0487f950eb36	not hispanic or latino	female	white	released	Dead	1934	2000	TCGA-25-1317_exposure	Not Reported	4c07a069-461c-516a-b231-36e8ee4b8deb	released	TCGA-25-1317_diagnosis	24199	not reported	0		34c73698-1092-5f12-b670-e84b1ca08e3a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-25-1317_treatment_1	TCGA-25-1317_treatment	released	e3ab8b0a-662a-5174-b35e-2b617c97602d	yes	Pharmaceutical Therapy, NOS	released	f4c86966-2794-5f8d-9798-9e283cacfe2c	no	Radiation Therapy, NOS	7269ee11-c643-4b55-b1a4-e682037a0b54
a090ec54-edf8-4188-9bfc-add752bdaefa.htseq.counts.gz	035349ef-55ec-4b88-8305-2847d6b6182a	TCGA-61-1910-01A-01R-1567-13	TCGA-61-1910-01A-01R	TCGA-61-1910-01A-01-TS1	TCGA-61-1910-01A-01-BS1	TCGA-61-1910-01A-01		TCGA-61-1910-01A	TCGA-61-1910	75f2d97a-b96c-403f-8055-5c5c8083e856	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		32905714-6e41-4df8-91dd-6d3068475b40	1.8	65e4e40b-f27f-4b84-9979-af659564363d			0.14	22	released	0612b7c1-5ba8-46e9-ace1-5ae8aa9366cb	RNA	R	0.14	UV Spec	released	False	91876dee-1ef7-41db-a257-4b2d08d9da66	01			1.0		0.0	5.0	94.0	95.0	TOP	8c1da66c-6d4f-438e-8d73-2f04af158488	released			1.0		0.0	5.0	94.0	95.0	BOTTOM	e0a84385-0458-4590-9ff6-ebe9c92e2d08	released	released	132.0						a8786e7f-5004-43c8-a5a8-fc2fb89d2ab0	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-1910_demographic	56	-20779		e31f8f34-ab84-5c8c-b48d-12a9d06a7117	not hispanic or latino	female	white	released	Alive	1950		TCGA-61-1910_exposure	Not Reported	a6c33e70-d70c-546c-94d5-8f8a16f5aa95	released	TCGA-61-1910_diagnosis	20779	not reported	0	1127	f94bab54-9a7b-555b-899c-90c46cb49a3f	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-61-1910_treatment_1	TCGA-61-1910_treatment	released	04768d65-5884-5889-ad49-95e7cd9236ad	yes	Pharmaceutical Therapy, NOS	released	80d6ae6b-b047-592e-9704-2f282ea6c50c	no	Radiation Therapy, NOS	035349ef-55ec-4b88-8305-2847d6b6182a
f12b9d7b-1b32-43e9-a496-0794db75f69e.htseq.counts.gz	776adc23-7d40-4c1a-94df-7a2ce6188db6	TCGA-04-1331-01A-01R-1569-13	TCGA-04-1331-01A-01R	TCGA-04-1331-01A-01-BS1	TCGA-04-1331-01A-01-TS1	TCGA-04-1331-01A-01		TCGA-04-1331-01A	TCGA-04-1331	6d10d4ee-6331-4bba-93bc-a7b64cc0b22a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.5		2CF541C5-B56A-4946-A5C4-DBB4D71D7908	1.8	7fbfdb3e-1fd2-4206-8d2e-7f68e4a15844			0.15	22	released	a8039ce1-b55e-49f4-89bc-43263c0b581e	RNA	R	0.15	UV Spec	released	False	63d33d83-7761-4065-8b16-09dd121371fe	01			5.0		0.0	65.0	30.0	88.0	BOTTOM	27aaf831-a80b-4a55-a239-3a24caca9c28	released			2.0		0.0	20.0	78.0	90.0	TOP	76f57a19-5698-4204-bb11-7b6a106d620a	released	released	91.0						a1ec9279-c1a6-4e58-97ed-9ec1f36187c5	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-04-1331_demographic	78	-28848	1336	484bfbce-553b-5967-b6b1-2db46d395d5d	not hispanic or latino	female	white	released	Dead	1926	2007	TCGA-04-1331_exposure	Not Reported	122a86dc-7f10-51fb-9b7f-a194a444007d	released	TCGA-04-1331_diagnosis	28848	not reported	0	1224	a5055ee4-957a-58aa-9f8d-4ee8c627de20	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-04-1331_treatment_1	TCGA-04-1331_treatment	released	55ad315b-8c4a-5c00-a8f1-ed219149db89	yes	Pharmaceutical Therapy, NOS	released	ccb64579-fa43-532e-9f4f-97223d2e70ff	no	Radiation Therapy, NOS	776adc23-7d40-4c1a-94df-7a2ce6188db6
a65ae799-abca-4512-a65f-04f775818ab2.htseq.counts.gz	9bd664a4-e3b4-4c59-bb5b-ba6c4355b249	TCGA-25-1329-01A-01R-1565-13	TCGA-25-1329-01A-01R	TCGA-25-1329-01A-01-TS1	TCGA-25-1329-01A-01-BS1	TCGA-25-1329-01A-01		TCGA-25-1329-01A	TCGA-25-1329	955c80be-53df-4565-9303-a7abf96a2f81	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				2.6	False	3.0		857409C6-75EC-4935-85BC-6D5F66AF4DB3	1.8	5cf09ce6-44b1-4f0e-89ac-3ea302d684d8			0.15	22	released	2fc5bc02-9b52-4ec3-b03d-bc14f73fb353	RNA	R	0.15	UV Spec	released	False	a91a4d13-2a51-4378-a5ec-60359d928890	01			10.0		0.0	5.0	75.0	95.0	TOP	603d7e2c-e298-4d4c-8479-94547312f95a	released			5.0		0.0	25.0	70.0	95.0	BOTTOM	53db6a63-1ab7-447b-a356-6af729dad49a	released	released	157.0						d7ad6239-b56b-4762-9656-7653f308e01d	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-25-1329_demographic	76	-28093	457	3300031e-8802-584a-9af4-d00c691a2330	not hispanic or latino	female	white	released	Dead	1926	2003	TCGA-25-1329_exposure	Not Reported	110f6b00-6b8a-5ac1-a8e3-9342a137c860	released	TCGA-25-1329_diagnosis	28093	not reported	0	90	728d06d8-6ccd-5a53-90a6-cb4107824d5a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-25-1329_treatment	TCGA-25-1329_treatment_1	released	94eb5635-bcdc-5024-98a0-919a48c5108e	not reported	Radiation Therapy, NOS	released	d05c5c5c-dd96-5597-921b-de83fd6fcd40	yes	Pharmaceutical Therapy, NOS	9bd664a4-e3b4-4c59-bb5b-ba6c4355b249
726b125e-47ab-43da-9737-f8cba68fbeae.htseq.counts.gz	a22d2bf8-30bd-40d9-9030-13eea0707c1c	TCGA-29-1781-01A-01R-1567-13	TCGA-29-1781-01A-01R	TCGA-29-1781-01A-01-TS1	TCGA-29-1781-01A-01-BS1	TCGA-29-1781-01A-01		TCGA-29-1781-01A	TCGA-29-1781	f6ebf3a7-31c6-4f4c-9a0b-74cf35bfedf6	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		959c11fe-f170-49bc-a1fe-73b799741b93	1.9	5fd66773-ed5a-438c-a7c1-d029f05798e5			0.15	22	released	cb76e438-6be3-4609-bdd6-50cc3436dccb	RNA	R	0.15	UV Spec	released	False	7d7e116a-24fe-4756-a4c9-b42ecd647af5	01	5.0		20.0		0.0	0.0	80.0	90.0	TOP	9de32ae8-99c2-4de0-8dfe-0a7431145cce	released	10.0		10.0		0.0	5.0	85.0	85.0	BOTTOM	cfa47f58-9a94-4faf-ad7e-2e5901d649f9	released	released	114.0						b9a63363-bd0c-496f-a375-fce0d0a370d8	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1781_demographic	69	-25404		34cdc2c3-656e-598f-98cd-ba99fa210ff2	not reported	female	white	released	Alive	1940		TCGA-29-1781_exposure	Not Reported	8d8b688c-0544-586b-b61b-0e85b2c0c789	released	TCGA-29-1781_diagnosis	25404	not reported	0	255	d76e4af6-34c3-5b30-9645-83c9a06479ea	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-29-1781_treatment_1	TCGA-29-1781_treatment	released	826878c2-60b4-5082-8e1d-6fb8c647eff0	no	Pharmaceutical Therapy, NOS	released	32792d93-6714-57b9-a3dc-5bc59a18a6f1	no	Radiation Therapy, NOS	a22d2bf8-30bd-40d9-9030-13eea0707c1c
1f2dbb8e-0713-4952-a9e0-70fefa263116.htseq.counts.gz	e3ac7fed-eba6-457a-a802-72326ca3cf56	TCGA-25-1634-01A-01R-1566-13	TCGA-25-1634-01A-01R	TCGA-25-1634-01A-01-BS1	TCGA-25-1634-01A-01-TS1	TCGA-25-1634-01A-01		TCGA-25-1634-01A	TCGA-25-1634	15556b28-c6bd-455a-87b6-4b7b3e33d0e4	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.4		F000A224-05C3-4915-8ECD-02BAFE059232	1.8	d10f0cee-d755-43cc-8d3d-8974cea0defb			0.17	22	released	988aa522-ee9f-462e-b80f-08a18bb0f2a2	RNA	R	0.17	UV Spec	released	False	623d62d8-b386-4c48-a3be-fffce7003f22	01			1.0		0.0	15.0	84.0	85.0	BOTTOM	d2bf3a3f-c51b-40a9-956d-2f77195d7a69	released			1.0		0.0	15.0	84.0	85.0	TOP	4345be84-2118-4725-8b31-1f16902d64b7	released	released	119.0						c0091bb4-1079-4254-ad42-42ac1ddd7f1e	Primary Tumor	01	0.1	released	Not Reported	released	TCGA-25-1634_demographic	75	-27749	1091	893d4088-f26b-55ea-aa87-aed8cf080262	not hispanic or latino	female	white	released	Dead	1927	2004	TCGA-25-1634_exposure	Not Reported	acff4eb3-b3e7-504b-9389-70208a27c061	released	TCGA-25-1634_diagnosis	27749	not reported	0	1081	ccfe5d13-dadc-5a66-a404-f202b80053e2	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-25-1634_treatment_1	TCGA-25-1634_treatment	released	46e56097-8973-5b82-bb6f-d05d378f15ab	yes	Pharmaceutical Therapy, NOS	released	3cdf91fd-268f-5fbc-aac9-6f7b6d0c4b1f	yes	Radiation Therapy, NOS	e3ac7fed-eba6-457a-a802-72326ca3cf56
2a4a2670-4ad4-49ac-8571-477c44201219.htseq.counts.gz	44bbb0d1-5a73-490b-a0f9-e7047720a1c4	TCGA-29-1777-01A-01R-1567-13	TCGA-29-1777-01A-01R	TCGA-29-1777-01A-01-BS1	TCGA-29-1777-01A-01-TS1	TCGA-29-1777-01A-01		TCGA-29-1777-01A	TCGA-29-1777	5ced5b58-fab4-4bcd-b706-d6e49ce0cfc5	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.3		bfd59906-509b-4ca3-9282-c881f9962e15	1.8	cbeba637-1a32-45f1-83f3-614725665436			0.17	22	released	fb8bef1b-94e4-44a9-b4a7-db2026306032	RNA	R	0.17	UV Spec	released	False	0ea85734-9934-4283-9de3-bc59e2b0ccfb	01	5.0		0.0		0.0	25.0	75.0	80.0	BOTTOM	e18509e1-c5b0-4c84-b397-22b8d89f8ccb	released	5.0		0.0		0.0	20.0	80.0	85.0	TOP	ebda1d10-aaa2-453b-b650-7d7f128ee0a7	released	released	147.0						afb43292-69c2-4d84-84f5-0bde9a6e9ea5	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-29-1777_demographic	47	-17356		76f43d25-03dd-5e87-a305-baf33d049fbf	not reported	female	white	released	Alive	1961		TCGA-29-1777_exposure	Not Reported	ed38b22e-e67f-5167-89ec-2e3c7eedb3f7	released	TCGA-29-1777_diagnosis	17356	not reported	0	374	06faab0f-085d-5399-a16e-833cb5d7e9d7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-29-1777_treatment	TCGA-29-1777_treatment_1	released	1926b00e-c834-5070-8fe4-063f9171cb7f	no	Radiation Therapy, NOS	released	5f5d0913-ecf3-5121-8221-92fbf1cbd209	yes	Pharmaceutical Therapy, NOS	44bbb0d1-5a73-490b-a0f9-e7047720a1c4
347a8eeb-204f-41df-98d3-61394d2b7cd7.htseq.counts.gz	581b0bcf-a7e5-44ec-818a-9193a0565095	TCGA-09-2053-01C-01R-1568-13	TCGA-09-2053-01C-01R	TCGA-09-2053-01C-01-BS1	TCGA-09-2053-01C-01-TS1	TCGA-09-2053-01C-01		TCGA-09-2053-01C	TCGA-09-2053	ea605be2-6578-4e01-8ec3-bbd84c0b7f1d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.7		0d28e549-3ed0-4a22-bac7-9cbe24e44f53	1.8	fd1b7b74-067f-4fc9-820a-b80b5954ee10			0.14	22	released	72df4d8e-1de0-44f2-9718-733423c515f7	RNA	R	0.14	UV Spec	released	False	0e6ff3e8-b75a-4bc3-b69d-7b875bf613a2	01			0.0		0.0	10.0	90.0	95.0	BOTTOM	fd41b083-8281-4f38-8b5a-e9b7ee750d65	released			0.0		0.0	10.0	90.0	95.0	TOP	195c7a54-114f-4e7c-a4f6-d7283fc4704a	released	released	109.0						9236e7c0-7b03-4bed-9f19-e3cf805be49b	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-09-2053_demographic	72	-26433		bb80c4c4-c773-51f5-99e1-61f3b1610405	not hispanic or latino	female	white	released	Alive	1933		TCGA-09-2053_exposure	Not Reported	a639c393-e116-5a7e-b95b-9d8b2568f97d	released	TCGA-09-2053_diagnosis	26433	not reported	0	1209	0517938d-2b87-5aae-a33c-e315635ccbe5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-09-2053_treatment_1	TCGA-09-2053_treatment	released	ee1c9cda-b43d-55f9-ae7c-4b3c66bb56b7	yes	Pharmaceutical Therapy, NOS	released	727de4af-4e11-5739-930d-233dbc34ad1f	no	Radiation Therapy, NOS	581b0bcf-a7e5-44ec-818a-9193a0565095
88f9c446-a966-4131-b379-63e3cc1b7aa9.htseq.counts.gz	63381694-16d0-4c7a-b2d3-313480e112f8	TCGA-24-1567-01A-01R-1566-13	TCGA-24-1567-01A-01R	TCGA-24-1567-01A-01-TS1	TCGA-24-1567-01A-01-BS1	TCGA-24-1567-01A-01		TCGA-24-1567-01A	TCGA-24-1567	2cb50c2d-e749-4172-b101-d975507435c5	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.3	False	1.1		90910bbc-49e1-495b-9b06-11056ff401df	1.8	97c0b20f-ee65-42b2-af2d-92dcf48b2cd5			0.14	22	released	54c4de33-3dbd-4d5b-b64a-1d0e9ab7978b	RNA	R	0.14	UV Spec	released	False	8e7252ae-f413-4af1-b067-3749e1e2321d	01			0.0		0.0	5.0	95.0	95.0	TOP	09e67e5f-318c-42e7-a0bf-b00fc7f85356	released			1.0		0.0	5.0	94.0	95.0	BOTTOM	1ef24432-6351-443b-9a7d-acbd6a4ab819	released	released	130.0						8a3e4430-40be-46e0-bb38-946435911371	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-1567_demographic	54	-19843	524	ace5236c-02a5-559b-a2d3-bea9b6fc13a9	not reported	female	white	released	Dead	1945	2000	TCGA-24-1567_exposure	Not Reported	043a4847-0135-589a-8f93-cc7c54f92d5a	released	TCGA-24-1567_diagnosis	19843	not reported	0	524	dbe92bcb-69f3-5886-b674-14650afaf711	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-24-1567_treatment_1	TCGA-24-1567_treatment	released	26eab02a-6655-5ecf-96d4-884c7ccbba6c	yes	Pharmaceutical Therapy, NOS	released	a278fc4d-ed97-5d6b-8d66-58f0cd87ba68	no	Radiation Therapy, NOS	63381694-16d0-4c7a-b2d3-313480e112f8
b4f37e7b-e458-4395-a204-8a1dad62a28b.htseq.counts.gz	66099894-b6d2-42a4-8805-c3bc5d038ca5	TCGA-WR-A838-01A-12R-A406-31	TCGA-WR-A838-01A-12R	TCGA-WR-A838-01A-01-TS1		TCGA-WR-A838-01A-12		TCGA-WR-A838-01A	TCGA-WR-A838	b8023162-5e82-40e6-ad8c-8acf81821f01	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV	110		200.0		False		false	8F364931-727D-4099-A1D2-E96C61461479	1.75	010e9bf0-b7a0-4c68-b028-90299840fbaf			0.18	23	released	9447f5e7-c0ae-4b58-a1d1-4dacc21f1e03	RNA	R	0.18	UV Spec	released	False	fdd4309d-c305-444f-91db-3bed9db0a680	12	0.0	0.0	5.0	0.0	0.0	10.0	85.0	90.0	TOP	e8ca96cd-a253-4090-86ba-60e7192b72fd	released												released	30.0						828b6893-62cd-4248-a31b-7da875d657f1	Primary Tumor	01		released	Not Reported	released	TCGA-WR-A838_demographic	72	-26418	304	2e3f8de2-09c9-56c0-9615-ff7b01989992	not hispanic or latino	female	black or african american	released	Dead	1941		TCGA-WR-A838_exposure	Not Reported	ef408a2c-81d9-531c-8e95-cb3b2f0e893d	released	TCGA-WR-A838_diagnosis	26418	not reported	0	245	fefb6772-4f28-54b1-8e0d-7b57065372c5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Ovary	released	No	Ovary	not reported	not reported	2013	TCGA-WR-A838_treatment	TCGA-WR-A838_treatment_1	released	7cfb0d44-4e59-517a-9019-0834b030ab52	no	Radiation Therapy, NOS	released	6fd0d059-9f45-52b8-b5f5-0284af192e5c	yes	Pharmaceutical Therapy, NOS	66099894-b6d2-42a4-8805-c3bc5d038ca5
7f3810b3-4ff8-4a86-944e-7c87cf5593a2.htseq.counts.gz	725a5a9a-8d85-4256-8851-301c3d696cc1	TCGA-13-A5FT-01A-11R-A406-31	TCGA-13-A5FT-01A-11R	TCGA-13-A5FT-01A-01-TSA		TCGA-13-A5FT-01A-11		TCGA-13-A5FT-01A	TCGA-13-A5FT	f3618472-32dc-4c90-a407-90050f68be85	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV	1211		230.0		False		true	B67517DE-A483-4563-8698-51CB95DC5CF1	1.83	819ce36b-9256-4ea0-947f-694029850c9d			0.18	23	released	2b08989a-3379-4f13-bd0e-e22865f1edc0	RNA	R	0.18	UV Spec	released	False	322c2111-1d14-4123-be9b-8be1407f3b22	11	1.0	0.0	8.0	0.0	0.0	0.0	92.0	80.0	TOP	85eaefa5-9f54-4a1a-b907-393ca55b627d	released												released	30.0						64bb8411-d52d-4ec9-b6a7-f0c25d8a050a	Primary Tumor	01		released	Not Reported	released	TCGA-13-A5FT_demographic	67	-24743		496656d8-5645-5852-b629-f8e4c3b9647e	not reported	female	black or african american	released	Alive	1942		TCGA-13-A5FT_exposure	Not Reported	9a181513-cf32-5546-9457-a33f41b7df69	released	TCGA-13-A5FT_diagnosis	24743	not reported	0	2143	46512cdd-749b-5942-92b7-1bce1b8021a2	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Ovary	released	No	Ovary	not reported	not reported	2009	TCGA-13-A5FT_treatment_1	TCGA-13-A5FT_treatment	released	f44f774d-abc9-5e57-93e0-f4844244bfb4	yes	Pharmaceutical Therapy, NOS	released	762c2a4d-d8c9-5cca-bb9a-17112fcc9206	no	Radiation Therapy, NOS	725a5a9a-8d85-4256-8851-301c3d696cc1
16b391ee-1f65-4665-bf34-5447eed6800b.htseq.counts.gz	a1a8fc1d-e8a6-4e82-b698-4ba4fbb3247d	TCGA-61-1724-01A-01R-1568-13	TCGA-61-1724-01A-01R	TCGA-61-1724-01A-01-TS1	TCGA-61-1724-01A-01-BS1	TCGA-61-1724-01A-01		TCGA-61-1724-01A	TCGA-61-1724	2ae65a06-df0f-4de1-a536-537cae0cc260	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.2		ec0d70e7-672b-425b-a558-d233e0ef1779	1.8	faab5b85-3c69-4c64-bba0-a8d5404939a2			0.15	22	released	534673b9-2fb1-49c9-964e-a8d546ab9a97	RNA	R	0.15	UV Spec	released	False	b6a8732f-03cc-4550-b249-61d93830c5b5	01			10.0		0.0	5.0	85.0	90.0	TOP	842b750e-e4ef-493a-aa87-8b270df9a629	released			5.0		0.0	0.0	95.0	90.0	BOTTOM	dc9700ec-ce3c-4286-80bd-a353c376977b	released	released	150.0						3545a19f-40bc-4414-8895-2a176f2989fa	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-61-1724_demographic	47	-17168	637	ea68bd4e-83c7-5ede-a7d8-58a344ab1732	not hispanic or latino	female	white	released	Dead	1960	2008	TCGA-61-1724_exposure	Not Reported	f45474d2-c149-59ee-80ac-9e4b104d8df9	released	TCGA-61-1724_diagnosis	17168	not reported	0	637	6395ea1f-b5c3-5f02-a6fb-9d10768d3764	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-61-1724_treatment_1	TCGA-61-1724_treatment	released	60e55104-fd29-5b20-8e00-dff610d51f64	yes	Pharmaceutical Therapy, NOS	released	34fef059-2a04-52f6-b86d-44c336665b9f	no	Radiation Therapy, NOS	a1a8fc1d-e8a6-4e82-b698-4ba4fbb3247d
03c8a50d-0484-42e6-ade8-d214684f62c9.htseq.counts.gz	797612c6-79cf-4ae8-a2a9-68f9bb4d263d	TCGA-29-2425-01A-01R-1569-13	TCGA-29-2425-01A-01R	TCGA-29-2425-01A-01-TS1	TCGA-29-2425-01A-01-BS1	TCGA-29-2425-01A-01		TCGA-29-2425-01A	TCGA-29-2425	40635bf3-d8ba-4833-b623-547e55e5d07e	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.0		ec04e6ae-ae66-4fc2-b77b-485f77ce39bc	1.8	3ce6b8c4-7020-447a-8eb8-5370eef05344			0.15	22	released	c11674a4-550b-4a24-9972-7412e0dac3fa	RNA	R	0.15	UV Spec	released	False	fcd6a1d7-eec8-4f30-a15b-71c80601f1fd	01			5.0		0.0	15.0	80.0	97.0	TOP	b02b7e9c-7826-4dda-9fc2-70867e37e9c7	released			10.0		0.0	10.0	80.0	97.0	BOTTOM	219c877f-a1fc-4322-bc83-e1ab4e10f906	released	released	129.0						0a6d3bb3-512a-47bc-9b84-b6fa017da9c3	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-29-2425_demographic	60	-22089		90915e14-fbfa-56e5-8fcd-04df28f44be4	not reported	female	white	released	Alive	1944		TCGA-29-2425_exposure	Not Reported	0365b72c-fdcf-5eab-b4cf-8f73f7fae320	released	TCGA-29-2425_diagnosis	22089	not reported	0	1977	0d0523a7-c86c-5ce8-a0ab-2cc6094af039	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-29-2425_treatment	TCGA-29-2425_treatment_1	released	afe76cb3-785a-5ba4-b647-a3aa0f8b49fb	no	Radiation Therapy, NOS	released	eb23a92c-6e23-57a1-80f1-601efd76395b	yes	Pharmaceutical Therapy, NOS	797612c6-79cf-4ae8-a2a9-68f9bb4d263d
04098317-63b1-43eb-9b7f-e8e619e52781.htseq.counts.gz	f2a22294-e969-4a26-b19e-1370f0947174	TCGA-61-2109-01A-01R-1568-13	TCGA-61-2109-01A-01R	TCGA-61-2109-01A-01-BS1	TCGA-61-2109-01A-01-TS1	TCGA-61-2109-01A-01		TCGA-61-2109-01A	TCGA-61-2109	dc5a6ce7-01e5-408d-812e-e3e0ddc1cde5	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.7		c16bfe93-016f-49d4-8895-05b9055344c9	1.8	c87ddfc3-d7a4-4704-b3cc-a19edfb63452			0.15	22	released	69525c8d-9d7d-48cd-8957-022691f04ce5	RNA	R	0.15	UV Spec	released	False	96ae7800-836f-4b93-be3d-2e0f57b26b09	01			5.0		5.0	0.0	90.0	97.0	BOTTOM	3b0f024a-5fd6-430c-8197-649c17917ebf	released			7.0		13.0	5.0	75.0	95.0	TOP	031075e9-b603-438c-89cb-a22f24f0da61	released	released	136.0						98198891-a060-4107-b56d-61f19ac5fab5	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-61-2109_demographic	40	-14900	629	0fc3268e-adb3-5388-9bfd-2e6056af74e5	not hispanic or latino	female	white	released	Dead	1959	2000	TCGA-61-2109_exposure	Not Reported	2c80b02c-b844-5f8b-a1db-8798ab8ae586	released	TCGA-61-2109_diagnosis	14900	not reported	0	629	d7e955fc-4cf9-5b0a-8555-41d566bd4e64	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-61-2109_treatment	TCGA-61-2109_treatment_1	released	f75efd48-3565-5fc6-9030-02c5b62923d7	no	Radiation Therapy, NOS	released	e4e8e548-d51d-5a65-bcfa-5f9b62e1e538	yes	Pharmaceutical Therapy, NOS	f2a22294-e969-4a26-b19e-1370f0947174
30bc60d4-7bf1-474e-a2f9-3c1108820cd1.htseq.counts.gz	e56da01f-19fd-4532-bb05-56389af50078	TCGA-04-1332-01A-01R-1564-13	TCGA-04-1332-01A-01R	TCGA-04-1332-01A-01-TS1	TCGA-04-1332-01A-01-BS1	TCGA-04-1332-01A-01		TCGA-04-1332-01A	TCGA-04-1332	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		97ED2B5D-4349-40FE-A612-949EBBF108C4	1.8	08e7c700-7038-40b5-bec0-2dd402e1a225			0.16	22	released	63a3b660-cc5a-449a-bf08-aee1782fd55a	RNA	R	0.16	UV Spec	released	False	2807e17e-0f72-460f-8501-95f029d880a2	01			3.0		0.0	89.0	8.0	90.0	TOP	7d1ae336-5e74-4d12-9048-04d036f8c676	released			8.0		0.0	52.0	40.0	89.0	BOTTOM	0f52bd8b-65e8-4648-b6b8-05ddc60f143a	released	released	100.0						b8243412-b7b4-4a7b-b823-4b33488ff429	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-04-1332_demographic	70	-25786	1247	b30355c0-e9f5-5b9d-88e5-05f6e7ec84d8	not hispanic or latino	female	white	released	Dead	1932	2005	TCGA-04-1332_exposure	Not Reported	76939224-6fba-5538-8ef6-b261ea4b639e	released	TCGA-04-1332_diagnosis	25786	not reported	0	1247	6686400d-d4de-5369-ae39-7518bd6bfcad	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-04-1332_treatment	TCGA-04-1332_treatment_1	released	c06afc1b-0d7e-5ba3-a070-aab9e7264afc	no	Radiation Therapy, NOS	released	6a20fe67-4b11-5e50-90fd-f5d50ec22948	yes	Pharmaceutical Therapy, NOS	e56da01f-19fd-4532-bb05-56389af50078
ff54b7b3-1622-43f7-a9b3-96a99384999b.htseq.counts.gz	824f26d9-bb67-44e0-a6a4-81f218054873	TCGA-04-1648-01A-01R-1567-13	TCGA-04-1648-01A-01R	TCGA-04-1648-01A-01-BS1	TCGA-04-1648-01A-01-TS1	TCGA-04-1648-01A-01		TCGA-04-1648-01A	TCGA-04-1648	cddce77f-21e6-4124-9f03-96fb5ca7cefa	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	1.2		B35F03FC-84CB-4468-9289-3DB91A6F913E	1.8	9248aa41-9572-4b91-8e00-13aa0e3dce12			0.15	22	released	221e48ca-0fa9-41cd-b68e-68e6da4a8d6a	RNA	R	0.15	UV Spec	released	False	31ddae1c-4d0f-4d3d-99f6-d78206757f53	01			15.0		0.0	10.0	75.0	80.0	BOTTOM	6cecc6c4-6af7-4db1-85c1-e9f88751d7a3	released			15.0		0.0	0.0	85.0	90.0	TOP	c9581bd1-0449-4188-b93e-911c77a3f3ea	released	released	118.0						bc979254-2b16-43ab-ba8d-7670a3b4ab3a	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-04-1648_demographic	57	-21113	871	bf5dd053-0971-5b16-9bd2-9ee9b821551d	not reported	female	white	released	Dead	1946	2005	TCGA-04-1648_exposure	Not Reported	5ad765c7-6f2e-5200-8f80-f878e3ed9294	released	TCGA-04-1648_diagnosis	21113	not reported	0		258aa1d0-810d-53d9-8274-f290e2d22468	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-04-1648_treatment_1	TCGA-04-1648_treatment	released	ad67d552-91e9-572f-bf31-f1cd23a967a4	yes	Pharmaceutical Therapy, NOS	released	b7ec434e-46b6-5ab5-bc2c-91ed3f4eeb4e	no	Radiation Therapy, NOS	824f26d9-bb67-44e0-a6a4-81f218054873
b14d1cf5-7063-4d0c-aa27-bf2802102751.htseq.counts.gz	33d38713-3b68-4a83-ab14-01f8577b5ee5	TCGA-13-0923-01A-01R-1564-13	TCGA-13-0923-01A-01R	TCGA-13-0923-01A-01-TS1	TCGA-13-0923-01A-01-BS1	TCGA-13-0923-01A-01		TCGA-13-0923-01A	TCGA-13-0923	378f7ea2-86b4-4072-80b8-e12d67193106	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV					False			06AB5B8C-7B57-43B0-8376-7A05C58AFC1A	1.7	b75de387-11ae-4d46-81a1-54d15ecae42a			0.15	22	released	2c82e0c0-ade1-4b50-a0ec-f3c2bee284ce	RNA	R	0.15	UV Spec	released	False	e47ce510-8c83-4559-8021-df5a77afcec5	01			5.0		0.0	10.0	85.0	90.0	TOP	d9d2ce88-c392-4e1a-abfc-ac656d4d2ed1	released			5.0		0.0	25.0	70.0	85.0	BOTTOM	13b1073e-fdb1-4c7c-9899-5251d0b8d32c	released	released							38e5fc32-615e-435d-ae6e-b79701aba593	Primary Tumor	01		released	Not Reported	released	TCGA-13-0923_demographic	74	-27081		b8d6ce63-c7cb-5f82-a118-f49f9fc7cb75	not hispanic or latino	female	white	released	Alive	1934		TCGA-13-0923_exposure	Not Reported	7c3e5423-ca3d-5408-927a-8967bbe0384c	released	TCGA-13-0923_diagnosis	27081	not reported	0	2547	47744210-bad0-50d1-a104-be4181e7ed85	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-0923_treatment	TCGA-13-0923_treatment_1	released	4c9c8bc1-8450-5812-85a2-9263e7d23512	no	Radiation Therapy, NOS	released	6a24289e-4629-5d05-a2c5-f21e668012d4	yes	Pharmaceutical Therapy, NOS	33d38713-3b68-4a83-ab14-01f8577b5ee5
d85fe825-5437-4717-8848-45e1290dd928.htseq.counts.gz	fa053e57-d734-4c2e-8038-44874029c246	TCGA-04-1347-01A-01R-1564-13	TCGA-04-1347-01A-01R	TCGA-04-1347-01A-01-BS1	TCGA-04-1347-01A-01-TS1	TCGA-04-1347-01A-01		TCGA-04-1347-01A	TCGA-04-1347	f0c353fd-947c-41e2-b643-3ecc0d69796c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.1		18BFB10C-5EDC-4253-A2A8-93533CB4B471	1.8	1a59f822-d8fc-4c7a-ad7b-b1b84078e09d			0.16	22	released	eb47d4b9-237c-4137-8789-329f2b7f50f3	RNA	R	0.16	UV Spec	released	False	980ab54a-cf04-4c49-abef-6d21c0b658d3	01			5.0		0.0	40.0	55.0	70.0	BOTTOM	f281f888-c433-4fa6-8957-3ace3e9e4f6c	released			2.0		0.0	5.0	93.0	99.0	TOP	c1c1b478-dc0f-4680-955b-2a40aeece34f	released	released	159.0						4c4747d9-c0bc-486e-b88c-5c1b8214d4de	Primary Tumor	01	0.1	released	Not Reported	released	TCGA-04-1347_demographic	81	-29695		cef50119-cfb0-5a18-84b4-6b9a87c26e3f	not hispanic or latino	female	white	released	Alive	1923		TCGA-04-1347_exposure	Not Reported	d688124e-21ab-52e8-a4e1-e30fa4eda648	released	TCGA-04-1347_diagnosis	29695	not reported	0	1919	603b066e-4598-53b0-8ea1-c4772b8e2165	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-04-1347_treatment_1	TCGA-04-1347_treatment	released	42e4ca0f-57f7-590b-a244-cd0d921d7cc2	yes	Pharmaceutical Therapy, NOS	released	767a0eff-c49f-561c-9def-532f6d7b1aeb	no	Radiation Therapy, NOS	fa053e57-d734-4c2e-8038-44874029c246
b64ef80a-d41c-4f92-a3ed-e43d55abb2c2.htseq.counts.gz	0f2ef2fa-cf6e-4d03-a648-ccd9fdf8b8c5	TCGA-13-0727-01A-01R-1564-13	TCGA-13-0727-01A-01R	TCGA-13-0727-01A-01-BS1	TCGA-13-0727-01A-01-TS1	TCGA-13-0727-01A-01		TCGA-13-0727-01A	TCGA-13-0727	90f4b65c-cfd4-4066-a5b9-842885c172e2	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.2		EA3709B4-0C79-4CF5-A7D6-DB9F08DD74B5	1.8	38957b36-539f-42f1-bd83-f8eb348165a4			0.16	22	released	b82028b9-e13e-475c-983c-1ecdba9d790c	RNA	R	0.16	UV Spec	released	False	06ac143a-983e-4a3a-bae1-e60a3f9a9db4	01			0.0		15.0	0.0	85.0	95.0	BOTTOM	aeb63964-0616-4be1-9203-91ea1c0794d4	released			0.0		10.0	10.0	80.0	95.0	TOP	6d8a1ef4-20dd-4641-9f62-9ee2782e24a5	released	released	155.0						6fcd7bb8-6cb0-4797-a5b5-d3ec4911a279	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-0727_demographic	71	-26185	462	c607c1f9-1240-5281-9ad1-0481bf7a2684	not hispanic or latino	female	white	released	Dead	1932	2004	TCGA-13-0727_exposure	Not Reported	f820881b-3240-54d4-83e2-9fb8a687da8d	released	TCGA-13-0727_diagnosis	26185	not reported	0	462	b8106532-5977-55ab-8efb-28955ed4a91a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-13-0727_treatment	TCGA-13-0727_treatment_1	released	589ab6e4-4f58-560b-9045-b1c606466cfd	no	Radiation Therapy, NOS	released	2918da17-439d-5402-89a3-27c570924be4	yes	Pharmaceutical Therapy, NOS	0f2ef2fa-cf6e-4d03-a648-ccd9fdf8b8c5
c255d022-a659-42bd-9099-6853b41b64c7.htseq.counts.gz	717ca3c0-0b0e-4cf3-af34-15d0fbfd7f68	TCGA-24-1471-01A-01R-1566-13	TCGA-24-1471-01A-01R	TCGA-24-1471-01A-01-BS1	TCGA-24-1471-01A-01-TS1	TCGA-24-1471-01A-01		TCGA-24-1471-01A	TCGA-24-1471	ceb19678-b453-4529-b6cb-d02f9cb101b4	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		d20b8ed1-c74e-4ee8-9ae2-5512429810bc	1.8	a30e415d-8fe3-4d1d-b183-381ab431bb4a			0.15	22	released	12c9315b-0088-4ec0-8937-5f0be78d60f8	RNA	R	0.15	UV Spec	released	False	7e3f1449-1c50-4790-b16e-e58d86e7e401	01			1.0		0.0	1.0	98.0	99.0	BOTTOM	5b870680-19ae-42ff-bbf5-2f0d82ca9caa	released			1.0		0.0	1.0	98.0	99.0	TOP	ff50c1a3-4de7-4dd7-8188-025d1df618d0	released	released	104.0						43d7d5cf-e988-4b6b-925e-2b7bbd67e4fc	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1471_demographic	60	-22081		2cc27fab-a108-5748-aefe-0bef861bc009	not reported	female	white	released	Alive	1949		TCGA-24-1471_exposure	Not Reported	954a5ad9-25f5-569f-a86d-2eb2d558be7e	released	TCGA-24-1471_diagnosis	22081	not reported	0	36	43f6535a-4e53-5545-8cb3-311a4901f939	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-24-1471_treatment	TCGA-24-1471_treatment_1	released	fc984d64-8a86-5f39-ae93-f96f0a16b7c6	no	Radiation Therapy, NOS	released	adece1ed-a05d-50f7-884d-c81a3816160f	yes	Pharmaceutical Therapy, NOS	717ca3c0-0b0e-4cf3-af34-15d0fbfd7f68
a72d4647-2034-4bc0-9a58-db0f97b7e76a.htseq.counts.gz	cf531e95-2758-4657-a6ea-aae42cf1f9d8	TCGA-20-0991-01A-01R-1564-13	TCGA-20-0991-01A-01R	TCGA-20-0991-01A-01-TS1	TCGA-20-0991-01A-01-BS1	TCGA-20-0991-01A-01		TCGA-20-0991-01A	TCGA-20-0991	36595b52-2b5f-4e87-80eb-37c29109e92a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	0.8		8FB04F5F-B278-4E3C-A88B-9597F7B93F6E	1.8	70004d87-7c1b-40e6-b246-04bb349dca6c			0.15	22	released	e0cba84f-cb18-445c-b2d7-7c6d85adf773	RNA	R	0.15	UV Spec	released	False	1648463b-ef78-416d-95ca-20d380e74539	01			2.0		2.0	0.0	96.0	98.0	TOP	0b680a7c-3b52-40f3-88e7-39ff4fb22cc9	released			5.0		2.0	0.0	93.0	98.0	BOTTOM	667c1bb6-434d-47b1-ac92-8a2996613ffe	released	released	85.0						62af5b99-db7f-4c92-97f1-92e825c15729	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-20-0991_demographic	78	-28694		36753d6c-f821-5dbf-a8b3-662cb2430bed	not hispanic or latino	female	white	released	Alive	1928		TCGA-20-0991_exposure	Not Reported	c487b169-4620-581f-832a-823f24dcf001	released	TCGA-20-0991_diagnosis	28694	not reported	0	797	b12547de-b3e3-59fe-a426-d67e9bb05533	Stage IIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-20-0991_treatment_1	TCGA-20-0991_treatment	released	074eba9c-2e6e-5aff-bfd2-bc2c49d8997e	yes	Pharmaceutical Therapy, NOS	released	0bac6761-7a5f-5ace-8dca-80cefb181dc5	no	Radiation Therapy, NOS	cf531e95-2758-4657-a6ea-aae42cf1f9d8
4524f1ca-c763-47af-8f80-331c64704d7d.htseq.counts.gz	de7e5b42-8601-4108-a1bf-9e8eb8d38a20	TCGA-24-1844-01A-01R-1567-13	TCGA-24-1844-01A-01R	TCGA-24-1844-01A-01-TS1	TCGA-24-1844-01A-01-BS1	TCGA-24-1844-01A-01		TCGA-24-1844-01A	TCGA-24-1844	a36a4440-15ef-4837-904b-380a964d16f1	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.1		5fd30c3c-9734-40dd-b81e-ae3f364c8fa8	1.8	53a60e9f-3541-4fe7-a7ea-87ee888c0446			0.16	22	released	6da09e60-59a5-448f-9f4c-5fa2cef63eea	RNA	R	0.16	UV Spec	released	False	b64dcd0c-2557-4b91-8d5f-171f02c53c16	01	0.0	0.0	0.0	0.0	0.0	20.0	80.0	80.0	TOP	de22faa4-e6c3-4f51-a17d-d450ee2ee1eb	released	0.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	BOTTOM	77eb1696-4cf6-4a2b-a225-52c0ee0f9082	released	released	126.0						8ea52904-f56c-4c1f-b8a4-9906805001ff	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-1844_demographic	64	-23542		1364e963-dbbb-5881-a86a-ad660efa2898	not reported	female	white	released	Alive	1945		TCGA-24-1844_exposure	Not Reported	74788be0-74a2-5196-a87b-de9723f364a6	released	TCGA-24-1844_diagnosis	23542	not reported	0	113	250e6c30-98ff-51b3-bc1f-cb87719b253c	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-24-1844_treatment	TCGA-24-1844_treatment_1	released	cdc87da0-37fe-53d8-9ce0-60d6f76618d9	no	Radiation Therapy, NOS	released	76d6a023-c151-5c6d-8728-65f51a5ddc9a	yes	Pharmaceutical Therapy, NOS	de7e5b42-8601-4108-a1bf-9e8eb8d38a20
16417d82-1ae0-4097-85c1-5e2df313fd35.htseq.counts.gz	228f601c-b657-479b-bcf4-f25bb2c823e4	TCGA-61-2097-01A-02R-1568-13	TCGA-61-2097-01A-02R	TCGA-61-2097-01A-01-BS1	TCGA-61-2097-01A-02-BS2	TCGA-61-2097-01A-02		TCGA-61-2097-01A	TCGA-61-2097	47681e4b-01e8-4779-b966-ce57aff4b712	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				2	False	2		6d23149d-a9b0-422f-a560-bc1b4a3b99d6	1.8	d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1	3	20	0.15	22	released	52f1124e-7049-43e3-9df3-c6c1095ad382	RNA	R	0.15	UV Spec	released	False	89ea3bd2-aab1-4a5f-9d40-f4a2d31543e7	02	0	0	0	0	0	20	80	80	TOP	0715c892-db1c-44ca-a67b-b73cdbf993b8	released	0	0	0	0	0	20	80	80	BOTTOM	eb2c3b3f-e0a2-4012-807f-1b49a2493ab8	released	released	125						dfcd4fbd-4441-40aa-a36a-13383c8d7f1a	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-61-2097_demographic	71	-25961		0cec735d-2aa7-5693-9b29-92c27b94bc05	not reported	female	white	released	Alive	1932		TCGA-61-2097_exposure	Not Reported	bdb737a2-02c7-5652-962b-a65f38a24f47	released	TCGA-61-2097_diagnosis	25961	not reported	0	1844	2ebeca9d-6570-5225-9bf4-a8868ccddcef	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-61-2097_treatment	TCGA-61-2097_treatment_1	released	a077e56e-400d-5b49-bbed-86e4b3016516	no	Radiation Therapy, NOS	released	a6ef125b-e9c6-5219-bd3f-f1e42a283a3f	yes	Pharmaceutical Therapy, NOS	228f601c-b657-479b-bcf4-f25bb2c823e4
3c052e47-a4d4-4e13-a67b-b50fd1b7cbe5.htseq.counts.gz	ab80f5df-afd7-44c4-9b61-1c1c6cad0a5f	TCGA-36-1574-01A-01R-1566-13	TCGA-36-1574-01A-01R	TCGA-36-1574-01A-01-TS1	TCGA-36-1574-01A-01-BS1	TCGA-36-1574-01A-01		TCGA-36-1574-01A	TCGA-36-1574	eeb9d147-608d-4692-8adf-2f601d23a8ff	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	0.7		174e0ef6-e8bc-4c43-8253-ee6d3ff9c1ce	1.8	ff781a4f-7281-4195-880f-3df099a401cc			0.15	22	released	9b2353da-8007-4e01-a8ba-9cfed2001a92	RNA	R	0.15	UV Spec	released	False	e018cce4-4715-4acf-be65-bfac9fcfb6a3	01			0.0		0.0	20.0	80.0	80.0	TOP	0ebf58a0-dd01-40b2-9f37-5970f65cf9bb	released			0.0		0.0	20.0	80.0	80.0	BOTTOM	f108ae98-b589-4ddc-91f4-15ab328fc6ba	released	released	144.0						353b6c00-ebfe-4650-8379-f46c8fe3e9cf	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-36-1574_demographic	48	-17847		46847140-fc89-5fa9-934e-d1c3ec70f956	not reported	female	asian	released	Alive	1959		TCGA-36-1574_exposure	Not Reported	685eca3c-d4ab-5d49-85d8-09a25ca59717	released	TCGA-36-1574_diagnosis	17847	not reported	0	686	c26a3c0e-765f-5b6f-be27-9e886aeaad31	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-36-1574_treatment	TCGA-36-1574_treatment_1	released	fa6eed8c-3187-56b6-83a7-e6424af3c8ae	no	Radiation Therapy, NOS	released	d8d58072-a876-5680-b85d-175242de85ec	yes	Pharmaceutical Therapy, NOS	ab80f5df-afd7-44c4-9b61-1c1c6cad0a5f
c96b872f-d842-4e6a-8845-59308a28c279.htseq.counts.gz	b23df492-673b-44fd-82b2-eee19e3ca4df	TCGA-25-2391-01A-01R-1569-13	TCGA-25-2391-01A-01R	TCGA-25-2391-01A-01-TS1	TCGA-25-2391-01A-01-BS1	TCGA-25-2391-01A-01		TCGA-25-2391-01A	TCGA-25-2391	f5033d52-ec36-4e67-88d8-b6d898b81b2f	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		32AC761D-67A0-46C5-AB01-AE9BBE7307CA	1.7	0ee0c708-77c4-4ac3-be13-0d08e6444003			0.15	22	released	7e919246-646e-478b-b6c9-f5e65ad5f948	RNA	R	0.15	UV Spec	released	False	9b808684-4e13-4564-92e1-4a4d48bbcc17	01			1.0		0.0	10.0	89.0	90.0	TOP	8356e1f7-f054-4869-9793-39e86a37225a	released			1.0		1.0	9.0	89.0	90.0	BOTTOM	36d1284c-605f-4346-b6c6-048f71df6393	released	released	161.0						2179798c-4fd4-4434-b1d5-1453f6054fa2	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-25-2391_demographic	57	-20939	1492	8b704245-4ea7-56dc-bc6e-04c1ea8b05a8	not hispanic or latino	female	white	released	Dead	1946	2007	TCGA-25-2391_exposure	Not Reported	80794472-40a2-5f55-b17b-c2f0c5011ea5	released	TCGA-25-2391_diagnosis	20939	not reported	0	1492	33b6e169-a746-5ca1-ab5c-eeaa38b79c2b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-25-2391_treatment	TCGA-25-2391_treatment_1	released	42ae62e3-b52d-5a77-b8f1-a4b696c24efa	no	Radiation Therapy, NOS	released	a548b7aa-50ae-5597-9424-2e2104f3a43b	yes	Pharmaceutical Therapy, NOS	b23df492-673b-44fd-82b2-eee19e3ca4df
462e7d42-19b7-4e95-bf2d-d2a66852f6cd.htseq.counts.gz	d8303621-de49-49b5-8bb1-9ce7e368fbf2	TCGA-59-2363-01A-01R-1569-13	TCGA-59-2363-01A-01R	TCGA-59-2363-01A-01-TS1	TCGA-59-2363-01A-01-BS1	TCGA-59-2363-01A-01		TCGA-59-2363-01A	TCGA-59-2363	f4d95c8e-fb84-46ca-acc0-827015cc9d0a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		9b047485-eb2b-4fc1-a22a-d96046b63bf2	1.8	1d3f29ac-5f19-452d-99b6-72c0abf1ce32			0.15	22	released	a444db59-d50b-4337-a5e6-92d5256bd67f	RNA	R	0.15	UV Spec	released	False	f09435db-d83c-4af6-b126-6cbcd305cd6b	01			0.0		0.0	10.0	90.0	90.0	TOP	40e807a6-44b6-41a0-ae0e-0d202fd9cc1d	released			5.0		1.0	10.0	84.0	90.0	BOTTOM	ea7d9017-b715-46a3-aa0a-dca2748be4d4	released	released	108.0						faf406a4-d3d4-4ff5-8a3b-86ecbc6802ab	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-59-2363_demographic	40			70e5088b-a97a-527d-8705-0671fabd9fdb	not hispanic or latino	female	asian	released	Alive	1967		TCGA-59-2363_exposure	Not Reported	9cf1a7f2-3a7a-5b24-aec4-f4a2fa870e59	released	TCGA-59-2363_diagnosis		not reported	0	165	219b42b0-2897-5644-adb6-0bd82706bdac	Stage IIIA	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-59-2363_treatment_1	TCGA-59-2363_treatment	released	d468d754-8679-52dc-8334-a9a587066a53	yes	Pharmaceutical Therapy, NOS	released	15958777-9f8e-50af-995d-a42f6d60595c	no	Radiation Therapy, NOS	d8303621-de49-49b5-8bb1-9ce7e368fbf2
864f36c5-41fa-4f90-b737-e164ce1eb845.htseq.counts.gz	dceb254b-34f5-4ef7-85e4-fd5d5212499b	TCGA-36-1576-01A-01R-1566-13	TCGA-36-1576-01A-01R	TCGA-36-1576-01A-01-TS1	TCGA-36-1576-01A-01-BS1	TCGA-36-1576-01A-01		TCGA-36-1576-01A	TCGA-36-1576	3445c524-5a37-40b6-8614-956d76eed939	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	2.6		2eb0b46a-ecd3-43b4-bfc2-e1c5e6101d1f	1.8	55b6bd7c-e77d-4019-93e9-b5410e4807b2			0.15	22	released	014b9a61-7164-4446-afce-38c34cbbfc1b	RNA	R	0.15	UV Spec	released	False	8c6c041e-f58f-4f00-b980-b5eb264aa0ba	01			2.0		0.0	10.0	88.0	95.0	TOP	683327b5-b127-439f-9a47-6bf7f1d01203	released			2.0		0.0	10.0	88.0	95.0	BOTTOM	82732edc-569c-4b5c-80d5-31f530cd30aa	released	released	118.0						24ffa457-5765-43c1-8cdd-b50a31dc5b56	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-36-1576_demographic	76	-27778		c18e2936-9d87-546c-a5a8-35e127f24d64	not reported	female	not reported	released	Alive	1930		TCGA-36-1576_exposure	Not Reported	f3560a75-9c82-5153-aaa0-1da7bd05f57d	released	TCGA-36-1576_diagnosis	27778	not reported	0	915	12f10f5c-d361-5f22-9b2e-011d487caa6b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-36-1576_treatment_1	TCGA-36-1576_treatment	released	6b1cd56a-4f01-551c-ab69-35e030dcf800	yes	Pharmaceutical Therapy, NOS	released	dff8e585-7ede-5263-b007-1a6ec4555f91	no	Radiation Therapy, NOS	dceb254b-34f5-4ef7-85e4-fd5d5212499b
fea3c4d0-7b9f-4279-989e-535aaefbdfeb.htseq.counts.gz	cafbe8e0-e615-4d17-88be-7fef215e5ece	TCGA-10-0927-01A-02R-1564-13	TCGA-10-0927-01A-02R	TCGA-10-0927-01A-02-BS2	TCGA-10-0927-01A-01-BS1	TCGA-10-0927-01A-02		TCGA-10-0927-01A	TCGA-10-0927	933dbfbd-4697-403e-bd73-c17cb300c94b	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.1		3d93f935-2a93-4987-99c6-0b75e2e59cd3	1.8	1930e83e-d1aa-459e-9f05-ab347df98dbf			0.15	22	released	3b04e4c3-d35f-40e4-bb5f-b854662c1604	RNA	R	0.15	UV Spec	released	False	3b87c711-ec50-4d19-8970-242aa215d3a2	02			0.0		10.0	30.0	60.0	75.0	BOTTOM	34116420-64e7-415c-bcf4-d6c5c7ba3e7c	released			0.0		5.0	5.0	90.0	95.0	TOP	9a7313d6-6b16-4e4f-b530-2a37dbc98170	released	released	95.0						97efbf70-83ef-49aa-ac3a-f0d0067a2a10	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-10-0927_demographic	65	-23982	2490	76e6cd60-baff-5f8f-8ad0-ad492278a8ef	hispanic or latino	female	not reported	released	Dead	1935	2006	TCGA-10-0927_exposure	Not Reported	c57e9903-b10b-57fc-a92e-bda75f8cbb34	released	TCGA-10-0927_diagnosis	23982	not reported	0	2478	9d23ef93-61ea-5258-8397-89ab16148670	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-10-0927_treatment_1	TCGA-10-0927_treatment	released	2426be39-043c-5adb-80ee-32ae5d5074ec	yes	Pharmaceutical Therapy, NOS	released	791b367f-dd3b-5eb2-b122-0109685f2baf	no	Radiation Therapy, NOS	cafbe8e0-e615-4d17-88be-7fef215e5ece
568de3f5-ff1b-4dc2-9a8b-1a3034e58ee0.htseq.counts.gz	3850d46d-d195-4c11-8d1c-9efbad5b9df1	TCGA-29-1690-01A-01R-1566-13	TCGA-29-1690-01A-01R	TCGA-29-1690-01A-01-BS1	TCGA-29-1690-01A-01-TS1	TCGA-29-1690-01A-01		TCGA-29-1690-01A	TCGA-29-1690	6b06281b-d3a9-440e-a86c-ee7db003352a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.4		a44f0507-fc95-410a-a6b2-b66caacee30e	1.8	d78906d7-c8f2-4bf0-86cc-2b60b067aaa6			0.15	22	released	72239f7b-29d5-4413-b72a-9e5aaf832e58	RNA	R	0.15	UV Spec	released	False	6d684e18-bf9e-4a96-bdf5-5317f15e2db5	01			0.0		0.0	0.0	100.0	90.0	BOTTOM	93d3d15e-ec2b-4359-ba33-8bc7e19384eb	released			0.0	1.0	0.0	0.0	100.0	95.0	TOP	760c759f-58f3-452d-a7a3-de166e8b1659	released	released	129.0						50633d92-0d7d-476e-8d4b-9a8de94771a2	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-29-1690_demographic	66	-24319	1448	bcfa97b6-fdd7-5b5f-8943-3e2bb1b2f8a1	not reported	female	white	released	Dead	1927	1996	TCGA-29-1690_exposure	Not Reported	148ad2a8-c77d-553d-aeff-cffa564383ff	released	TCGA-29-1690_diagnosis	24319	not reported	0	1360	dd1b849b-25d5-5b61-8c30-9bdbb0ea6514	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1993	TCGA-29-1690_treatment_1	TCGA-29-1690_treatment	released	cfa2cba4-3d53-528e-9832-84aaed112097	yes	Pharmaceutical Therapy, NOS	released	e83411da-55fb-57c5-b623-4e184c181a72	no	Radiation Therapy, NOS	3850d46d-d195-4c11-8d1c-9efbad5b9df1
655c5a8b-a87a-482e-95cf-1519b3146534.htseq.counts.gz	34f2c391-c521-42d7-be4e-1050a3380d08	TCGA-25-1313-01A-01R-1565-13	TCGA-25-1313-01A-01R	TCGA-25-1313-01A-01-BS1	TCGA-25-1313-01A-01-TS1	TCGA-25-1313-01A-01		TCGA-25-1313-01A	TCGA-25-1313	d73a0a33-e4e8-44bd-9580-2038ab06583a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.5	False	2.0		3F5AAE21-3694-4AC2-8A18-4970090A08F4	1.8	ab99683f-6116-463d-8bf6-5782809d4729			0.16	22	released	0ee2ab6e-46c8-4927-9f8f-95b1a846f79b	RNA	R	0.16	UV Spec	released	False	d2d431ca-0540-4b87-a41d-52df315c3e01	01			0.0		0.0	20.0	80.0	90.0	BOTTOM	737ad7a3-621b-4690-aed5-2c8f6fe5a4e6	released			0.0		0.0	30.0	70.0	90.0	TOP	b3bd676b-4dfb-4ab3-9f96-5615490ade91	released	released							2e142ad3-0560-4e09-b5ce-ba9df578963d	Primary Tumor	01	1.5	released	Not Reported	released	TCGA-25-1313_demographic	62	-22982	820	eb34da9e-5cca-54f5-8a3b-7a4745c1edb5	not hispanic or latino	female	white	released	Dead	1938	2002	TCGA-25-1313_exposure	Not Reported	adbaa766-3c3d-53d2-ac34-cfd61a418eb8	released	TCGA-25-1313_diagnosis	22982	not reported	0	820	1ad23243-90b7-58dd-a896-f3a3432ad5f2	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-25-1313_treatment_1	TCGA-25-1313_treatment	released	c4ef7400-99dd-54d2-9d53-24fce32cd64d	yes	Pharmaceutical Therapy, NOS	released	e9515711-ffd8-53a5-b970-1a4ff3a601d2	no	Radiation Therapy, NOS	34f2c391-c521-42d7-be4e-1050a3380d08
ad9a29de-7c46-4caa-a802-b18053b4e32d.htseq.counts.gz	310e2052-8e80-473e-875b-78b402853a66	TCGA-29-2427-01A-01R-1569-13	TCGA-29-2427-01A-01R	TCGA-29-2427-01A-01-TS1	TCGA-29-2427-01A-01-BS1	TCGA-29-2427-01A-01		TCGA-29-2427-01A	TCGA-29-2427	6f25001a-f890-4fd0-a994-e62a9ea5c6f3	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		b53536ca-770c-4482-b2f7-4284d804db2e	1.8	f1579d6e-6efd-47b5-b2b4-a97e1480ce0a			0.13	22	released	64a01f37-4193-47a9-a2e5-bf73320f486c	RNA	R	0.13	UV Spec	released	False	07a1666c-2b86-4021-a6f9-2ea4b06ebef9	01			5.0		0.0	15.0	80.0	90.0	TOP	9a2ec747-2714-4a3a-84a5-5d6855ee018f	released			5.0		0.0	15.0	80.0	90.0	BOTTOM	18e2a214-81fd-424b-9df8-79f5cb01a124	released	released	159.0						41b8564a-48df-44ab-9242-8d1d89697658	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-29-2427_demographic	60	-21940		4444344c-f573-5cad-9e24-348cf054c8ca	not reported	female	white	released	Alive	1944		TCGA-29-2427_exposure	Not Reported	3d04038a-6194-5c3a-aac4-3dce1f0b418b	released	TCGA-29-2427_diagnosis	21940	not reported	0	1900	da1f114e-7c5a-51fc-9d84-66d67b4f7676	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-29-2427_treatment_1	TCGA-29-2427_treatment	released	86f24af2-e21e-558b-9433-0fa406f05002	yes	Pharmaceutical Therapy, NOS	released	252184f3-65c1-51c2-bfbf-33ef83c9971a	no	Radiation Therapy, NOS	310e2052-8e80-473e-875b-78b402853a66
760e59a8-b3bb-4d63-9e0e-23b5023546a4.htseq.counts.gz	baf3f97c-0feb-4623-affc-d0f3fe44c570	TCGA-09-0367-01A-01R-1564-13	TCGA-09-0367-01A-01R	TCGA-09-0367-01A-01-TS1	TCGA-09-0367-01A-01-BS1	TCGA-09-0367-01A-01		TCGA-09-0367-01A	TCGA-09-0367	9bbc01b4-056c-4ddc-aca4-ff20718646d0	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV					False			8a24fe8a-9f7f-4fbf-86c7-704427ccaf89	1.8	047e04aa-6a91-4535-b279-50430098e638			0.18	22	released	8afdc136-3f03-43f4-8ddc-b80c3afa15bc	RNA	R	0.18	UV Spec	released	False	84fe89e2-4072-495e-b2f7-f57781dc463b	01			0.0		1.0	9.0	90.0	95.0	TOP	e8d46b30-6655-4c5b-9354-0a193e9467b9	released			0.0		0.0	5.0	95.0	98.0	BOTTOM	03399067-8b76-4a57-aa39-ba0a642ebe2c	released	released							593a4322-bd6f-49d3-9fc6-0f56a1943664	Primary Tumor	01		released	Not Reported	released	TCGA-09-0367_demographic	67	-24473	547	51e8191f-bc19-5752-94b7-b3a4ea24578f	not hispanic or latino	female	native hawaiian or other pacific islander	released	Dead	1934	2002	TCGA-09-0367_exposure	Not Reported	09d31723-23ee-572b-8bb5-b687b29c524c	released	TCGA-09-0367_diagnosis	24473	not reported	0		3b0fadff-1eaa-5a35-9045-24288b57a3dd	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-09-0367_treatment	TCGA-09-0367_treatment_1	released	468cac62-c860-5e8f-b4b0-f22c7544080f	no	Radiation Therapy, NOS	released	683c0026-29bf-50ae-a0db-f09fd1236b7f	yes	Pharmaceutical Therapy, NOS	baf3f97c-0feb-4623-affc-d0f3fe44c570
0315439e-694c-4b14-a27c-29dfa117c764.htseq.counts.gz	691ec8c8-17b3-4c26-83f6-bd76817d9238	TCGA-13-0885-01A-02R-1569-13	TCGA-13-0885-01A-02R	TCGA-13-0885-01A-02-BS2	TCGA-13-0885-01A-01-BS1	TCGA-13-0885-01A-02		TCGA-13-0885-01A	TCGA-13-0885	2a924999-1fbf-470a-97bd-fd2276a9a366	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.2		81DFFD49-45F0-4A20-AC27-B8316B2E0289	1.8	e0f48d4d-4c10-4b83-9a13-9427a08371d3			0.16	22	released	34a40847-50c8-4150-910a-cf62c86c7e09	RNA	R	0.16	UV Spec	released	False	21a663ad-d772-4797-b1ff-ff5128f22354	02			2.0		20.0	0.0	78.0	80.0	BOTTOM	f81d65cc-0e63-43c6-b022-17d16fa61f9a	released	90.0		2.0		19.0	1.0	78.0	80.0	TOP	5245b3d4-1105-40ba-aa2a-8f093459f125	released	released	120.0						8486f0d0-2bb2-41a0-8b21-308407ce4aba	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0885_demographic	70	-25763		83bbd790-7f3e-5f1e-91be-9aaf019078bd	not hispanic or latino	female	white	released	Alive	1930		TCGA-13-0885_exposure	Not Reported	01529f38-3462-595f-b80d-4628e930aaed	released	TCGA-13-0885_diagnosis	25763	not reported	0	3388	65552a39-e03f-5986-9476-19628f3e6d7e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-13-0885_treatment	TCGA-13-0885_treatment_1	released	3c9fc7f5-2aed-50e8-b25b-9b2f60e6e352	no	Radiation Therapy, NOS	released	0494e692-de4e-5b98-a298-d6fb31b29659	yes	Pharmaceutical Therapy, NOS	691ec8c8-17b3-4c26-83f6-bd76817d9238
4d337bb6-8e53-4142-8c22-432bce3e754d.htseq.counts.gz	18863638-3369-4ca3-bc0f-a251448259b3	TCGA-30-1860-01A-01R-1568-13	TCGA-30-1860-01A-01R	TCGA-30-1860-01A-01-BS1	TCGA-30-1860-01A-01-TS1	TCGA-30-1860-01A-01		TCGA-30-1860-01A	TCGA-30-1860	563853a2-9ac2-48be-adf3-1e547ee2b274	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.5		d5b8e59f-1ae5-4e22-b933-48e48a364788	1.8	1b8eed7b-173e-4e38-80a4-a3a0aea469a1			0.15	22	released	fdbcb9be-686b-4301-a1f7-b1efed35c4ca	RNA	R	0.15	UV Spec	released	False	b25ba42d-dd08-495c-83f6-71ee932db6f2	01			10.0		0.0	5.0	85.0	95.0	BOTTOM	3f2f52d2-e19d-4b63-9bf7-d02377f667b7	released			0.0		0.0	10.0	90.0	95.0	TOP	751e5a7f-2a59-40cc-866f-cc3780f7330b	released	released	103.0						5ae1ae22-b891-472a-b737-e48c73b91798	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-30-1860_demographic	58	-21406	1366	e6e91e72-6dca-5afc-a512-914d653d4a4f	hispanic or latino	female	white	released	Dead	1944	2005	TCGA-30-1860_exposure	Not Reported	55774a0d-a4d8-5b58-ae1b-3b84e53723ba	released	TCGA-30-1860_diagnosis	21406	not reported	0	1366	770910a1-1949-574d-a201-4d4ada40e373	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-30-1860_treatment_1	TCGA-30-1860_treatment	released	b36f19ed-d195-5035-8041-92879b6e0608	yes	Pharmaceutical Therapy, NOS	released	0849482a-d6f8-57ba-94b3-5252b4b71bd2	yes	Radiation Therapy, NOS	18863638-3369-4ca3-bc0f-a251448259b3
b269c35d-7f91-4c66-8bef-59906ec87745.htseq.counts.gz	5e57bd1d-f38d-447d-9d7c-1fa1c5a2ecaa	TCGA-29-1697-01A-01R-1567-13	TCGA-29-1697-01A-01R	TCGA-29-1697-01A-01-BS1	TCGA-29-1697-01A-01-TS1	TCGA-29-1697-01A-01		TCGA-29-1697-01A	TCGA-29-1697	42ebd30b-175e-4ece-a806-e55cb7e40e96	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.9		294ba09f-347a-4129-847d-211cdf73ca99	1.8	75435634-4311-49d8-8e42-ae1069c1e2ef			0.15	22	released	abafa246-ba22-4c5c-9d5d-cad685be95fa	RNA	R	0.15	UV Spec	released	False	eb49f284-4047-4854-9d30-ff97cf8d3bd6	01			2.0		0.0	0.0	98.0	95.0	BOTTOM	a93e70b2-87b6-41db-ba0d-f370e0abc3c9	released			2.0		0.0	0.0	98.0	95.0	TOP	e1588d4d-264d-4973-9cf9-5ade9a3ff5ca	released	released	140.0						3669f3bd-dffe-4737-bf81-07f38deceb2e	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1697_demographic	62	-22933	949	c1569def-c3d1-50c7-89d8-2a3decd38865	not reported	female	white	released	Dead	1941	2005	TCGA-29-1697_exposure	Not Reported	5afd9e51-4682-539e-9380-fcc2653dab8d	released	TCGA-29-1697_diagnosis	22933	not reported	0	949	0be1c54a-5169-5542-894c-fa5257137496	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-29-1697_treatment_1	TCGA-29-1697_treatment	released	fbc5673c-2253-5aff-914e-ba17f2e00fd5	yes	Pharmaceutical Therapy, NOS	released	f79e3788-db4d-56a4-994a-eb405d6fccc4	no	Radiation Therapy, NOS	5e57bd1d-f38d-447d-9d7c-1fa1c5a2ecaa
3ef6bcf6-93a8-4c7c-b2c1-9c48fba76b32.htseq.counts.gz	8fb1bf2a-709c-4408-b10e-4e13316de1ce	TCGA-23-1109-01A-01R-1564-13	TCGA-23-1109-01A-01R	TCGA-23-1109-01A-01-TS1	TCGA-23-1109-01A-01-BS1	TCGA-23-1109-01A-01		TCGA-23-1109-01A	TCGA-23-1109	7c466a5f-a6b4-4d1a-a0f5-ddcd7ef90ff1	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.0		d70d81ca-5eb2-426c-afc7-4d52bc36bfb2	1.8	d47e074a-f78e-40c5-8af4-f737ce010041			0.15	22	released	522ecca3-fee2-4364-8b5b-692b49128ed0	RNA	R	0.15	UV Spec	released	False	2cae90e9-d2b6-413c-a453-1c477e8fb206	01			0.0		0.0			90.0	TOP	97b03fed-53f2-4f0d-92f8-bd428a8727c9	released			0.0		0.0			90.0	BOTTOM	36198b33-5879-4991-91b7-f5b6621f8f6d	released	released	105.0						146f9463-de59-4418-9099-2425a6f86a0f	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-23-1109_demographic	62	-23002	1562	51854744-93b7-5026-a52b-398fdc2b8ec0	not hispanic or latino	female	white	released	Dead	1937	2003	TCGA-23-1109_exposure	Not Reported	6601a690-32ba-5451-92c3-54bd7e222a45	released	TCGA-23-1109_diagnosis	23002	not reported	0	1562	412e8ae0-f962-5ef4-8fa1-0cb072d378af	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-23-1109_treatment_1	TCGA-23-1109_treatment	released	ef5de077-c15e-5230-ba6e-ab25bbeb1eae	yes	Pharmaceutical Therapy, NOS	released	5ad1d6e4-f119-548e-994c-585e7119e113	yes	Radiation Therapy, NOS	8fb1bf2a-709c-4408-b10e-4e13316de1ce
e6993299-9429-4689-acb9-1fff67ce6642.htseq.counts.gz	c6f0c082-488a-4065-9cbf-35b54c61198e	TCGA-30-1866-01A-02R-1568-13	TCGA-30-1866-01A-02R	TCGA-30-1866-01A-02-BS2	TCGA-30-1866-01A-01-BS1	TCGA-30-1866-01A-02		TCGA-30-1866-01A	TCGA-30-1866	cbc7f427-5f7b-4267-ad56-055d8880a4cc	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.2		bda3960c-1610-4bff-b60e-b9c8f3a4454a	1.8	e2c174f6-eac3-449e-879c-9335ccf4ccd6			0.15	22	released	e1fa0c1a-1313-479e-8f28-1a098e58575e	RNA	R	0.15	UV Spec	released	False	30685af0-824e-4eea-aaca-c55443589b2f	02			0.0		0.0	5.0	95.0	99.0	BOTTOM	c7539c9f-48aa-4af8-a182-233f4b6d3068	released			0.0		0.0	5.0	95.0	99.0	TOP	9116a600-0030-448a-8405-827d06464235	released	released	133.0						887e9b15-4a8c-4950-8954-b9f6bff18bb1	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-30-1866_demographic	61	-22562	1114	279cd324-6a0b-5661-a9fa-20e52a631c31	not hispanic or latino	female	white	released	Dead	1942	2006	TCGA-30-1866_exposure	Not Reported	5962b3b5-e3d6-5d49-bd27-6a1ee2ee63c5	released	TCGA-30-1866_diagnosis	22562	not reported	0	1114	85df57f5-3d3c-516c-8925-cfddbb62eedd	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-30-1866_treatment_1	TCGA-30-1866_treatment	released	4f7cc528-ee3a-50da-a4a9-a9e92effa1d4	yes	Pharmaceutical Therapy, NOS	released	2e2ad35a-eda0-590a-a6f1-485f44ae5752	no	Radiation Therapy, NOS	c6f0c082-488a-4065-9cbf-35b54c61198e
87ccd166-7fbd-498c-b03f-d4c369ff30ef.htseq.counts.gz	aab022a8-5b6b-4ee1-9b68-f321e7e73a3c	TCGA-24-2267-01A-01R-1568-13	TCGA-24-2267-01A-01R	TCGA-24-2267-01A-01-TS1	TCGA-24-2267-01A-01-BS1	TCGA-24-2267-01A-01		TCGA-24-2267-01A	TCGA-24-2267	99a61986-7b23-46b5-99a4-efba6bad3766	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.5		24844312-f32c-4366-945e-96d9a923f82a	1.8	9ebb3535-6536-49fc-a88b-473235972378			0.15	22	released	6d17a41a-de77-457b-89a2-098dd75396ef	RNA	R	0.15	UV Spec	released	False	6f23bd0f-e94a-4307-a8ed-1fda008e14cc	01			1.0		0.0	4.0	95.0	95.0	TOP	1c03b8f4-baa7-4a37-9672-2b91f3ca0f29	released			1.0		0.0	14.0	85.0	90.0	BOTTOM	d7bddc1a-9847-4aa6-94eb-c21e45e820c0	released	released	105.0						00be5ec1-3b0f-4b5a-b116-4efce25d2cc8	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-2267_demographic	58	-21293	1446	299c04b0-8890-5057-97b4-2e1177e03833	not reported	female	white	released	Dead	1935	1996	TCGA-24-2267_exposure	Not Reported	1c4c8584-8bbc-50ec-aa0f-5e16aaddfc8e	released	TCGA-24-2267_diagnosis	21293	not reported	0	1446	9e118376-2d24-5552-a922-a86dbf96b389	Stage IIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1993	TCGA-24-2267_treatment	TCGA-24-2267_treatment_1	released	d930659d-707a-5a63-8b9a-af729088c26b	no	Radiation Therapy, NOS	released	ad3b6136-3d09-5858-9c33-b1fb4789b4a7	yes	Pharmaceutical Therapy, NOS	aab022a8-5b6b-4ee1-9b68-f321e7e73a3c
06199259-c8da-4b44-b957-8148e31b38cf.htseq.counts.gz	ac6a0145-0b78-4ce9-bdba-cccdc5a6a63d	TCGA-24-1103-01A-01R-1565-13	TCGA-24-1103-01A-01R	TCGA-24-1103-01A-01-TS1	TCGA-24-1103-01A-01-BS1	TCGA-24-1103-01A-01		TCGA-24-1103-01A	TCGA-24-1103	f34aa3b6-e966-49c6-bc55-130545772c53	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		B9628222-5530-4A82-9F13-2773173A0C95	1.8	202abe19-20e0-4ea9-8653-bf5145da351c			0.15	22	released	5b1a8147-dc5a-40ff-8071-30d495de5dcb	RNA	R	0.15	UV Spec	released	False	80b520fe-b033-48a3-b0c3-dba65b795c07	01			5.0		0.0	0.0	0.0	90.0	TOP	626b516a-0522-4cf6-ac17-458fb9b39297	released			5.0		0.0	0.0	0.0	90.0	BOTTOM	7318516f-445c-4455-bef7-4229045e6edd	released	released	140.0						6f9a6f73-285d-4a9c-80eb-5f2ebc1787a4	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-24-1103_demographic	50	-18583	1646	70b9fc46-3ebc-5ab0-adbb-162e6a4ea01c	not reported	female	black or african american	released	Dead	1951	2005	TCGA-24-1103_exposure	Not Reported	7c264428-6916-56e2-bc0e-b468daeeee19	released	TCGA-24-1103_diagnosis	18583	not reported	0	1646	d8c22b70-6252-5c9a-ad92-ede1bb3d8804	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-24-1103_treatment_1	TCGA-24-1103_treatment	released	373f5c9e-47a5-5608-bc86-bbde8569ea08	yes	Pharmaceutical Therapy, NOS	released	bb613be8-961d-5e06-a8fd-8cf0bbb11dac	no	Radiation Therapy, NOS	ac6a0145-0b78-4ce9-bdba-cccdc5a6a63d
ce511378-d8f8-494e-a07d-2e0dbed68bf8.htseq.counts.gz	47ffccad-ba4f-412e-ac62-4b4a30a55473	TCGA-04-1365-01A-01R-1565-13	TCGA-04-1365-01A-01R	TCGA-04-1365-01A-01-BS1	TCGA-04-1365-01A-01-TS1	TCGA-04-1365-01A-01		TCGA-04-1365-01A	TCGA-04-1365	0484a929-7a7f-4926-8d25-470ddab082ec	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.2		049FC54E-4D17-4B68-9E41-268529C9F18F	1.7	2535da6b-39f0-41de-afd3-82cb37916b95			0.15	22	released	5355cfa3-3f75-4314-85c5-d48519f7ef4d	RNA	R	0.15	UV Spec	released	False	c9961dd3-e2d2-4bc6-b81c-cb5bec5c2c54	01			1.0		0.0	5.0	94.0	99.0	BOTTOM	e731bd77-daff-44b7-a5cb-19858abb6293	released			1.0		0.0	5.0	94.0	95.0	TOP	136edbd4-a232-411e-9795-7ab0bd785b14	released	released	124.0						c91df211-f021-40ea-aa79-9fe01a309ad8	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-04-1365_demographic	87	-31925		ad52a183-6a6a-50ad-8f74-a12962008af9	not hispanic or latino	female	white	released	Alive	1916		TCGA-04-1365_exposure	Not Reported	e8cd3e1d-1fff-5f8e-aedb-640ea5aeb8d9	released	TCGA-04-1365_diagnosis	31925	not reported	0	947	2dd073be-5331-55f3-bb9b-aa2a4a04d8b8	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-04-1365_treatment_1	TCGA-04-1365_treatment	released	1d005f8a-69b3-5766-a618-e16fd9b3c857	yes	Pharmaceutical Therapy, NOS	released	5c924e77-3ff0-5b67-9f21-44d930d43e93	no	Radiation Therapy, NOS	47ffccad-ba4f-412e-ac62-4b4a30a55473
fd15971c-b78e-4bba-bf87-59cd758b7cc6.htseq.counts.gz	70a2a8cb-c46a-4122-83a5-05b1fb24dfaa	TCGA-13-1512-01A-01R-1565-13	TCGA-13-1512-01A-01R	TCGA-13-1512-01A-01-TS1	TCGA-13-1512-01A-01-BS1	TCGA-13-1512-01A-01		TCGA-13-1512-01A	TCGA-13-1512	82093ed9-a3c8-4e34-931f-4ec7ae745711	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.4	False	2.0		66DC098E-9ADD-4446-AB6D-FEA35D5FD33B	1.8	67e85198-4b8c-45db-b433-683b1899f3ea			0.13	22	released	40774eef-173a-4056-a434-0a64ef36d2cc	RNA	R	0.13	UV Spec	released	False	c9887497-c0ab-4707-ba50-4fbfc7849da5	01			5.0		0.0	1.0	94.0	99.0	TOP	2fd7c3b6-e8fe-4542-b392-811c192282ae	released			10.0		0.0	1.0	89.0	99.0	BOTTOM	fbdc48b1-7344-41d9-90a4-f585b9b202b5	released	released	143.0						92baeb34-1fa4-4ee5-8c29-5596c4a29a29	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1512_demographic	49	-18134		605e97f3-8618-5b7b-8c23-0e82f639a1f0	not hispanic or latino	female	white	released	Alive	1959		TCGA-13-1512_exposure	Not Reported	cf64c369-6ad4-54f6-9803-7da73135acd9	released	TCGA-13-1512_diagnosis	18134	not reported	0	442	f8565836-3634-5b5c-8823-e193d83d3527	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1512_treatment	TCGA-13-1512_treatment_1	released	4097ce7e-d213-575d-8b16-c7b485005a51	no	Radiation Therapy, NOS	released	20d5ef1a-e3c5-5696-bde0-2eaea72b6daf	yes	Pharmaceutical Therapy, NOS	70a2a8cb-c46a-4122-83a5-05b1fb24dfaa
ac6e38b7-143c-491e-9892-4c28f51ddce5.htseq.counts.gz	c9cd12a4-b4b3-416e-9046-9c06dd884547	TCGA-24-1423-01A-01R-1565-13	TCGA-24-1423-01A-01R	TCGA-24-1423-01A-01-BS1	TCGA-24-1423-01A-01-TS1	TCGA-24-1423-01A-01		TCGA-24-1423-01A	TCGA-24-1423	f64ebc7f-0e5a-42b4-af57-6cdb90d24f90	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.8		47331163-68e9-44fd-8b80-b9f70058957f	1.8	b493df11-1929-4e35-ac44-49057cdbd86b			0.17	22	released	6312898c-065a-4b4c-8706-69374b2d6f5b	RNA	R	0.17	UV Spec	released	False	0556782f-6b2c-4867-9bbd-624d1c312738	01			10.0		30.0	0.0	60.0	95.0	BOTTOM	8e1e9415-8cf4-41b5-a038-1e6f03193d0f	released			10.0		5.0	0.0	85.0	90.0	TOP	43615c8b-4834-48bd-b92f-251ceb7073fe	released	released	182.0						eaf742ea-5bdc-4f44-a390-77cba766d260	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-24-1423_demographic	61	-22281		a4ae248f-d90b-5ced-a3c7-bf5619b4bffd	not reported	female	white	released	Alive	1947		TCGA-24-1423_exposure	Not Reported	2471cd1a-245f-5e4f-ae19-d6830608c4af	released	TCGA-24-1423_diagnosis	22281	not reported	0	190	4b898782-211b-5014-b4fc-29731d9e4489	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1423_treatment_1	TCGA-24-1423_treatment	released	cec363c1-32ad-5a4b-83c9-de9b39019371	yes	Pharmaceutical Therapy, NOS	released	daf9c3a2-fdd8-55fa-aeed-0b37b8fd4d57	no	Radiation Therapy, NOS	c9cd12a4-b4b3-416e-9046-9c06dd884547
24a828c5-596e-4a8a-ae44-9787841c6978.htseq.counts.gz	aa0bedc4-7870-4501-9fea-072c8ec35501	TCGA-61-2009-01A-01R-1568-13	TCGA-61-2009-01A-01R	TCGA-61-2009-01A-01-BS1	TCGA-61-2009-01A-01-TS1	TCGA-61-2009-01A-01		TCGA-61-2009-01A	TCGA-61-2009	ae914f23-87b9-4169-a7f7-a3483078c902	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				2.0	False	2.0		39de8c59-e593-47d3-932d-575a4537b4dc	1.8	b6ed2184-0885-49ba-8b00-a3e57e4e5500			0.14	22	released	b6362265-9a1d-412b-9768-365ca2adae08	RNA	R	0.14	UV Spec	released	False	579bb41a-e5cd-443b-a074-27c61beed930	01			5.0		0.0	10.0	85.0	90.0	BOTTOM	39107a07-daa5-4194-aedc-269f33d3dd2e	released			1.0		0.0	5.0	94.0	95.0	TOP	098afc71-5dba-4fcd-8059-9d4d806db2b3	released	released	152.0						8832fa0d-1bd8-42a9-b002-1a02500d48eb	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-61-2009_demographic	65	-23772		c2e9ac12-63d8-5aff-8006-3a819ceb9302	not hispanic or latino	female	white	released	Alive	1941		TCGA-61-2009_exposure	Not Reported	0e1af3f4-e5a4-5904-812d-8958954af78e	released	TCGA-61-2009_diagnosis	23772	not reported	0	1212	c813f3eb-5dd8-5697-90d3-e91a0bd284b0	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-61-2009_treatment_1	TCGA-61-2009_treatment	released	b6d59614-d381-5d14-919c-ab5fcfbef994	yes	Pharmaceutical Therapy, NOS	released	883871c7-ecf6-5669-8b76-a651137bf869	no	Radiation Therapy, NOS	aa0bedc4-7870-4501-9fea-072c8ec35501
94823ae2-8fb8-4be7-b2ca-88dff791b29b.htseq.counts.gz	b84b9118-3a5a-41c0-bc25-0d83c7a82655	TCGA-13-0883-01A-02R-1569-13	TCGA-13-0883-01A-02R	TCGA-13-0883-01A-02-BS2	TCGA-13-0883-01A-01-BS1	TCGA-13-0883-01A-02		TCGA-13-0883-01A	TCGA-13-0883	5c159ab5-8475-4d93-89b8-b6befed4a5b3	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.4		7AC6471C-1BA0-4AA5-9A2E-70413C9768F8	1.8	1cc5dd24-87c4-4b49-851f-618d0ca98875			0.16	22	released	c12585e6-4b3f-4917-b379-60ca456070be	RNA	R	0.16	UV Spec	released	False	62d3a2bd-8a72-48ca-bf02-47ecd8535d84	02			2.0		10.0	0.0	88.0	90.0	BOTTOM	b3603594-ed44-4e5e-861a-52aa4eeb71de	released			2.0		20.0	0.0	78.0	80.0	TOP	a00b3891-5c61-43b1-a0d3-9857ac0d942a	released	released	173.0						c084ec17-62a3-43d7-bc0d-ab806bcd35a3	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0883_demographic	61	-22395	2097	580cfffe-92f6-5401-9167-dac54793bc2e	not hispanic or latino	female	white	released	Dead	1941	2007	TCGA-13-0883_exposure	Not Reported	63106c97-3353-5b85-9e0e-e093ed3ecc0e	released	TCGA-13-0883_diagnosis	22395	not reported	0	2097	1ca82c95-b632-5780-9c0b-cc470669922c	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-13-0883_treatment_1	TCGA-13-0883_treatment	released	83fa843a-ae9f-5c39-b575-e697f8a5fd90	yes	Pharmaceutical Therapy, NOS	released	aa138e2d-759a-59fa-85ed-c7a2a5d7e157	no	Radiation Therapy, NOS	b84b9118-3a5a-41c0-bc25-0d83c7a82655
52a3d27b-f415-4e7c-8000-957574724cfd.htseq.counts.gz	0f6a4813-5da3-483e-8237-db82b79b97d8	TCGA-24-1603-01A-01R-1566-13	TCGA-24-1603-01A-01R	TCGA-24-1603-01A-01-TS1	TCGA-24-1603-01A-01-BS1	TCGA-24-1603-01A-01		TCGA-24-1603-01A	TCGA-24-1603	19427350-619b-4b9c-a3ba-37f667bb2843	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.0		b5ea4cb8-5f2a-4a6d-88ed-f36c1b12e3f9	1.8	f4187f4f-9c52-4065-818b-c884183a5a70			0.14	22	released	2555d448-3cac-46ba-8d5e-bca158e48dfc	RNA	R	0.14	UV Spec	released	False	966ebdc5-662e-450b-9c8c-50853ac5c4d6	01			5.0		8.0	0.0	87.0	95.0	TOP	41cdbaf5-d3cc-43d2-91ce-9176ab694e1b	released			12.0		8.0	0.0	80.0	95.0	BOTTOM	10b614a2-04d5-437a-896b-34d0ecf2db37	released	released	142.0						bb14a720-4899-48d9-a57b-e1fd2aa9d8ec	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-24-1603_demographic	53	-19681	2742	d5969403-73a4-5315-a0c2-0c82873ad345	not reported	female	white	released	Dead	1943	2003	TCGA-24-1603_exposure	Not Reported	ad7291cc-bda8-595f-9548-8e14d1e01010	released	TCGA-24-1603_diagnosis	19681	not reported	0	2742	6ebcfddc-d5a4-507d-9a7b-141c1dbe899d	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1996	TCGA-24-1603_treatment	TCGA-24-1603_treatment_1	released	9a3a551e-7fcb-5ce7-9efa-913311ec6bfe	no	Radiation Therapy, NOS	released	8db9b286-4cc8-5402-b36d-5637e668d9be	yes	Pharmaceutical Therapy, NOS	0f6a4813-5da3-483e-8237-db82b79b97d8
8166ba38-a099-4a07-8271-0587fe8d10d7.htseq.counts.gz	da33a57d-2ade-476b-b72e-985a87833210	TCGA-24-1430-01A-01R-1566-13	TCGA-24-1430-01A-01R	TCGA-24-1430-01A-01-BS1	TCGA-24-1430-01A-01-TS1	TCGA-24-1430-01A-01		TCGA-24-1430-01A	TCGA-24-1430	3018efe7-13a1-47ae-a726-8fc967c73841	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.7	False	2.0		d0f95ced-e33f-4796-a6a4-3030f8e21761	1.8	4c19d12e-0160-4d01-b621-65335156488b			0.15	22	released	777f285b-2ead-49df-88bc-ed992027d40a	RNA	R	0.15	UV Spec	released	False	511a763d-60f4-413f-a80e-510336b83668	01			0.0		0.0	5.0	95.0	95.0	BOTTOM	da84d3c2-9588-4907-9a03-4ea2847621aa	released			0.0		0.0	5.0	95.0	95.0	TOP	206fc526-1f7c-49f7-84b3-26ed0be0b14e	released	released	153.0						eb401991-7a9a-494a-8f7c-072f39e40ec2	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-24-1430_demographic	68	-24939	863	a7a4f433-78e4-5763-b441-d0eb0f1eb85f	not reported	female	white	released	Dead	1932	2002	TCGA-24-1430_exposure	Not Reported	c0fbca74-5e83-5463-a75e-109ecf40b36e	released	TCGA-24-1430_diagnosis	24939	not reported	0	863	2a0f08c5-3c4b-577d-927e-0626042b4204	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-24-1430_treatment	TCGA-24-1430_treatment_1	released	5b1f79c6-9afc-5ccc-b844-1230f88cf803	no	Radiation Therapy, NOS	released	9b06b484-f437-59fa-8bae-d322d3b300fe	yes	Pharmaceutical Therapy, NOS	da33a57d-2ade-476b-b72e-985a87833210
85ca6ac2-6cec-4249-9166-54a2f0e10404.htseq.counts.gz	e5b1b8b4-24fa-4e8d-b9c3-4d00406c2d79	TCGA-10-0928-01A-02R-1564-13	TCGA-10-0928-01A-02R	TCGA-10-0928-01A-01-BS1	TCGA-10-0928-01A-02-BS2	TCGA-10-0928-01A-02		TCGA-10-0928-01A	TCGA-10-0928	29d26e7e-f4ae-4476-9a3f-27d5ec2ccb8a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.0		859b2662-493a-4ead-9ac7-0aa8d0a7a3d8	1.8	9aa3ae15-1033-46f1-a304-993f5d41cd50			0.15	22	released	42019bf7-9187-4493-be2d-0d8733365c60	RNA	R	0.15	UV Spec	released	False	b544b8b2-a5f1-428d-8203-d27ce6b67a17	02			0.0		5.0	5.0	90.0	95.0	TOP	7e1a20f2-31da-4b50-8d26-005e67baa47c	released			0.0		5.0	5.0	90.0	95.0	BOTTOM	facd92de-6893-4650-a327-1f15554a01fc	released	released	88.0						4416312b-c64f-4fb2-9819-6ccf9b8ab219	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-10-0928_demographic	71	-26066	563	86af060d-7656-5dea-bef2-06252f78bea5	not reported	female	white	released	Dead	1929	2001	TCGA-10-0928_exposure	Not Reported	9796105d-6559-52b9-9879-d247d5fe43af	released	TCGA-10-0928_diagnosis	26066	not reported	0	563	b513bda1-4ea9-5a15-be5c-afdf0225f33f	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-10-0928_treatment	TCGA-10-0928_treatment_1	released	8e5cb970-4c0d-59ae-bbb8-b542474096f1	no	Radiation Therapy, NOS	released	244e7bf1-5d91-5ce8-83c2-a2eda005f32a	yes	Pharmaceutical Therapy, NOS	e5b1b8b4-24fa-4e8d-b9c3-4d00406c2d79
24b7176d-483b-416e-8ecd-d3beae934fc3.htseq.counts.gz	7508650c-8a1f-40e1-ae61-b669ccabc83e	TCGA-29-1688-01A-01R-1566-13	TCGA-29-1688-01A-01R	TCGA-29-1688-01A-01-BS1	TCGA-29-1688-01A-01-TS1	TCGA-29-1688-01A-01		TCGA-29-1688-01A	TCGA-29-1688	05019013-7ea5-4905-ac79-901146ba2ee2	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.5	False	2.5		cb2bd608-b9d4-497e-9058-2269dc86b5b3	1.8	5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf			0.15	22	released	03717e91-31fb-4e23-ae05-71d227cd5484	RNA	R	0.15	UV Spec	released	False	3ae8b914-962f-44c2-b91d-75cd81467f1b	01			0.0		0.0	0.0	100.0	80.0	BOTTOM	4b930846-2a6b-42e3-a986-1c74d92d95ae	released			0.0		0.0	0.0	100.0	70.0	TOP	0917166e-3623-4f88-bc19-5b3e6fd856f9	released	released	121.0						3385e66c-5764-4260-929f-b653a23c7afb	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-29-1688_demographic	39	-14574	2400	99a2d09f-0a52-5f26-8588-75ce3c50c76b	not reported	female	white	released	Dead	1953	1998	TCGA-29-1688_exposure	Not Reported	37bd92de-d1a1-5e55-be66-50b0c2f15352	released	TCGA-29-1688_diagnosis	14574	not reported	0	2400	167fdc87-5221-5292-9ca8-de9c2fc60e5b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1992	TCGA-29-1688_treatment_1	TCGA-29-1688_treatment	released	0faa6f44-801a-5319-82d8-acf2892d876f	yes	Pharmaceutical Therapy, NOS	released	041496d3-ca85-527c-8ad9-c68f439ff33e	yes	Radiation Therapy, NOS	7508650c-8a1f-40e1-ae61-b669ccabc83e
2f635d92-f453-41c4-b5e8-d7c3256877dd.htseq.counts.gz	e7a6c6fe-be01-4779-b066-b46c35f1d070	TCGA-24-2280-01A-01R-1568-13	TCGA-24-2280-01A-01R	TCGA-24-2280-01A-01-TS1	TCGA-24-2280-01A-01-BS1	TCGA-24-2280-01A-01		TCGA-24-2280-01A	TCGA-24-2280	97ad0360-3be4-401a-a94c-7f2800a1b519	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.5		deb1a0d1-92a0-4c10-b491-a6a1ca5e3192	1.8	e39a23c8-1bc3-4bfb-9b1e-3075f98782fa			0.14	22	released	4be130c9-644e-4495-becc-4da775618880	RNA	R	0.14	UV Spec	released	False	f85cf897-47a8-4d4f-a43b-7d0fe60b0a53	01			2.0		0.0	15.0	83.0	75.0	TOP	2dd90f1f-fe80-438f-bb4e-5d80716e6962	released			2.0		0.0	10.0	88.0	80.0	BOTTOM	fb1d3270-6539-4e93-b546-a1bcb1d7efe2	released	released	133.0						e24b153c-001b-43a3-b0d4-2b6eec615cfd	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-2280_demographic	74	-27356		20c0c7cf-6af3-503b-bf45-29229f4e17cb	not reported	female	white	released	Alive	1930		TCGA-24-2280_exposure	Not Reported	85240d7f-9a44-5e8c-9668-134fbc9cee65	released	TCGA-24-2280_diagnosis	27356	not reported	0	2143	1d5b60d6-7bc9-56ad-8e82-0acd994fd1c7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-24-2280_treatment_1	TCGA-24-2280_treatment	released	c15a3ea4-c3c7-5fda-9d6f-346dd703b0dc	yes	Pharmaceutical Therapy, NOS	released	317d070b-4f4b-58cf-a8e0-83c2f5517b93	no	Radiation Therapy, NOS	e7a6c6fe-be01-4779-b066-b46c35f1d070
eeb18b62-a0f1-4af8-8115-cdaeaeef0f32.htseq.counts.gz	fb796bbd-63d7-4148-a95c-7b5ec0f11a35	TCGA-25-2401-01A-01R-1569-13	TCGA-25-2401-01A-01R	TCGA-25-2401-01A-01-BS1	TCGA-25-2401-01A-01-TS1	TCGA-25-2401-01A-01		TCGA-25-2401-01A	TCGA-25-2401	3bc8a74f-49bd-46b6-a3a4-68ca838e83c6	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.8		5B192072-1F11-4316-AC39-81085F7E425D	1.8	c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c			0.14	22	released	97e3dec3-1bca-4be2-9b4a-f0656a478fe9	RNA	R	0.14	UV Spec	released	False	76282c36-33b4-4f54-a5bb-0a7ea903ab39	01			5.0		1.0	19.0	75.0	80.0	BOTTOM	8c7e8e52-32b5-4abc-831a-1e32c7780162	released			1.0		0.0	10.0	89.0	90.0	TOP	998ebf95-b49a-46c5-b501-b877912cbd44	released	released	162.0						efc25de9-e672-4b44-9003-5b277a47a625	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-25-2401_demographic	64	-23711	90	61b69ecd-1137-5c6b-8e08-e9acae100eb2	not hispanic or latino	female	white	released	Dead	1940	2004	TCGA-25-2401_exposure	Not Reported	d89c3107-6446-5500-9455-7eb9d9a3e0d2	released	TCGA-25-2401_diagnosis	23711	not reported	0	90	012f225f-1cb8-5962-a806-b05cca31ffd9	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-25-2401_treatment_1	TCGA-25-2401_treatment	released	6c6c5765-4cd0-56d9-910e-d555c45a7c11	not reported	Pharmaceutical Therapy, NOS	released	d51b968c-33f8-5c0c-a1e2-7f32f53f231f	no	Radiation Therapy, NOS	fb796bbd-63d7-4148-a95c-7b5ec0f11a35
3a34e792-461f-45f5-9c4e-a29deeef9ce2.htseq.counts.gz	a4545555-bb38-4346-8dd6-ce45dd0950bd	TCGA-29-1703-01A-01R-1567-13	TCGA-29-1703-01A-01R	TCGA-29-1703-01A-01-TS1	TCGA-29-1703-01A-01-BS1	TCGA-29-1703-01A-01		TCGA-29-1703-01A	TCGA-29-1703	b3511675-fd68-4745-8020-e290ca0fd115	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.4		c8397af0-67d2-4e69-993b-7349657e9953	1.8	64e3f978-d213-45e2-bb52-e9b9a2032dc0			0.14	22	released	c99ee4e8-f869-4987-9283-a643412f6ea6	RNA	R	0.14	UV Spec	released	False	38304d01-f347-423f-afe6-060872a71104	01			10.0		0.0	0.0	90.0	95.0	TOP	275260f3-64da-44d8-9488-c53230c4dce2	released			2.0		0.0	0.0	98.0	95.0	BOTTOM	bac4f162-fe80-42ee-91c2-7a3fa4486957	released	released	117.0						d86b5d2b-9a8e-4bfa-9549-12fd45e8c296	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1703_demographic	56	-20622	1815	d3239bb4-63cb-5ba3-911b-f8ef467f8bb5	not reported	female	black or african american	released	Dead	1949	2009	TCGA-29-1703_exposure	Not Reported	8331f387-3bbe-5946-a79b-7048b733c756	released	TCGA-29-1703_diagnosis	20622	not reported	0	1815	17951518-166e-5b1e-b7a9-d3cda6b3bd1c	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-29-1703_treatment	TCGA-29-1703_treatment_1	released	2fd1d9cb-646d-5b93-893b-daff67331324	no	Radiation Therapy, NOS	released	ac1fac49-1488-50e2-9827-232fca2f66de	yes	Pharmaceutical Therapy, NOS	a4545555-bb38-4346-8dd6-ce45dd0950bd
72dad4d7-0138-4de3-924c-119658aa9084.htseq.counts.gz	f16399c2-174e-482c-99b3-0874e8b923e9	TCGA-59-A5PD-01A-11R-A406-31	TCGA-59-A5PD-01A-11R	TCGA-59-A5PD-01A-01-TSA		TCGA-59-A5PD-01A-11		TCGA-59-A5PD-01A	TCGA-59-A5PD	7ebc776e-bde1-4563-adb1-8bd441872733	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV	730		130.0		False		false	9A3CB382-654F-4DFD-BF41-7615710D2825	1.78	356a00a0-d19a-498c-8ed7-20ce89cd21eb			0.17	23	released	be90f089-49c4-4e3d-a213-58642e77ff1e	RNA	R	0.17	UV Spec	released	False	edb3dc0c-65d3-4b63-9faf-5ddd9c7e8b46	11	40.0	20.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	ab7fbb47-0d01-4fdf-bfcf-42fcb4dacf4c	released												released	30.0						9609e049-77c8-46ea-884e-32e18d7a9602	Primary Tumor	01		released	Not Reported	released	TCGA-59-A5PD_demographic	55	-20263	624	84b549ae-9aa7-5dd3-aaef-b55ad5f6eb0d	not hispanic or latino	female	black or african american	released	Dead	1956	2012	TCGA-59-A5PD_exposure	Not Reported	a8257457-ab0b-59f1-a293-07529ad150fb	released	TCGA-59-A5PD_diagnosis	20263	not reported	0		5ed98837-320c-5c31-8af9-e461980aa32f	Stage IC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Ovary	released	Yes	Ovary	not reported	not reported	2011	TCGA-59-A5PD_treatment_1	TCGA-59-A5PD_treatment	released	624ed46b-2c4b-51da-be8a-74ec7d1acd6f	yes	Pharmaceutical Therapy, NOS	released	bc577759-b3e4-5129-808e-a75df0eeb960	no	Radiation Therapy, NOS	f16399c2-174e-482c-99b3-0874e8b923e9
1be906cc-a22b-4c94-975b-d0d68257f4da.htseq.counts.gz	6d936414-f24d-4cfb-874e-0c8c6dfc3a1d	TCGA-25-1633-01A-01R-1566-13	TCGA-25-1633-01A-01R	TCGA-25-1633-01A-01-BS1	TCGA-25-1633-01A-01-TS1	TCGA-25-1633-01A-01		TCGA-25-1633-01A	TCGA-25-1633	20336269-5a5b-4ba7-8fe8-665a1f9af738	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.3		B3B45EA2-B154-45DC-B49D-422500EA1D9C	1.8	7517c446-401d-4501-bf27-916e0835deac			0.16	22	released	83146764-198a-4f5c-aa23-05421cbe1bb5	RNA	R	0.16	UV Spec	released	False	41f2b317-9baf-41c4-8bd0-c555f4ef34bd	01			1.0		0.0	20.0	79.0	80.0	BOTTOM	8a63b727-ea03-48ea-9f9f-7cc786eea30b	released			1.0		0.0	5.0	94.0	95.0	TOP	f39839fc-b550-43e5-9f57-937cfdf32219	released	released	141.0						170514dc-2d77-48f3-b9d0-42c216211e5b	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-25-1633_demographic	64	-23407	1891	e394758b-5b02-5855-a821-a660650ab989	not hispanic or latino	female	white	released	Dead	1938	2007	TCGA-25-1633_exposure	Not Reported	811bea29-7cd2-522b-b60c-789cc7f37293	released	TCGA-25-1633_diagnosis	23407	not reported	0	1843	a2f9c05f-49fc-5fcf-8f44-9a62df7e890e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-25-1633_treatment	TCGA-25-1633_treatment_1	released	2253f219-7f50-5701-aef6-ab41b0a2129b	no	Radiation Therapy, NOS	released	9779522b-20fe-5b40-8026-a94309a056fd	yes	Pharmaceutical Therapy, NOS	6d936414-f24d-4cfb-874e-0c8c6dfc3a1d
0fc26774-1494-4578-97df-7b4fee07483b.htseq.counts.gz	be659073-2a57-48ba-afd8-4ed6cc7699a3	TCGA-13-1492-01A-01R-1565-13	TCGA-13-1492-01A-01R	TCGA-13-1492-01A-01-TS1	TCGA-13-1492-01A-01-BS1	TCGA-13-1492-01A-01		TCGA-13-1492-01A	TCGA-13-1492	63c6a89b-b28c-434a-a632-5de6545db731	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	2.5		566BE185-8A2E-43C4-9762-65216AB9AC44	1.8	3991212e-874f-4c0c-a822-4a149ecda1b2			0.16	22	released	b676e030-b7e4-4a20-aac9-57b8c7a2028c	RNA	R	0.16	UV Spec	released	False	0c5226bd-5c9b-4506-8004-2136ec69767c	01			5.0		0.0	1.0	94.0	99.0	TOP	893fd41e-d481-4430-b8e3-b7952e9a4f6a	released			5.0		0.0	1.0	94.0	99.0	BOTTOM	8f143732-b6e9-4ce4-bc41-b2aa51955587	released	released	127.0						e66d5c81-a9e3-4642-9bcb-655372f247a5	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1492_demographic	66	-24332	3819	71d375c1-b32a-5221-950d-48517ae1bf94	not hispanic or latino	female	white	released	Dead	1936		TCGA-13-1492_exposure	Not Reported	e66bd566-a80d-5010-9202-e4a1c8cf4232	released	TCGA-13-1492_diagnosis	24332	not reported	0	2237	a182868e-521c-5039-8b4e-1c047fbbfd11	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-13-1492_treatment_1	TCGA-13-1492_treatment	released	de492d38-d2d5-5f8c-ad33-8d062f901065	yes	Pharmaceutical Therapy, NOS	released	bc3d82c5-b314-50ed-802b-3b50c6bdf997	no	Radiation Therapy, NOS	be659073-2a57-48ba-afd8-4ed6cc7699a3
353ff7d9-113b-4802-8cc4-635cd44b8706.htseq.counts.gz	7ff1b14a-1ca7-4efb-9e95-74c37dcbb425	TCGA-13-0913-02A-01R-1564-13	TCGA-13-0913-02A-01R	TCGA-13-0913-02A-01-BS1	TCGA-13-0913-02A-01-TS1	TCGA-13-0913-02A-01		TCGA-13-0913-02A	TCGA-13-0913	3e8a51bf-7e1f-4eab-af83-3c60d04db1bf	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.4		61FBF10C-A508-4D83-971D-5A48BA81F08A	1.8	733f0607-6c6b-4385-9868-fa6f155a9a2e			0.14	22	released	194a6538-dd75-4ba9-8682-0fb6c5cc552e	RNA	R	0.14	UV Spec	released	False	6b986153-ffca-4d53-888b-8adf80cccb5f	01			10.0		0.0	20.0	70.0	70.0	BOTTOM	1ac7ab05-f6af-42db-acd0-0d303a1dd585	released			10.0		0.0	20.0	70.0	90.0	TOP	6b3e1267-f670-4836-9e04-012d1b63f14a	released	released	171.0						bbe91b44-cb43-4763-8783-169c458c5c3c	Recurrent Tumor	02	0.3	released	Not Reported	released	TCGA-13-0913_demographic	53	-19573		7566af4a-1027-5501-b6dd-0c2b437a7790	not hispanic or latino	female	white	released	Alive	1953		TCGA-13-0913_exposure	Not Reported	40f8ef17-df09-5278-97c7-a2231834ed7a	released	TCGA-13-0913_diagnosis	19573	not reported	0	3325	2be71456-45a9-5969-9734-1a2d672374ed	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-13-0913_treatment_1	TCGA-13-0913_treatment	released	e5417994-ca2c-591a-ad92-2120ee99066c	yes	Pharmaceutical Therapy, NOS	released	1e298880-0a07-516f-990d-749cd230ff0d	no	Radiation Therapy, NOS	7ff1b14a-1ca7-4efb-9e95-74c37dcbb425
fa2df153-c852-4df1-8499-fe2517dee301.htseq.counts.gz	2d28a9f4-b95d-47b8-ba4c-918692c6b902	TCGA-10-0937-01A-02R-1564-13	TCGA-10-0937-01A-02R	TCGA-10-0937-01A-02-BS2	TCGA-10-0937-01A-01-BS1	TCGA-10-0937-01A-02		TCGA-10-0937-01A	TCGA-10-0937	a5030259-cf9c-4a58-8710-b9da8ee59320	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.6		2a86dcb5-1af7-447d-b20f-eef4972048a0	1.8	6392a07a-79e2-4272-abfe-329d1029bb09			0.15	22	released	0c5cdff9-10e5-4d0c-ae72-cebbcd6d47a2	RNA	R	0.15	UV Spec	released	False	03c4677e-eae6-48b2-8840-9d2ef801a330	02			0.0		5.0	15.0	80.0	85.0	BOTTOM	d5858cfe-47d7-442a-a3a0-fde1e69b919e	released			0.0		5.0	20.0	75.0	80.0	TOP	37919e58-3142-472b-8dc2-f55a22a976ce	released	released	109.0						8585d596-4d6b-4f6c-bb46-a2661f9ca05a	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-10-0937_demographic	44	-16222	608	ec4793f1-4af3-5052-bc55-d865c8d8a000	not reported	female	white	released	Dead	1961	2006	TCGA-10-0937_exposure	Not Reported	1389661f-a4b2-5c3b-869d-3a4233d46c07	released	TCGA-10-0937_diagnosis	16222	not reported	0	460	4a6e1e14-2751-5cb3-b3b1-b559944ace34	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-10-0937_treatment	TCGA-10-0937_treatment_1	released	237d5a37-b0e1-50be-a0bc-5e78e355e012	no	Radiation Therapy, NOS	released	55e1dbe3-e618-5caf-a8b2-2c4693c480d1	yes	Pharmaceutical Therapy, NOS	2d28a9f4-b95d-47b8-ba4c-918692c6b902
7ee8ec85-e646-40c4-beef-5b8e8ab35168.htseq.counts.gz	ee330208-7bc7-4c3d-8cc1-6a8bb69d0e72	TCGA-23-1021-01B-01R-1564-13	TCGA-23-1021-01B-01R	TCGA-23-1021-01B-01-BS1	TCGA-23-1021-01B-01-TS1	TCGA-23-1021-01B-01		TCGA-23-1021-01B	TCGA-23-1021	b923ac70-70ea-4a82-8466-46350c5803bf	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.0		4339A934-71A0-4E92-91D6-BEB0207939ED	1.8	9819f772-6987-47d5-8ab4-235ac2b993e2			0.16	22	released	cc0e4de8-c805-47fe-b3ae-560b2f9e6a7a	RNA	R	0.16	UV Spec	released	False	d9acf0b0-d747-41b8-8330-d46b3ffe4eb4	01			5.0		0.0	0.0		80.0	BOTTOM	43618d42-5e31-4911-b670-ee2d2773bda2	released			0.0		0.0			90.0	TOP	80c2d0cc-5647-4f11-973d-7ef404254284	released	released	125.0						36c901d8-885d-4fc0-8cd2-69229fddc566	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-23-1021_demographic	45	-16484	1446	5bf4dbf9-9ad3-56b4-a16a-b891ca34a898	not hispanic or latino	female	white	released	Dead	1959	2007	TCGA-23-1021_exposure	Not Reported	700f793b-2cb6-5c75-826c-7c90fa9bcf85	released	TCGA-23-1021_diagnosis	16484	not reported	0	1446	aa38d2f9-46a7-5bed-ba31-29109424d54a	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-23-1021_treatment_1	TCGA-23-1021_treatment	released	05ed4f39-8c3b-5695-8068-f771b73e9f9a	yes	Pharmaceutical Therapy, NOS	released	f3469830-8e5e-50fc-a8df-4e016b741a1e	no	Radiation Therapy, NOS	ee330208-7bc7-4c3d-8cc1-6a8bb69d0e72
acaec383-b91d-46a9-a1d1-6eb4764cd000.htseq.counts.gz	2f496741-845e-4cdf-839e-030d1b533d8b	TCGA-10-0938-01A-02R-1564-13	TCGA-10-0938-01A-02R	TCGA-10-0938-01A-01-BS1	TCGA-10-0938-01A-02-BS2	TCGA-10-0938-01A-02		TCGA-10-0938-01A	TCGA-10-0938	7ca97692-0bf5-4bbd-81ce-10a051d04bd5	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		faa8920a-3b4a-4767-bdb1-5d086e51fe92	1.8	f7b5774e-bfb3-4e6d-8a24-009f3c294109			0.16	22	released	fa99d9ea-8c28-4870-886c-bc160ae6b166	RNA	R	0.16	UV Spec	released	False	e49c6c83-a54e-4c21-bfeb-4921e4499545	02			0.0		10.0	20.0	70.0	85.0	TOP	22a8ea74-7de1-453c-857c-2e7001fa42fe	released			0.0		5.0	15.0	80.0	80.0	BOTTOM	4143e826-d8fd-41bd-a948-34cbcc3c7518	released	released	169.0						c11664e8-8883-4a0f-87c3-6fdc903860d5	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-10-0938_demographic	80	-29558	636	6b9e14b1-a534-5fd8-9147-5a6e1b068be7	not reported	female	white	released	Dead	1922	2003	TCGA-10-0938_exposure	Not Reported	a8087d55-acf0-51f4-9b6c-849f7cd48e8f	released	TCGA-10-0938_diagnosis	29558	not reported	0	604	95b0caf3-50a8-5bc7-ac12-e0b9f543e36e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-10-0938_treatment	TCGA-10-0938_treatment_1	released	897d1bc2-1b39-5451-96fa-c762361d9bce	no	Radiation Therapy, NOS	released	98bac705-c3a0-5e42-89db-f4eb577949e7	yes	Pharmaceutical Therapy, NOS	2f496741-845e-4cdf-839e-030d1b533d8b
eeddee84-15ec-401f-95ee-de2bb7015168.htseq.counts.gz	ed74489c-fc44-4b33-87cc-7e83868216a0	TCGA-04-1364-01A-01R-1565-13	TCGA-04-1364-01A-01R	TCGA-04-1364-01A-01-TS1	TCGA-04-1364-01A-01-BS1	TCGA-04-1364-01A-01		TCGA-04-1364-01A	TCGA-04-1364	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.2		CA87C9DF-D4ED-41BD-AEC9-B41C4FEC54A4	1.8	2fadaf5a-402b-483d-bc26-08feb3dc162d			0.16	22	released	9b54e08c-da2d-4714-8587-5f7b69ca4a8c	RNA	R	0.16	UV Spec	released	False	76db9f2d-cbf5-40aa-953f-5a792c277855	01			2.0		0.0	5.0	93.0	99.0	TOP	9fef64ee-6549-4b5b-a306-401d62d57d92	released			2.0		0.0	5.0	93.0	99.0	BOTTOM	d155a2aa-3dd7-4418-9c71-d6529df0f381	released	released	152.0						c8f56f7e-6b69-4276-ba97-7a70c4fa5071	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-04-1364_demographic	61	-22294	1024	fca74eca-e5f7-5dfb-8b16-08f9b4d83590	not hispanic or latino	female	white	released	Dead	1942	2005	TCGA-04-1364_exposure	Not Reported	251b044c-36dc-5255-8cf1-59e9575685fd	released	TCGA-04-1364_diagnosis	22294	not reported	0		6b68d896-594c-5763-b893-8203984ca9c1	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-04-1364_treatment	TCGA-04-1364_treatment_1	released	6cec0a76-dfae-5167-8402-ce169f777321	no	Radiation Therapy, NOS	released	c61760d7-70f4-5e2c-86aa-6772967a03c2	yes	Pharmaceutical Therapy, NOS	ed74489c-fc44-4b33-87cc-7e83868216a0
8ed16638-71b1-47bf-9fbf-1e9efee46e07.htseq.counts.gz	b457553f-19e4-49e3-b52c-163873b1c6b5	TCGA-31-1946-01A-01R-1568-13	TCGA-31-1946-01A-01R	TCGA-31-1946-01A-01-BS1	TCGA-31-1946-01A-01-TS1	TCGA-31-1946-01A-01		TCGA-31-1946-01A	TCGA-31-1946	da274941-3edd-420b-9262-bbd959923c67	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.0		5ef31a8f-38e7-486b-8efc-99cd8c1ec06d	1.8	05abb2f5-07c3-42da-92d9-0b4560fb6f09			0.17	22	released	dfa9351a-c515-4797-b960-e4f6672f4ec3	RNA	R	0.17	UV Spec	released	False	bc3f113f-324e-4fe2-a2e3-7eaf589ad3b9	01			5.0		0.0	40.0	55.0	85.0	BOTTOM	96e4efe5-cf1e-42eb-bb15-b3e7711fe916	released			2.0		0.0	13.0	85.0	85.0	TOP	412289ba-f5a6-43b4-a002-8d95cadc246c	released	released	134.0						d445f92f-5b61-4131-b474-f0ce49e52379	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-31-1946_demographic	30	-11146		52037f73-8727-533e-ad4c-c42bb53d20a2	not reported	female	not reported	released	Alive	1976		TCGA-31-1946_exposure	Not Reported	580351ea-9c84-5556-b522-c23fe0493ac7	released	TCGA-31-1946_diagnosis	11146	not reported	0	918	c421708e-784f-5520-8391-a1d9ce7ae6ae	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-31-1946_treatment_1	TCGA-31-1946_treatment	released	83c8e901-6d04-5e08-b79b-ad5626ff58f0	yes	Pharmaceutical Therapy, NOS	released	d8c671d0-213e-5d91-af1a-cdb539436e7b	no	Radiation Therapy, NOS	b457553f-19e4-49e3-b52c-163873b1c6b5
b3b1dbca-bce2-40a3-92a4-848f616b98e3.htseq.counts.gz	d45044c2-2d62-41dd-9a61-68d5ab6a1f6d	TCGA-04-1514-01A-01R-1566-13	TCGA-04-1514-01A-01R	TCGA-04-1514-01A-01-TS1	TCGA-04-1514-01A-01-BS1	TCGA-04-1514-01A-01		TCGA-04-1514-01A	TCGA-04-1514	e9483296-cb91-497a-b955-39a3c3289dac	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.1		A0487B93-029F-48EB-AF5C-06A2F5A3FAAA	1.8	cc5e2498-a9e6-48be-bbda-9aa101546ca4			0.16	22	released	eb7409ce-648d-4ac6-b6f1-698e83b7054a	RNA	R	0.16	UV Spec	released	False	1f648f22-b1db-4e58-9cff-4c620dde71fc	01			5.0		0.0	10.0	85.0	95.0	TOP	0a727057-86e2-47b9-be79-eeec6e07542b	released			5.0		0.0	10.0	85.0	95.0	BOTTOM	e6ce9cf7-7fb0-4dd2-a322-a84becdb2bdc	released	released	103.0						18e0f4ed-43e2-451f-82bd-102260a30aaa	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-04-1514_demographic	45	-16725	1720	487bc60d-e5db-52e4-88dc-f4f3e93f6695	not hispanic or latino	female	white	released	Dead	1959	2008	TCGA-04-1514_exposure	Not Reported	0b91a603-8787-502e-a2c0-cc765176ea42	released	TCGA-04-1514_diagnosis	16725	not reported	0		79a5c305-99a7-5b90-b77c-918193fb98fb	Stage IIIA	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-04-1514_treatment	TCGA-04-1514_treatment_1	released	f647827c-59b6-586c-b904-2f635ea833ac	no	Radiation Therapy, NOS	released	fcaf6147-d864-534a-afd5-6f73bc1258b8	yes	Pharmaceutical Therapy, NOS	d45044c2-2d62-41dd-9a61-68d5ab6a1f6d
790570e9-099f-4458-88c9-1ebe12205a67.htseq.counts.gz	5c34d866-c659-4df9-88ae-146c1a4462d9	TCGA-13-1499-01A-01R-1565-13	TCGA-13-1499-01A-01R	TCGA-13-1499-01A-01-BS1	TCGA-13-1499-01A-01-TS1	TCGA-13-1499-01A-01		TCGA-13-1499-01A	TCGA-13-1499	b25570ed-baca-4e3f-87c6-2ef18119ba49	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	2.1		3FC4A433-FAD1-4CC1-9BD6-A45E2707F6D0	1.8	1f677d4c-6feb-4a3a-9f12-ba1d43920a80			0.15	22	released	88151a1a-f6cf-4fc3-b17c-661c5cf20938	RNA	R	0.15	UV Spec	released	False	e2403b4e-40c4-4cff-973b-b76d4489766b	01			5.0		0.0	20.0	75.0	80.0	BOTTOM	70245996-46ca-4e68-ab44-0fc043794b88	released			1.0		0.0	20.0	79.0	80.0	TOP	116d81fb-17b7-46f8-abb6-e1fb37fbbfc9	released	released	122.0						16220eed-5ba3-4067-9dcf-d7327a44c05d	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1499_demographic	56	-20668		f5853584-62ad-5679-9cb3-8ca4b7d8a998	not hispanic or latino	female	white	released	Alive	1949		TCGA-13-1499_exposure	Not Reported	6202f343-9edf-5cbe-85fe-8cc62a838815	released	TCGA-13-1499_diagnosis	20668	not reported	0	3500	148128fe-490f-5ecb-9eb0-7bfd1594cfd3	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-13-1499_treatment_1	TCGA-13-1499_treatment	released	aa16666b-e9ca-5150-868e-01c13207e75c	yes	Pharmaceutical Therapy, NOS	released	89d4ac03-0516-5efe-87d2-b896c064abf1	no	Radiation Therapy, NOS	5c34d866-c659-4df9-88ae-146c1a4462d9
5a928267-356d-47e9-b8b2-f477eaa261fa.htseq.counts.gz	a0765b46-5fbb-49d0-b8aa-682486927d0f	TCGA-61-2102-01A-01R-1568-13	TCGA-61-2102-01A-01R	TCGA-61-2102-01A-01-TS1	TCGA-61-2102-01A-01-BS1	TCGA-61-2102-01A-01		TCGA-61-2102-01A	TCGA-61-2102	7a08efd0-f984-430e-a8eb-1881047214b6	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.5		f0521e47-1cc3-4f72-9efd-3d128f57e614	1.8	7ac6af79-c14a-4026-84aa-a288afcb96da			0.15	22	released	b1bbb84a-afce-4949-8ce6-bbf3488d7e49	RNA	R	0.15	UV Spec	released	False	91fba3e8-2706-4172-a6e6-50e092077678	01			10.0		85.0	85.0	5.0	85.0	TOP	560f25cb-a79f-4eee-ad74-a0130d207db1	released			15.0		25.0	0.0	60.0	85.0	BOTTOM	1597b3f0-3481-4fe3-964c-3d54a2db6283	released	released	162.0						d800778e-cc83-4447-9cfa-ca29adeacb8f	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-61-2102_demographic	74	-27256	197	59f2314e-8e36-5351-b82e-da8dc14da71e	not reported	female	white	released	Dead	1925	1999	TCGA-61-2102_exposure	Not Reported	20f2c491-f925-52d2-803c-e88009aab836	released	TCGA-61-2102_diagnosis	27256	not reported	0	197	84670ab1-8300-5eb8-b801-8c98bdb6bb25	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-61-2102_treatment	TCGA-61-2102_treatment_1	released	fb9a5e5e-2e41-553f-884d-4c76f7b94700	no	Radiation Therapy, NOS	released	f3441fad-1e57-541b-9464-767b3e5a5b56	yes	Pharmaceutical Therapy, NOS	a0765b46-5fbb-49d0-b8aa-682486927d0f
e8b90f89-c047-404e-9e04-5589ff43495a.htseq.counts.gz	14e66fbb-a92a-459e-bbff-e7909c519d28	TCGA-24-1428-01A-01R-1564-13	TCGA-24-1428-01A-01R	TCGA-24-1428-01A-01-BS1	TCGA-24-1428-01A-01-TS1	TCGA-24-1428-01A-01		TCGA-24-1428-01A	TCGA-24-1428	9c744ff8-1cde-4176-b6d7-0ab62bf42620	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.5		9fcdd584-25e6-4a5a-ae15-f2956de32822	1.8	30b9b778-1422-4842-ae99-658b8b1d7605			0.17	22	released	34885715-dcac-4ce9-bf28-88177799708b	RNA	R	0.17	UV Spec	released	False	a7db9467-696c-4516-b788-e243109fdb47	01			5.0		0.0	10.0	85.0	90.0	BOTTOM	cc2baf2f-05d9-4e2a-9dbc-35a2729b00b8	released			1.0		0.0	10.0	89.0	90.0	TOP	092eb401-0310-4619-8f06-8fd5b46560bc	released	released	103.0						b0dfa5b0-79fc-4f28-bca7-d47f54c05775	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1428_demographic	50	-18306		cc02ff8d-6eff-5479-acd0-8b3230bcfafa	not reported	female	white	released	Alive	1958		TCGA-24-1428_exposure	Not Reported	0d00342f-c967-5235-af3b-34692e251679	released	TCGA-24-1428_diagnosis	18306	not reported	0	529	f6f658e1-75aa-52b0-ae5b-eec6c0b88964	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1428_treatment_1	TCGA-24-1428_treatment	released	33b95ae0-bb8b-5419-8a8c-a5d7d387b795	yes	Pharmaceutical Therapy, NOS	released	999d1991-c579-5d87-bcc1-95332145d16c	no	Radiation Therapy, NOS	14e66fbb-a92a-459e-bbff-e7909c519d28
e0b32572-2ff9-4929-9917-83624e63aa2a.htseq.counts.gz	057d832a-c0c7-4335-80ee-4e9b626abc29	TCGA-04-1357-01A-01R-1565-13	TCGA-04-1357-01A-01R	TCGA-04-1357-01A-01-BS1	TCGA-04-1357-01A-01-TS1	TCGA-04-1357-01A-01		TCGA-04-1357-01A	TCGA-04-1357	feda41d8-ca56-425d-b149-4d5485328107	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.5		D1D902A3-DF76-4623-B2E7-88FFA9E1542F	1.8	ec1fc406-d1c4-4eba-ab6b-6cfb460f0862			0.15	22	released	fd2b5f5e-838f-4781-aecd-76d9deef488c	RNA	R	0.15	UV Spec	released	False	9365488b-2e3a-4433-86a4-ec98d186abe3	01	50.0		1.0		0.0	20.0	79.0	90.0	BOTTOM	96386ac1-65c6-413e-8c0e-f3ede77e195d	released			0.0		0.0	50.0	50.0	70.0	TOP	82ac1e1c-e4a7-4ff9-ab5b-bbf3cbe9ba1f	released	released	100.0						45893b0e-301f-474a-b390-936d7d74f57e	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-04-1357_demographic	52	-18999		d7683fcc-e135-5577-a315-c40ebae61ab8	not reported	female	not reported	released	Alive	1953		TCGA-04-1357_exposure	Not Reported	75777ee1-f4b0-533b-8393-cc50ca0bb327	released	TCGA-04-1357_diagnosis	18999	not reported	0		8c7d9620-74be-55aa-a89c-500df4e535a1	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-04-1357_treatment	TCGA-04-1357_treatment_1	released	ad9e2c2c-271c-5716-a98c-7fd282c7ccfd	no	Radiation Therapy, NOS	released	82a75eff-41d6-5432-a3e8-e0686e5f9b84	yes	Pharmaceutical Therapy, NOS	057d832a-c0c7-4335-80ee-4e9b626abc29
9f8c8f79-2581-48fb-90bb-5d3e898689d6.htseq.counts.gz	8a94ff47-144a-4a1a-8346-60fa0517d0f3	TCGA-24-1560-01A-01R-1566-13	TCGA-24-1560-01A-01R	TCGA-24-1560-01A-01-BS1	TCGA-24-1560-01A-01-TS1	TCGA-24-1560-01A-01		TCGA-24-1560-01A	TCGA-24-1560	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.1		464e1a20-b2d1-49c4-8da5-11b8c0f96b4e	1.8	a7ea40ed-6cfb-42b7-92b7-64d6ba988414			0.13	22	released	eca2adc0-dd4d-4ed6-8aa8-5edb20cc2260	RNA	R	0.13	UV Spec	released	False	340f41e4-6015-4f48-9987-873bbdfadde1	01			0.0		0.0	2.0	98.0	95.0	BOTTOM	f5e67453-b8d9-4f8d-84be-05608fca2722	released			0.0		0.0	2.0	98.0	95.0	TOP	517e0086-04fb-47e2-8809-4b9768c17ba9	released	released	107.0						aeff4cbe-7abb-449a-a6f4-65e030548f4c	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1560_demographic	51	-18671	1341	78a963aa-07fe-526a-93c8-3f2bc9d8d317	not reported	female	white	released	Dead	1948	2002	TCGA-24-1560_exposure	Not Reported	5e1bc87b-ca89-5439-8721-a2d853217b3b	released	TCGA-24-1560_diagnosis	18671	not reported	0	1341	c81c054c-bd20-5c4f-b3bd-3d67dc613c2b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-24-1560_treatment_1	TCGA-24-1560_treatment	released	21f3dea3-30fb-5903-b585-8f45abaea726	yes	Pharmaceutical Therapy, NOS	released	433292e6-7678-56ee-8919-2c720079f7f2	no	Radiation Therapy, NOS	8a94ff47-144a-4a1a-8346-60fa0517d0f3
45197059-d0fc-49bb-819b-bd7621427236.htseq.counts.gz	6317f5f6-ade0-4999-b7a8-9140650a916d	TCGA-59-2351-01A-01R-1569-13	TCGA-59-2351-01A-01R	TCGA-59-2351-01A-01-TS1	TCGA-59-2351-01A-01-BS1	TCGA-59-2351-01A-01		TCGA-59-2351-01A	TCGA-59-2351	16829472-5666-4fba-9bf9-360ec1689aa0	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	2.0		6cec74e9-4ad7-4c6d-abdd-36ba1573d6ad	1.8	7e58cfd1-07eb-44e2-a563-fa7a00b338a3			0.13	22	released	9f360b7c-f8b4-475e-9d86-5239ee9cac23	RNA	R	0.13	UV Spec	released	False	4691ea59-038f-48b4-8b0c-01793ed5cb78	01			1.0		1.0	19.0	79.0	80.0	TOP	966e6ef8-f18b-48d1-86e8-f9c626a4f7cc	released			1.0		1.0	19.0	79.0	80.0	BOTTOM	2bc77b82-f44c-4879-ae75-4d55872e6a9d	released	released	151.0						5de10a41-af67-4417-9152-54a184a37f68	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-59-2351_demographic	51			3ba18647-da19-54a4-8a1c-be83eb7827d5	not hispanic or latino	female	white	released	Alive	1948		TCGA-59-2351_exposure	Not Reported	666ab165-033e-585c-b2e6-03dc1633c9fd	released	TCGA-59-2351_diagnosis		not reported	0	3532	9e178568-ef7f-5e7a-b7af-7397c47741bb	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-59-2351_treatment	TCGA-59-2351_treatment_1	released	68edb0f8-6e65-5c15-87d8-7dcaf238f2ee	no	Radiation Therapy, NOS	released	f7a41dea-8c53-5def-8ebd-89a9c658c34e	yes	Pharmaceutical Therapy, NOS	6317f5f6-ade0-4999-b7a8-9140650a916d
cc7bfa3f-7301-44d4-b29a-35905c59eae6.htseq.counts.gz	d861c6c3-4a79-472b-a950-b9440367a66a	TCGA-13-0908-01B-01R-1565-13	TCGA-13-0908-01B-01R	TCGA-13-0908-01B-01-TS1	TCGA-13-0908-01B-01-BS1	TCGA-13-0908-01B-01		TCGA-13-0908-01B	TCGA-13-0908	0ba7b6cc-e5f5-47d7-859a-24e31aa336ab	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.4		AE735D44-31EA-4345-9B3E-E92C7F236569	1.8	5324831d-94be-40c6-bcb1-5b29bbbaab1b			0.17	22	released	b90ed610-0c26-4ca1-b285-a399551ae178	RNA	R	0.17	UV Spec	released	False	8069502b-1ce4-47d8-b97e-0ae489ba44e4	01			0.0		0.0	10.0	90.0	90.0	TOP	ee2524ac-c719-4a1f-8e39-a71d08e033dc	released			0.0		0.0	10.0	90.0	90.0	BOTTOM	c5bc1ddd-1c6c-4ab1-aee0-e0885990e553	released	released	101.0						b2f596ea-10ad-4a17-aea3-88756fb0b7f9	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-0908_demographic	58	-21422	1843	0efe3097-e953-59c4-8eb1-a4d8d5c68285	not hispanic or latino	female	white	released	Dead	1947		TCGA-13-0908_exposure	Not Reported	d283533a-af74-5484-8c6f-5085f46b68a1	released	TCGA-13-0908_diagnosis	21422	not reported	0	1364	c01d98f7-34f8-57cb-9d1c-53780e4956b8	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-13-0908_treatment	TCGA-13-0908_treatment_1	released	b1adcf6a-97c0-5251-8054-aa11a5482e16	no	Radiation Therapy, NOS	released	449f28d8-c3dc-5de0-85ed-43f448bb7d74	yes	Pharmaceutical Therapy, NOS	d861c6c3-4a79-472b-a950-b9440367a66a
3344d45a-7ec5-4d77-8d77-b95aa55b7f4c.htseq.counts.gz	674f762b-05d1-4541-bf0a-b295f04817a5	TCGA-61-1738-01A-01R-1567-13	TCGA-61-1738-01A-01R	TCGA-61-1738-01A-01-BS1	TCGA-61-1738-01A-01-TS1	TCGA-61-1738-01A-01		TCGA-61-1738-01A	TCGA-61-1738	72c40fba-f502-489b-ad87-843f52655894	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.2		05898c76-9832-4724-ada5-ff47eb3838b5	1.8	1ca9af90-a8db-4f7e-b17a-0bf32fed98c7			0.15	22	released	a77abfa5-9177-4ec4-aee1-4e55566ac926	RNA	R	0.15	UV Spec	released	False	70e2f786-7418-4fb2-9ac4-ff6c310637cc	01	3.0	2.0	5.0		0.0	0.0	95.0	90.0	BOTTOM	941a44db-9fde-4bcb-9a7e-88c3a8afa74c	released			2.0		0.0	0.0	98.0	95.0	TOP	cbef3d98-4444-4703-b76e-0474439cb502	released	released	154.0						ce503b11-3be6-4c58-85b6-d987033232e0	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-61-1738_demographic	60	-21965	1089	b3cb6309-cf5e-5396-ad1d-840561b1e2ed	not reported	female	black or african american	released	Dead	1945	2007	TCGA-61-1738_exposure	Not Reported	965a1b04-8fe6-50dc-bc27-796406a917f4	released	TCGA-61-1738_diagnosis	21965	not reported	0	1089	5ab9e1b0-8ef3-58e0-9d0d-da2727fd5dc1	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-61-1738_treatment_1	TCGA-61-1738_treatment	released	2104cff3-2983-5226-9408-905cc8a58263	yes	Pharmaceutical Therapy, NOS	released	1eaf6e5c-6627-55fb-8f09-f6de63ab34d8	no	Radiation Therapy, NOS	674f762b-05d1-4541-bf0a-b295f04817a5
44c2a2eb-6671-4951-9088-cdf4c23d60d8.htseq.counts.gz	869f80f4-0901-460c-a1a0-317ddb0219e3	TCGA-24-1930-01A-01R-1567-13	TCGA-24-1930-01A-01R	TCGA-24-1930-01A-01-TS1	TCGA-24-1930-01A-01-BS1	TCGA-24-1930-01A-01		TCGA-24-1930-01A	TCGA-24-1930	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.0		746ac85a-ea6d-4d60-859f-69bf580a707c	1.8	d85ca8ac-9458-4f3a-b2ef-db4df852f75e			0.15	22	released	6d31d489-8ab5-4756-928f-621d2f05cfd3	RNA	R	0.15	UV Spec	released	False	3d1e9654-d74d-4397-984e-611a5f3d5738	01	0.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	TOP	bb8a446a-db5c-45a5-b5f3-0e7f84a60370	released	0.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	BOTTOM	0e6935ab-52a7-41ec-b55a-af0ffd17022c	released	released	122.0						b9e08539-3921-490e-9f35-013f9704d516	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-24-1930_demographic	53	-19387	2467	54ce0094-e7b7-5ac4-b909-215939d4d01e	not reported	female	white	released	Dead	1945	2004	TCGA-24-1930_exposure	Not Reported	19295c42-b1ba-54e1-9079-425927e2234f	released	TCGA-24-1930_diagnosis	19387	not reported	0	2467	2cd199cc-198a-518f-b3da-a3f3640b2ba7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-24-1930_treatment_1	TCGA-24-1930_treatment	released	2d4e7d95-dc86-5eba-b10b-a6c795297b00	yes	Pharmaceutical Therapy, NOS	released	2262a9a9-e859-55d3-90bd-5074c52ee546	yes	Radiation Therapy, NOS	869f80f4-0901-460c-a1a0-317ddb0219e3
cbe087ce-2924-4c5a-b307-51c80b41d6d8.htseq.counts.gz	c45ee2dd-90cf-4234-af0c-7b554197d407	TCGA-13-1477-01A-01R-1565-13	TCGA-13-1477-01A-01R	TCGA-13-1477-01A-01-BS1	TCGA-13-1477-01A-01-TS1	TCGA-13-1477-01A-01		TCGA-13-1477-01A	TCGA-13-1477	13f5814c-1f99-4ffa-84a4-3bbd8979faae	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.3		2507FA0F-9709-4B5D-9EC1-907637FB373A	1.8	eb7fbe7d-ca45-4f35-b384-0d396349da06			0.15	22	released	9980828e-6082-4266-a047-ef920d0b0ccf	RNA	R	0.15	UV Spec	released	False	25956b20-bce2-4ef6-931d-2bc6cf856486	01			0.0		0.0	20.0	80.0	70.0	BOTTOM	5e469773-19c9-47e2-a141-a9023f02fb54	released			5.0		0.0	15.0	80.0	80.0	TOP	40cfd8ee-5054-4b2f-9a66-0820397a0d75	released	released	132.0						79908395-d442-44a3-8e91-97c3ae97ddd5	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-1477_demographic	49	-18111	1662	b24d11cb-3d0e-5e1e-a82e-75025a577914	not hispanic or latino	female	white	released	Dead	1951	2004	TCGA-13-1477_exposure	Not Reported	b6b7d082-d633-51b7-b0e3-4530afa900a1	released	TCGA-13-1477_diagnosis	18111	not reported	0	1662	999ac7a5-2147-5a8f-afac-d62ded2f8f79	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-13-1477_treatment	TCGA-13-1477_treatment_1	released	bc902138-7d50-5a41-ba40-4935459f3eb9	yes	Radiation Therapy, NOS	released	7d4554ce-0368-52b0-8fec-ff22dc292e8d	yes	Pharmaceutical Therapy, NOS	c45ee2dd-90cf-4234-af0c-7b554197d407
c65d79cb-b639-4030-97d9-ddb84bc39195.htseq.counts.gz	772794b0-853a-428a-9ea6-0816baee5240	TCGA-24-1425-01A-02R-1566-13	TCGA-24-1425-01A-02R	TCGA-24-1425-01A-01-BS1	TCGA-24-1425-01A-02-BS2	TCGA-24-1425-01A-02		TCGA-24-1425-01A	TCGA-24-1425	b120b701-c194-43d7-a491-3206fac38ec1	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.5		06592570-be8f-49d4-a42f-068ad60efe34	1.8	f580e84b-b405-43dc-9dae-4588cedf435f			0.14	22	released	17c838ba-fc9c-4c96-ada8-c461a8a4af68	RNA	R	0.14	UV Spec	released	False	2698c7f4-148b-4bdb-b704-4eae2b1a15dd	02			10.0		0.0	25.0	65.0	75.0	TOP	a98f855c-c0e6-4815-9a18-395d258e7621	released			1.0		0.0	30.0	69.0	70.0	BOTTOM	a6fe1ea1-7b06-4337-8d6e-6a799ef51d5b	released	released	112.0						7d0d7e28-9530-4d03-9041-aeca61ecf42c	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-1425_demographic	45	-16764		aedc9d93-ac86-5686-a44b-83c6a60b6bcb	not reported	female	white	released	Alive	1963		TCGA-24-1425_exposure	Not Reported	1f490462-da9b-5cc1-a2ba-b11026e6ff03	released	TCGA-24-1425_diagnosis	16764	not reported	0	181	a4520404-b3dd-59ab-a30e-b3073be4407c	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1425_treatment_1	TCGA-24-1425_treatment	released	96b8a4e7-207b-5039-8609-cb8292f8df83	yes	Pharmaceutical Therapy, NOS	released	c8533376-0d48-5ff0-a8f4-86f4bd19a3bf	no	Radiation Therapy, NOS	772794b0-853a-428a-9ea6-0816baee5240
6e40a1e7-9ff6-455f-8f70-77611a66088e.htseq.counts.gz	a845d3b0-206a-4966-9845-1b4b562d672e	TCGA-29-1762-01A-01R-1567-13	TCGA-29-1762-01A-01R	TCGA-29-1762-01A-01-BS1	TCGA-29-1762-01A-01-TS1	TCGA-29-1762-01A-01		TCGA-29-1762-01A	TCGA-29-1762	5495b18a-10ec-427b-83b8-03ef4b587b13	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	0.9		f94712a1-78da-4341-9ac9-6ea41c11610e	1.8	c3559ae3-3355-4f38-9c07-e557e435fcbd			0.14	22	released	fc76c02e-d9b1-4fde-9275-2336c3e8ce07	RNA	R	0.14	UV Spec	released	False	4d548438-8ad9-4c29-bc1c-cd22f16d55df	01			10.0		0.0	5.0	85.0	90.0	BOTTOM	16561800-adee-4503-aea0-31320f85cc44	released			20.0		0.0	5.0	75.0	85.0	TOP	30a33cd4-4485-4a15-9eb6-2d2bb79ab844	released	released	120.0						5df514e7-6e12-474a-92f2-067898b351ac	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1762_demographic	59	-21879	2634	5670d6e7-a5d0-5321-9e29-1b6c44e7d0d4	not reported	female	white	released	Dead	1939	2005	TCGA-29-1762_exposure	Not Reported	a7f8f7a9-f40e-54e5-88f2-4c0acd4ef24e	released	TCGA-29-1762_diagnosis	21879	not reported	0	2606	0516c666-98fd-5556-b9f5-084913c790dc	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-29-1762_treatment	TCGA-29-1762_treatment_1	released	166b8b13-30ac-58cb-b940-cfae6060fb58	no	Radiation Therapy, NOS	released	00847499-aede-5624-848d-ca326c05a5dd	yes	Pharmaceutical Therapy, NOS	a845d3b0-206a-4966-9845-1b4b562d672e
1ade6fa3-de71-4760-9760-8abc10963255.htseq.counts.gz	45a97e88-7139-4eb8-b659-2d9e3beda744	TCGA-13-0714-01A-01R-1564-13	TCGA-13-0714-01A-01R	TCGA-13-0714-01A-01-TS1	TCGA-13-0714-01A-01-BS1	TCGA-13-0714-01A-01		TCGA-13-0714-01A	TCGA-13-0714	1e14f098-17b2-4f54-8e4f-e38088008df7	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.2		96EB4BD1-CE3B-44D8-8095-076712A3E082	1.8	da337502-6fef-45b6-8770-b2f0889cd802			0.19	22	released	db2de945-ce47-4c35-8795-8af8b099aec5	RNA	R	0.19	UV Spec	released	False	3c98bdfc-8269-4e57-b706-191bf0cf8c92	01			1.0		19.0		80.0	81.0	TOP	1e09c7c3-482d-45f6-9330-fc2969faa4f7	released			1.0		9.0		90.0	91.0	BOTTOM	26bf9350-7b7e-441a-ab21-86861194cb19	released	released	191.0						7cb799d4-b69f-4cac-b975-1df91396250a	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-13-0714_demographic	55	-20109	189	228a6c55-1ab5-5019-bd8f-387fb592df71	not hispanic or latino	female	white	released	Dead	1945	2000	TCGA-13-0714_exposure	Not Reported	f2e35561-fb1f-55aa-a6db-574c5229e4b0	released	TCGA-13-0714_diagnosis	20109	not reported	0	189	a2212176-e116-5cb8-adee-defab8d379bf	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-13-0714_treatment_1	TCGA-13-0714_treatment	released	021a904d-eae5-58d6-bc29-94f61323ed13	yes	Pharmaceutical Therapy, NOS	released	be736da6-b59e-5da9-b184-ad682b358041	no	Radiation Therapy, NOS	45a97e88-7139-4eb8-b659-2d9e3beda744
9ac17699-409b-4750-9317-aacc8c04da46.htseq.counts.gz	329ae6b7-3f35-4fb8-bf04-25b179fdfc5c	TCGA-24-1604-01A-01R-1566-13	TCGA-24-1604-01A-01R	TCGA-24-1604-01A-01-BS1	TCGA-24-1604-01A-01-TS1	TCGA-24-1604-01A-01		TCGA-24-1604-01A	TCGA-24-1604	65435f50-a35d-49e3-a36e-b95d9e274ca0	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.4		de978a3d-92f9-4bd8-98f4-f8a3ec09b362	1.8	a658045c-93a6-4aac-abbb-1cd6093b7735			0.15	22	released	8983b9c7-d0a3-45c3-98fb-718e85d6e672	RNA	R	0.15	UV Spec	released	False	6abefb40-eb92-4c06-ae5e-2369d915d3aa	01			5.0		25.0	0.0	70.0	93.0	BOTTOM	723beda5-e12c-4e4a-8023-fd758839a322	released			5.0		45.0	0.0	50.0	90.0	TOP	6d8ad821-149e-41cc-9926-71b32c12469c	released	released	129.0						b3909bea-c426-4dad-94a9-15577e9f0c09	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-24-1604_demographic	66	-24471	2688	88b4acdd-e3e8-5e2a-9820-0fd2ed174d45	not reported	female	white	released	Dead	1930	2003	TCGA-24-1604_exposure	Not Reported	4bb90ccb-8c8e-5373-87cc-801696c49069	released	TCGA-24-1604_diagnosis	24471	not reported	0	2688	d92abbe4-d3f0-57cb-84bb-a07a6746bd3f	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1996	TCGA-24-1604_treatment_1	TCGA-24-1604_treatment	released	9de104ff-7e53-52d1-a516-fbf9dc3149ba	yes	Pharmaceutical Therapy, NOS	released	7678f010-6e8d-582c-8bf7-40cdc871a1f8	no	Radiation Therapy, NOS	329ae6b7-3f35-4fb8-bf04-25b179fdfc5c
f3c8c91a-71e0-4b1d-a03f-06ed0123ce9a.htseq.counts.gz	f706498f-ee95-4143-aeec-97b9b36f2c97	TCGA-25-2398-01A-01R-1569-13	TCGA-25-2398-01A-01R	TCGA-25-2398-01A-01-BS1	TCGA-25-2398-01A-01-TS1	TCGA-25-2398-01A-01		TCGA-25-2398-01A	TCGA-25-2398	fd4740db-76a8-4362-be71-7b609479bb67	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.5		CFF4E9E3-AC10-4A50-BE90-5A12822FEF42	1.8	3a080008-8266-4e2d-a143-adac14991b22			0.14	22	released	f86a52d7-cebb-4eaf-b477-26618a2a5d80	RNA	R	0.14	UV Spec	released	False	eddbd412-f149-4d71-aaf5-f4ef85e5f49f	01			5.0		0.0	25.0	70.0	75.0	BOTTOM	6cd65019-046f-4701-ba45-95c5a357e0f4	released			5.0		0.0	35.0	60.0	65.0	TOP	db9bffbb-cffb-48c6-9494-10677a3fc7aa	released	released	151.0						a5ad2377-7f60-4c8a-8343-4589b01dc4c5	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-25-2398_demographic	71	-26267	1369	f3608d2c-1467-5436-8977-622ae51edd70	not hispanic or latino	female	white	released	Dead	1933	2007	TCGA-25-2398_exposure	Not Reported	624971e8-e23c-56b8-b576-de89105d1d4e	released	TCGA-25-2398_diagnosis	26267	not reported	0	1369	b83acbb5-bdc4-5596-ae26-e11bf4b79790	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-25-2398_treatment_1	TCGA-25-2398_treatment	released	518860a6-a467-5dfe-945c-9b7b9e9f8b86	yes	Pharmaceutical Therapy, NOS	released	d4a15da1-ef9a-5d35-804f-0da34e4d7b6b	no	Radiation Therapy, NOS	f706498f-ee95-4143-aeec-97b9b36f2c97
053f5fb2-8b5f-4252-82fd-ba167a58c23f.htseq.counts.gz	76d8c21d-81b4-4c87-994e-2ccca5326f79	TCGA-25-2404-01A-01R-1569-13	TCGA-25-2404-01A-01R	TCGA-25-2404-01A-01-TS1	TCGA-25-2404-01A-01-BS1	TCGA-25-2404-01A-01		TCGA-25-2404-01A	TCGA-25-2404	22178c3c-6b04-46d8-8041-dc83fa195029	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	2.0		7B13E549-204D-47F8-93EB-D8C5C8D259FA	1.8	05ab6bb9-0cb1-47f1-8dd2-92a48239e82e			0.14	22	released	f2afdc8e-06b6-42fb-8884-675558bff89f	RNA	R	0.14	UV Spec	released	False	3c1cbd1d-e75f-4894-bed9-420f65a14ea1	01			1.0		1.0	28.0	70.0	70.0	TOP	cc560f7f-9491-4242-80ac-74f2ff537b1b	released			0.0		1.0	14.0	85.0	85.0	BOTTOM	08aa7e79-0ec6-475e-90bd-4ee3feaf12d1	released	released	114.0						7c1f016a-1728-4496-acbc-97aa89c5ee58	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-25-2404_demographic	38	-14184	883	2491559b-7a65-500d-b886-d23b26c6aadd	not hispanic or latino	female	american indian or alaska native	released	Dead	1967	2007	TCGA-25-2404_exposure	Not Reported	5fa758f6-4532-50fb-9c8a-af89ec8f1c93	released	TCGA-25-2404_diagnosis	14184	not reported	0	883	8a61260e-5e20-5dc5-94bf-549afb0dbbd8	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-25-2404_treatment	TCGA-25-2404_treatment_1	released	87318159-dd0c-52a3-be85-bf3c51c29f67	no	Radiation Therapy, NOS	released	7062eeff-17e2-53ba-a74e-6604eaa0cda2	yes	Pharmaceutical Therapy, NOS	76d8c21d-81b4-4c87-994e-2ccca5326f79
7707599c-51ca-4801-adf9-1c9642254fdb.htseq.counts.gz	3fb670e2-3446-410e-83ba-c083d71bf204	TCGA-29-1783-01A-01R-1567-13	TCGA-29-1783-01A-01R	TCGA-29-1783-01A-01-TS1	TCGA-29-1783-01A-01-BS1	TCGA-29-1783-01A-01		TCGA-29-1783-01A	TCGA-29-1783	460616ec-f66f-483b-88c1-757edd86261d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		6ebf4763-bb2a-4ef5-ab22-23460980df1c	1.9	dad3688e-fdd7-4c85-a1df-cf0e1cc0a235			0.15	22	released	1573b761-5322-41c5-b902-d64f46524660	RNA	R	0.15	UV Spec	released	False	5c390a96-5bd5-4912-a638-d112b11a8433	01	5.0		2.0		0.0	20.0	78.0	90.0	TOP	4cffe5bf-5305-4080-93ef-b9f7765612fd	released	5.0		0.0		0.0	15.0	85.0	90.0	BOTTOM	8c7be673-e292-4596-b2e7-7b0691de0755	released	released	156.0						7d811a29-b303-453e-9c0e-91ae12907510	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1783_demographic	58	-21284		fd7dbd5b-6da2-5b5c-9857-6f220f063c51	not reported	female	white	released	Alive	1951		TCGA-29-1783_exposure	Not Reported	44b3c2af-ab52-5953-bbc6-2b547391246d	released	TCGA-29-1783_diagnosis	21284	not reported	0	220	76e57c55-e185-57fb-8980-6ccd1a2ee446	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-29-1783_treatment_1	TCGA-29-1783_treatment	released	477b7398-76de-5506-99e3-88180d820dca	yes	Pharmaceutical Therapy, NOS	released	f66ffc46-9d26-52f7-9fde-2f846ac8beb9	no	Radiation Therapy, NOS	3fb670e2-3446-410e-83ba-c083d71bf204
c773cdc3-7702-4833-9b12-ba954ac4b357.htseq.counts.gz	4ca576a9-7f21-44b3-adff-14ae0ddc9723	TCGA-13-1485-01A-02R-1565-13	TCGA-13-1485-01A-02R	TCGA-13-1485-01A-02-BS2	TCGA-13-1485-01A-01-BS1	TCGA-13-1485-01A-02		TCGA-13-1485-01A	TCGA-13-1485	49bfd0fe-48ce-49db-9f76-ce2310410950	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.6		5ABB28A5-1BF3-4E90-AD3B-3692893C8686	1.8	50f08f95-3c5a-4d6b-bacc-ccb4a3a720b8			0.15	22	released	d8fdef60-9f24-4e61-add0-c7ea015a9d2e	RNA	R	0.15	UV Spec	released	False	30a464e7-6424-44ff-a858-b847678fc9b6	02			0.0		0.0	30.0	70.0	80.0	BOTTOM	d33cd2ff-9521-4ae7-a458-6cd672e3048d	released			0.0		0.0	30.0	70.0	80.0	TOP	2db443ac-fdab-4759-8e64-eb343b89aa91	released	released	130.0						558827de-87a0-4041-89b2-fe439ac820a2	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-1485_demographic	48	-17642	629	4ad24e85-b885-58a1-a2c0-f1278fae3a4a	not hispanic or latino	female	white	released	Dead	1953	2002	TCGA-13-1485_exposure	Not Reported	db3db10b-fd4a-5708-bf64-3d2762fe4baa	released	TCGA-13-1485_diagnosis	17642	not reported	0	629	ee7f23f5-f972-5fb6-8afe-1a30f1780e54	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-13-1485_treatment_1	TCGA-13-1485_treatment	released	fc689f89-8273-5be3-93b1-81c3bdefa61c	yes	Pharmaceutical Therapy, NOS	released	3671878d-769a-51b6-b78a-2378e342c7b4	no	Radiation Therapy, NOS	4ca576a9-7f21-44b3-adff-14ae0ddc9723
d3d0227f-bf96-43be-aee0-d11518748e11.htseq.counts.gz	da8fcd97-0fa1-42d5-b0db-e16cecb7d4d8	TCGA-36-1569-01A-01R-1566-13	TCGA-36-1569-01A-01R	TCGA-36-1569-01A-01-TS1	TCGA-36-1569-01A-01-BS1	TCGA-36-1569-01A-01		TCGA-36-1569-01A	TCGA-36-1569	7d82ce56-32eb-4107-aa5c-c568764805c9	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.6		52192360-2ACE-401C-9642-B3D6F677362D	1.8	bb12d2f5-1865-435a-8edf-f9ee7689e0a4			0.16	22	released	f163f23e-7afd-45d5-aec2-0cfb89cbb5e8	RNA	R	0.16	UV Spec	released	False	88aee093-9b08-418d-a13b-bfeec9fc3925	01			0.0		0.0	10.0	90.0	90.0	TOP	f47a78ac-7858-487d-9012-24c5c39db80d	released			0.0		0.0	10.0	90.0	90.0	BOTTOM	2db04a2a-1eb8-4a91-8876-32d02009cacb	released	released	106.0						eacec9c7-f638-4f61-bd7b-a60995267213	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-36-1569_demographic	52	-19151		ccfa0a00-6da8-544e-b65d-fcaddc7d839a	not reported	female	white	released	Alive	1955		TCGA-36-1569_exposure	Not Reported	76be120f-a72f-5d20-b2c3-cd1fef8d8b1c	released	TCGA-36-1569_diagnosis	19151	not reported	0	885	e53d6502-63a5-5b12-b41d-ff5effc62a8e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-36-1569_treatment_1	TCGA-36-1569_treatment	released	79d1707f-17f1-591d-9fa0-a7fd2273dc39	yes	Pharmaceutical Therapy, NOS	released	499ee2db-64c0-5acc-8b37-9c55a09eea9c	no	Radiation Therapy, NOS	da8fcd97-0fa1-42d5-b0db-e16cecb7d4d8
30b1f3cd-604d-4a13-a196-1216658c87fa.htseq.counts.gz	560d56bc-35ee-4361-b2d3-be361a0c6de9	TCGA-24-1846-01A-01R-1567-13	TCGA-24-1846-01A-01R	TCGA-24-1846-01A-01-BS1	TCGA-24-1846-01A-01-TS1	TCGA-24-1846-01A-01		TCGA-24-1846-01A	TCGA-24-1846	67f526f1-def5-43b4-bc89-154baae190fc	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.1		fb12e5b3-1529-4873-90fd-7ba0a78dd9f4	1.8	4b073708-9525-4340-90dc-ede08ee24977			0.15	22	released	0fe6a4c1-7f25-4ac3-b848-e60a4f353cfb	RNA	R	0.15	UV Spec	released	False	2ca00e1f-a87c-4872-ba4e-2a9971dcdbba	01	0.0	0.0	15.0	15.0	0.0	5.0	80.0	80.0	BOTTOM	08e47dff-31a5-4515-8b39-58f3e11a4c7a	released	0.0	0.0	20.0	20.0	0.0	10.0	70.0	70.0	TOP	cbd38011-a782-4c70-8498-79c3d143409e	released	released	134.0						046c032f-69e8-4815-b7ab-28858392d6b0	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-24-1846_demographic	45	-16534		c265a8c5-231d-5f56-bea9-1444d77aeceb	not reported	female	not reported	released	Alive	1964		TCGA-24-1846_exposure	Not Reported	e9cac973-f068-58be-98fd-fbc7b1f029fd	released	TCGA-24-1846_diagnosis	16534	not reported	0	133	cc622c11-e77b-5fd6-b673-baeb226d3ce6	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-24-1846_treatment	TCGA-24-1846_treatment_1	released	d13984a8-7135-5021-a2f0-7bc08c643fbe	no	Radiation Therapy, NOS	released	bbd3bdf1-f3a4-58dd-a3ca-34e5078d2d06	yes	Pharmaceutical Therapy, NOS	560d56bc-35ee-4361-b2d3-be361a0c6de9
60fdab7c-849a-440f-815a-c67741e1106c.htseq.counts.gz	fb3b94a8-4b34-44cf-b4dc-2236b423c041	TCGA-24-0968-01A-01R-1569-13	TCGA-24-0968-01A-01R	TCGA-24-0968-01A-01-TS1	TCGA-24-0968-01A-01-BS1	TCGA-24-0968-01A-01		TCGA-24-0968-01A	TCGA-24-0968	619b14f3-b8cc-4c0a-8304-6719853d592a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.2		887A21BF-12C4-47C7-A48D-A7FAA05C57B2	1.8	b2f7c706-ec61-45d4-9394-44921dc99f8c			0.14	22	released	f8421895-6ee9-45ce-b5a7-a5952332ce48	RNA	R	0.14	UV Spec	released	False	f7659147-70c8-4992-821b-62041abdcb73	01			0.0		0.0	10.0	90.0	92.0	TOP	0ecb0b53-3dd6-46d9-a492-c179639330a6	released			0.0		0.0	20.0	80.0	85.0	BOTTOM	75dde44c-1150-4c27-9b81-42cc7c8be0bf	released	released	126.0						bd548e12-22a8-471f-b13f-fd7ea5e4e406	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-24-0968_demographic	59	-21664		df7b1d1e-430e-5b44-b7fe-e7cadded22e0	not reported	female	white	released	Dead	1946		TCGA-24-0968_exposure	Not Reported	8e2695d2-3312-5696-9808-e7a2be82ad3f	released	TCGA-24-0968_diagnosis	21664	not reported	0	598	87361581-dac1-527d-bb58-01c4d69a5e91	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-24-0968_treatment_1	TCGA-24-0968_treatment	released	e6076f62-f450-54a2-b4f2-4a15c02fc998	yes	Pharmaceutical Therapy, NOS	released	8d2c6479-f37b-5d93-b863-876e8fa63988	no	Radiation Therapy, NOS	fb3b94a8-4b34-44cf-b4dc-2236b423c041
e78e6e23-183e-4492-8b69-28cf7c2623f4.htseq.counts.gz	ffa69b9c-c03c-4f60-840a-8fa6a8814bb8	TCGA-24-1419-01A-01R-1565-13	TCGA-24-1419-01A-01R	TCGA-24-1419-01A-01-TS1	TCGA-24-1419-01A-01-BS1	TCGA-24-1419-01A-01		TCGA-24-1419-01A	TCGA-24-1419	5e18b17d-4626-4b6d-8ac6-e560cee0376c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.8		0a8c75aa-8031-4f1d-9dba-9029b009d677	1.8	7bf43d51-2714-419e-a52f-863ca54c90e5			0.15	22	released	94d566ab-09f2-45ca-b039-77d8ac00ae00	RNA	R	0.15	UV Spec	released	False	0d70b9ce-2ae5-4b7f-b60c-5d3d967628e4	01			0.0		25.0	0.0	75.0	95.0	TOP	4e3b292c-2e03-4a9a-8d8c-4b1c178e2039	released			2.0		15.0	0.0	83.0	90.0	BOTTOM	08bb7421-dfee-4e8f-8bdb-74a1626872f1	released	released	137.0						92d562df-4a58-43da-8811-843d3d3c9438	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-1419_demographic	62	-22659		3f13178e-a4ea-57f8-a075-e6c7d1ca68bd	not reported	female	white	released	Alive	1946		TCGA-24-1419_exposure	Not Reported	f841956a-b3e8-5f7f-be89-7e31f86b880e	released	TCGA-24-1419_diagnosis	22659	not reported	0	239	0e5dd5f1-3f97-56e1-a043-2c72b348edc7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1419_treatment_1	TCGA-24-1419_treatment	released	f2011893-e9ea-5254-b4c4-6bdb62d499e5	yes	Pharmaceutical Therapy, NOS	released	9d51deb3-1711-5307-8b2d-811f88bca941	no	Radiation Therapy, NOS	ffa69b9c-c03c-4f60-840a-8fa6a8814bb8
b00351d7-1785-4157-9955-aadc2f195181.htseq.counts.gz	4b47a430-8624-4b2d-99f6-23d61c58d423	TCGA-24-2036-01A-01R-1568-13	TCGA-24-2036-01A-01R	TCGA-24-2036-01A-01-BS1	TCGA-24-2036-01A-01-TS1	TCGA-24-2036-01A-01		TCGA-24-2036-01A	TCGA-24-2036	c9226204-cb61-40b8-8a94-a7e71c14ea3a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.1		3c1ecc69-a121-4c32-b15a-1e5bbf2f8d7e	1.8	788ade22-382b-49ca-b2b1-447a2072d0ea			0.13	22	released	eb2d30d2-abe6-4b61-963d-363209c84dbb	RNA	R	0.13	UV Spec	released	False	e818506a-8fd5-4dda-8349-19c409dc7dab	01	2.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	b5e4a123-5f0d-459a-9ab3-7ba94d6f7244	released	0.0	0.0	0.0	0.0	0.0	10.0	90.0	80.0	TOP	a09a994b-2da2-4b47-a479-2ac663d0fa9f	released	released	104.0						389cd452-fcf0-498b-9e65-7e28dbe8d5a4	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-2036_demographic	50	-18582	1947	8d1986bb-40dd-57cb-9ca9-33b4a9651882	not reported	female	white	released	Dead	1946	2001	TCGA-24-2036_exposure	Not Reported	43a1336a-9ec8-5755-ac33-f3a95cd63615	released	TCGA-24-2036_diagnosis	18582	not reported	0	1947	74e1f295-8a60-5d66-95ed-2dd395075e1e	Stage IIIA	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1996	TCGA-24-2036_treatment	TCGA-24-2036_treatment_1	released	1a9d9ad6-eb9a-544e-ae73-fe307f320b65	yes	Radiation Therapy, NOS	released	b9e81a3d-6c11-5c5a-8d93-9341b2302129	yes	Pharmaceutical Therapy, NOS	4b47a430-8624-4b2d-99f6-23d61c58d423
39ae7d32-a9c6-4599-a860-5c25e05899fb.htseq.counts.gz	e9e2d846-6e5e-4004-864e-2decd039b8a8	TCGA-23-2077-01A-01R-1568-13	TCGA-23-2077-01A-01R	TCGA-23-2077-01A-01-TS1	TCGA-23-2077-01A-01-BS1	TCGA-23-2077-01A-01		TCGA-23-2077-01A	TCGA-23-2077	ef57bc45-858f-4d4e-8407-b7eadfa43be5	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.1		55589297-f28e-422c-beee-6cb19a2350be	1.8	16c61c5a-a9b3-4022-9b79-d593e3519794	3.2	20	0.16	22	released	7e750266-09fa-445c-8657-61d609a5e442	RNA	R	0.16	UV Spec	released	False	2625dbfd-43df-41f0-8152-f2a9df1e1648	01			0		0	5	95	95	TOP	b658f179-d2f9-4a22-a915-22a36159cf9a	released			0		0	5	95	95	BOTTOM	fe4d3109-2e84-44ee-8599-04c1931d2012	released	released	128						70944721-dbf3-4a65-ae98-a008a48ba55e	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-23-2077_demographic	45	-16552		0710e66b-9d53-5515-b2cb-efd06694efa5	not hispanic or latino	female	white	released	Alive	1954		TCGA-23-2077_exposure	Not Reported	e5dbbd07-7c1b-5322-a4ad-b10e1188a424	released	TCGA-23-2077_diagnosis	16552	not reported	0	3525	11764381-ed45-5beb-b0c8-dec64df1b651	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-23-2077_treatment_1	TCGA-23-2077_treatment	released	3b62eccc-0bf4-57ab-92fd-c13fc7fcd22d	yes	Pharmaceutical Therapy, NOS	released	b3dafbc4-eb4d-5509-9216-2626b9466861	no	Radiation Therapy, NOS	e9e2d846-6e5e-4004-864e-2decd039b8a8
da436927-a3f5-4f12-b63d-d6f13f436ab7.htseq.counts.gz	a6901cf4-d678-4816-b071-58bd614c3477	TCGA-13-1497-01A-01R-1565-13	TCGA-13-1497-01A-01R	TCGA-13-1497-01A-01-BS1	TCGA-13-1497-01A-01-TS1	TCGA-13-1497-01A-01		TCGA-13-1497-01A	TCGA-13-1497	bc4bc342-20bf-40c3-af26-2c6f942da93d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.3		108519AE-4684-4B6E-8A7D-225BFC5084F3	1.8	eb61bd52-e5fa-4c33-a2e4-1353a42184d9			0.15	22	released	1a7507bc-9727-461c-8e2a-bd42ad668a87	RNA	R	0.15	UV Spec	released	False	060f9936-d9b7-4f3f-8b9a-49b864a12705	01			10.0		0.0	5.0	85.0	95.0	BOTTOM	4fb415dd-e72d-451a-9064-99c2f28934d5	released			15.0		0.0	5.0	80.0	95.0	TOP	df740e3b-2d04-4a35-8927-ed788875d668	released	released	124.0						87ebfaf3-1ab2-4224-b556-0998a6ac16ff	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-1497_demographic	47	-17528		9c931a7a-6e3c-5a87-a410-c936e9789e42	not hispanic or latino	female	white	released	Alive	1957		TCGA-13-1497_exposure	Not Reported	e07e85fd-7754-533b-a3b2-f30bfe6c6685	released	TCGA-13-1497_diagnosis	17528	not reported	0	3871	b1652541-14ef-5640-8541-d042fdc2524a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-13-1497_treatment_1	TCGA-13-1497_treatment	released	32eef092-9d44-5311-97eb-a20c85b6eab5	yes	Pharmaceutical Therapy, NOS	released	6399754c-8906-5395-942f-205595f1b6a9	no	Radiation Therapy, NOS	a6901cf4-d678-4816-b071-58bd614c3477
e956031b-931a-4ccc-b0d5-51cb1ab9baed.htseq.counts.gz	a44b3f46-1c43-4fe3-85bc-a371a9c1a324	TCGA-24-1469-01A-01R-1566-13	TCGA-24-1469-01A-01R	TCGA-24-1469-01A-01-TS1	TCGA-24-1469-01A-01-BS1	TCGA-24-1469-01A-01		TCGA-24-1469-01A	TCGA-24-1469	cd6e5d3d-1c86-40dd-9cb3-b2e2075dec56	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.5		8f0b80d0-cf56-477c-898b-bb92934f64d4	1.8	7b6fe6e3-145b-46e6-884e-fcec23514674			0.15	22	released	20567842-2a60-4508-843c-7fb1e8fcca43	RNA	R	0.15	UV Spec	released	False	7857b385-0c41-4ce1-bcde-ad09dd087823	01			1.0		0.0	4.0	95.0	95.0	TOP	9a49f54b-0127-4b14-a85e-269e6d785d26	released			1.0		0.0	4.0	95.0	95.0	BOTTOM	6fc1655c-f6dc-440c-991f-999d34bec42b	released	released	139.0						389c632d-45cf-447e-9069-11b2fcb543f5	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-1469_demographic	71	-25937		a68ea48a-8b0a-554f-a2a7-29d4474fe9e5	not reported	female	white	released	Alive	1937		TCGA-24-1469_exposure	Not Reported	c66710dd-fbf8-502c-89a1-17bd5469fe58	released	TCGA-24-1469_diagnosis	25937	not reported	0	277	c35644a3-29fa-58ef-96eb-39833b3fd41f	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1469_treatment	TCGA-24-1469_treatment_1	released	a3e878cc-484a-5420-bdbf-c28781031d39	no	Radiation Therapy, NOS	released	7b16e165-9d63-5192-a1c4-df6a967b2c0d	yes	Pharmaceutical Therapy, NOS	a44b3f46-1c43-4fe3-85bc-a371a9c1a324
f7722eae-ade1-4087-a6d7-aff561972b73.htseq.counts.gz	a0cb1ab4-56e1-408e-943a-fdc6f9d1f036	TCGA-57-1993-01A-01R-1568-13	TCGA-57-1993-01A-01R	TCGA-57-1993-01A-01-BS1	TCGA-57-1993-01A-01-TS1	TCGA-57-1993-01A-01		TCGA-57-1993-01A	TCGA-57-1993	15fc17cd-d073-4f81-a4a2-2db3cb9d7069	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.5		55495e3a-6052-4fb1-b8a9-10b54dcdfbea	1.8	55f9061c-54e7-465c-af61-21d8bc8ecbe0			0.15	22	released	384ac8e6-d11c-48c2-8f8e-5dec7e871fc7	RNA	R	0.15	UV Spec	released	False	a5e74a0c-875c-4950-b3c8-4a7c0dbbb6c3	01			0.0		0.0	30.0	70.0	95.0	BOTTOM	4aecaa34-5d56-489d-b5a5-a7646864c1c6	released			0.0		0.0	10.0	90.0	95.0	TOP	26748d79-df35-48ad-9c58-57203a229d85	released	released	139.0						41dbed72-2bd8-4e94-9e20-ba18211bdcbc	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-57-1993_demographic	56	-20498		ca281c52-a2d4-5e1b-8bd2-7d277fd5297b	not hispanic or latino	female	white	released	Alive	1951		TCGA-57-1993_exposure	Not Reported	6c732fe6-9b26-576d-9db6-c02c28ee1add	released	TCGA-57-1993_diagnosis	20498	not reported	0	763	3d3ca882-be6d-531d-8a29-55d8eb0f5f55	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-57-1993_treatment_1	TCGA-57-1993_treatment	released	6550b0ff-615a-5f2f-8dd5-56e8e2be0bff	yes	Pharmaceutical Therapy, NOS	released	86b00aca-8e27-53cc-9482-58183bc3d7cc	no	Radiation Therapy, NOS	a0cb1ab4-56e1-408e-943a-fdc6f9d1f036
78c27c9c-843b-4e6a-a36a-1aa4dcb8decf.htseq.counts.gz	0b71f5fc-6b46-497c-87a2-76c89bc34727	TCGA-25-1321-01A-01R-1565-13	TCGA-25-1321-01A-01R	TCGA-25-1321-01A-01-TS1	TCGA-25-1321-01A-01-BS1	TCGA-25-1321-01A-01		TCGA-25-1321-01A	TCGA-25-1321	6ad8bc89-d8e9-48c2-bc25-c8e51f972b4d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.6	False	3.0		5D309784-AED1-4946-817D-37AC8969315C	1.8	74ad9d3e-97a9-419d-8842-3fb37d3f099a			0.16	22	released	74fbd8cf-b8a3-4ed2-87a7-80e3026aa6a2	RNA	R	0.16	UV Spec	released	False	58dc0e2f-7972-41a2-95c5-a466ebfe63a1	01			0.0		0.0	10.0	90.0	90.0	TOP	3cdd3537-543e-41b9-b024-f4b843205c0e	released			5.0		0.0	10.0	85.0	90.0	BOTTOM	83ae5429-f69e-4e70-8f65-f27fa68b5d5b	released	released	187.0						57f7a91d-c569-433f-ae21-8a22e5d187bf	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-25-1321_demographic	65	-23987	1033	90f4c061-f159-5a33-9711-19ed94507147	not hispanic or latino	female	white	released	Dead	1936	2003	TCGA-25-1321_exposure	Not Reported	1985a053-495a-5aac-a209-4fe3d2c89950	released	TCGA-25-1321_diagnosis	23987	not reported	0	1033	75f56478-bab2-51ee-821d-9db5567f6b98	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-25-1321_treatment	TCGA-25-1321_treatment_1	released	0210d1cd-b459-5acf-95bd-bd0e38b825be	no	Radiation Therapy, NOS	released	0856754d-8c3b-5e52-a74b-1e9a25c50f8f	yes	Pharmaceutical Therapy, NOS	0b71f5fc-6b46-497c-87a2-76c89bc34727
195a13be-31a4-47ce-bc3d-6aba8451e304.htseq.counts.gz	750f8926-4361-4a92-8c72-59c82baad867	TCGA-30-1862-01A-02R-1568-13	TCGA-30-1862-01A-02R	TCGA-30-1862-01A-01-BS1	TCGA-30-1862-01A-02-BS2	TCGA-30-1862-01A-02		TCGA-30-1862-01A	TCGA-30-1862	58f5a54e-de50-4cca-afa1-cc331d8b3479	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV					False			a6b7b0c1-5954-487b-b27d-73850a08a194	1.8	ab0701bc-0bc5-4008-a75b-5f665ef9c14a			0.15	22	released	27716f4a-11a2-4c5f-9387-fc8dc613131d	RNA	R	0.15	UV Spec	released	False	435274be-1d2a-4b64-9d4b-2bceaf700030	02			0.0		0.0	40.0	60.0	70.0	TOP	e21a9aeb-597a-4202-9026-5d8505237256	released			0.0		0.0	30.0	70.0	80.0	BOTTOM	223b3dda-6e14-404e-9301-85e97e8a8e65	released	released	124.0						6211110a-552c-492f-b066-c3b41db7fbad	Primary Tumor	01		released	Not Reported	released	TCGA-30-1862_demographic	65	-23895	186	bf047813-e305-5aa3-a47a-6582e28a88c3	not hispanic or latino	female	white	released	Dead	1938	2003	TCGA-30-1862_exposure	Not Reported	d37c4968-3168-5776-9692-5b5cc8845e9e	released	TCGA-30-1862_diagnosis	23895	not reported	0	186	43530a4f-d2b9-5c4b-b4a5-1450b2fa35a4	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-30-1862_treatment_1	TCGA-30-1862_treatment	released	f55d87e8-3c95-5fc7-bd8b-293a4340c49d	no	Pharmaceutical Therapy, NOS	released	e901e62d-705b-53c7-8bfa-c10e4797f089	no	Radiation Therapy, NOS	750f8926-4361-4a92-8c72-59c82baad867
d490312c-c941-4336-8b94-163881b72be6.htseq.counts.gz	2dd5b4a6-8c22-4fc3-a5ef-a8133ba86520	TCGA-23-1114-01B-01R-1566-13	TCGA-23-1114-01B-01R	TCGA-23-1114-01B-01-TS1	TCGA-23-1114-01B-01-BS1	TCGA-23-1114-01B-01		TCGA-23-1114-01B	TCGA-23-1114	c0c3caab-9277-4a31-a96c-c607e38d5ccc	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		d5c00586-d7e4-4909-be2b-ffc4f9ef2e82	1.8	7cfe1419-65be-4860-9f99-75f4a139d9ac			0.17	22	released	d96b5c5c-af8f-4015-a50b-4223ce2123c6	RNA	R	0.17	UV Spec	released	False	e51d32a0-c31c-408c-b920-5d93914fafca	01			0.0		0.0	20.0	80.0	80.0	TOP	453252ed-fb64-497a-ad1e-366b5737eaac	released			0.0		0.0	20.0	80.0	80.0	BOTTOM	e8ba0c6f-94e8-4ebb-86e4-882753640bbb	released	released	104.0						424254f5-1bdf-43ed-b867-33a73a3c919f	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-23-1114_demographic	55	-20409	2089	53467ffb-93bb-5572-b01e-19602c063a44	not hispanic or latino	female	white	released	Dead	1945	2005	TCGA-23-1114_exposure	Not Reported	f6b9af5a-22bd-5789-9fe6-5091059af95d	released	TCGA-23-1114_diagnosis	20409	not reported	0	2089	2f26a07c-893d-5252-be5b-5dcb2902113a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-23-1114_treatment	TCGA-23-1114_treatment_1	released	4ce7f4c7-428f-5c90-85c3-de43de186e0c	no	Radiation Therapy, NOS	released	15562c8e-66f7-5636-94c4-e7657f02b210	yes	Pharmaceutical Therapy, NOS	2dd5b4a6-8c22-4fc3-a5ef-a8133ba86520
253d376e-81e8-446f-ace4-985184741bc3.htseq.counts.gz	9c066f2f-f110-4d60-b60e-bd4c5346ac38	TCGA-24-1424-01A-01R-1565-13	TCGA-24-1424-01A-01R	TCGA-24-1424-01A-01-BS1	TCGA-24-1424-01A-01-TS1	TCGA-24-1424-01A-01		TCGA-24-1424-01A	TCGA-24-1424	c3e443b9-5dc5-4793-91e3-534f21485268	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.2		2b1dfcc6-e4ee-4443-9472-171569244648	1.8	d3fbcdaa-11af-4233-9700-57c6e1628c4b			0.16	22	released	812a96f8-bac3-4e38-80ce-e554c399b508	RNA	R	0.16	UV Spec	released	False	55eacb41-678c-42cf-a153-6cfb2f5e84fc	01			3.0		12.0	0.0	85.0	95.0	BOTTOM	c621b053-57a0-46e5-9cb9-b35216aafef9	released			3.0		32.0	0.0	65.0	95.0	TOP	60fe0b86-27a1-4a3e-ab27-2601008cb58c	released	released	133.0						9f88d3b0-edc0-4fca-a4a9-4d8aacedf9a7	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-24-1424_demographic	67	-24545		63997bed-da2a-57ae-81e4-53468e3d556a	not reported	female	white	released	Alive	1941		TCGA-24-1424_exposure	Not Reported	614c74b3-8847-5705-8125-d9bf87bef7a6	released	TCGA-24-1424_diagnosis	24545	not reported	0	183	51ca0e22-1a4d-5b23-a0bb-f197df114dfe	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1424_treatment_1	TCGA-24-1424_treatment	released	4f0ecfc1-1678-56c1-9fb8-4e3f56389c4c	yes	Pharmaceutical Therapy, NOS	released	0abda174-3602-5b21-9c07-80eb17808870	no	Radiation Therapy, NOS	9c066f2f-f110-4d60-b60e-bd4c5346ac38
511ebfdb-5384-4dac-9ea3-8916b541a7e9.htseq.counts.gz	9b758f1a-94c2-41e1-b9be-e78b60ad4ea8	TCGA-29-1768-01A-01R-1567-13	TCGA-29-1768-01A-01R	TCGA-29-1768-01A-01-BS1	TCGA-29-1768-01A-01-TS1	TCGA-29-1768-01A-01		TCGA-29-1768-01A	TCGA-29-1768	838693d5-1ae0-4d75-834b-e1b89b96b0ed	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.0		12d9b343-a52d-4a36-ba7b-31bfeb66da50	1.8	d327786c-eb87-43b2-abd1-7bb9446cf34f			0.17	22	released	86a5e014-0e18-4526-ad42-f686fb274779	RNA	R	0.17	UV Spec	released	False	4a93f819-f50a-429a-bc77-75c1afbe4597	01	5.0		0.0		0.0	75.0	25.0	80.0	BOTTOM	0bd351c0-aed9-4bb2-a773-e56918399ad5	released			0.0		0.0	50.0	50.0	90.0	TOP	62464711-a212-4d0b-8ae8-d4e75c238043	released	released	116.0						f21ac7ce-b8b2-4c44-be65-4c4abf8a86c4	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1768_demographic	50	-18396	952	b5de4fa5-1048-53ef-a848-07a9f6060389	not reported	female	white	released	Dead	1956	2008	TCGA-29-1768_exposure	Not Reported	e337f9ae-f30d-552e-a71f-902013895052	released	TCGA-29-1768_diagnosis	18396	not reported	0	950	302790a0-c173-5320-8b25-111b75f0f6eb	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-29-1768_treatment	TCGA-29-1768_treatment_1	released	4f251ebd-6d1c-552c-b671-fdc13d5ad0b6	no	Radiation Therapy, NOS	released	0e5c100b-93aa-5285-b24e-ba3fc8fa57c9	yes	Pharmaceutical Therapy, NOS	9b758f1a-94c2-41e1-b9be-e78b60ad4ea8
b5381bca-ac72-41f2-840a-f7f23382fdd3.htseq.counts.gz	982202b5-2000-4dcf-b4e3-9b6be43fa50f	TCGA-29-1693-01A-01R-1567-13	TCGA-29-1693-01A-01R	TCGA-29-1693-01A-01-BS1	TCGA-29-1693-01A-01-TS1	TCGA-29-1693-01A-01		TCGA-29-1693-01A	TCGA-29-1693	6fb71a0c-bc50-48c8-acfa-db94be1e151a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	0.7		90087244-634d-45eb-a877-ff7cc6bd2282	1.8	7e5d2390-1e04-4e46-aa48-4b0131076007			0.15	22	released	ad590357-2dcc-48ff-ae9f-1a29f68cdc78	RNA	R	0.15	UV Spec	released	False	e9236c1e-21f6-40e9-8588-f92f07a62745	01			2.0		0.0	0.0	98.0	90.0	BOTTOM	df0f1f1b-2da4-4ee3-a5c3-77d2ed3830a6	released			2.0		0.0	0.0	98.0	85.0	TOP	4e3372ca-7a0e-4716-882e-2513dcdcbf14	released	released	126.0						13caa1a6-03a5-4fcf-9b54-4dfa86fb5c84	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1693_demographic	72	-26300		0af1dec6-33f4-596f-864c-bc10b4e264f1	not reported	female	white	released	Alive	1929		TCGA-29-1693_exposure	Not Reported	af301e16-2bb8-51cf-93f5-663ce1cc8971	released	TCGA-29-1693_diagnosis	26300	not reported	0	3096	ebc68b2a-3891-5bad-92aa-ae5e37033678	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-29-1693_treatment	TCGA-29-1693_treatment_1	released	07f20521-78b1-5110-a0ef-d60bc53f10a8	yes	Radiation Therapy, NOS	released	a8ae22eb-17cc-5cea-9377-04d58e615399	yes	Pharmaceutical Therapy, NOS	982202b5-2000-4dcf-b4e3-9b6be43fa50f
ff2264ee-19ac-4f74-b3fe-eaca826ea493.htseq.counts.gz	cff3c50e-a10c-428f-b7c1-01b2b78a4e26	TCGA-04-1519-01A-01R-1565-13	TCGA-04-1519-01A-01R	TCGA-04-1519-01A-01-TS1	TCGA-04-1519-01A-01-BS1	TCGA-04-1519-01A-01		TCGA-04-1519-01A	TCGA-04-1519	e9b5336e-d724-4e7d-8c81-1147abd0a80d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	1.3		53840C6E-E1AA-415E-BB85-8E1B8976F45C	1.8	193d3e7f-ec7f-453a-9c2a-77b240c4ba19			0.16	22	released	4d0203a3-2caf-4664-b90d-068689b3c9cd	RNA	R	0.16	UV Spec	released	False	1df0a897-76c8-409d-aa28-f0633541dd76	01			0.0		0.0	10.0	90.0	95.0	TOP	46c38c26-c736-4338-8989-5442872dd89b	released			0.0		0.0	10.0	90.0	95.0	BOTTOM	5b6f7391-88ee-44bc-acf6-076d34d8fa53	released	released	117.0						ef8a2e99-c991-4d51-81ba-34f9a57949b8	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-04-1519_demographic	48	-17671		3f483df1-55d7-5848-ad8c-8ba70f3f0607	not reported	female	not reported	released	Alive	1959		TCGA-04-1519_exposure	Not Reported	a3dffe37-015e-5282-8da6-4decaa366aa8	released	TCGA-04-1519_diagnosis	17671	not reported	0	24	942ad6a8-7831-5c90-9f54-5783643971c4	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-04-1519_treatment	TCGA-04-1519_treatment_1	released	cc88078d-f903-5f2e-8c76-a5404d8c8966	not reported	Radiation Therapy, NOS	released	8dc4b2ef-7d4b-56ef-8410-6d2cb772f87e	not reported	Pharmaceutical Therapy, NOS	cff3c50e-a10c-428f-b7c1-01b2b78a4e26
4fc22ec0-632d-4491-9d3e-99878010a689.htseq.counts.gz	b81aa496-dcc1-4725-9ea2-33477c2afb23	TCGA-04-1655-01A-01R-1566-13	TCGA-04-1655-01A-01R	TCGA-04-1655-01A-01-TS1	TCGA-04-1655-01A-01-BS1	TCGA-04-1655-01A-01		TCGA-04-1655-01A	TCGA-04-1655	f8a5547f-f1bc-4c01-8b68-25b5ee0caeab	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.1		D808763E-D67C-460C-B5D6-85CC5C1C05BC	1.8	520e1d91-a556-4443-8c08-feec29c0c4fe			0.16	22	released	0fc23fa3-5152-407e-b0be-e8d5ecd576bd	RNA	R	0.16	UV Spec	released	False	bbed134d-6132-47cf-ac23-e565d05c1958	01			3.0		0.0	2.0	95.0	99.0	TOP	41e4592c-b94d-4f45-bd36-911bf75248bc	released			0.0		0.0	10.0	90.0	95.0	BOTTOM	55f36120-46fb-4c88-b137-81798b011a9f	released	released	158.0						43d20453-c167-4893-819d-754785da9a71	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-04-1655_demographic	49	-17988	1380	f5f5b470-d479-571a-9747-9f299b78084b	not reported	female	white	released	Dead	1950	2002	TCGA-04-1655_exposure	Not Reported	84e4d127-17cd-5be7-9c8c-d847d1829cf2	released	TCGA-04-1655_diagnosis	17988	not reported	0		776c7f23-897d-51d4-8cf1-95e17ae2cf79	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-04-1655_treatment	TCGA-04-1655_treatment_1	released	ea73130c-0d24-5dbd-bb73-eb3208584a6f	no	Radiation Therapy, NOS	released	6f260e77-df55-50cc-899b-dae71d74e7d9	yes	Pharmaceutical Therapy, NOS	b81aa496-dcc1-4725-9ea2-33477c2afb23
a1ca5d5d-d468-476a-99be-0d6ea90f6533.htseq.counts.gz	e8550e57-639a-43e1-b1a3-7f137ded2c6c	TCGA-59-2354-01A-01R-1569-13	TCGA-59-2354-01A-01R	TCGA-59-2354-01A-01-BS1	TCGA-59-2354-01A-01-TS1	TCGA-59-2354-01A-01		TCGA-59-2354-01A	TCGA-59-2354	d7925dfc-18ce-46ab-a47b-9d06eacc96d0	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	2.4		cbdd4d6e-0df4-4abd-af75-b3a66bdba9cc	1.8	33367eb6-4ca9-4daf-9e47-30a47a78e144			0.14	22	released	4f7b1796-92b2-4881-bb35-cdf377f831df	RNA	R	0.14	UV Spec	released	False	b701256b-4e87-4c3c-bafa-79d4680fe331	01			0.0		0.0	10.0	90.0	90.0	BOTTOM	660ad7d8-618f-4b6e-ab96-a070c05adcd9	released			0.0		0.0	10.0	90.0	90.0	TOP	f9f56cfd-8248-451e-96e1-c803113982fd	released	released	144.0						7ce668a0-da92-4201-9f07-2c5b02df2c88	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-59-2354_demographic	63		1046	87faef0a-06fb-53fa-b2e6-7ac6f4cb94c1	not hispanic or latino	female	white	released	Dead	1942	2007	TCGA-59-2354_exposure	Not Reported	234f9005-f201-5ecf-a5ac-6695a716898d	released	TCGA-59-2354_diagnosis		not reported	0		d102e815-6af9-5d9f-b5ff-36b7b8730c4b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-59-2354_treatment	TCGA-59-2354_treatment_1	released	dcbd83c4-6827-5b46-8f65-b68ba8d3b247	no	Radiation Therapy, NOS	released	c356571c-6a09-587d-934e-e5a810d144e8	yes	Pharmaceutical Therapy, NOS	e8550e57-639a-43e1-b1a3-7f137ded2c6c
0d11c451-2dfa-40ed-93fc-261d94f299f3.htseq.counts.gz	4580703f-a98b-429c-b29e-c81fb9c86b4f	TCGA-29-1763-01A-02R-1567-13	TCGA-29-1763-01A-02R	TCGA-29-1763-01A-02-BS2	TCGA-29-1763-01A-01-BS1	TCGA-29-1763-01A-02		TCGA-29-1763-01A	TCGA-29-1763	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.3		f90e0db8-f656-411c-be72-8e0774d2336b	1.8	af63aa43-ab5f-44c5-85cf-01d84be261a3			0.16	22	released	9c396963-dd07-46b4-989d-d42229078351	RNA	R	0.16	UV Spec	released	False	3b0666f8-b8f9-4289-807d-3baf21029f5f	02			5.0		0.0	0.0	95.0	75.0	BOTTOM	13339452-2898-48c6-ba63-b39f8fd87e0c	released			5.0		0.0	0.0	95.0	70.0	TOP	0e52583c-5792-4c59-ac2f-8eb42cc26eba	released	released	113.0						3231d01a-e80c-46a1-8c9c-3492dca9f250	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-29-1763_demographic	43	-16021		8ae2cac3-bc30-5b1f-969f-cad425be9356	not reported	female	black or african american	released	Alive	1961		TCGA-29-1763_exposure	Not Reported	733e4828-47ed-56c0-bdbd-02eec56e056d	released	TCGA-29-1763_diagnosis	16021	not reported	0	2032	d1f6b014-7b53-518b-a401-c80c673bf79b	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-29-1763_treatment	TCGA-29-1763_treatment_1	released	b9499b9f-eef9-51af-92a5-55e855112876	yes	Radiation Therapy, NOS	released	1bbeb3b0-c83b-506b-80b2-96fccb1ed342	yes	Pharmaceutical Therapy, NOS	4580703f-a98b-429c-b29e-c81fb9c86b4f
b2ccd224-e50e-4dac-898f-83bda68866e8.htseq.counts.gz	048627c9-33d6-446b-b9a0-f254d2d5d48a	TCGA-20-1686-01A-01R-1566-13	TCGA-20-1686-01A-01R	TCGA-20-1686-01A-01-BS1	TCGA-20-1686-01A-01-TS1	TCGA-20-1686-01A-01		TCGA-20-1686-01A	TCGA-20-1686	f007fa7a-7da9-4cb0-8aea-623af1a122c5	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.8		c87ff195-1793-455a-bb19-e495a915befe	1.8	efabaf9d-2e46-4d4e-9b1b-763ec4d8d537			0.17	22	released	baf3c6b0-8c73-43b3-8e94-dac06e10aa26	RNA	R	0.17	UV Spec	released	False	776492c5-ff6f-4ae8-bcb6-9ed639992f96	01	1.0		0.0		0.0	30.0	70.0	80.0	BOTTOM	f7d1707d-5007-4774-8ca7-49c62b6dfc22	released			0.0		0.0	35.0	65.0	80.0	TOP	228c3630-c8f7-40cc-8cb9-30fd3859f7d1	released	released	115.0						13f9890c-e405-4625-888e-496eee30dfb4	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-20-1686_demographic	75	-27588		197ab3f9-6726-5731-bfc7-6b08ced01e17	not hispanic or latino	female	white	released	Alive	1933		TCGA-20-1686_exposure	Not Reported	fd716e57-c73a-585b-a0f9-e4d4fd5f5b14	released	TCGA-20-1686_diagnosis	27588	not reported	0	89	1ed1ad50-2936-5821-988a-f9c6e3f2728f	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-20-1686_treatment_1	TCGA-20-1686_treatment	released	979c1143-b977-5768-9111-a39139d2f550	yes	Pharmaceutical Therapy, NOS	released	216371a2-e571-542c-bb72-ee0f63f7346e	no	Radiation Therapy, NOS	048627c9-33d6-446b-b9a0-f254d2d5d48a
7d1a066f-8791-45ff-98e5-f4eb3d1e1d8d.htseq.counts.gz	42eb61ce-cf22-411d-861c-9245948cc474	TCGA-24-1431-01A-01R-1566-13	TCGA-24-1431-01A-01R	TCGA-24-1431-01A-01-TS1	TCGA-24-1431-01A-01-BS1	TCGA-24-1431-01A-01		TCGA-24-1431-01A	TCGA-24-1431	384170fc-e8be-426a-a54e-bf1ca61f2986	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		862aa4a2-d399-4aa0-998e-40b331c198ca	1.8	0e968ed4-9fbd-482b-b91d-ce7190dc91ed			0.16	22	released	5e9e8e86-1fc9-4ba8-be18-ffad22931040	RNA	R	0.16	UV Spec	released	False	6a0d445e-4d50-47ee-9c4c-7db2b231527a	01			0.0		0.0	10.0	90.0	90.0	TOP	56af0d60-12ff-42cd-bf25-1a6e1282bf6e	released			1.0		0.0	5.0	94.0	95.0	BOTTOM	cd2b0ba2-18ee-45d6-9b65-28574f20525c	released	released	176.0						44f5f2b7-94ac-4bbd-8ca8-bb5be4b0fbdb	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-24-1431_demographic	67	-24758	583	60cbb98e-688e-507e-8f47-5429ab9d40b4	not reported	female	white	released	Dead	1932	2000	TCGA-24-1431_exposure	Not Reported	e8b4dd9a-e328-50dc-b7eb-5d1414db10bc	released	TCGA-24-1431_diagnosis	24758	not reported	0	583	4ea91113-9bc3-52d6-92be-98286edfdb2e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-24-1431_treatment_1	TCGA-24-1431_treatment	released	0e1c8500-4cae-576a-8c58-24b604f564f7	yes	Pharmaceutical Therapy, NOS	released	59c0259d-6e2a-5736-ace6-f9f0cb199276	no	Radiation Therapy, NOS	42eb61ce-cf22-411d-861c-9245948cc474
b9aa8d09-5536-4b37-8259-8018bfa6d886.htseq.counts.gz	5bbc766c-877e-4112-bb80-ff6f2aaeb389	TCGA-24-1924-01A-01R-1567-13	TCGA-24-1924-01A-01R	TCGA-24-1924-01A-01-TS1	TCGA-24-1924-01A-01-BS1	TCGA-24-1924-01A-01		TCGA-24-1924-01A	TCGA-24-1924	26558703-a659-43f2-86cb-0695989bc14e	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.0		4199b57a-81f5-4d5f-9f4c-1e514dcd26dc	1.8	2592f314-cc0a-4d00-bdcf-6376afd32bb7			0.13	22	released	01fc7dde-58e3-466e-bd10-cdd6e4c4f862	RNA	R	0.13	UV Spec	released	False	97a146da-4cce-4d06-9fb0-637c29d7c8f3	01	0.0	0.0	20.0	10.0	0.0	10.0	70.0	70.0	TOP	fba40711-32d3-4959-96d3-fcbe4bf6021f	released	0.0	0.0	10.0	5.0	0.0	20.0	70.0	70.0	BOTTOM	624ef7e2-100f-40c8-b153-82b50e3f35ba	released	released	148.0						525471c8-0249-45ed-a443-db52ca6c04d9	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1924_demographic	65	-23801	919	ebc2ba2c-fc56-5869-b71c-e4f8b4479474	not reported	female	white	released	Dead	1936	2003	TCGA-24-1924_exposure	Not Reported	70d7cd5a-be5f-54b3-a03b-de2573647eee	released	TCGA-24-1924_diagnosis	23801	not reported	0	919	2d0eccd4-29ce-5014-9267-b0c39ebbf933	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-24-1924_treatment_1	TCGA-24-1924_treatment	released	ad997878-545f-534b-a2d8-b9f9d4f62847	yes	Pharmaceutical Therapy, NOS	released	ba91a268-44c4-5348-b906-56556ec299ff	no	Radiation Therapy, NOS	5bbc766c-877e-4112-bb80-ff6f2aaeb389
5817ee66-fd3b-413a-a479-9a89a5a28a99.htseq.counts.gz	ec002c5e-6b5f-4918-9dba-fe4e1ff06a8e	TCGA-13-1409-01A-01R-1565-13	TCGA-13-1409-01A-01R	TCGA-13-1409-01A-01-BS1	TCGA-13-1409-01A-01-TS1	TCGA-13-1409-01A-01		TCGA-13-1409-01A	TCGA-13-1409	18e0e996-8f23-4f53-94a5-dde38b550863	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.6		3F18B612-EE50-4459-8CAF-61A12157DD8A	1.8	850f50c3-4d01-4838-bd3a-641942bb2855			0.15	22	released	d7030b99-aad1-4cc1-bc11-355d380f2474	RNA	R	0.15	UV Spec	released	False	a5af5acd-6855-40b1-bf2e-1b4c79a1357d	01			5.0		0.0	10.0	85.0	90.0	BOTTOM	dc1c8c75-97e7-4a32-9581-9c7bac1a0a87	released			5.0		0.0	20.0	75.0	80.0	TOP	4226415a-3f9d-4a34-b017-1af964c8be5a	released	released	123.0						930c3552-f960-4a57-aa35-b504807a9676	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-13-1409_demographic	73	-26836	1742	cf0eeee1-5dd7-5bef-ad40-5d881bf9d762	not hispanic or latino	female	white	released	Dead	1935		TCGA-13-1409_exposure	Not Reported	b2abdfc3-622c-5617-a7b0-0330eb0f3cf7	released	TCGA-13-1409_diagnosis	26836	not reported	0	208	6b0f33e6-884d-5a93-8335-9f55569790a7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1409_treatment_1	TCGA-13-1409_treatment	released	1140ff80-4d83-58f4-b151-0737143a0984	yes	Pharmaceutical Therapy, NOS	released	c9c78335-6d3f-52a5-92a9-c41ccbd8d4d8	no	Radiation Therapy, NOS	ec002c5e-6b5f-4918-9dba-fe4e1ff06a8e
aa77a3af-80ce-44d2-b227-faec0f734468.htseq.counts.gz	f6c8cc7c-1730-48e2-a2a7-4f6ef0e80938	TCGA-04-1361-01A-01R-1565-13	TCGA-04-1361-01A-01R	TCGA-04-1361-01A-01-BS1	TCGA-04-1361-01A-01-TS1	TCGA-04-1361-01A-01		TCGA-04-1361-01A	TCGA-04-1361	a6aad7f9-8444-4c2f-8e4b-b19fd453544f	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.8		5116FD62-7A2C-425A-A99E-D47C1B456961	1.8	746ba0b0-f7a4-4f43-9961-97dccc756e71			0.16	22	released	016703b6-0df1-410a-91d9-857da7e01ed2	RNA	R	0.16	UV Spec	released	False	649a4231-7a0f-4457-923c-58b9eedfe777	01			1.0		0.0	30.0	69.0	80.0	BOTTOM	b4e0df05-3e78-4414-9430-b4d97a09befb	released			1.0		0.0	30.0	69.0	80.0	TOP	58eecb9c-dfa5-450a-8057-4545340dc5ac	released	released	93.0						702cc8d9-38f6-474a-bd7e-e56820c5a5b0	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-04-1361_demographic	57	-20860		7640a9d1-04b1-5950-8139-52e731454d82	not reported	female	white	released	Alive	1948		TCGA-04-1361_exposure	Not Reported	78e98ab0-3a8d-5688-b36f-e1d9db4e2c02	released	TCGA-04-1361_diagnosis	20860	not reported	0	989	20329fd9-e669-5e99-8572-55ca9d382aec	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-04-1361_treatment	TCGA-04-1361_treatment_1	released	919c412a-9363-54c4-bacf-d58a709a0a04	no	Radiation Therapy, NOS	released	940ff4b9-83f5-526e-b361-550d78e856ef	yes	Pharmaceutical Therapy, NOS	f6c8cc7c-1730-48e2-a2a7-4f6ef0e80938
b1d5c444-da0d-4360-bd45-31c94217adfc.htseq.counts.gz	d1eac399-b52d-4bf3-a70b-08070987f1d3	TCGA-25-1319-01A-01R-1565-13	TCGA-25-1319-01A-01R	TCGA-25-1319-01A-01-TS1	TCGA-25-1319-01A-01-BS1	TCGA-25-1319-01A-01		TCGA-25-1319-01A	TCGA-25-1319	914d8613-3c25-4a10-be50-28b42f4d3a5d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				2.5	False	3.0		62BFD64E-1C60-49A8-BAD0-B173DD22C951	1.8	8f0f34fb-bbef-4a17-8324-4ebda56f9e0e			0.16	22	released	82cd0ab1-2679-4409-826d-bbe43ea6193c	RNA	R	0.16	UV Spec	released	False	6d5da75a-05f5-44cf-a66f-0b140fce68e3	01			5.0		0.0	5.0	90.0	95.0	TOP	4d68fbd5-1e16-4050-aeae-c6ca6c0a34f6	released			0.0		10.0	40.0	50.0	95.0	BOTTOM	ad3a89ef-7efe-4a65-92de-1b4457cf6e84	released	released	162.0						c063d066-9073-4f05-8a38-601aa65dc5bf	Primary Tumor	01	1.0	released	Not Reported	released	TCGA-25-1319_demographic	73	-26786	1977	87285b0c-753a-5853-a163-2d40aeeb0262	not hispanic or latino	female	white	released	Dead	1927	2005	TCGA-25-1319_exposure	Not Reported	5448ce20-10f2-5436-ac0e-22ab88c5ddb9	released	TCGA-25-1319_diagnosis	26786	not reported	0	1977	db3baf3d-297f-5c6c-a175-b0c27145f449	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-25-1319_treatment_1	TCGA-25-1319_treatment	released	a761991d-ecf8-5c56-9a6c-1366ad17f6bd	yes	Pharmaceutical Therapy, NOS	released	92fb3354-b375-5e12-8c52-9863d5367d02	no	Radiation Therapy, NOS	d1eac399-b52d-4bf3-a70b-08070987f1d3
c29d7649-364a-4fe5-9dd2-9f8937a565e4.htseq.counts.gz	96dcad2e-bc49-49fa-844c-50041ce8728a	TCGA-13-1410-01A-01R-1565-13	TCGA-13-1410-01A-01R	TCGA-13-1410-01A-01-BS1	TCGA-13-1410-01A-01-TS1	TCGA-13-1410-01A-01		TCGA-13-1410-01A	TCGA-13-1410	c3f9ee36-d34f-472b-ac7f-801a0d400aa4	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.9		0F641D88-673B-48C4-97F5-730DA3FD343C	1.8	fdda1428-ad6b-4337-a959-83bae1f9664b			0.15	22	released	d5c0d15c-754f-4d0c-b591-f015734119ac	RNA	R	0.15	UV Spec	released	False	741ff0d5-f651-4c21-81e9-9c40c0736fc4	01			1.0		0.0	5.0	94.0	95.0	BOTTOM	dda5a121-c1dc-4163-a746-af90d53948a8	released			0.0		0.0	5.0	95.0	95.0	TOP	d9211bc5-759c-42ad-acbd-a0dc7798d272	released	released	162.0						62812cb1-e25e-4a3f-9e8e-1993b138e1a6	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-13-1410_demographic	57	-20950		dddcc9ce-814f-57e6-88a2-e528d7447fbb	not hispanic or latino	female	white	released	Alive	1951		TCGA-13-1410_exposure	Not Reported	ebeb9e38-32f4-5cac-a4df-fde1ad6d7769	released	TCGA-13-1410_diagnosis	20950	not reported	0	2464	5e13b45b-37a6-5228-8b30-a580f27d1c1a	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1410_treatment	TCGA-13-1410_treatment_1	released	35b5209f-4450-58fe-87f6-96613c89f7fb	no	Radiation Therapy, NOS	released	6fdefac0-5b97-5733-a0aa-c71912ddd5f7	yes	Pharmaceutical Therapy, NOS	96dcad2e-bc49-49fa-844c-50041ce8728a
111d4d64-e1cc-404d-8fa9-ca0a545041cb.htseq.counts.gz	3d49df57-8228-4934-925e-191cf7ce6f53	TCGA-09-2044-01B-01R-1568-13	TCGA-09-2044-01B-01R	TCGA-09-2044-01B-01-BS1	TCGA-09-2044-01B-01-TS1	TCGA-09-2044-01B-01		TCGA-09-2044-01B	TCGA-09-2044	7d03ddb6-f3fe-4b50-8bba-514aa65e7d0e	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.4	False	1.8		42d7c4ad-b379-4dc0-ba67-16aa6ead89d9	1.8	658b4847-33bc-414c-a2bb-ce9379ef57bd			0.15	22	released	08693365-98ab-4cc4-8bd7-a2778680f41e	RNA	R	0.15	UV Spec	released	False	815854b2-c54d-49b8-b1f4-7773d1dad3d0	01			1.0		0.0	5.0	94.0	95.0	BOTTOM	3ee9af83-dbc6-4c81-9732-2c174fb32946	released			0.0		1.0	9.0	90.0	90.0	TOP	e382e900-de5f-4cf6-87b9-afa4aebea4b4	released	released	159.0						1f60c05e-f171-4815-b0da-40aa1b24f300	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-09-2044_demographic	77	-28231		1d738d5b-91e3-54ea-8834-4818e8cc11ed	not hispanic or latino	female	asian	released	Alive	1932		TCGA-09-2044_exposure	Not Reported	74de3056-5c7a-535c-95a2-77211c636726	released	TCGA-09-2044_diagnosis	28231	not reported	0	186	44bb6d41-522c-5051-b9a5-d0fb8e4f3d93	Stage IIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-09-2044_treatment_1	TCGA-09-2044_treatment	released	35e0e3a4-9bf1-5055-b999-873a29806072	yes	Pharmaceutical Therapy, NOS	released	154fbe2f-d112-5bb8-8427-fb209bdab068	no	Radiation Therapy, NOS	3d49df57-8228-4934-925e-191cf7ce6f53
4e1c9b43-bfd3-4242-9d55-66ad4b66d84f.htseq.counts.gz	e47fcf06-ebb9-4406-8a9d-53da70ffb467	TCGA-24-1842-01A-01R-1567-13	TCGA-24-1842-01A-01R	TCGA-24-1842-01A-01-BS1	TCGA-24-1842-01A-01-TS1	TCGA-24-1842-01A-01		TCGA-24-1842-01A	TCGA-24-1842	09c77947-a333-4392-b18d-a6c1f08764a1	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.5		3465aae7-0664-44e5-a27f-c02fd73526a1	1.8	6cb78602-e09f-4dbc-b3e5-684ebe77bddc			0.16	22	released	6efc1dd3-9f0f-455f-8168-eaf97d7bdaca	RNA	R	0.16	UV Spec	released	False	0d9c9ad7-94e6-4c24-ae56-4e14ecfff704	01	0.0	0.0	0.0	0.0	0.0	15.0	85.0	85.0	BOTTOM	9934e7e4-d1e5-4f32-ae50-d290ef1c52eb	released	0.0	0.0	0.0	0.0	0.0	15.0	85.0	85.0	TOP	5d87953b-1468-4ca3-b2ce-035d657d7044	released	released	123.0						8c53c83d-85c8-49b5-8838-cb0585c894b2	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-24-1842_demographic	49	-18227		1002b6b2-c01e-55fc-80a0-ffb1512d7c36	not reported	female	white	released	Alive	1960		TCGA-24-1842_exposure	Not Reported	55e9064e-5c40-5537-9b79-3e781abc16e6	released	TCGA-24-1842_diagnosis	18227	not reported	0	253	53645a91-09b0-52fe-a6c3-029904ef194e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-24-1842_treatment	TCGA-24-1842_treatment_1	released	c994f920-7c4b-5e02-8f9e-f14efe9b945e	no	Radiation Therapy, NOS	released	71ac16e3-310e-5af1-a0d1-70d154961cc5	yes	Pharmaceutical Therapy, NOS	e47fcf06-ebb9-4406-8a9d-53da70ffb467
9c6f2d76-7701-434e-a876-c04ab14cccea.htseq.counts.gz	451c9c6d-f062-4ca2-8459-efed929bd305	TCGA-25-1628-01A-01R-1566-13	TCGA-25-1628-01A-01R	TCGA-25-1628-01A-01-TS1	TCGA-25-1628-01A-01-BS1	TCGA-25-1628-01A-01		TCGA-25-1628-01A	TCGA-25-1628	3f917550-89a6-404b-94df-938c99121411	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	2.0		790D6E48-15D0-45F9-B6DD-182787298EBA	1.8	a3083fd8-f5d0-486b-bf3d-31ae094b1cbf			0.15	22	released	61f6b4fc-7b00-4d36-a2cc-78d26b620e38	RNA	R	0.15	UV Spec	released	False	bf96086a-9aaf-45f3-a95f-e48d8b890e22	01			5.0		0.0	10.0	85.0	95.0	TOP	35d35463-e15c-4be7-b62e-9a8e169c005a	released			5.0		0.0	10.0	85.0	95.0	BOTTOM	b18022f1-2c8f-4a48-b8e9-df04efe7b09c	released	released	105.0						efe5ae48-c145-4b24-a1df-ba485d355dfa	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-25-1628_demographic	67	-24488	627	6e2d232b-ab2e-50d6-bfae-ee839c5600ad	not hispanic or latino	female	white	released	Dead	1935	2003	TCGA-25-1628_exposure	Not Reported	b3623f4d-786d-5919-8fce-97f9f7bf0dff	released	TCGA-25-1628_diagnosis	24488	not reported	0	627	8a7f1425-a395-5f52-8f54-d892a3e2f7e7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-25-1628_treatment_1	TCGA-25-1628_treatment	released	66b0034c-d87f-52a6-9ba1-87b88c1aca9f	yes	Pharmaceutical Therapy, NOS	released	23777ecf-03ee-5cd8-a454-ff354ab7ddc9	no	Radiation Therapy, NOS	451c9c6d-f062-4ca2-8459-efed929bd305
bde7dae9-5985-4195-b22b-cc0babb99c75.htseq.counts.gz	f54a4cd6-4501-4285-89e4-9dc7c4ddc803	TCGA-09-1666-01A-01R-1566-13	TCGA-09-1666-01A-01R	TCGA-09-1666-01A-01-TS1	TCGA-09-1666-01A-01-BS1	TCGA-09-1666-01A-01		TCGA-09-1666-01A	TCGA-09-1666	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.5		2de50dd9-b607-4a87-baae-468c4bf43205	1.8	529b7dd2-075c-4e93-b8c8-6990d3297c30			0.16	22	released	9151adb7-8a1e-4781-8737-0940f48bac89	RNA	R	0.16	UV Spec	released	False	482ae695-203e-44d2-a7da-6079fa10e787	01			2.0		0.0	5.0	93.0	95.0	TOP	0176ba08-e81b-4392-b6ae-2be1aac6b1f4	released			2.0		0.0	5.0	93.0	95.0	BOTTOM	da8d3b7c-3945-4281-8907-19a24dd29f68	released	released	111.0						77ab9685-021c-4d99-8980-79bec534828e	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-09-1666_demographic	57	-21066		365f1918-1b27-5ca8-8eb2-e4ba49ddcfeb	not hispanic or latino	female	white	released	Alive	1946		TCGA-09-1666_exposure	Not Reported	df834f9b-66ce-5662-9a42-710c402c55f5	released	TCGA-09-1666_diagnosis	21066	not reported	0	1752	2bb77198-9515-588e-b65c-6ed8cd866bca	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-09-1666_treatment_1	TCGA-09-1666_treatment	released	2cf2b8b3-9cdd-54af-bb68-2909321a01ab	yes	Pharmaceutical Therapy, NOS	released	e69dea00-1e6c-5edb-a6f4-8b6eac4085fa	no	Radiation Therapy, NOS	f54a4cd6-4501-4285-89e4-9dc7c4ddc803
73bc4ef3-2d63-4829-a28e-f400abf4290a.htseq.counts.gz	af511f8c-d5bf-4dcf-a388-b070ff91774e	TCGA-29-2414-02A-01R-1569-13	TCGA-29-2414-02A-01R	TCGA-29-2414-02A-01-TS1	TCGA-29-2414-02A-01-BS1	TCGA-29-2414-02A-01		TCGA-29-2414-02A	TCGA-29-2414	a2319490-b85d-4219-a1b0-fa1ec432d5c8	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.0		1A4882EA-818E-4A23-8584-2881D0DE8406	1.8	1558c0c4-6bd2-482d-9c4e-2430a402dacc			0.16	22	released	4db51ece-d641-4e3d-a214-ec7728b6397d	RNA	R	0.16	UV Spec	released	False	fbb635b8-7811-4dab-b8ae-7b88a63f2050	01			10.0		0.0	30.0	60.0	90.0	TOP	9e8b6cda-a655-40f9-a448-d45218dc54c8	released			0.0		0.0	20.0	80.0	90.0	BOTTOM	d98dd76c-5162-4b4d-b0fa-0604d8a40117	released	released	150.0						dffc14ad-f9fc-4d33-b5e2-8c57019816fe	Recurrent Tumor	02	0.3	released	Not Reported	released	TCGA-29-2414_demographic	75	-27417	2621	7b9aeb08-3b4c-5661-bec0-b3b74dc9ec8a	not reported	female	white	released	Dead	1923	2005	TCGA-29-2414_exposure	Not Reported	9ddfa6c8-882b-5014-b95c-e996183632d0	released	TCGA-29-2414_diagnosis	27417	not reported	0	2621	1911c0e4-d523-5681-9cc6-332707c4c25e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-29-2414_treatment	TCGA-29-2414_treatment_1	released	6a5666f9-cc38-5f1c-a8b6-ec1953ac9ff2	yes	Radiation Therapy, NOS	released	05378657-f28b-596e-9c75-e01314d078f2	yes	Pharmaceutical Therapy, NOS	af511f8c-d5bf-4dcf-a388-b070ff91774e
89758e34-511b-465a-81db-2af07f047d5f.htseq.counts.gz	e82c71fa-c8fd-46f5-8dcc-e3fa253c4b9d	TCGA-04-1338-01A-01R-1564-13	TCGA-04-1338-01A-01R	TCGA-04-1338-01A-01-TS1	TCGA-04-1338-01A-01-BS1	TCGA-04-1338-01A-01		TCGA-04-1338-01A	TCGA-04-1338	31872f6a-d225-4f91-b38d-4505d19e406c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		889AF2DB-7FF9-45B1-8FD4-28D57CF870A7	1.7	ad64ff86-b39c-4704-823d-98fcefd88db6			0.16	22	released	53c75a9b-d341-43d1-9425-566d93e2cd98	RNA	R	0.16	UV Spec	released	False	5c45b224-f1b7-4423-aac9-cc8dbfc84e55	01			15.0			30.0	55.0	85.0	TOP	33f6254c-7df6-4570-b2df-1dde268a9d64	released			15.0			40.0	45.0	85.0	BOTTOM	7f2ab5c1-f165-468c-a413-b45b4059bb6f	released	released	114.0						7b90d4ab-6c0a-4428-9ef1-20c7c09ff9e7	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-04-1338_demographic	78	-28789		e8692f76-bc92-57a4-9d02-6ea94d74b7b9	not hispanic or latino	female	white	released	Alive	1927		TCGA-04-1338_exposure	Not Reported	bf7ec4bf-3ce0-5d43-9f58-0df88ae78155	released	TCGA-04-1338_diagnosis	28789	not reported	0	1418	5a6c0be4-e300-56d1-85c2-bb11bf6409b8	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-04-1338_treatment_1	TCGA-04-1338_treatment	released	a2113de8-7b31-5992-8225-88e857190db9	yes	Pharmaceutical Therapy, NOS	released	281b59c3-bf65-5194-ae83-64187eba70fc	no	Radiation Therapy, NOS	e82c71fa-c8fd-46f5-8dcc-e3fa253c4b9d
7f0f3d94-1376-470a-a959-cd56039ae10a.htseq.counts.gz	46cc57be-b388-45da-b753-8522a9d5c847	TCGA-13-0797-01A-01R-1564-13	TCGA-13-0797-01A-01R	TCGA-13-0797-01A-01-BS1	TCGA-13-0797-01A-01-TS1	TCGA-13-0797-01A-01		TCGA-13-0797-01A	TCGA-13-0797	0de910b1-edaf-47e4-a265-727ee12ac1c3	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.6		84ED21CA-E018-44C5-86E4-57927ABBCC9A	1.8	9bd35257-52b8-4277-9cc9-48c5f316932b			0.15	22	released	7b94e812-0557-4637-b045-63ba6fe7e764	RNA	R	0.15	UV Spec	released	False	75597933-0277-4317-b823-db8e18243b37	01			0.0		0.0	10.0	90.0	98.0	BOTTOM	35def05e-dee8-4875-8efd-c2262c07de5c	released			0.0		0.0	5.0	95.0	98.0	TOP	f73bb3f4-9dac-462a-bbb7-feec138ebf1d	released	released	168.0						52f8884e-c99a-44ae-8d74-6b219070902e	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-0797_demographic	49	-18051		000181a9-73a5-5da4-9bf0-5e025cfce047	not hispanic or latino	female	white	released	Alive	1959		TCGA-13-0797_exposure	Not Reported	1a91bf4d-e735-55ca-ab18-5d8eb86750ed	released	TCGA-13-0797_diagnosis	18051	not reported	0	2121	1721bac4-b2e8-508d-8b99-aed22fef7600	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-0797_treatment	TCGA-13-0797_treatment_1	released	a8e3feee-1dca-5f8c-845b-80182d750816	no	Radiation Therapy, NOS	released	9d2c9d89-f1ff-58a1-a0a2-971f08aa71cf	yes	Pharmaceutical Therapy, NOS	46cc57be-b388-45da-b753-8522a9d5c847
062b6d0c-06b0-4d27-8702-32501278cd9c.htseq.counts.gz	b44b0d52-562a-476a-a607-a7148d128359	TCGA-24-0979-01A-01R-1565-13	TCGA-24-0979-01A-01R	TCGA-24-0979-01A-01-BS1	TCGA-24-0979-01A-01-TS1	TCGA-24-0979-01A-01		TCGA-24-0979-01A	TCGA-24-0979	9a30dee8-962a-49db-a85a-c39515c91b68	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	0.8		3385E5B4-EBD4-4317-8805-EE6EA47A2E4A	1.8	639429a9-c1d3-410d-828a-c3b44d648609			0.15	22	released	1aaa29cd-d6b5-4fa5-a39f-39c5c45d8ae3	RNA	R	0.15	UV Spec	released	False	51bea6f7-1023-4a6b-a8f7-96d006b242dc	01	50.0		5.0		0.0	25.0	70.0	85.0	BOTTOM	32ea68ae-904f-4d69-a8ff-5a59e2a65ccd	released			0.0		0.0	25.0	75.0	85.0	TOP	0dda30a8-16ff-4e27-b1be-bc9327e052c0	released	released	99.0						9b072344-31cf-471a-af4f-23ae73a98c93	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-0979_demographic	53	-19595	1264	267cae75-6ddd-5309-979e-1fa1196aa5e1	not reported	female	white	released	Dead	1950	2006	TCGA-24-0979_exposure	Not Reported	1ef31439-c19a-5113-88c6-6988b3cfbbea	released	TCGA-24-0979_diagnosis	19595	not reported	0	1264	600bf167-5408-5802-8f4b-f20f53e15337	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-24-0979_treatment	TCGA-24-0979_treatment_1	released	a25fada3-32e0-5ee1-99b3-944dedf07040	yes	Radiation Therapy, NOS	released	e6a77ac0-6639-5ae4-b9f9-8d777ecc0db6	yes	Pharmaceutical Therapy, NOS	b44b0d52-562a-476a-a607-a7148d128359
c9689d9f-6138-42a8-a58e-1b44dc4b193f.htseq.counts.gz	4b83b0f5-4fc7-4a3a-a090-3ce497fb1af4	TCGA-25-2393-01A-01R-1569-13	TCGA-25-2393-01A-01R	TCGA-25-2393-01A-01-BS1	TCGA-25-2393-01A-01-TS1	TCGA-25-2393-01A-01		TCGA-25-2393-01A	TCGA-25-2393	b4b49027-7815-4813-9769-a3fe3a26a37a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.3		0B780E04-2DE3-4C56-9B93-1919F4BBE5D4	1.8	93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e			0.14	22	released	2d7b2444-7987-4522-9c20-92b9f539fe90	RNA	R	0.14	UV Spec	released	False	e56337d7-25e3-48b1-a4fd-5aaaab08f5cf	01			5.0		1.0	14.0	80.0	85.0	BOTTOM	57857d1a-37a7-4981-805a-609817bcbe0e	released			5.0		1.0	14.0	80.0	85.0	TOP	a20e3f24-82c2-4886-a478-09dc932809fe	released	released	144.0						e69d97a1-39ab-49a6-9f73-5be13fa49d30	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-25-2393_demographic	81	-29585	1157	d287eb95-3746-5617-b7a4-31ccca93dffb	not hispanic or latino	female	white	released	Dead	1922	2006	TCGA-25-2393_exposure	Not Reported	82c906c0-3ffd-5f52-b8c4-bd6e06da34c4	released	TCGA-25-2393_diagnosis	29585	not reported	0	1157	635b00aa-baef-5228-96e1-96c52b8da8a3	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-25-2393_treatment_1	TCGA-25-2393_treatment	released	cb83e3b2-0214-5c66-8323-f16b873c937c	yes	Pharmaceutical Therapy, NOS	released	ebf44a84-1696-59f7-9b25-926975930d32	no	Radiation Therapy, NOS	4b83b0f5-4fc7-4a3a-a090-3ce497fb1af4
4610ddcb-2924-4d3f-9d2a-b6416f7c3f03.htseq.counts.gz	f6d3729d-8c3f-499b-9d56-1fcc75ffbb59	TCGA-29-A5NZ-01A-11R-A406-31	TCGA-29-A5NZ-01A-11R	TCGA-29-A5NZ-01A-01-TSA		TCGA-29-A5NZ-01A-11		TCGA-29-A5NZ-01A	TCGA-29-A5NZ	f1cb3d48-1415-408d-89d1-dfdcc5924963	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV	515		1040.0		False		true	B7F69EE0-E844-434B-A76B-390590C85864	1.91	ea715147-2b94-4bed-9531-ba91c13630fe			0.18	23	released	e8767908-d2ad-4e8d-a452-59bed409ab0c	RNA	R	0.18	UV Spec	released	False	b0e103fb-82fc-44dd-9a45-35d8b4020b3c	11	0.0	0.0	10.0	5.0	0.0	10.0	80.0	80.0	TOP	f88dabee-0b8b-4c80-990f-36467458ea03	released												released	30.0						cfa92815-5221-46e2-b7a2-958c556bb390	Primary Tumor	01		released	Not Reported	released	TCGA-29-A5NZ_demographic	66	-24161	1088	5fcf9981-1d44-5962-8284-883451d2d003	not reported	female	black or african american	released	Dead	1945	2013	TCGA-29-A5NZ_exposure	Not Reported	77648193-9746-56d4-b1d0-4e1f399cf3c3	released	TCGA-29-A5NZ_diagnosis	24161	not reported	0	984	ac1e9d43-af66-5f28-8eff-48495da484b3	Stage IIIC	C48.1	not reported	8460/3	Papillary serous cystadenocarcinoma	no	No	not reported	Specified parts of peritoneum	released	No	Ovary	not reported	not reported	2011	TCGA-29-A5NZ_treatment_1	TCGA-29-A5NZ_treatment	released	300e9b89-cb86-5bae-b9d4-d741b31bb5a4	yes	Pharmaceutical Therapy, NOS	released	275f3df6-15f6-50ba-ac5d-5173abae5a42	no	Radiation Therapy, NOS	f6d3729d-8c3f-499b-9d56-1fcc75ffbb59
ab9f8d1d-d981-4139-8191-ad8db91c187f.htseq.counts.gz	5b330499-64c3-459d-a051-48ab0662f8e5	TCGA-OY-A56Q-01A-11R-A406-31	TCGA-OY-A56Q-01A-11R	TCGA-OY-A56Q-01A-01-TS1		TCGA-OY-A56Q-01A-11		TCGA-OY-A56Q-01A	TCGA-OY-A56Q	c7cf6755-8856-435b-a443-174b22a25b07	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV	120		370.0		False		false	3EF6F66B-8B6E-48E6-9CF4-F8A6B236856D	1.93	3a1867ff-7c1e-47c1-854f-90c0af4b2d03			0.15	23	released	61db4375-3cda-4a66-869b-74354279dfb3	RNA	R	0.15	UV Spec	released	False	e98e7efa-66a3-412f-aefc-3a82b024e1c0	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	b98349c7-e9b1-4cab-917b-988a413d8371	released												released	30.0						d5cad767-265f-480f-a3bf-185bd4a75d5e	Primary Tumor	01		released	Not Reported	released	TCGA-OY-A56Q_demographic	78	-28623		d29528b8-bba5-5033-8fed-7dc94e0f4764	not hispanic or latino	female	black or african american	released	Alive	1934		TCGA-OY-A56Q_exposure	Not Reported	37b06693-d3f5-51d1-90dc-61863e4dcc8d	released	TCGA-OY-A56Q_diagnosis	28623	not reported	0	576	e64f78a3-2512-50f4-8b0c-34493a440422	Stage IIA	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Ovary	released	No	Ovary	not reported	not reported	2012	TCGA-OY-A56Q_treatment_1	TCGA-OY-A56Q_treatment	released	ea093ba3-52a5-5d39-b3ab-09d2e611d336	yes	Pharmaceutical Therapy, NOS	released	af64e246-f0f8-51c9-8cc0-473354478c58	no	Radiation Therapy, NOS	5b330499-64c3-459d-a051-48ab0662f8e5
451aa144-4d34-4858-b81e-3458db34892b.htseq.counts.gz	be260015-b33d-4f36-a66e-598214fcc4d8	TCGA-23-1027-01A-02R-1564-13	TCGA-23-1027-01A-02R	TCGA-23-1027-01A-02-BS2	TCGA-23-1027-01A-01-BS1	TCGA-23-1027-01A-02		TCGA-23-1027-01A	TCGA-23-1027	c9e58844-9d61-44a2-aee6-1760bc19711b	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	0.8		568C3873-A64C-4D46-8001-EF3EC63750ED	1.8	edbc81a6-2593-45c5-8131-3c4615d1807f			0.17	22	released	1e52a17b-7e25-45b9-81f4-6a874cb4b8c0	RNA	R	0.17	UV Spec	released	False	de198416-4775-4b8e-9d17-039f3e73632c	02			0.0		5.0	10.0	85.0	90.0	BOTTOM	08a84ac3-d0b4-4056-b4df-ef6fa85c9008	released			0.0		5.0	5.0	90.0	95.0	TOP	ae48dc7c-b645-4baf-8aa9-e4db50ad6c3d	released	released	103.0						ddb8c0dd-c3df-4b78-850d-56b0644e12d7	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-23-1027_demographic	48	-17588	976	de6818be-e2c7-5255-b1fa-d8444f500277	not hispanic or latino	female	white	released	Dead	1957	2007	TCGA-23-1027_exposure	Not Reported	e8ff0590-8d15-503c-8910-ee67b28e110a	released	TCGA-23-1027_diagnosis	17588	not reported	0	966	ed60e55e-cdc8-51e1-9be4-00d4c65cb2ce	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-23-1027_treatment	TCGA-23-1027_treatment_1	released	9f7b72b5-ce0c-5818-93bd-511e96f93728	no	Radiation Therapy, NOS	released	14a86bc3-86c2-53eb-8d18-b8198e08b1ea	yes	Pharmaceutical Therapy, NOS	be260015-b33d-4f36-a66e-598214fcc4d8
08dd298e-9a5b-495f-8f5f-42998ae6dabf.htseq.counts.gz	6cabdb21-403a-46a7-9a9e-3bcd7c1cd681	TCGA-04-1536-01A-01R-1566-13	TCGA-04-1536-01A-01R	TCGA-04-1536-01A-01-TS1	TCGA-04-1536-01A-01-BS1	TCGA-04-1536-01A-01		TCGA-04-1536-01A	TCGA-04-1536	1fe19c6b-71d0-4b07-923b-74ea32210db0	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.5	False	1.8		167826A1-0854-442E-8AF5-85294D1CB0B9	1.8	6d6a042c-5d29-410a-bbe0-d03d78f9cee9			0.15	22	released	3a2798dc-0aa3-469c-b4ba-683d12320f07	RNA	R	0.15	UV Spec	released	False	7c9b873a-8d33-4cac-a143-2479c57e1b30	01			0.0		0.0	5.0	95.0	95.0	TOP	08041de2-b6e7-434e-af1a-d616e2e6bf36	released			5.0		10.0	0.0	85.0	70.0	BOTTOM	269c835e-ebb2-4a0b-a428-8eacb2774937	released	released	116.0						841bdebe-253d-4183-a3a1-e2780c859187	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-04-1536_demographic	60	-21939	885	4075c35e-4315-55c2-8f7e-f4fccace1701	not reported	female	black or african american	released	Dead	1941	2003	TCGA-04-1536_exposure	Not Reported	5555db3e-ab6b-51cd-bdbe-3223283273e4	released	TCGA-04-1536_diagnosis	21939	not reported	0		f17fde83-65f4-517c-a222-7ce85742a76a	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-04-1536_treatment_1	TCGA-04-1536_treatment	released	d1808729-233e-5d5b-94f6-d392d1479c39	yes	Pharmaceutical Therapy, NOS	released	9ce48eab-0d8c-5500-afb6-f15cba3c0ba6	no	Radiation Therapy, NOS	6cabdb21-403a-46a7-9a9e-3bcd7c1cd681
2ab2d4f1-4171-4326-91e1-e2c795004468.htseq.counts.gz	d234796d-722c-45e8-9449-8d65c994aea3	TCGA-61-2110-01A-01R-1568-13	TCGA-61-2110-01A-01R	TCGA-61-2110-01A-01-BS1	TCGA-61-2110-01A-01-TS1	TCGA-61-2110-01A-01		TCGA-61-2110-01A	TCGA-61-2110	88180134-710f-46ea-9b06-5e5d860d6d9f	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.4		d7a597dc-d607-4e20-90a9-a181d6c11d17	1.8	6561cdb8-8499-41a6-8a79-ef0119e34c66			0.13	22	released	54c27ebd-e56a-4929-8ac5-9c3f548ac0e1	RNA	R	0.13	UV Spec	released	False	b3f5ca74-ca20-4a79-9d40-45e1af4f270e	01			7.0		45.0	3.0	45.0	70.0	BOTTOM	e42d96bc-a002-4f4c-817b-d3a5b1af1172	released			5.0		25.0	5.0	65.0	75.0	TOP	657eac90-dffd-4a49-815e-751d197a315e	released	released	94.0						6ae6b10a-fc2b-4c6e-a30e-0299c22ac042	Primary Tumor	01	0.1	released	Not Reported	released	TCGA-61-2110_demographic	56	-20718	1354	f60176dd-6543-512c-8308-244afc979cf1	not hispanic or latino	female	white	released	Dead	1942	2001	TCGA-61-2110_exposure	Not Reported	19696bca-7ac0-59c1-9468-86fc8b0a04ba	released	TCGA-61-2110_diagnosis	20718	not reported	0	1354	1e51ebe2-c57d-5a2a-8421-1f6cbdf4003b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-61-2110_treatment_1	TCGA-61-2110_treatment	released	99456cd4-c915-5c59-896f-f39a770fb607	yes	Pharmaceutical Therapy, NOS	released	40938b97-fc11-528c-8a13-07959e393c9c	yes	Radiation Therapy, NOS	d234796d-722c-45e8-9449-8d65c994aea3
56427511-2167-465f-bdde-689b895b3d4b.htseq.counts.gz	e09d9ae2-b5b5-47ac-8d22-f10d7c3066d1	TCGA-23-1028-01A-01R-1564-13	TCGA-23-1028-01A-01R	TCGA-23-1028-01A-01-TS1	TCGA-23-1028-01A-01-BS1	TCGA-23-1028-01A-01		TCGA-23-1028-01A	TCGA-23-1028	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	0.8		CCD0A1B3-DE92-473C-AA1B-8EE25DE408A2	1.8	8f6e45b3-2857-4eb8-a723-5429f7fd8f0c			0.14	22	released	7ed482a8-aa10-42b3-bd02-57aeaeed76b3	RNA	R	0.14	UV Spec	released	False	bbd3516f-ed5e-4d99-8647-0bfad043ffef	01			5.0		10.0	10.0	75.0	80.0	TOP	56dde40f-224a-49a7-a24c-9fc8b44e0a66	released			5.0		15.0	10.0	70.0	75.0	BOTTOM	94323365-fde7-4d57-a4c7-0f6ded12fa41	released	released	97.0						4363b3c8-bfdb-4668-b72a-d15ed0f5bfff	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-23-1028_demographic	43	-16018		c98a0351-dc5f-5f3c-984f-638eae453300	hispanic or latino	female	white	released	Alive	1961		TCGA-23-1028_exposure	Not Reported	e9edd4f4-fdcd-510f-8e48-b31d11b17e12	released	TCGA-23-1028_diagnosis	16018	not reported	0	1503	26b720a3-88e1-5202-a2e2-08f958ebe521	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-23-1028_treatment	TCGA-23-1028_treatment_1	released	a66174fd-178d-511f-9c97-9a42c2cc621e	no	Radiation Therapy, NOS	released	088fe669-f318-5587-89f0-187475694b19	yes	Pharmaceutical Therapy, NOS	e09d9ae2-b5b5-47ac-8d22-f10d7c3066d1
773a7fb2-61e4-4a6a-9eab-1cddcb8b83cd.htseq.counts.gz	f1a59bca-ac4b-404f-9091-093bcb00df05	TCGA-61-2002-01A-01R-1568-13	TCGA-61-2002-01A-01R	TCGA-61-2002-01A-01-TS1	TCGA-61-2002-01A-01-BS1	TCGA-61-2002-01A-01		TCGA-61-2002-01A	TCGA-61-2002	85bb4987-51e7-40fe-ad59-2aa56754eca9	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	1.2		8030b8aa-9686-45b3-bf39-1889a6b8b36f	1.8	14cd154a-6ea5-4ad9-92e4-72f53ee5d60b			0.14	22	released	0d9bf4ba-57c4-4e16-ad25-954c8495a9ee	RNA	R	0.14	UV Spec	released	False	421cc42a-68cd-47bf-bb82-8b55acb883b0	01			5.0		10.0	5.0	80.0	95.0	TOP	7f64b50a-e622-4523-ac97-24023925caf1	released			8.0		8.0	8.0	76.0	90.0	BOTTOM	0ac8e44a-e0cc-44e6-91b7-32686289b3da	released	released	161.0						c9aa3e59-a10a-4e4c-b8cb-40d970f43df7	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-61-2002_demographic	46	-17115		eaf6457d-9150-5a07-a240-9aabc2e07928	not hispanic or latino	female	white	released	Alive	1962		TCGA-61-2002_exposure	Not Reported	daedbb3d-0565-5bef-b85d-29db62b241aa	released	TCGA-61-2002_diagnosis	17115	not reported	0	547	578ddcf5-2778-5527-9652-d17bc06c620c	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-61-2002_treatment	TCGA-61-2002_treatment_1	released	77095dda-43e6-5a0a-bcb5-fb3ab57e2fec	no	Radiation Therapy, NOS	released	a36e3020-6eb0-5653-a96a-f1a34eddbd0a	yes	Pharmaceutical Therapy, NOS	f1a59bca-ac4b-404f-9091-093bcb00df05
53ff71a4-9487-4ae6-9d25-f55cfb70cf81.htseq.counts.gz	6880a21b-3185-4fed-aac5-1fc3d848bae3	TCGA-13-0888-01A-01R-1564-13	TCGA-13-0888-01A-01R	TCGA-13-0888-01A-01-TS1	TCGA-13-0888-01A-01-BS1	TCGA-13-0888-01A-01		TCGA-13-0888-01A	TCGA-13-0888	6cf9f872-2e59-45cf-bb5e-ebd7fa1b3caf	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.2		DFDEBDE5-C16E-4B29-9986-8EB557648AC5	1.8	b6ee33d9-26fc-491a-90af-25f3da976da0			0.15	22	released	344f5204-ebba-454b-a47f-facfb6611bda	RNA	R	0.15	UV Spec	released	False	90fefa8a-33f9-4e74-9e38-3f9718cfad23	01			20.0		15.0	0.0	65.0	85.0	TOP	ffd7136c-4224-4e96-b6bd-91271f3be8be	released			15.0		15.0	0.0	70.0	85.0	BOTTOM	958e8b83-20ce-4ec9-9e0f-62be3c6ba1cb	released	released	81.0						34cd279f-98ef-49de-8b13-16913f972d4e	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0888_demographic	78	-28498	2811	352a0590-c7a1-5b86-8a71-0f34b1ff6d0d	not hispanic or latino	female	white	released	Dead	1925		TCGA-13-0888_exposure	Not Reported	437a542c-6360-5798-97af-e8ae5e8fe13e	released	TCGA-13-0888_diagnosis	28498	not reported	0	2141	83afec30-398a-5fbb-87e1-c57d34a7da26	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-13-0888_treatment	TCGA-13-0888_treatment_1	released	2708db92-2815-586a-94ce-9660f24951e3	no	Radiation Therapy, NOS	released	362fd33d-fec8-5e73-aa44-4c8b7b395959	yes	Pharmaceutical Therapy, NOS	6880a21b-3185-4fed-aac5-1fc3d848bae3
054352e9-a6fb-4f61-b524-2741017c2bbf.htseq.counts.gz	de003ee5-3625-4d68-94d9-b7bb1d4a77f7	TCGA-61-1721-01A-01R-1569-13	TCGA-61-1721-01A-01R	TCGA-61-1721-01A-01-TS1	TCGA-61-1721-01A-01-BS1	TCGA-61-1721-01A-01		TCGA-61-1721-01A	TCGA-61-1721	1c0318d9-0472-4840-add4-46bb9f914a30	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.0		f44d906c-f069-45e6-9cc4-49eb0da74226	1.8	226f9774-e22b-4b8b-8259-934edb649fc3			0.15	22	released	6a67c51c-3380-4ace-a2ba-c357d8a0b34c	RNA	R	0.15	UV Spec	released	False	7e4b5124-2529-4469-ba3c-472c6c668868	01			15.0		0.0	0.0	85.0	80.0	TOP	eacba516-57de-4a57-8c1a-28d301941281	released			15.0		0.0	0.0	85.0	80.0	BOTTOM	8a0e1590-8e6d-4c65-b44c-90096f254f6a	released	released	123.0						a65361d0-e9ae-4d90-bbf7-70bc213d263e	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-61-1721_demographic	38	-13894		1eb55aba-7ecf-530a-91c4-218735f5c0e5	not hispanic or latino	female	white	released	Alive	1970		TCGA-61-1721_exposure	Not Reported	06a3effc-b48d-5f99-8c19-305119add62d	released	TCGA-61-1721_diagnosis	13894	not reported	0	338	dcf90374-280a-5d2e-992f-9c76e9acd8e3	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	Yes	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-61-1721_treatment_1	TCGA-61-1721_treatment	released	5ded9494-f4be-5737-859d-ac4539eba6b7	yes	Pharmaceutical Therapy, NOS	released	317421ae-09b2-5042-acb5-8e8b08650fd1	no	Radiation Therapy, NOS	de003ee5-3625-4d68-94d9-b7bb1d4a77f7
75303476-cdec-4ae4-aaf5-01abdc3213ab.htseq.counts.gz	c44d4c5c-b855-4e82-bd90-0f4b6c0e0015	TCGA-29-1778-01A-01R-1567-13	TCGA-29-1778-01A-01R	TCGA-29-1778-01A-01-BS1	TCGA-29-1778-01A-01-TS1	TCGA-29-1778-01A-01		TCGA-29-1778-01A	TCGA-29-1778	44e840c9-ea54-4dba-9b2a-264ef1f2c304	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.1		439a81dd-dc54-49e5-942c-4aa8d0be8701	1.8	7ecd0f7a-d186-422b-a2e1-833dfc400e39			0.15	22	released	3945a35f-a5aa-4840-afd8-dfc3f87d9338	RNA	R	0.15	UV Spec	released	False	2a69f244-7cd9-4f17-916b-a49b9044b15a	01	10.0		0.0		0.0	40.0	60.0	85.0	BOTTOM	f22cd01a-2d39-464a-9c96-60391fac355e	released	15.0		0.0		0.0	20.0	80.0	80.0	TOP	03053642-c87d-488d-b2e6-d75900c0cca3	released	released	100.0						be6771b3-dc5e-46fb-998a-a66a6fd63c85	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-29-1778_demographic	77	-28147		c85be1b6-1039-536e-988b-2c193dd334e2	not reported	female	white	released	Alive	1931		TCGA-29-1778_exposure	Not Reported	287a81d3-2ecb-5c42-9c7c-cb03be16c920	released	TCGA-29-1778_diagnosis	28147	not reported	0	454	64f96092-ae3e-556c-9c0c-cbba2bdef290	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-29-1778_treatment	TCGA-29-1778_treatment_1	released	fb421159-b9d1-5a4c-8cbd-1e1b8de351f6	no	Radiation Therapy, NOS	released	51371589-b5f0-5542-849c-8d58833dac42	yes	Pharmaceutical Therapy, NOS	c44d4c5c-b855-4e82-bd90-0f4b6c0e0015
db2f54d8-82cb-48b2-a3d4-1fb7daa8e75c.htseq.counts.gz	7dfc5429-a50c-43ec-b7db-14b9bcd0aacf	TCGA-29-1785-01A-01R-1567-13	TCGA-29-1785-01A-01R	TCGA-29-1785-01A-01-TS1	TCGA-29-1785-01A-01-BS1	TCGA-29-1785-01A-01		TCGA-29-1785-01A	TCGA-29-1785	1aea3c25-d2bc-4ff5-bc27-32e939944e9d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.2		b520ed75-17dd-420f-b444-4436bb03f40f	1.9	dcff1416-56fd-4d8e-a472-a40a00ef3066			0.16	22	released	fbd44390-8786-45e6-af20-2013481cd750	RNA	R	0.16	UV Spec	released	False	c45eaf04-d2b3-4049-aa8d-6104b91f920f	01	15.0		2.0		0.0	10.0	88.0	70.0	TOP	92dd91fb-debd-463d-bc19-8e9912f80cfc	released	15.0		0.0		0.0	10.0	90.0	80.0	BOTTOM	addf4816-2135-4b77-bf4f-5567c4843928	released	released	112.0						051e9ab0-af6a-4bd7-8673-c596dc6e78a0	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1785_demographic	55	-20417	1104	e84a85c2-be73-5952-b964-921c0feadca1	not reported	female	white	released	Dead	1951	2009	TCGA-29-1785_exposure	Not Reported	ce3abbd0-310a-55c5-9205-cfa29ad09bfc	released	TCGA-29-1785_diagnosis	20417	not reported	0	1053	3af0fe9d-b0be-520d-93e2-62c3dde90896	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-29-1785_treatment	TCGA-29-1785_treatment_1	released	ed796433-2627-589a-bd13-572865e856d5	no	Radiation Therapy, NOS	released	a57c9c8f-11e2-5982-9f73-038e5ea86a40	yes	Pharmaceutical Therapy, NOS	7dfc5429-a50c-43ec-b7db-14b9bcd0aacf
59633988-fe8b-4f38-a6ef-06910fef0846.htseq.counts.gz	0c21604d-54bb-4b15-bcfa-a1e20d1e2156	TCGA-30-1892-01A-01R-1568-13	TCGA-30-1892-01A-01R	TCGA-30-1892-01A-01-BS1	TCGA-30-1892-01A-01-TS1	TCGA-30-1892-01A-01		TCGA-30-1892-01A	TCGA-30-1892	a09f0626-002a-48fd-8b2d-c66b8285cf23	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.2		fb7c966c-9b16-4781-9c01-2db480c88d63	1.8	bb8dc795-80ff-4b42-8cf8-9f9716c13967			0.15	22	released	f7c3e41d-d4d7-4e15-a348-d73cf7d8f4d2	RNA	R	0.15	UV Spec	released	False	92f05631-c736-46b6-a7f3-8a3136a5f869	01			10.0		0.0	20.0	70.0	80.0	BOTTOM	eea7bc4a-8967-4b50-a476-e5ce862958d9	released			10.0		0.0	10.0	80.0	90.0	TOP	65549f07-9148-43b5-8c8c-94d17148a918	released	released	126.0						5b68e68c-3cbf-4506-ac94-4b23b3daba70	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-30-1892_demographic	52	-19256	1484	caf0b95d-2121-5698-a1cf-f4408b39c118	not hispanic or latino	female	white	released	Dead	1952	2008	TCGA-30-1892_exposure	Not Reported	ed8e50d4-facf-51a8-9ddd-9274f55ff2e8	released	TCGA-30-1892_diagnosis	19256	not reported	0	1484	2ac4a173-7eee-5fca-8f3f-6ee590714833	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-30-1892_treatment	TCGA-30-1892_treatment_1	released	53a518b3-e090-5044-9dbf-c2c82ca3ebc3	no	Radiation Therapy, NOS	released	7b02b526-940f-591a-ada9-4402bc7eeb9e	yes	Pharmaceutical Therapy, NOS	0c21604d-54bb-4b15-bcfa-a1e20d1e2156
f00793a7-8ba8-4486-95d1-3ea0beae2508.htseq.counts.gz	fd63ef7d-66f2-4eb8-8b5f-518bca900350	TCGA-09-0366-01A-01R-1564-13	TCGA-09-0366-01A-01R	TCGA-09-0366-01A-01-TS1	TCGA-09-0366-01A-01-BS1	TCGA-09-0366-01A-01		TCGA-09-0366-01A	TCGA-09-0366	23771dab-2aab-4d2b-95e2-9af7092cee6b	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV					False			6C254448-2CF7-4283-9026-988273C712A1	1.8	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7			0.19	22	released	1cb92112-2d5a-4fac-9ea3-f5bd0a53ee4c	RNA	R	0.19	UV Spec	released	False	8e2d86fd-25b6-475d-abd3-6a93b204c351	01			0.0		0.0	0.0	100.0	98.0	TOP	8221da81-0e4d-48fd-a814-123e49fdb0b5	released			0.0		0.0	5.0	95.0	98.0	BOTTOM	1a24dcff-2bd0-430f-9b17-d2487425878d	released	released							f2e6f90f-6117-406d-8106-2ef4b37e19d2	Primary Tumor	01		released	Not Reported	released	TCGA-09-0366_demographic	55	-20440	1757	4168d972-f335-5e36-8145-ad9b8ef7441c	not reported	female	white	released	Dead	1944	2003	TCGA-09-0366_exposure	Not Reported	3056ef37-85ad-5291-837f-d7355de65319	released	TCGA-09-0366_diagnosis	20440	not reported	0		8e24dabb-8325-5099-846c-4f4bf21d7515	Stage IIIC	C48.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Specified parts of peritoneum	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-09-0366_treatment	TCGA-09-0366_treatment_1	released	5ada961d-9f41-50bd-a6c4-ec939f27eb85	no	Radiation Therapy, NOS	released	3acf4456-10e7-5b48-9bbf-953b4f76ced1	yes	Pharmaceutical Therapy, NOS	fd63ef7d-66f2-4eb8-8b5f-518bca900350
92a8c68d-23ec-467f-84c0-4876b71359f8.htseq.counts.gz	4342050d-43d1-4943-835a-450036ae644c	TCGA-VG-A8LO-01A-11R-A406-31	TCGA-VG-A8LO-01A-11R	TCGA-VG-A8LO-01A-01-DX1		TCGA-VG-A8LO-01A-11	TCGA-VG-A8LO-01A-02-DX2	TCGA-VG-A8LO-01A	TCGA-VG-A8LO	8628f1b2-3763-4ba9-a375-083874bb18f2	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV	122	0	260.0		False		false	6FF4C359-F127-44E6-A1A2-641D60A3665F	1.84	fbad0ba1-131d-48af-9957-e9ca56f54e84			0.18	23	released	64ca0f4d-9a26-4376-bd63-5cc1939e527b	RNA	R	0.18	UV Spec	released	False	7baa0d2c-064f-490c-974b-ca6d3f2d2176	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	TOP	b39a4d64-82a1-4a04-8ab6-918f3058b83b	released												released	30.0	de99fdb4-e051-5947-b195-75207645d717	Not Reported	8f608e14-ea83-4bf5-b49a-956e859c0649	released	FFPE	ccd3903e-eee6-41f0-9a07-4351a00a7dc3	Primary Tumor	01		released	Not Reported	released	TCGA-VG-A8LO_demographic	55	-20274	24	bd84ae7e-b25d-59f9-9161-7cc10e02bf9f	not hispanic or latino	female	black or african american	released	Dead	1958	2013	TCGA-VG-A8LO_exposure	Not Reported	18a1e7d0-12f6-52dd-b04c-b461755fcc2c	released	TCGA-VG-A8LO_diagnosis	20274	not reported	0		aaaed386-e2f5-53c2-bdc4-6508fdec1123	Stage IV	C56.9	not reported	8460/3	Papillary serous cystadenocarcinoma	no	No	not reported	Ovary	released	No	Ovary	not reported	not reported	2013	TCGA-VG-A8LO_treatment	TCGA-VG-A8LO_treatment_1	released	24e3a3e4-fea0-54a7-81de-f636e54333f7	no	Radiation Therapy, NOS	released	74e8fa76-b763-5155-a0df-0e9063a7e841	yes	Pharmaceutical Therapy, NOS	4342050d-43d1-4943-835a-450036ae644c
4e618fff-4f1a-403f-bfb7-3a613758383c.htseq.counts.gz	7386e1ca-deec-48de-8d64-b6be72f6f3ae	TCGA-13-0762-01A-01R-1564-13	TCGA-13-0762-01A-01R	TCGA-13-0762-01A-01-TS1	TCGA-13-0762-01A-01-BS1	TCGA-13-0762-01A-01		TCGA-13-0762-01A	TCGA-13-0762	6485b68f-caa7-45cd-9bc5-78c2add8191d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.1		5FC6D44F-6057-4014-9800-86050279F42E	1.8	c2f1b1b8-f914-4665-a779-901ebb41965f			0.18	22	released	f92d2af0-2617-4380-a3e8-45a1a6a17b8f	RNA	R	0.18	UV Spec	released	False	daf7af4e-f651-4bbe-a68d-ab4a2ca2841d	01			0.0		0.0	10.0	90.0	95.0	TOP	6e3dc8cb-c3cf-4b6c-a27c-7a692b97ee22	released			1.0		5.0		94.0	95.0	BOTTOM	6f3b37f7-9bef-4866-bb07-dbb60257d37c	released	released	150.0						b76ac1b8-f934-45d1-a7d1-780f99a79584	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-13-0762_demographic	65	-23960		35416893-69c6-54f9-881e-2201d801d116	not hispanic or latino	female	white	released	Alive	1941		TCGA-13-0762_exposure	Not Reported	0d3d4cba-04c6-5d5b-8374-0c3fb8a9e3cb	released	TCGA-13-0762_diagnosis	23960	not reported	0	3400	814eacd3-27a0-5c0c-b4f7-18f4355ab3c4	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-13-0762_treatment_1	TCGA-13-0762_treatment	released	c2dd27a5-d08d-55ce-aede-b0c7c18a747e	yes	Pharmaceutical Therapy, NOS	released	bca2d4a7-9197-54e5-977c-c66c5ac81669	no	Radiation Therapy, NOS	7386e1ca-deec-48de-8d64-b6be72f6f3ae
3fe6e5df-486e-4887-b79a-89a1591f4a29.htseq.counts.gz	8e40d064-2527-452f-8559-514bf5620501	TCGA-24-1434-01A-01R-1566-13	TCGA-24-1434-01A-01R	TCGA-24-1434-01A-01-BS1	TCGA-24-1434-01A-01-TS1	TCGA-24-1434-01A-01		TCGA-24-1434-01A	TCGA-24-1434	5503b3a1-7d03-41b2-9ec8-e478c5414d67	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.5	False	1.5		0a5fd2a4-560b-4769-ba4e-868854471961	1.8	368f21cd-dd07-440d-89f5-5874e37fe63b			0.16	22	released	32280c88-e2d4-40af-9e23-170502f9ddf4	RNA	R	0.16	UV Spec	released	False	a29595aa-44f9-47ef-a52b-fd80ac1c320c	01			5.0		0.0	20.0	75.0	80.0	BOTTOM	db10a516-27ac-4dde-a922-2b4a804ddead	released			1.0		0.0	10.0	89.0	90.0	TOP	5c90f4ac-d2c5-4ecc-903e-15c0501db247	released	released	177.0						e6751f11-2f24-426c-a34f-c03cddc999cc	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-24-1434_demographic	59	-21810	568	c792a067-b1c0-5367-8655-db6c055fbd87	not reported	female	white	released	Dead	1940	2000	TCGA-24-1434_exposure	Not Reported	93fcb479-d851-5781-9fbf-1aa7e749675b	released	TCGA-24-1434_diagnosis	21810	not reported	0	568	13f08258-6176-5a27-8f77-a01958a576b2	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-24-1434_treatment_1	TCGA-24-1434_treatment	released	75ba408f-3347-5c2f-9032-b58dbff27935	yes	Pharmaceutical Therapy, NOS	released	8c1f4723-4bcf-5383-a19d-9c115b44b9cd	no	Radiation Therapy, NOS	8e40d064-2527-452f-8559-514bf5620501
7d5d98d6-91b7-470f-879c-8e83ab4d3fc6.htseq.counts.gz	c433b3b4-a8a6-4c33-96c7-b0558efc1f07	TCGA-24-1416-01A-01R-1565-13	TCGA-24-1416-01A-01R	TCGA-24-1416-01A-01-BS1	TCGA-24-1416-01A-01-TS1	TCGA-24-1416-01A-01		TCGA-24-1416-01A	TCGA-24-1416	f9793a4b-c0e7-4475-bf80-69543b7ee2f6	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.5		c5a7b8b5-65b5-47d0-84dc-882024042a6f	1.8	67fcea16-d5bc-4edd-b66d-bfc5d56d976d			0.16	22	released	43545411-bd66-4d8f-836d-194c3d5011a8	RNA	R	0.16	UV Spec	released	False	44fdf578-b65c-4d5d-a1aa-d76f5d5871f6	01			5.0		25.0	0.0	70.0	80.0	BOTTOM	9af08ca1-7925-4689-9ade-e5a848e9ca19	released			5.0		40.0	0.0	55.0	80.0	TOP	dbe2dee5-0c05-46cd-baec-7293be19fd17	released	released	141.0						7404e874-190e-4353-8755-1d9be35eedb7	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1416_demographic	34	-12772		37d34efc-4522-5f67-89af-6ad888895583	not reported	female	white	released	Alive	1974		TCGA-24-1416_exposure	Not Reported	4516ea3f-c4a3-5fe7-bbb3-dfa97950ab75	released	TCGA-24-1416_diagnosis	12772	not reported	0	194	3bef7a6b-f7be-543c-a896-f3126e11480c	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1416_treatment_1	TCGA-24-1416_treatment	released	bc48d1fe-698d-515a-b8db-db98a3fe0552	yes	Pharmaceutical Therapy, NOS	released	b6c3d59a-b00d-5004-b272-f08a9ae2aee4	no	Radiation Therapy, NOS	c433b3b4-a8a6-4c33-96c7-b0558efc1f07
7a181264-18d3-4a81-b8c1-43e08ddab953.htseq.counts.gz	321a266d-b0d2-4800-a0ab-1368692e4677	TCGA-57-1582-01A-01R-1566-13	TCGA-57-1582-01A-01R	TCGA-57-1582-01A-01-TS1	TCGA-57-1582-01A-01-BS1	TCGA-57-1582-01A-01		TCGA-57-1582-01A	TCGA-57-1582	4ea50685-3b63-440a-b037-597ef2529e7d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	2.0		0ed35510-c6ad-416b-8b57-e97005471dc1	1.8	cb7a4405-b9a5-4e1a-825f-c3ee205c8a90			0.15	22	released	262b33fc-7786-4f90-adfa-a20a7afab974	RNA	R	0.15	UV Spec	released	False	b604c246-8b0a-4304-8701-727349963c2a	01			0.0		0.0	10.0	90.0	90.0	TOP	9e678536-fc06-43d6-8e9b-82f6376eda8e	released			0.0		0.0	10.0	90.0	90.0	BOTTOM	178eeee4-86e8-41f6-ac53-394a94d64ccf	released	released	126.0						84ee744e-ee7f-46e4-b1bd-40524ffcc902	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-57-1582_demographic	50		731	cabdf363-332d-5055-8622-1a81a9a566fc	not reported	female	white	released	Dead	1956	2008	TCGA-57-1582_exposure	Not Reported	1e10fc34-df4d-5e70-9409-2cd6f0a2ed7a	released	TCGA-57-1582_diagnosis		not reported	0	731	46a3eb27-df60-59e2-9770-f710ce3057a5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-57-1582_treatment	TCGA-57-1582_treatment_1	released	2012c078-f776-54bd-9420-efc9f564bc6f	no	Radiation Therapy, NOS	released	283e3b24-ee6a-50fa-9e8d-102ba526275a	yes	Pharmaceutical Therapy, NOS	321a266d-b0d2-4800-a0ab-1368692e4677
9d2d7bcb-8af4-4143-bd1c-b7b5a239795f.htseq.counts.gz	f814caf2-364a-47d4-b940-79ac50ba641f	TCGA-25-1630-01A-01R-1566-13	TCGA-25-1630-01A-01R	TCGA-25-1630-01A-01-TS1	TCGA-25-1630-01A-01-BS1	TCGA-25-1630-01A-01		TCGA-25-1630-01A	TCGA-25-1630	263e85e2-7b6f-453f-8fd0-e5ea1409fece	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.4		0BF406EC-B97B-4A05-9EBB-F40CF96233E9	1.8	c5a82b6e-048d-4377-9b6c-4417ba1876fe			0.16	22	released	e4e26fa1-321d-40e0-b48c-5f69c7f72adb	RNA	R	0.16	UV Spec	released	False	f980ca5c-af74-44e3-830f-d9dfb88833ed	01			1.0		0.0	10.0	89.0	90.0	TOP	cd9becbf-211f-473b-9a38-ff0fecc7ea57	released			5.0		0.0	10.0	85.0	90.0	BOTTOM	72d16d97-78e9-46a9-bdfd-db8d5b99041a	released	released	100.0						899b4fa3-95cb-4f8e-930c-bc29e20b5144	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-25-1630_demographic	73	-27006	1162	8731f7e7-074d-5810-ae94-e09b25cf790d	not hispanic or latino	female	white	released	Dead	1929	2005	TCGA-25-1630_exposure	Not Reported	224ce489-f5a5-520c-a738-cfc0ec7d640e	released	TCGA-25-1630_diagnosis	27006	not reported	0	239	3c66f500-b2a5-5482-af5d-a85b32db3b8f	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-25-1630_treatment_1	TCGA-25-1630_treatment	released	c9fef63c-8e30-56c3-a0f2-37278d8f6f7b	yes	Pharmaceutical Therapy, NOS	released	79b18290-a7b8-5b0c-9922-a85b4d5adcc6	no	Radiation Therapy, NOS	f814caf2-364a-47d4-b940-79ac50ba641f
ec69e15f-b3cf-4f42-94ed-72d80565a1b6.htseq.counts.gz	e5c54353-53b2-43fd-ac97-85b0fed7961a	TCGA-25-1312-01A-01R-1565-13	TCGA-25-1312-01A-01R	TCGA-25-1312-01A-01-BS1	TCGA-25-1312-01A-01-TS1	TCGA-25-1312-01A-01		TCGA-25-1312-01A	TCGA-25-1312	66face4a-f35c-4364-90e5-8f28e6372606	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				2.5	False	3.0		9AD5ADDB-713E-4FF7-97F1-123FA771AC5B	1.8	0d7561dc-7069-41df-ba49-8fcd4df52efb			0.15	22	released	7521aa42-f196-455c-aa83-4ad15120194f	RNA	R	0.15	UV Spec	released	False	85ac94a4-3c0f-4d84-ae16-d142f4e10a21	01			0.0		0.0	15.0	85.0	95.0	BOTTOM	01f182af-46ce-4838-9897-7a489c40734e	released			0.0		0.0	10.0	90.0	95.0	TOP	9d91008f-8c12-4e4e-aefe-ee9daff487f8	released	released	132.0						ce884866-7563-44b2-a7b0-849512c66abf	Primary Tumor	01	1.0	released	Not Reported	released	TCGA-25-1312_demographic	69	-25537	31	3eec1dc1-4d6d-5b73-bbde-6688b95c256a	not hispanic or latino	female	white	released	Dead	1932	2001	TCGA-25-1312_exposure	Not Reported	43418cbe-3707-5295-9368-98505ecded6a	released	TCGA-25-1312_diagnosis	25537	not reported	0	31	7c0d838a-d4ca-5f23-85c8-672a6ef301b9	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-25-1312_treatment	TCGA-25-1312_treatment_1	released	46926ff0-1c00-56ad-a1f3-e60215b191eb	no	Radiation Therapy, NOS	released	1ba4a516-6cec-5dce-ae1a-a29e11f7ad72	not reported	Pharmaceutical Therapy, NOS	e5c54353-53b2-43fd-ac97-85b0fed7961a
4b449f26-ee8f-47d1-9d93-de9ceb61ffba.htseq.counts.gz	58aa1725-a45f-4424-b0a3-37eacfb4acb4	TCGA-61-2000-01A-01R-1568-13	TCGA-61-2000-01A-01R	TCGA-61-2000-01A-01-TS1	TCGA-61-2000-01A-01-BS1	TCGA-61-2000-01A-01		TCGA-61-2000-01A	TCGA-61-2000	29949b65-2913-4c86-bbd7-b85c5df6f15e	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1	False	1		4e13b897-c34a-4422-9c66-7ca8b2734ef2	1.8	f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	2.8	20	0.14	22	released	d8cf1f87-b108-486d-875c-6278b115acac	RNA	R	0.14	UV Spec	released	False	54ac58f6-e4d2-48ad-8e2a-ad9371a315e1	01			15		10	10	65	90	TOP	1ae6e2bd-7e0d-42e1-a0f3-c13499f536a6	released			8		8	5	79	90	BOTTOM	9bfc0d2d-aa54-4bb7-9f81-d47995a829da	released	released	102						fdb8966d-55c9-49be-80dd-369246604aad	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-2000_demographic	67	-24723		2281e96f-9ac0-5e8c-9510-0876507277a1	not hispanic or latino	female	white	released	Alive	1941		TCGA-61-2000_exposure	Not Reported	3a92791e-5363-54be-b9f0-6ec01a6d3c5b	released	TCGA-61-2000_diagnosis	24723	not reported	0	441	9b576de5-79c4-5514-93fa-4d5497230584	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-61-2000_treatment_1	TCGA-61-2000_treatment	released	469d1ce0-7f4a-5347-81bd-4aaa3d0b86ba	yes	Pharmaceutical Therapy, NOS	released	1a0f7fd1-d868-5029-81a1-473594177e34	no	Radiation Therapy, NOS	58aa1725-a45f-4424-b0a3-37eacfb4acb4
98e7898a-bd2e-4c49-9f76-aea65d7960a3.htseq.counts.gz	23bebeda-8b5f-498b-88a7-550154a54801	TCGA-61-2092-01A-01R-1568-13	TCGA-61-2092-01A-01R	TCGA-61-2092-01A-01-TS1	TCGA-61-2092-01A-01-BS1	TCGA-61-2092-01A-01		TCGA-61-2092-01A	TCGA-61-2092	c183d3fb-2eee-44f8-890e-b9bf907141e6	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.3		35b4bfa3-e6a5-4b55-a7f1-bc39953422c0	1.8	0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	3	20	0.15	22	released	49f15675-0238-415a-abe4-cb5c0e6bc87f	RNA	R	0.15	UV Spec	released	False	76aead43-2b3f-459a-98d3-2fc67f762c48	01			0		0	10	90	99	TOP	060203fd-43c4-4e4c-8b3b-6d537a56e73c	released			0		0	5	95	99	BOTTOM	e19c34fd-bcf6-468f-b1a4-689c912ae78f	released	released	160						962bb8fd-018e-49d0-b1df-dc0192e1b2a6	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-2092_demographic	57	-21072		53de236f-819a-54ee-9111-6556f3647385	not reported	female	white	released	Alive	1947		TCGA-61-2092_exposure	Not Reported	5675456a-dfbb-53ea-93de-8ca30c01cebc	released	TCGA-61-2092_diagnosis	21072	not reported	0	1573	8fd8c018-04a7-549f-a3a6-ac8e9b87c065	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-61-2092_treatment_1	TCGA-61-2092_treatment	released	be613efd-20bc-5870-9b78-a6f91d5a46fe	yes	Pharmaceutical Therapy, NOS	released	e69ef619-a6ae-5941-a261-0a6ee83ea47a	no	Radiation Therapy, NOS	23bebeda-8b5f-498b-88a7-550154a54801
e5c1e1c2-d80c-47a1-9f18-8125b186b1cd.htseq.counts.gz	1846edbe-a1c9-4433-8e18-a8b7fb663972	TCGA-61-1907-01A-01R-1567-13	TCGA-61-1907-01A-01R	TCGA-61-1907-01A-01-TS1	TCGA-61-1907-01A-01-BS1	TCGA-61-1907-01A-01		TCGA-61-1907-01A	TCGA-61-1907	7ab3765f-910a-41c9-86cc-08534d2a4e4b	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.6		ae7e4795-496e-47d0-ad60-cec04e5876b0	1.8	6d9a1fe4-7131-487c-a7ff-0cf8a53919ed			0.15	22	released	12df98d3-bfc2-4207-8572-ea9ce1373de3	RNA	R	0.15	UV Spec	released	False	32c4eb7d-281f-409c-9115-266eccf8c0c2	01			1.0		0.0	5.0	94.0	95.0	TOP	b0464aeb-8877-43cb-82b3-e993183285a6	released			0.0		0.0	5.0	95.0	95.0	BOTTOM	525f99b8-8596-4e25-b42a-4832e9dcb408	released	released	121.0						0230bc74-adc5-4443-ac9e-342d7f344ce7	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-1907_demographic	63	-23204		6bdcf0d2-e322-541f-990b-836a67d89453	not hispanic or latino	female	white	released	Alive	1943		TCGA-61-1907_exposure	Not Reported	fade20dd-fa87-5c8b-a1c7-a0dcab04f72a	released	TCGA-61-1907_diagnosis	23204	not reported	0	952	f1a0d46b-6431-59c0-a037-7730f9269b42	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-61-1907_treatment	TCGA-61-1907_treatment_1	released	e2cf157b-2a68-59de-a307-1262ad857b1b	no	Radiation Therapy, NOS	released	63c632af-dfc3-5e5d-86cd-893909ebfd9f	yes	Pharmaceutical Therapy, NOS	1846edbe-a1c9-4433-8e18-a8b7fb663972
21fccc2c-bc60-4ed4-ba78-5dfbb0d5f498.htseq.counts.gz	12993d63-aa97-40d6-a48b-c0d38725ed12	TCGA-25-1316-01A-01R-1565-13	TCGA-25-1316-01A-01R	TCGA-25-1316-01A-01-TS1	TCGA-25-1316-01A-01-BS1	TCGA-25-1316-01A-01		TCGA-25-1316-01A	TCGA-25-1316	58427bce-6b81-4083-aeda-25f59e292bbc	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				2.5	False	3.0		B766CB7E-C4EC-489C-AEF0-BE28132D5BA5	1.8	6cb5e275-1284-482b-a4e9-933acf9aad44			0.16	22	released	decde436-3932-4c8a-a8f7-21465e53cbca	RNA	R	0.16	UV Spec	released	False	6e1181f2-912e-4c07-a174-a0b125ba484d	01			0.0		0.0	2.0	98.0	98.0	TOP	050f7f9f-a802-4a8e-8467-e40a36e90503	released			0.0		0.0	5.0	95.0	98.0	BOTTOM	14e296ac-b3bd-43b1-b67d-0f0e6446f94c	released	released	147.0						fdf5e5b9-8d6c-4581-93d4-bedae0bf371d	Primary Tumor	01	1.5	released	Not Reported	released	TCGA-25-1316_demographic	55	-20331	1279	8f0f2afc-3c1a-5e58-bdac-9601041f917b	not hispanic or latino	female	white	released	Dead	1945	2003	TCGA-25-1316_exposure	Not Reported	d53c26d1-cc65-5449-8ea6-3eef9f2b81d9	released	TCGA-25-1316_diagnosis	20331	not reported	0	1126	01932ba3-2753-5aa5-b4bc-15b1972bc184	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-25-1316_treatment	TCGA-25-1316_treatment_1	released	9ffd597a-dcc4-59f7-97dc-c7f403419f02	no	Radiation Therapy, NOS	released	8f01c9b7-f710-5bff-8889-e3f9afad0a57	yes	Pharmaceutical Therapy, NOS	12993d63-aa97-40d6-a48b-c0d38725ed12
9e51cba1-f13e-46a1-b37a-99e6db2d6134.htseq.counts.gz	f3ab6e3a-ac86-485e-abf3-b9d8164b078b	TCGA-04-1530-01A-02R-1569-13	TCGA-04-1530-01A-02R	TCGA-04-1530-01A-02-BS2	TCGA-04-1530-01A-01-BS1	TCGA-04-1530-01A-02		TCGA-04-1530-01A	TCGA-04-1530	42b3dfa3-152f-4ab7-ac9f-988c7f473bea	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.4		6CB3AECE-ADBB-4AED-A036-2E2D28D68369	1.8	b3ad87d3-1240-4fc9-8e29-14a9a5186319			0.14	22	released	c87da3bf-d82e-4b99-a8e1-85b6e2ee08aa	RNA	R	0.14	UV Spec	released	False	3ad65323-8c46-4a65-8ada-683ffd6c2de9	02			15.0		45.0	0.0	40.0	70.0	BOTTOM	c78fa438-630d-4e54-bd7e-e914836f66bb	released			10.0		15.0	0.0	75.0	70.0	TOP	8cb941db-9ee8-49cc-b0c2-211af61b347e	released	released	64.0						2b89e52a-a064-4151-87e1-20fec4eed015	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-04-1530_demographic	68	-25013	3622	1403a8ca-ec97-5425-bb3c-49e4dc50322c	not hispanic or latino	female	white	released	Dead	1927	2004	TCGA-04-1530_exposure	Not Reported	0943a6ae-e76e-5927-a4ed-1f8ce920593a	released	TCGA-04-1530_diagnosis	25013	not reported	0		3f5e6198-cbee-5262-a733-ce32d75b7057	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1995	TCGA-04-1530_treatment	TCGA-04-1530_treatment_1	released	153f2aef-ee14-5507-8a67-d42e561f5ace	no	Radiation Therapy, NOS	released	0c74d528-df42-5f42-95fc-eb5a0368f541	yes	Pharmaceutical Therapy, NOS	f3ab6e3a-ac86-485e-abf3-b9d8164b078b
4013973f-bab5-4844-951c-c80f34fcb828.htseq.counts.gz	7a63ea75-9c44-4c96-9325-1d0cca52e4c4	TCGA-23-1107-01A-01R-1564-13	TCGA-23-1107-01A-01R	TCGA-23-1107-01A-01-TS1	TCGA-23-1107-01A-01-BS1	TCGA-23-1107-01A-01		TCGA-23-1107-01A	TCGA-23-1107	acb7ec56-8a47-495f-a11b-2c9fb5d8fe95	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		700802e6-8058-4485-8210-3e5b8f10bbf3	1.8	2b25b605-1d45-499e-99ed-ad9b4a7722a5			0.15	22	released	d40fca3b-5650-4a88-ad52-a31133848291	RNA	R	0.15	UV Spec	released	False	996e70d7-cbbd-4772-93da-14664238bc3b	01			5.0		0.0	0.0	0.0	90.0	TOP	f36ddc6a-25ec-441b-9e70-57810d827977	released			5.0		0.0	0.0	0.0	90.0	BOTTOM	d6017cb3-c915-4dd1-a1bd-4fe67600ab38	released	released	119.0						255026d7-92a8-46f3-95ca-d1128e8ec3db	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-23-1107_demographic	59	-21561	9	a11794df-2f45-5422-bff0-439ff680ce2d	not hispanic or latino	female	white	released	Dead	1940	1999	TCGA-23-1107_exposure	Not Reported	10b608a9-90a8-5f18-ba23-16df62c8b618	released	TCGA-23-1107_diagnosis	21561	not reported	0	9	c5596e3d-d994-5f01-98ef-e04beffcc90b	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-23-1107_treatment_1	TCGA-23-1107_treatment	released	182896cf-2ce2-5104-8c27-539958d0b751	no	Pharmaceutical Therapy, NOS	released	ff33860a-fae6-5bfe-abe3-29eb0f909303	no	Radiation Therapy, NOS	7a63ea75-9c44-4c96-9325-1d0cca52e4c4
edbf38b1-342c-44a6-8d6f-b5bc871848d8.htseq.counts.gz	0f6025df-28f8-4b73-bc53-5d35f39e686b	TCGA-04-1542-01A-01R-1566-13	TCGA-04-1542-01A-01R	TCGA-04-1542-01A-01-TS1	TCGA-04-1542-01A-01-BS1	TCGA-04-1542-01A-01		TCGA-04-1542-01A	TCGA-04-1542	0c1a2e7d-e7e4-481e-a012-ef214c444497	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.0		E3103C8A-50CB-43FE-9670-2BFB5D1DC318	1.8	2988eb13-a2c0-4cd2-a559-76f0cce2689b			0.13	22	released	514a6c1d-2234-4a52-9a94-b81b17f70bcb	RNA	R	0.13	UV Spec	released	False	d531b928-89db-479f-b0d4-94f1ff35f896	01			1.0		0.0	20.0	79.0	80.0	TOP	962fd94a-59f6-49c3-8354-79631e5e19f8	released			5.0		42.0	0.0	63.0	80.0	BOTTOM	ab989ce3-156d-40d7-96ff-88a9f77206d2	released	released	115.0						d33fd264-13db-4642-afca-37125751cc28	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-04-1542_demographic	52	-19263	2561	fb7f748c-1e48-553a-aa93-63181a69f871	not reported	female	white	released	Dead	1949	2008	TCGA-04-1542_exposure	Not Reported	90727d68-af43-5809-a980-a5c2b8e09875	released	TCGA-04-1542_diagnosis	19263	not reported	0		5c54e4c7-4168-5896-9e70-26530bcbb200	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-04-1542_treatment	TCGA-04-1542_treatment_1	released	38e25d4e-a949-58c6-a84d-461f854c58fc	no	Radiation Therapy, NOS	released	5de5930e-e4f5-5501-b8ff-6d76545cea79	yes	Pharmaceutical Therapy, NOS	0f6025df-28f8-4b73-bc53-5d35f39e686b
3146c2ae-ff5e-4097-8005-f4d261af032e.htseq.counts.gz	18e670ba-466c-4591-aa62-8258e37656be	TCGA-23-1110-01A-01R-1564-13	TCGA-23-1110-01A-01R	TCGA-23-1110-01A-01-TS1	TCGA-23-1110-01A-01-BS1	TCGA-23-1110-01A-01		TCGA-23-1110-01A	TCGA-23-1110	9fb1ba57-2007-4477-b000-2d36f163efd2	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	0.8		07361efd-0b7d-4dcb-afe3-464200f59ac0	1.8	d93e1f93-20d0-493f-8b54-939fa4ba64f9			0.16	22	released	89633760-be77-432b-b7fd-200e8c070f1b	RNA	R	0.16	UV Spec	released	False	791b42c2-82db-4e70-bc83-322815d31ac7	01			0.0		0.0			95.0	TOP	04ccc391-1194-4dc4-8692-607901904c83	released			5.0		0.0			95.0	BOTTOM	9586db89-39c2-4109-9575-b2c545d3a490	released	released	116.0						5adca90e-f8ae-4a74-9c7f-a2b64fda2b31	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-23-1110_demographic	42	-15383		bb0f6ffa-ac50-5de2-be4c-54c7494ab86f	hispanic or latino	female	white	released	Alive	1961		TCGA-23-1110_exposure	Not Reported	a07d5648-22a4-5aea-8c40-de2f83b6ee6e	released	TCGA-23-1110_diagnosis	15383	not reported	0	1658	8d884ab0-aab2-532e-8036-a5b79eb4ce6d	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-23-1110_treatment_1	TCGA-23-1110_treatment	released	0f3088c1-b9a5-566b-b32b-58daf4540bb0	yes	Pharmaceutical Therapy, NOS	released	e65a832f-f238-5469-b484-f9c0bb0dbe8e	no	Radiation Therapy, NOS	18e670ba-466c-4591-aa62-8258e37656be
065393c7-9928-4fdc-9dbf-68ba9c708561.htseq.counts.gz	44b78a11-dfad-46f5-a203-599dc26ff876	TCGA-57-1585-01A-01R-1566-13	TCGA-57-1585-01A-01R	TCGA-57-1585-01A-01-BS1	TCGA-57-1585-01A-01-TS1	TCGA-57-1585-01A-01		TCGA-57-1585-01A	TCGA-57-1585	5ed14506-f69a-4da8-9965-72d3270b9f72	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	0.8		2c748aca-e5b2-4418-9820-1343293d379f	1.8	06df1324-bc1b-4bc3-bb01-4ef55a5aeef5			0.15	22	released	445e429d-82bd-4e01-bde1-0571781f75f9	RNA	R	0.15	UV Spec	released	False	5ad238f3-e3e3-49fd-ad4b-ce27bbbd6519	01			5.0		0.0	15.0	80.0	85.0	BOTTOM	dc0fc133-7b19-49c1-a568-3b1372306ae0	released			5.0		0.0	10.0	85.0	90.0	TOP	7964fedc-0a0c-4908-95a8-a5a8be5d8023	released	released	111.0						1e9787c4-b4f7-481a-b44d-cf975ec8bfb7	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-57-1585_demographic	57	-20862	53	2f038007-2450-5b90-830c-b6054faa83c3	not hispanic or latino	female	white	released	Dead	1950	2007	TCGA-57-1585_exposure	Not Reported	1e612314-cb4e-52c3-9a42-ae6b3b2b3212	released	TCGA-57-1585_diagnosis	20862	not reported	0	53	b2f8b028-ac9c-5bbc-9a49-f4d0e7331f71	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-57-1585_treatment_1	TCGA-57-1585_treatment	released	305b01d3-2da0-5d57-86e8-925d0fb36cfd	yes	Pharmaceutical Therapy, NOS	released	f72d699b-9f21-5812-b0e3-9187bf1e3bc9	no	Radiation Therapy, NOS	44b78a11-dfad-46f5-a203-599dc26ff876
c62a3590-7d1d-4a46-b021-279e7a36b77e.htseq.counts.gz	174517fa-47e7-454e-a113-976d473d03e6	TCGA-13-0720-01A-01R-1564-13	TCGA-13-0720-01A-01R	TCGA-13-0720-01A-01-TS1	TCGA-13-0720-01A-01-BS1	TCGA-13-0720-01A-01		TCGA-13-0720-01A	TCGA-13-0720	0d23fa5b-95f8-4626-a4d2-c72ad3cc553b	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	8.0		0A196866-A083-40AC-90E3-5ECA3B141645	1.8	1fe43034-df2b-4bef-be77-07dbb68083a4			0.16	22	released	3412cfba-f90e-4653-b191-9787b2359a9c	RNA	R	0.16	UV Spec	released	False	1b5d3a07-44a3-4664-b155-500cf5c950fe	01	80.0		3.0	20.0	10.0	2.0	85.0	88.0	TOP	c541bfd4-c049-4fad-ae6d-efc62810bd60	released			1.0		5.0	1.0	93.0	94.0	BOTTOM	4e8d3836-a57b-4629-93ae-36e54976447d	released	released	112.0						5c315f82-d4ac-40fd-9cc2-c4bc61286f8e	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-13-0720_demographic	48	-17799	1355	4361c0b6-dffe-5928-aabe-49e87f1a9447	not hispanic or latino	female	white	released	Dead	1953	2004	TCGA-13-0720_exposure	Not Reported	005392b9-6e68-5d2c-a54a-6c1c6e06ec05	released	TCGA-13-0720_diagnosis	17799	not reported	0	1355	2946e499-dcfb-57a8-8e37-07c35d2228f7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-13-0720_treatment_1	TCGA-13-0720_treatment	released	2c88878f-4f97-5508-ac66-ffe647428f64	yes	Pharmaceutical Therapy, NOS	released	52c3f16b-43d6-5f3b-b00b-54f81ff2d588	no	Radiation Therapy, NOS	174517fa-47e7-454e-a113-976d473d03e6
659a82b6-9aae-4aed-8df7-964697ad1640.htseq.counts.gz	73749b1b-78d9-46f6-ae7f-27ac7fcc2a5a	TCGA-24-1551-01A-01R-1566-13	TCGA-24-1551-01A-01R	TCGA-24-1551-01A-01-BS1	TCGA-24-1551-01A-01-TS1	TCGA-24-1551-01A-01		TCGA-24-1551-01A	TCGA-24-1551	499a9b57-ee1a-4012-bbab-c6ad955b5e0a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.2		474ac527-45a2-4258-bec4-0a48a3b80742	1.8	0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8			0.14	22	released	71826565-cfc2-4642-9444-1f6bb6b21b2b	RNA	R	0.14	UV Spec	released	False	8e0fd573-95bc-479e-b246-ceeecdf6ed47	01			5.0		0.0	15.0	80.0	90.0	BOTTOM	41335e52-92cb-47c1-b5d6-cfaf07041b09	released			5.0		0.0	5.0	90.0	99.0	TOP	681cb51e-c47d-4877-8041-54e92143e106	released	released	128.0						a081a22a-184f-44af-92cf-674c7d349e03	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1551_demographic	53	-19661	1579	ca38c8a5-7219-5217-8608-05cd8bd450f7	not reported	female	white	released	Dead	1944	2001	TCGA-24-1551_exposure	Not Reported	0844882a-7265-5a0b-b948-bb76da455180	released	TCGA-24-1551_diagnosis	19661	not reported	0	1579	d6ee4cbf-9c84-5fef-bb8e-d5df71a1e6f7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1997	TCGA-24-1551_treatment_1	TCGA-24-1551_treatment	released	d0d58e12-9946-500c-9e39-422a3b0a9bde	yes	Pharmaceutical Therapy, NOS	released	9951e7f0-c6b1-519b-b0ef-0e857cde665b	no	Radiation Therapy, NOS	73749b1b-78d9-46f6-ae7f-27ac7fcc2a5a
e2cf2389-07bc-49d0-9426-82a98728a685.htseq.counts.gz	f1c342c3-4ac2-4e04-9f9d-2cdc535a00e5	TCGA-24-1850-01A-01R-1567-13	TCGA-24-1850-01A-01R	TCGA-24-1850-01A-01-BS1	TCGA-24-1850-01A-01-TS1	TCGA-24-1850-01A-01		TCGA-24-1850-01A	TCGA-24-1850	b6b607cd-67b8-4c04-a212-a4e8c0743f05	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.5	False	2.0		a8c2f09f-6971-48e1-b890-f1d63611cdbd	1.9	9d88c064-c348-4f3f-a1f1-5884e0b66d9e			0.15	22	released	523d3e82-2929-4434-9fb0-42ee8812935a	RNA	R	0.15	UV Spec	released	False	fccb7131-30f9-4d57-b169-566ee6041fdf	01			5.0		0.0	10.0	85.0	95.0	BOTTOM	1229a1be-6ac6-49dd-a170-f6a6c4cf796a	released			0.0		0.0	20.0	80.0	95.0	TOP	9fc9bdb4-0398-4cad-8be5-fc656870c9ea	released	released	150.0						511be3b8-efdb-4e2e-8115-7b83e16471c1	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1850_demographic	72	-26369		d6afc291-5d82-5eb0-90e0-91d9933e5c0a	not reported	female	white	released	Alive	1937		TCGA-24-1850_exposure	Not Reported	f6d289a0-18c5-516e-b521-f66848111efe	released	TCGA-24-1850_diagnosis	26369	not reported	0	168	f34214f1-17e6-51fa-a214-6826ccc10fd8	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-24-1850_treatment	TCGA-24-1850_treatment_1	released	b0328c0c-f7ff-526e-9535-360ebe7a5d00	no	Radiation Therapy, NOS	released	ed3df2ca-b1a5-5dd9-bd5b-df75649408f8	yes	Pharmaceutical Therapy, NOS	f1c342c3-4ac2-4e04-9f9d-2cdc535a00e5
f7d12919-2133-403d-9492-155e4666fb94.htseq.counts.gz	92e62438-437b-46aa-a44d-16eb28a87de2	TCGA-09-0364-01A-02R-1564-13	TCGA-09-0364-01A-02R	TCGA-09-0364-01A-02-BS2	TCGA-09-0364-01A-01-BS1	TCGA-09-0364-01A-02		TCGA-09-0364-01A	TCGA-09-0364	6746533a-8d0b-4ebc-87ec-49c8738121a8	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV					False			27b9efd3-7748-4deb-96a2-3869a19bfa6f	1.8	2d0702a8-bf85-458e-879c-ebc03a2aa3d1			0.16	22	released	989c5d99-5f32-4435-8026-069ac89d2d31	RNA	R	0.16	UV Spec	released	False	1c2624d8-ae43-4772-829a-4cdaa1b7cc4d	02			0.0		0.0	10.0	90.0	95.0	BOTTOM	cc970d57-686a-4e49-b83b-b1b4c6b70410	released			0.0		0.0	10.0	90.0	95.0	TOP	1546ea7d-1678-4910-a51e-2a1a41a96fc7	released	released							469795c3-7cfa-4b95-9b0f-3fc7a3336f22	Primary Tumor	01		released	Not Reported	released	TCGA-09-0364_demographic	80	-29262	887	96fdbdf8-56b5-569a-b4f2-a155e1ed249d	not hispanic or latino	female	white	released	Dead	1918	2000	TCGA-09-0364_exposure	Not Reported	3b2ea46d-bcd6-5c71-8ee8-3a33ab9879b4	released	TCGA-09-0364_diagnosis	29262	not reported	0		42b4a2fe-7c3d-5839-b189-e22b4b061c28	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-09-0364_treatment	TCGA-09-0364_treatment_1	released	dabdbfb4-d19e-5d16-b464-b9a38486eafd	yes	Radiation Therapy, NOS	released	2d5caa82-e087-59f1-9cdc-91d86c0acd40	yes	Pharmaceutical Therapy, NOS	92e62438-437b-46aa-a44d-16eb28a87de2
1e10d520-3bcf-4edd-93d0-03be32f7e8d7.htseq.counts.gz	6eafaa3f-20a3-4846-a1bb-f96ecbf6a8c8	TCGA-29-2428-01A-01R-1569-13	TCGA-29-2428-01A-01R	TCGA-29-2428-01A-01-TS1	TCGA-29-2428-01A-01-BS1	TCGA-29-2428-01A-01		TCGA-29-2428-01A	TCGA-29-2428	b0585c7a-7205-4dac-9d54-6da89674accb	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.7		45a6c74c-045b-4fdd-a93d-9e1a8d36e4cb	1.8	9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b			0.14	22	released	88d4bc02-94ff-4acd-a257-c08f63fccff1	RNA	R	0.14	UV Spec	released	False	bc5ecdce-6c6d-465c-bbf6-865afc5e7e3c	01			5.0		0.0	5.0	90.0	95.0	TOP	3667d0cf-166c-4f28-85ee-a86aaf1c5667	released			0.0		0.0	20.0	80.0	90.0	BOTTOM	e5b6420f-0b66-4b78-b396-6bf8a075f55b	released	released	155.0						15d26f43-0581-4cdd-aa2f-a04ad6901fd8	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-2428_demographic	58	-21392		f49495f3-6a81-572b-b92a-f1ffdb45a55d	not reported	female	white	released	Alive	1947		TCGA-29-2428_exposure	Not Reported	a27812af-f848-5587-80b1-da526f33abc6	released	TCGA-29-2428_diagnosis	21392	not reported	0	1372	e20d29d9-559f-572a-8639-75c5d0f20e06	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-29-2428_treatment_1	TCGA-29-2428_treatment	released	0168a7b5-1870-5ccc-93c0-a70ddaf0435d	yes	Pharmaceutical Therapy, NOS	released	1137f07e-391a-5b5f-a537-bd03d22f3f20	no	Radiation Therapy, NOS	6eafaa3f-20a3-4846-a1bb-f96ecbf6a8c8
968544ba-7990-41e8-a0ee-5206ceeb47ca.htseq.counts.gz	e3685cc2-6974-45c1-b2be-ddb406e9f3f9	TCGA-04-1350-01A-01R-1565-13	TCGA-04-1350-01A-01R	TCGA-04-1350-01A-01-BS1	TCGA-04-1350-01A-01-TS1	TCGA-04-1350-01A-01		TCGA-04-1350-01A	TCGA-04-1350	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		C4BB615C-ABBA-4136-AAB4-52EA1FE88D14	1.8	56822a73-96f7-40ba-a5c2-6eec113b52d9			0.15	22	released	5f529d11-b4aa-4745-a556-863ab80ca542	RNA	R	0.15	UV Spec	released	False	9d532938-6a14-4ff1-b219-36fc3d609049	01			1.0		0.0	5.0	94.0	99.0	BOTTOM	5c94303e-4b9a-48d9-8e64-2541eade8a6b	released			1.0		0.0	5.0	94.0	99.0	TOP	0013c195-a6a5-45d3-8d87-1025e5a8f258	released	released	229.0						c8a0c290-56de-4ebe-80d3-ca8fb2f85188	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-04-1350_demographic	46	-16942	1946	a8d4c73c-f71c-5015-9cfe-d6499ca3919b	not reported	female	white	released	Dead	1957	2008	TCGA-04-1350_exposure	Not Reported	8fce01d5-69b2-50bc-88e3-b84987e878de	released	TCGA-04-1350_diagnosis	16942	not reported	0		2755ddb9-4175-5754-a34d-883256cd0dc5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-04-1350_treatment_1	TCGA-04-1350_treatment	released	70cff311-0405-558e-9315-4e4c896ee22f	yes	Pharmaceutical Therapy, NOS	released	be3ff3bd-d801-5b71-94ab-a9b321903f23	no	Radiation Therapy, NOS	e3685cc2-6974-45c1-b2be-ddb406e9f3f9
d04892ff-0ddc-45d1-93a7-abe21c67eb94.htseq.counts.gz	e2f515e9-b3d0-4f76-b7ce-9c732102b67c	TCGA-61-1733-01A-01R-1567-13	TCGA-61-1733-01A-01R	TCGA-61-1733-01A-01-BS1	TCGA-61-1733-01A-01-TS1	TCGA-61-1733-01A-01		TCGA-61-1733-01A	TCGA-61-1733	04ecaf38-0232-4dcd-9242-308a22cc1331	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.5		bc4e6e92-d716-4ab3-8459-4f339caecffd	1.8	e6f856bf-0694-4c21-aecc-0d8dd54761f1			0.15	22	released	ec79f582-79f9-4480-9af5-3d6a787bebb7	RNA	R	0.15	UV Spec	released	False	17748f90-1f61-4177-b8b6-5803581b7cff	01			5.0		0.0	0.0	95.0	85.0	BOTTOM	29704093-9666-4b98-a73e-4451db841e32	released	5.0		2.0		0.0	0.0	98.0	85.0	TOP	feaea5e2-8c15-4890-af4c-c81a7c86bff2	released	released	98.0						a047a512-409f-4293-9585-9933f1503f9d	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-61-1733_demographic	71	-26180		84a893c5-e066-5859-b953-0c02021e7041	not reported	female	white	released	Alive	1935		TCGA-61-1733_exposure	Not Reported	ef0d8db0-3a1f-534a-8f28-76a43c508b83	released	TCGA-61-1733_diagnosis	26180	not reported	0	967	a285514c-8992-5900-abf4-fa923c71587d	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-61-1733_treatment_1	TCGA-61-1733_treatment	released	98d2486c-7723-52be-a3a6-8fc5265976be	yes	Pharmaceutical Therapy, NOS	released	c1f9e9f5-8b41-509f-ab2c-ef451286bf24	no	Radiation Therapy, NOS	e2f515e9-b3d0-4f76-b7ce-9c732102b67c
d522e111-8a5f-48de-b894-1bf7505bda98.htseq.counts.gz	48c976e0-46f8-470b-bc36-981ea0c6106c	TCGA-24-1562-01A-01R-1566-13	TCGA-24-1562-01A-01R	TCGA-24-1562-01A-01-TS1	TCGA-24-1562-01A-01-BS1	TCGA-24-1562-01A-01		TCGA-24-1562-01A	TCGA-24-1562	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.0		0ce36daf-9512-4860-a5a3-b2ff7f487c5a	1.8	eb8cb3b3-d1b1-4d2d-b048-7394931040bd			0.15	22	released	085ad7a3-b541-4d0f-97e0-beb2efca8bd9	RNA	R	0.15	UV Spec	released	False	56c819a5-e4e7-4b90-971f-8d8dd81aeddb	01			10.0		0.0	10.0	80.0	90.0	TOP	f4b420b6-a2f3-4d03-96f4-a429c5d64b8d	released			5.0		0.0	10.0	85.0	90.0	BOTTOM	7a3a55d0-2158-442e-a14c-89627c590101	released	released	108.0						a323f2f5-b250-40a6-a318-084a3933e829	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-1562_demographic	67	-24747	1384	3740a77e-8604-5e34-a9b5-3f155618c3a1	not reported	female	white	released	Dead	1932	2002	TCGA-24-1562_exposure	Not Reported	59f25aa8-9398-5b01-86fc-5d63339aca6f	released	TCGA-24-1562_diagnosis	24747	not reported	0	1384	dc319f5b-52f4-5442-b2fd-18f751b79b72	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-24-1562_treatment	TCGA-24-1562_treatment_1	released	2a193a3f-26e3-5c56-9e56-681f8a714c4b	no	Radiation Therapy, NOS	released	87ec9acb-16cd-5b00-94cb-55a3bd287afb	yes	Pharmaceutical Therapy, NOS	48c976e0-46f8-470b-bc36-981ea0c6106c
fd638406-d933-47da-ba38-8ffc5046d49e.htseq.counts.gz	8488d9c6-a7c9-4f7f-8212-68c8902b8d6c	TCGA-09-2051-01A-01R-1568-13	TCGA-09-2051-01A-01R	TCGA-09-2051-01A-01-BS1	TCGA-09-2051-01A-01-TS1	TCGA-09-2051-01A-01		TCGA-09-2051-01A	TCGA-09-2051	02594e5e-8751-47c1-9245-90c66984b665	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	0.8		242a1ff3-05ad-4623-b5aa-9bb556e2cfa9	1.8	6bc296b8-ac74-4ff9-872d-5f7e4a3d011a			0.14	22	released	a8879098-49c1-49f9-a24f-83e936e630be	RNA	R	0.14	UV Spec	released	False	7a705344-8abe-4ae6-ba0c-3a4c8a16c229	01			0.0		0.0	5.0	95.0	99.0	BOTTOM	15f52287-f11d-4aff-baa0-407a7db6113f	released			0.0		0.0	10.0	90.0	98.0	TOP	09cb2b86-223c-4012-aea0-0fb939abfd46	released	released	100.0						c46d2ade-620c-44a6-93ba-8edda9909c1b	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-09-2051_demographic	42	-15650		d24768bc-31cf-5dee-8acb-c094538cc104	not hispanic or latino	female	white	released	Alive	1962		TCGA-09-2051_exposure	Not Reported	7fa9ef18-0a93-5ba1-9d50-f4916029c1db	released	TCGA-09-2051_diagnosis	15650	not reported	0	1919	1d60ab6b-010d-5421-9e30-11b38b71be6e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-09-2051_treatment	TCGA-09-2051_treatment_1	released	016cc344-a106-5152-a0c4-a64a22a43942	no	Radiation Therapy, NOS	released	f282f955-7051-522c-9863-e7562f52632d	yes	Pharmaceutical Therapy, NOS	8488d9c6-a7c9-4f7f-8212-68c8902b8d6c
1ac930e3-e67d-410d-9182-44d85799fd18.htseq.counts.gz	66e03a86-2fc7-4fc7-bba4-d69d2612abb9	TCGA-59-2352-01A-01R-1569-13	TCGA-59-2352-01A-01R	TCGA-59-2352-01A-01-BS1	TCGA-59-2352-01A-01-TS1	TCGA-59-2352-01A-01		TCGA-59-2352-01A	TCGA-59-2352	758e6b52-062e-4ca0-84d1-ea38477414ac	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	2.0		15f65643-b84c-4239-bc14-0ddacdfe0425	1.8	a209a8f4-9462-4ade-be57-caaec54999cb			0.15	22	released	cb39af02-00f4-4431-8f6f-55b2f2744fdd	RNA	R	0.15	UV Spec	released	False	51c94c62-410c-4e31-8f4f-8c67fae5a203	01			5.0		0.0	10.0	85.0	90.0	BOTTOM	a137850c-18c0-48b5-91aa-dafec1feb1ff	released			1.0		0.0	10.0	89.0	90.0	TOP	ef2a283e-ca0f-47fe-aff7-c10c4423c09a	released	released	127.0						2892b681-6001-4124-ae86-3363be75463b	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-59-2352_demographic	78		286	ea4eb7f5-e69a-5300-8b57-2b53ea2b245f	not hispanic or latino	female	white	released	Dead	1924	2002	TCGA-59-2352_exposure	Not Reported	15b02919-4e00-5ca0-816a-e8b62388f9d2	released	TCGA-59-2352_diagnosis		not reported	0		ea0ad7ed-ad39-564d-80bc-d7365bdeeff0	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-59-2352_treatment_1	TCGA-59-2352_treatment	released	e525fefd-413a-5aa1-970e-1e55bd5de5f5	not reported	Pharmaceutical Therapy, NOS	released	766420b9-7a3c-5667-a5d4-395a3941463e	not reported	Radiation Therapy, NOS	66e03a86-2fc7-4fc7-bba4-d69d2612abb9
59bebce4-6006-42a6-8d73-c6ef8fb3c9ce.htseq.counts.gz	6efcccbe-e06b-48cd-8b4d-7bf6f6082e3f	TCGA-29-1774-01A-01R-1567-13	TCGA-29-1774-01A-01R	TCGA-29-1774-01A-01-BS1	TCGA-29-1774-01A-01-TS1	TCGA-29-1774-01A-01		TCGA-29-1774-01A	TCGA-29-1774	d3dd5e69-9752-4b50-9b1f-814afbc2c3dd	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		8d8dd2f0-09d8-42a2-84e0-4209e45e2330	1.8	bdb953e0-32fc-4f28-b40f-aa870a2bccb6			0.16	22	released	13aaa816-9883-4b1b-9b4d-41c561067491	RNA	R	0.16	UV Spec	released	False	8e1092a0-c134-4d37-a4a3-bbd5a496f7f1	01			2.0		0.0	20.0	78.0	90.0	BOTTOM	f02c7673-a415-40ac-8e84-3c7ca38b5188	released			2.0		0.0	20.0	78.0	90.0	TOP	fc56e04c-830f-4e84-ab7f-4a942bcfdfa6	released	released	131.0						145c1cbf-1d36-4439-896b-afabfcc8d864	Primary Tumor	01	1.0	released	Not Reported	released	TCGA-29-1774_demographic	82	-29991		1d15823e-4daa-5758-8481-cfa43f826e1e	not hispanic or latino	female	white	released	Alive	1926		TCGA-29-1774_exposure	Not Reported	7782c099-47bc-544e-bc6c-34e2fa102ced	released	TCGA-29-1774_diagnosis	29991	not reported	0	527	dbf2bcbf-39a4-5c2a-8db3-883fffc89e0e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-29-1774_treatment	TCGA-29-1774_treatment_1	released	168ec590-d425-5f64-9493-68e3ea3df84d	no	Radiation Therapy, NOS	released	15356c37-f7bf-5c69-9af6-debd0ab82a6b	yes	Pharmaceutical Therapy, NOS	6efcccbe-e06b-48cd-8b4d-7bf6f6082e3f
f9bf79a2-9d3a-4df1-a03d-5a9dad5b5fbf.htseq.counts.gz	d1851dc4-4ec2-4884-b81a-45a835ffef5d	TCGA-29-1694-01A-01R-1567-13	TCGA-29-1694-01A-01R	TCGA-29-1694-01A-01-BS1	TCGA-29-1694-01A-01-TS1	TCGA-29-1694-01A-01		TCGA-29-1694-01A	TCGA-29-1694	1db60f09-7f5a-4f21-8003-06a6abc781db	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		ccfb9f1d-1779-4fae-a34f-c46a19d4b095	1.8	e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6			0.15	22	released	61f3b24d-ceba-469d-982d-a31eb635b02c	RNA	R	0.15	UV Spec	released	False	29229350-5046-4a05-a833-1a7349067415	01			0.0		0.0	20.0	80.0	80.0	BOTTOM	68cc12ec-6b18-48d1-bfda-6b45bafac0da	released			0.0		0.0	15.0	85.0	85.0	TOP	d9e65542-f4c3-4c27-96ae-1d8d3f48862b	released	released	98.0						4d74ff85-24e2-4e93-aa23-94d58efd22e4	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-29-1694_demographic	45	-16523	1187	109ece40-b218-5b70-83d3-e21fe429076f	not reported	female	white	released	Dead	1957	2005	TCGA-29-1694_exposure	Not Reported	a99d0c62-f885-5077-aba3-3c9e46361661	released	TCGA-29-1694_diagnosis	16523	not reported	0		8c0fa4a4-95b4-5ff6-aa24-077fd12ff564	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-29-1694_treatment	TCGA-29-1694_treatment_1	released	71f71a25-ef58-5fc9-b2b5-ca5883263da3	yes	Radiation Therapy, NOS	released	9a6bed44-b755-5042-b1e3-4ba4f80c53ab	yes	Pharmaceutical Therapy, NOS	d1851dc4-4ec2-4884-b81a-45a835ffef5d
f84a525a-7fab-4c5c-b37a-6027787ee817.htseq.counts.gz	545d6fda-0a55-4204-adb2-055015ace467	TCGA-57-1586-01A-02R-1567-13	TCGA-57-1586-01A-02R	TCGA-57-1586-01A-01-BS1	TCGA-57-1586-01A-02-BS2	TCGA-57-1586-01A-02		TCGA-57-1586-01A	TCGA-57-1586	48e66676-dbed-48a4-9a7f-a6d247b15c17	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.5		1245d63d-8859-496a-828e-4ccad717c114	1.8	2dcac69e-7167-4979-8327-be74d2c1202b			0.15	22	released	094a970c-acd7-4baf-b58e-1046934ce0d8	RNA	R	0.15	UV Spec	released	False	3eca914b-5b2a-41d0-b9c6-e7276c611b98	02			1.0		0.0	5.0	94.0	95.0	TOP	fea4c08b-05ba-4dde-943f-c01766ffac06	released			0.0		0.0	5.0	95.0	90.0	BOTTOM	e764dd3a-c4f4-4243-9ec1-8f62274fb5ab	released	released	129.0						e4d6fa52-fb29-47ac-aade-8f6020a5b55e	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-57-1586_demographic	66	-24304		d42e36ed-2e6e-5b2f-a8eb-51b647fce8a9	not hispanic or latino	female	white	released	Alive	1941		TCGA-57-1586_exposure	Not Reported	85851f44-210d-5799-a5b7-125e7d495d3e	released	TCGA-57-1586_diagnosis	24304	not reported	0	679	09ee5001-6b33-5395-aca0-afdc0186713b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-57-1586_treatment	TCGA-57-1586_treatment_1	released	f6788a24-d566-5385-86e1-ee0fcc2fbb64	no	Radiation Therapy, NOS	released	8a7c67a5-68d4-553c-a379-11db11829dd7	yes	Pharmaceutical Therapy, NOS	545d6fda-0a55-4204-adb2-055015ace467
c5e8e5e5-91e0-4e3c-97ad-e1cb63aaf70a.htseq.counts.gz	78b94b66-0ac1-4a6b-af93-53d557d40406	TCGA-61-2104-01A-01R-1568-13	TCGA-61-2104-01A-01R	TCGA-61-2104-01A-01-BS1	TCGA-61-2104-01A-01-TS1	TCGA-61-2104-01A-01		TCGA-61-2104-01A	TCGA-61-2104	05263959-c4f5-4540-b6d2-d8c8a128861f	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.5		38d2e115-ec9a-40e5-bfa0-30fb1db60691	1.8	721a8fc8-bb54-4ec3-a19c-340c35f05280			0.16	22	released	d9f193a6-eeeb-40d5-8c3d-e8bf0e2f5369	RNA	R	0.16	UV Spec	released	False	0e329e06-f308-4910-8eb0-544b9049fe85	01			5.0		15.0	5.0	75.0	77.0	BOTTOM	7b3ca402-80d0-4b8c-9bf0-5350be286ef8	released			8.0		12.0	10.0	70.0	85.0	TOP	fed6e808-15d3-4922-ab69-e3650d4243d1	released	released	138.0						87b7ed22-4fe1-4539-8c37-ab085e2cb9c1	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-2104_demographic	53	-19432		f30ef53b-8af1-5eac-93f1-59318e77e83b	not reported	female	white	released	Alive	1950		TCGA-61-2104_exposure	Not Reported	b267cdf3-1e41-5d56-b6ba-25e0441b86e9	released	TCGA-61-2104_diagnosis	19432	not reported	0	2338	d4287397-a95b-595b-8b83-3bc606532e4f	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-61-2104_treatment	TCGA-61-2104_treatment_1	released	dbddac35-5f96-5ee1-80a7-39d98af27eaf	no	Radiation Therapy, NOS	released	b8a0cc58-8b67-5085-a757-bdb16bf67931	yes	Pharmaceutical Therapy, NOS	78b94b66-0ac1-4a6b-af93-53d557d40406
e377a906-e48f-4f6c-998e-7f914b8cd712.htseq.counts.gz	2dc9a586-30ad-4b6e-abbc-5b850e8b8d82	TCGA-04-1651-01A-01R-1567-13	TCGA-04-1651-01A-01R	TCGA-04-1651-01A-01-BS1	TCGA-04-1651-01A-01-TS1	TCGA-04-1651-01A-01		TCGA-04-1651-01A	TCGA-04-1651	55153632-1673-487a-85c0-f156377db1fc	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	1.5		703BEFE1-07E0-48AE-826E-133A59F97068	1.8	b8426635-7d02-40e4-b9b9-695ae9a9b3fc			0.14	22	released	fe2481fa-ffe2-4419-9900-f0205d94a4fc	RNA	R	0.14	UV Spec	released	False	98ec9d66-3316-4665-aa16-d2f9feb8013c	01			2.0		0.0	10.0	88.0	85.0	BOTTOM	62199560-a607-40f5-b030-80a174c8125e	released			2.0		0.0	8.0	90.0	90.0	TOP	246daec2-ff44-40f4-a856-89da1f342016	released	released	100.0						7d9f2d6d-3ec6-4fed-9d3a-52e813bd8be6	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-04-1651_demographic	53	-19628	1102	3b99b3f1-6556-5121-8085-9073925eba9d	not hispanic or latino	female	white	released	Dead	1951	2007	TCGA-04-1651_exposure	Not Reported	7fd072b1-678f-5889-a426-a5074598f8c1	released	TCGA-04-1651_diagnosis	19628	not reported	0		d97f7ad8-0280-573e-a4e4-226d1a92d8fb	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-04-1651_treatment_1	TCGA-04-1651_treatment	released	1069f357-8b4d-569c-8664-b089c1d5aff4	yes	Pharmaceutical Therapy, NOS	released	70576f37-118f-5afe-87eb-148820617bac	no	Radiation Therapy, NOS	2dc9a586-30ad-4b6e-abbc-5b850e8b8d82
b2552f6f-dd15-410f-a621-195d90f44831.htseq.counts.gz	567ced20-00cf-46f4-8bb8-a8553eba7f4b	TCGA-24-1417-01A-01R-1565-13	TCGA-24-1417-01A-01R	TCGA-24-1417-01A-01-BS1	TCGA-24-1417-01A-01-TS1	TCGA-24-1417-01A-01		TCGA-24-1417-01A	TCGA-24-1417	48f831b0-5d91-44ae-bc4e-db57ca84fe46	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.3		4058a172-a0f6-4c91-9c79-aab63525340f	1.8	e76a7745-3193-4650-9a7a-c96329690be3			0.17	22	released	47fbd0ab-35b4-451f-adf0-fd421d00169c	RNA	R	0.17	UV Spec	released	False	81d7dfe5-2d79-4868-a38a-2bd1b006acba	01			15.0		15.0	0.0	70.0	85.0	BOTTOM	23ab8e32-3bc0-43ec-8434-3a1fb7f54ffc	released			10.0		15.0	0.0	75.0	85.0	TOP	a1bfa913-5f8b-4f4c-8379-0edee9daad87	released	released	129.0						1fce45c1-b4e9-40fb-b914-23ec7472aca2	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-1417_demographic	54	-19775		f9e14320-3849-5728-8080-595d28eab5c8	not reported	female	white	released	Alive	1954		TCGA-24-1417_exposure	Not Reported	49f4a464-b4d3-5346-8d57-ae178a5f3b25	released	TCGA-24-1417_diagnosis	19775	not reported	0	238	4b027297-035f-56ce-821c-31213eea6b4c	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1417_treatment	TCGA-24-1417_treatment_1	released	58e34a10-744d-5bc5-9e6f-18ccef94b95d	no	Radiation Therapy, NOS	released	f61ca592-a4c9-5215-80b0-c57c467e76de	yes	Pharmaceutical Therapy, NOS	567ced20-00cf-46f4-8bb8-a8553eba7f4b
95595a36-1582-4fb6-bf79-f0111b0abfc9.htseq.counts.gz	6dbafc46-d850-47f4-a9ee-8f30b3f06260	TCGA-23-2078-01A-01R-1568-13	TCGA-23-2078-01A-01R	TCGA-23-2078-01A-01-BS1	TCGA-23-2078-01A-01-TS1	TCGA-23-2078-01A-01		TCGA-23-2078-01A	TCGA-23-2078	ebe677e6-94b6-45be-a58d-eaae4cf63d12	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	0.9		19ed5fbe-17e1-43f3-bfa0-32f474a00be8	1.8	9f35075d-4d81-44f2-a672-12028d6231be	3	20	0.15	22	released	9098835a-243b-4757-a39a-edcc5d631fd9	RNA	R	0.15	UV Spec	released	False	5d080506-3a0c-493c-8eb3-be36c43e7318	01			1		0	10	89	90	BOTTOM	7db37047-3ad5-4aff-b568-fc496df7f508	released			1		0	10	89	90	TOP	c1e1c7cc-0a12-4f15-8b94-57414753099e	released	released	136						dc3d8cea-908f-423f-976d-150bb1050063	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-23-2078_demographic	66	-24223		ff617d73-37ba-5c86-9928-ca9ee553692f	not hispanic or latino	female	white	released	Alive	1935		TCGA-23-2078_exposure	Not Reported	55e16158-ad79-52ac-9253-be2cb97173ff	released	TCGA-23-2078_diagnosis	24223	not reported	0	2661	2d20c4d9-3e33-5e7a-90e1-7a4f1dbae09a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Specified parts of peritoneum	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-23-2078_treatment	TCGA-23-2078_treatment_1	released	17e4fc0d-a5b6-5818-bdc4-8e2779727abd	no	Radiation Therapy, NOS	released	8eab55ee-4d1e-57b5-91b2-dda818e77196	yes	Pharmaceutical Therapy, NOS	6dbafc46-d850-47f4-a9ee-8f30b3f06260
7dfc4c0f-bb68-4ac1-95fc-e2a3fee16704.htseq.counts.gz	787405d2-849f-4438-b166-2dc0ed327b86	TCGA-24-1413-01A-01R-1565-13	TCGA-24-1413-01A-01R	TCGA-24-1413-01A-01-TS1	TCGA-24-1413-01A-01-BS1	TCGA-24-1413-01A-01		TCGA-24-1413-01A	TCGA-24-1413	3fc8f799-5bd3-4f48-baf0-c458ce86ab7e	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.1		2ca18d08-e930-4244-a0d5-316dfbca0fb4	1.8	545867ef-1299-410d-bbbf-d6c189344b0f			0.15	22	released	b61a50f9-93ed-4290-a1e9-68c4278cdca0	RNA	R	0.15	UV Spec	released	False	b6ba711b-f2ae-44ca-b36f-92d77302d57d	01			10.0		40.0	0.0	50.0	85.0	TOP	8e76a2e6-ab2f-4d66-8017-c128c68763d8	released			20.0		20.0	0.0	60.0	85.0	BOTTOM	963bdc29-e21a-4b5f-9ff7-9bb4d4b6abea	released	released	128.0						c20183e0-600b-4d1d-975f-2b6e43c35d0d	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-1413_demographic	51	-18846		74a17d97-ff76-50a8-858a-cc082f7219c2	not reported	female	white	released	Alive	1957		TCGA-24-1413_exposure	Not Reported	ce2ab9fa-9ea5-5d6a-b2c3-9ddc194812ab	released	TCGA-24-1413_diagnosis	18846	not reported	0	192	7ad436d5-5f18-51e6-a99d-d533a2c7e2cc	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1413_treatment	TCGA-24-1413_treatment_1	released	d3c5b21a-960c-5ddb-a798-7eb73176d614	no	Radiation Therapy, NOS	released	ac695700-e170-58b7-b8b2-9b435f795b0d	yes	Pharmaceutical Therapy, NOS	787405d2-849f-4438-b166-2dc0ed327b86
8bb54b5a-d23c-46a2-839e-32355236477b.htseq.counts.gz	b15f7d4e-fafa-499e-b3ae-b895571687bf	TCGA-31-1959-01A-01R-1568-13	TCGA-31-1959-01A-01R	TCGA-31-1959-01A-01-BS1	TCGA-31-1959-01A-01-TS1	TCGA-31-1959-01A-01		TCGA-31-1959-01A	TCGA-31-1959	186d40cd-624c-4016-a497-b30c892d393c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.1		c78c6998-1f86-4dd2-bf41-78f12d43c33a	1.8	25b1eb9f-7b97-4da2-96a9-a4a3aaaca192			0.14	22	released	a6d90e53-86b5-4f73-a4df-d5998ebff2ef	RNA	R	0.14	UV Spec	released	False	751378fb-337e-4946-9ff2-9878998c66ba	01	2.0		0.0		0.0	40.0	60.0	70.0	BOTTOM	13ffdaa0-16e9-4e42-b74a-bd8374cbbf8f	released	2.0		3.0		0.0	37.0	60.0	75.0	TOP	c9408cb9-448f-47f7-bad3-36f89f225596	released	released	92.0						dd8556f8-461a-468d-8604-c4f2366b1cd7	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-31-1959_demographic	49	-18247		f9c4143c-c920-522f-9333-0e259cb78801	not hispanic or latino	female	white	released	Alive	1960		TCGA-31-1959_exposure	Not Reported	21ed04dc-91b8-5504-8ec4-b64288164e0a	released	TCGA-31-1959_diagnosis	18247	not reported	0	67	121cc11a-b0d3-537e-ae08-106d193c7667	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-31-1959_treatment	TCGA-31-1959_treatment_1	released	8aca474d-6dba-5b4e-bd7d-3cbe12ceacf0	no	Radiation Therapy, NOS	released	fb5e4b15-6ca4-54eb-a807-4ae8f2bf5126	yes	Pharmaceutical Therapy, NOS	b15f7d4e-fafa-499e-b3ae-b895571687bf
5a8d910c-004f-4368-ad4d-0e8deec45384.htseq.counts.gz	4dec595e-82fe-49ab-a318-e72ae78d3b28	TCGA-30-1861-01A-01R-1568-13	TCGA-30-1861-01A-01R	TCGA-30-1861-01A-01-BS1	TCGA-30-1861-01A-01-TS1	TCGA-30-1861-01A-01		TCGA-30-1861-01A	TCGA-30-1861	0724f800-e873-45d0-bc56-809d0ec4f6e9	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.8		446be880-d1d8-4b63-b4d5-5aa0468ccafe	1.8	32a58029-c8aa-4647-a932-bbf57e82fc48			0.15	22	released	9078a669-44c3-44fc-94b5-c173d6a42848	RNA	R	0.15	UV Spec	released	False	6ee2c939-e84c-4211-878d-e899a27faf00	01			0.0		0.0	25.0	75.0	80.0	BOTTOM	30a7078c-aeeb-4c9d-b0d8-8d66163299cd	released			0.0		0.0	25.0	75.0	80.0	TOP	a7c5de2f-252d-44e2-b5fa-9beef553a8d6	released	released	119.0						2642249c-adc7-48e2-8493-1597e269c2c9	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-30-1861_demographic	74	-27103	1058	306e3132-57a0-51fc-87e4-1d00bf8466d0	not hispanic or latino	female	white	released	Dead	1928	2004	TCGA-30-1861_exposure	Not Reported	be5a8387-3137-5b46-90ec-2e8f18511a1d	released	TCGA-30-1861_diagnosis	27103	not reported	0	1058	4df9c324-0ddb-5e04-beb7-a6c37bf5e8a8	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-30-1861_treatment	TCGA-30-1861_treatment_1	released	f56963e8-ab67-5731-ba95-895fd7b0bc20	not reported	Radiation Therapy, NOS	released	2cbccaeb-0711-5974-8080-f08944438427	not reported	Pharmaceutical Therapy, NOS	4dec595e-82fe-49ab-a318-e72ae78d3b28
ac6dbd3b-d3fc-4126-b637-e6be2e7454db.htseq.counts.gz	ac0f9a42-de6f-4afa-af27-8763348b1974	TCGA-61-1900-01A-01R-1567-13	TCGA-61-1900-01A-01R	TCGA-61-1900-01A-01-BS1	TCGA-61-1900-01A-01-TS1	TCGA-61-1900-01A-01		TCGA-61-1900-01A	TCGA-61-1900	ef653772-e5d2-46ec-8610-f81d75d7353c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.5		b0dd202d-16dc-42ec-ad83-6f02b37b919f	1.8	92adf6a1-4880-4ee4-8ebe-09a943dbfe04			0.15	22	released	fababb90-b818-4b8d-a624-ed22523314ea	RNA	R	0.15	UV Spec	released	False	aaaae7e3-9488-4bc3-a96e-481699c214fc	01			10.0		0.0	10.0	80.0	90.0	BOTTOM	b39e97c1-2493-4131-a66b-67e95511ce4b	released			0.0		0.0	5.0	95.0	95.0	TOP	cc98d24b-5f6f-4732-ba40-1592f7a5a538	released	released	101.0						fb634d39-a4fe-493e-a982-2e360e69cbd2	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-61-1900_demographic	51	-18963		22cfffda-6e29-57b4-9e79-7c5e73abe719	not hispanic or latino	female	black or african american	released	Alive	1957		TCGA-61-1900_exposure	Not Reported	b5800fb4-f058-51e9-a055-270c7393eba9	released	TCGA-61-1900_diagnosis	18963	not reported	0	176	c6b4d84c-73bf-54db-b28c-a0e675a19216	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-61-1900_treatment	TCGA-61-1900_treatment_1	released	50d4f01f-a356-572e-8d49-b21789af5f5b	no	Radiation Therapy, NOS	released	0fee1989-f49e-56a1-8576-288860b5f155	yes	Pharmaceutical Therapy, NOS	ac0f9a42-de6f-4afa-af27-8763348b1974
85fe5749-1fef-49a2-bbac-9200c3c5a1cb.htseq.counts.gz	1c710ed8-4e82-48ce-a559-71a5c790c2e5	TCGA-13-1411-01A-01R-1565-13	TCGA-13-1411-01A-01R	TCGA-13-1411-01A-01-BS1	TCGA-13-1411-01A-01-TS1	TCGA-13-1411-01A-01		TCGA-13-1411-01A	TCGA-13-1411	a9d3a7b0-faf8-4e56-8600-d9e6882a4f23	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.5	False	1.7		F73F2D6F-3FD9-4457-921A-9EE0E47A6470	1.8	0069c63d-f699-41d4-9798-9a109d1c09df			0.15	22	released	c87b41be-cde2-4237-a1a6-39f8bf4d3187	RNA	R	0.15	UV Spec	released	False	62ac9cfc-84cc-46a7-961c-2b5ffd57dc7a	01			0.0		0.0	10.0	90.0	90.0	BOTTOM	6ad1b17a-2edc-4e90-a769-781e192666b7	released			1.0		0.0	10.0	89.0	90.0	TOP	8b721a35-974d-4831-90d5-6874833d2a2d	released	released	133.0						157062b7-9451-4a83-9047-294497df3b28	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-1411_demographic	81	-29874	531	27139b74-ed7d-5c9a-a505-c3f8562efbce	not hispanic or latino	female	white	released	Dead	1927		TCGA-13-1411_exposure	Not Reported	f62335ae-6fdd-59de-8cd7-8195679d2578	released	TCGA-13-1411_diagnosis	29874	not reported	0	128	33ef06dd-c3cb-5ba0-b224-c83af2b6171b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1411_treatment	TCGA-13-1411_treatment_1	released	0023c0f9-b6fb-5ead-b992-e0e4f116abb0	no	Radiation Therapy, NOS	released	7b7c09b2-4ca3-5e04-9238-b1c2e42498bf	yes	Pharmaceutical Therapy, NOS	1c710ed8-4e82-48ce-a559-71a5c790c2e5
ab89687d-2019-406c-95e8-a189c13c9fc0.htseq.counts.gz	60fc45dd-0bbf-4f15-a474-be17c294362a	TCGA-61-1728-01A-01R-1568-13	TCGA-61-1728-01A-01R	TCGA-61-1728-01A-01-TS1	TCGA-61-1728-01A-01-BS1	TCGA-61-1728-01A-01		TCGA-61-1728-01A	TCGA-61-1728	07fbdb3c-8337-4319-8255-f2363f8a031e	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.1		7611c4d4-f58b-404e-93f1-949c865c9e12	1.8	bf909020-d6a1-49f1-8007-4192d39abd04			0.15	22	released	24e866d8-fe78-4821-89b3-6360af6870f3	RNA	R	0.15	UV Spec	released	False	5834c3f4-b593-4ad1-bd92-c838679e5ef4	01			10.0		0.0	0.0	90.0	90.0	TOP	7436378c-e436-4aba-a1aa-89314dcdccce	released			15.0		0.0	0.0	85.0	90.0	BOTTOM	52c330f2-48ca-4158-a994-07cdbc130f80	released	released	145.0						9c3d5caf-78e2-4a1c-9e08-1ca5aa1c5625	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-61-1728_demographic	59	-21582		3a226523-d211-5c33-ab72-74b052e22634	not hispanic or latino	female	white	released	Alive	1948		TCGA-61-1728_exposure	Not Reported	b5de6027-d9f5-5928-bf12-740edd51f6b9	released	TCGA-61-1728_diagnosis	21582	not reported	0	848	947ce4f7-c76d-587a-af7d-533e4eeb9b1f	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-61-1728_treatment	TCGA-61-1728_treatment_1	released	f656a5c5-3c82-5dc0-b931-b7ca5d849549	no	Radiation Therapy, NOS	released	36ded4c3-ac09-557e-8d2e-d82e9460b896	yes	Pharmaceutical Therapy, NOS	60fc45dd-0bbf-4f15-a474-be17c294362a
65c32518-eda4-4a4b-8d39-00a28936664d.htseq.counts.gz	9c48e058-3b95-4be8-9939-93de97fc6403	TCGA-25-2392-01A-01R-1569-13	TCGA-25-2392-01A-01R	TCGA-25-2392-01A-01-BS1	TCGA-25-2392-01A-01-TS1	TCGA-25-2392-01A-01		TCGA-25-2392-01A	TCGA-25-2392	7413c891-f74e-456f-bc70-69c83fb53c70	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		C520D0D6-F104-492C-A4C2-844390F55570	1.8	95b7a71d-8cf5-4660-ac1d-52a888cd2f20			0.15	22	released	7d97700d-1f24-4f28-adc2-f82361483227	RNA	R	0.15	UV Spec	released	False	4edc6e9d-3f94-4326-a5b7-2a041a0a34aa	01			0.0		0.0	15.0	85.0	85.0	BOTTOM	67d64f48-5192-4066-882d-a373ed1fb8f1	released			1.0		0.0	5.0	94.0	95.0	TOP	e2bc74f8-5f1e-480a-9daa-91508a8c7a80	released	released	175.0						bbfeb712-4736-49c9-9cc6-74a94c6e8195	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-25-2392_demographic	75	-27667	31	0239e132-69ad-584f-a099-4a1b626fdc4d	not hispanic or latino	female	white	released	Dead	1928	2003	TCGA-25-2392_exposure	Not Reported	7198e7c3-6f5c-577b-ac33-c5d1dbe24418	released	TCGA-25-2392_diagnosis	27667	not reported	0	31	99ca4e5c-3912-5835-8d01-9492e0b5074f	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-25-2392_treatment	TCGA-25-2392_treatment_1	released	f156e02a-a3e2-5333-8eb7-3ad870a73902	no	Radiation Therapy, NOS	released	76d016eb-05cd-5dd7-89df-ea6c736804d0	no	Pharmaceutical Therapy, NOS	9c48e058-3b95-4be8-9939-93de97fc6403
b28d6dd2-923a-4160-8876-7b0fbb7a7a26.htseq.counts.gz	6c0d0bfc-2cc8-4800-ae7d-957497b0d241	TCGA-10-0936-01A-01R-1564-13	TCGA-10-0936-01A-01R	TCGA-10-0936-01A-01-BS1	TCGA-10-0936-01A-01-TS1	TCGA-10-0936-01A-01		TCGA-10-0936-01A	TCGA-10-0936	7016714b-6af8-45dd-8341-1493927e5515	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		6b9a13e4-760e-476f-a0a7-fb42ab7c63c5	1.7	04112b9c-6ef4-49cd-bed8-43151b5bbe1f			0.14	22	released	805911c8-210d-436a-81ed-e8f8ffacc048	RNA	R	0.14	UV Spec	released	False	b891699a-f445-4c67-b7c7-f9a5e88285df	01			0.0		5.0	5.0	90.0	90.0	BOTTOM	3ede0f32-9bf9-46be-aabd-4793365bf020	released			0.0		5.0	5.0	90.0	90.0	TOP	e5976a6c-f284-43bd-9597-6f9d3b5439dc	released	released	159.0						88c24748-3aee-4a05-8730-9a802f1876d2	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-10-0936_demographic	69	-25454	1123	014b5a3f-ce4b-5e1b-bb9f-caa0d307e19f	not hispanic or latino	female	black or african american	released	Dead	1936	2008	TCGA-10-0936_exposure	Not Reported	77fda196-b774-5602-b4f8-648e52d4de46	released	TCGA-10-0936_diagnosis	25454	not reported	0	1089	68108d81-543a-5c73-a998-dd9bd6fdcd9e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-10-0936_treatment_1	TCGA-10-0936_treatment	released	ba7769d6-f512-54ae-9373-a2d9b5cc7a78	yes	Pharmaceutical Therapy, NOS	released	7402965a-bc8e-5082-b49c-5c5fa25f5a84	no	Radiation Therapy, NOS	6c0d0bfc-2cc8-4800-ae7d-957497b0d241
3769209b-a12f-4a84-9d68-0e1c934e5aea.htseq.counts.gz	469769fc-b712-4bbd-9814-f93552acb600	TCGA-25-1631-01A-01R-1569-13	TCGA-25-1631-01A-01R	TCGA-25-1631-01A-01-TS1	TCGA-25-1631-01A-01-BS1	TCGA-25-1631-01A-01		TCGA-25-1631-01A	TCGA-25-1631	6a1be87b-c4e0-4fd4-b050-50a245b22038	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				2.0	False	2.0		1C74F61E-1131-4782-8117-20C59B86D845	1.8	29c4cab9-c19e-4416-ad88-484cc02a980f			0.13	22	released	072b11fc-5a77-4e81-8450-8b19251b54b9	RNA	R	0.13	UV Spec	released	False	82b03dfe-f3ac-40e8-b8d8-7b4f6b9ebbee	01			10.0		0.0	10.0	80.0	90.0	TOP	64da2a3d-515c-4393-9b63-f70b3ddef2b8	released			10.0		0.0	10.0	80.0	90.0	BOTTOM	0c3e79d3-e8ee-4721-94ee-cf2923f033bc	released	released	110.0						6b4aff1a-568e-453f-9679-55b3442c491d	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-25-1631_demographic	73	-26687	9	add82ac4-19b9-5d45-a879-a9ca0d73962b	not hispanic or latino	female	white	released	Dead	1929	2002	TCGA-25-1631_exposure	Not Reported	fee08a9b-c82e-5df8-b48a-6a4266858d57	released	TCGA-25-1631_diagnosis	26687	not reported	0	9	407c0da4-f263-5ceb-abd5-c62004aaf0b5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-25-1631_treatment	TCGA-25-1631_treatment_1	released	d5a84b53-ef3f-574a-b25e-9ca3b214e0c4	no	Radiation Therapy, NOS	released	5d7b0495-0094-595a-83cb-df041296fbc8	no	Pharmaceutical Therapy, NOS	469769fc-b712-4bbd-9814-f93552acb600
875c2a27-9732-4b8a-affc-8ea591595a43.htseq.counts.gz	bfc4d15f-747b-4702-a000-4536f0422de6	TCGA-09-1659-01B-01R-1564-13	TCGA-09-1659-01B-01R	TCGA-09-1659-01B-01-BS1	TCGA-09-1659-01B-01-TS1	TCGA-09-1659-01B-01		TCGA-09-1659-01B	TCGA-09-1659	644a88a7-dc56-468a-af5c-60278aab7642	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		f10b2e12-02b2-42e0-a5b2-a02c1daabbdf	1.8	32d5209e-2ef2-4ef0-b902-585542d7d16b			0.16	22	released	2c8256d0-fd64-4057-8c95-46c6b368fad1	RNA	R	0.16	UV Spec	released	False	bb0aaf3c-cc37-4d91-9b09-2f5af33cf3e5	01			3.0		17.0	0.0	80.0	85.0	BOTTOM	e8c4fbf1-6540-4e8e-b163-58d009066a2e	released			10.0		5.0	0.0	85.0	85.0	TOP	8a082fbd-7649-4b19-8cb6-24f30dc4b2ba	released	released	110.0						01a6f7cd-10cc-4f33-aa75-b29abd6c2edb	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-09-1659_demographic	51	-18733	304	a5962b77-641c-5dd7-8efa-361ca8a34954	not hispanic or latino	female	white	released	Dead	1946	1997	TCGA-09-1659_exposure	Not Reported	36e75525-1e23-5bda-9d69-3412294da0ef	released	TCGA-09-1659_diagnosis	18733	not reported	0		0f558703-06e8-564a-b36a-1cec509b1429	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1997	TCGA-09-1659_treatment	TCGA-09-1659_treatment_1	released	41d0d5a4-19a7-54b1-8a5b-6025e3d5dc59	no	Radiation Therapy, NOS	released	5161b800-2949-518c-9b6a-e0be9d00d9ac	yes	Pharmaceutical Therapy, NOS	bfc4d15f-747b-4702-a000-4536f0422de6
97d62176-1e34-4508-886b-df643f8a7e75.htseq.counts.gz	04a40917-633c-48eb-be1d-cc0b0b4efd30	TCGA-24-0982-01A-01R-1565-13	TCGA-24-0982-01A-01R	TCGA-24-0982-01A-01-TS1	TCGA-24-0982-01A-01-BS1	TCGA-24-0982-01A-01		TCGA-24-0982-01A	TCGA-24-0982	206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.0		75BE9FE6-5606-4F29-A08F-69E3F50912D0	1.8	ae158b16-5d93-42d5-a793-3294629af24d			0.16	22	released	482b4082-67ce-4e07-9a22-77d3e6e29efe	RNA	R	0.16	UV Spec	released	False	14ff92dd-94fa-475a-9b66-6a66e6ba316c	01			0.0		0.0	25.0	75.0	85.0	TOP	7a24140e-0062-41a3-bf71-a70ce3f4124c	released			0.0		0.0	35.0	65.0	75.0	BOTTOM	86d455fe-9855-4106-b487-ef4cde3c86de	released	released	127.0						7fec33cd-6f46-44c7-8204-e0f42b543abe	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-24-0982_demographic	77	-28201	679	849e1718-c71c-5361-b7d6-b8cc306d138e	not reported	female	white	released	Dead	1926	2004	TCGA-24-0982_exposure	Not Reported	1e039aaa-a4ff-5aff-a922-288b7c44e009	released	TCGA-24-0982_diagnosis	28201	not reported	0	679	39a59ccd-64aa-5441-84ae-81793fbe9199	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-24-0982_treatment_1	TCGA-24-0982_treatment	released	88d82bd4-e3c4-5e2c-a783-c22aa9dc0f3f	yes	Pharmaceutical Therapy, NOS	released	d81ea43b-389a-5133-a0dd-61f3ff1b9e3b	no	Radiation Therapy, NOS	04a40917-633c-48eb-be1d-cc0b0b4efd30
1e918517-3a1f-45ae-953b-b65ecfaffd2d.htseq.counts.gz	4ee41786-e711-4e20-8a02-66034e1228f8	TCGA-09-2045-01A-01R-1568-13	TCGA-09-2045-01A-01R	TCGA-09-2045-01A-01-BS1	TCGA-09-2045-01A-01-TS1	TCGA-09-2045-01A-01		TCGA-09-2045-01A	TCGA-09-2045	3768d34f-1527-40db-b116-cd80cee5ec3a	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.5		6c826e9d-b1aa-4c84-b294-c8fb41818da1	1.8	7b412fd9-4414-440f-b768-70666037c768			0.14	22	released	053e6bec-8aab-429a-b8a3-ec7a3267fa01	RNA	R	0.14	UV Spec	released	False	06664e36-b611-4112-8889-63bce9fcce32	01			1.0		0.0	5.0	94.0	95.0	BOTTOM	0f965c79-cfe6-499e-98a9-a696bfe83f6f	released			0.0		0.0	10.0	90.0	90.0	TOP	0abe6ecb-c4ba-492f-939f-9dfa84b0af35	released	released	161.0						4d5aaf12-a500-4709-9c99-5b9fef2c79b1	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-09-2045_demographic	50	-18285	1069	6ca6b1db-10fc-590d-a441-127763862ffa	not hispanic or latino	female	asian	released	Dead	1946	1998	TCGA-09-2045_exposure	Not Reported	fc7cc3c8-4dc3-5cd9-be5f-0f93e313f6b6	released	TCGA-09-2045_diagnosis	18285	not reported	0		0ffcd742-a709-52d5-b7ac-ea8a72376fdf	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1996	TCGA-09-2045_treatment_1	TCGA-09-2045_treatment	released	24394150-db0a-5bc3-8dda-959e1a7c0b61	yes	Pharmaceutical Therapy, NOS	released	fbf4c9d9-7fcc-5779-8624-88535dfac6a3	no	Radiation Therapy, NOS	4ee41786-e711-4e20-8a02-66034e1228f8
5b23f813-9970-485b-8577-ab2f3c029c26.htseq.counts.gz	ea103009-5c2a-4c16-af57-9d332936185a	TCGA-25-1623-01A-01R-1566-13	TCGA-25-1623-01A-01R	TCGA-25-1623-01A-01-BS1	TCGA-25-1623-01A-01-TS1	TCGA-25-1623-01A-01		TCGA-25-1623-01A	TCGA-25-1623	808eb134-9c7d-43bb-b86c-2f3259193954	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.8		A57CB221-076A-4EE5-8C77-D1E33070597C	1.8	3e4f0ca7-8428-47df-80a3-3bc9153aedfa			0.15	22	released	cdb8fa05-7a39-437b-949f-07887caecd03	RNA	R	0.15	UV Spec	released	False	0454d8f9-b1d6-4726-9e3f-130e5291e72b	01			5.0		0.0	25.0	70.0	80.0	BOTTOM	e305f292-cf49-4cc0-bd23-bc1399e95e4a	released			5.0		0.0	40.0	55.0	70.0	TOP	0fe7be03-c1ff-4faf-9c06-fc7a7c5060c4	released	released	100.0						09f0e0d8-1f35-4781-8c71-5b0843483cd7	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-25-1623_demographic	71	-26060	565	23ac0f67-276c-5d57-b52e-1764a643b863	not hispanic or latino	female	white	released	Dead	1935	2007	TCGA-25-1623_exposure	Not Reported	8cdbd05e-e11a-5374-83b7-726df134ad12	released	TCGA-25-1623_diagnosis	26060	not reported	0	565	c76423fa-47c5-5e83-9344-ce0ca6c75063	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-25-1623_treatment	TCGA-25-1623_treatment_1	released	0e34a67f-e60a-5054-bc19-16e8b492c914	no	Radiation Therapy, NOS	released	01f1e570-8aae-5582-9ee8-edac4342734c	yes	Pharmaceutical Therapy, NOS	ea103009-5c2a-4c16-af57-9d332936185a
6e6ab126-1ab3-428c-b780-a1a98c475154.htseq.counts.gz	dcce8c4c-ee88-4c50-86f9-51bb2a291e41	TCGA-23-1113-01A-01R-1564-13	TCGA-23-1113-01A-01R	TCGA-23-1113-01A-01-BS1	TCGA-23-1113-01A-01-TS1	TCGA-23-1113-01A-01		TCGA-23-1113-01A	TCGA-23-1113	6209e80d-a115-4f8e-bf0d-18461401a1c6	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.0		a7fa848e-2492-4802-9cb2-58ec66fc3dd4	1.8	88656b94-cd24-4c4c-b625-635ef692cf13			0.15	22	released	3cfb2d0f-678f-4057-949b-29dcccddc28d	RNA	R	0.15	UV Spec	released	False	5576fa57-1c5c-4c56-87e2-a17a30694287	01			1.0		0.0			95.0	BOTTOM	2458fccf-526c-4639-84fa-54061bcc3cd5	released			5.0		0.0			95.0	TOP	57c411b9-9c95-4c31-a3b5-110683e0e020	released	released	110.0						9552886e-881b-4bed-842c-596fcc8d87c3	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-23-1113_demographic	48	-17791	949	5a2431ef-c08f-54a7-8154-48b049a5370f	not hispanic or latino	female	white	released	Dead	1954	2004	TCGA-23-1113_exposure	Not Reported	28b53c86-4393-5d93-93df-5a253eb820a0	released	TCGA-23-1113_diagnosis	17791	not reported	0		b23cc40b-3cda-5ccc-9089-804096c70d8b	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-23-1113_treatment	TCGA-23-1113_treatment_1	released	f9bad516-36e1-5939-aae3-a947ec9eb0b2	no	Radiation Therapy, NOS	released	bc5b587b-3fd5-5627-8a8c-7cef1c6e0006	yes	Pharmaceutical Therapy, NOS	dcce8c4c-ee88-4c50-86f9-51bb2a291e41
25d6dd26-51c7-40dd-962a-c00abb70c5cb.htseq.counts.gz	ff7edff0-bfb5-4520-b729-cc8faa3390ab	TCGA-13-0884-01B-01R-1565-13	TCGA-13-0884-01B-01R	TCGA-13-0884-01B-01-TS1	TCGA-13-0884-01B-01-BS1	TCGA-13-0884-01B-01		TCGA-13-0884-01B	TCGA-13-0884	63a75e0b-9241-4f0e-9236-01a2e2c05b7e	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.3		D15552F3-1407-4C01-9B59-DFAC5D4EF095	1.8	5339b819-0e19-4b7d-a098-6f58afc07180			0.16	22	released	dd2892e3-1bec-4a0d-8881-7c8c72633291	RNA	R	0.16	UV Spec	released	False	57704565-219c-480e-8795-2e8838a01204	01			1.0		0.0	10.0	89.0	90.0	TOP	4bcf3062-6cc6-4759-9515-4d1674763ca5	released			1.0		0.0	10.0	89.0	90.0	BOTTOM	48ab706e-f243-4f72-b7c5-8b4a5b5dbcc0	released	released	107.0						4aa80346-4292-4863-9891-bb4c218880b3	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-13-0884_demographic	39	-14538	3260	ae611d16-8057-5154-9ece-95a2375c0d0d	not hispanic or latino	female	white	released	Dead	1960	2007	TCGA-13-0884_exposure	Not Reported	ae3d590c-11b2-5603-ae72-36477e4c585a	released	TCGA-13-0884_diagnosis	14538	not reported	0	3260	e48908e4-4f4e-59d5-a1a0-2344695aed5f	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-13-0884_treatment	TCGA-13-0884_treatment_1	released	7867df2e-1008-525a-80a2-a852709f7689	no	Radiation Therapy, NOS	released	93426d44-3eea-51af-9b25-d6c928001448	yes	Pharmaceutical Therapy, NOS	ff7edff0-bfb5-4520-b729-cc8faa3390ab
51b8dd7e-1686-46bb-9a29-b0a368eaadcc.htseq.counts.gz	874a58d2-25b6-441e-94ef-458771c2b9b2	TCGA-13-1501-01A-01R-1565-13	TCGA-13-1501-01A-01R	TCGA-13-1501-01A-01-TS1	TCGA-13-1501-01A-01-BS1	TCGA-13-1501-01A-01		TCGA-13-1501-01A	TCGA-13-1501	561968ce-da9a-4d69-8bc2-bc87b9550f93	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.5		7D27D441-D069-4674-A761-299E315D67C1	1.8	d6c7ab9b-7928-4b66-9fc7-7d3c8146e92d			0.15	22	released	b081907a-6b9c-49d3-a3a3-84e60228bc52	RNA	R	0.15	UV Spec	released	False	08dc2059-595a-4d80-bba9-1a82141a825a	01			0.0		0.0	30.0	70.0	70.0	TOP	955ec489-489b-4ec1-8410-3f5e0bccc505	released			1.0		0.0	30.0	69.0	70.0	BOTTOM	8fabb2f9-a340-49c1-ab64-9208a2fe1760	released	released	134.0						7579e91b-80df-4ab7-a775-e33418d17b1f	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1501_demographic	50	-18393	1314	e89502e6-68a4-5a1d-a6c1-13aa96457707	not hispanic or latino	female	white	released	Dead	1956		TCGA-13-1501_exposure	Not Reported	2132a89b-b63c-5aa5-94ae-bc89e1989ada	released	TCGA-13-1501_diagnosis	18393	not reported	0	999	834e617b-cd0e-5abb-b039-d8e48e862451	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-13-1501_treatment	TCGA-13-1501_treatment_1	released	fd6af9dd-59a5-5c52-82e8-86bcf871cdde	no	Radiation Therapy, NOS	released	5c5b47f0-5857-5ab0-a053-5ae91ac4bf37	yes	Pharmaceutical Therapy, NOS	874a58d2-25b6-441e-94ef-458771c2b9b2
276e88b0-deb7-452f-9499-bd770c72f0cc.htseq.counts.gz	5ab29210-930e-4f81-b9d0-49b934e54e89	TCGA-25-1877-01A-01R-1567-13	TCGA-25-1877-01A-01R	TCGA-25-1877-01A-01-TS1	TCGA-25-1877-01A-01-BS1	TCGA-25-1877-01A-01		TCGA-25-1877-01A	TCGA-25-1877	077079c3-6877-467b-b9cc-5c650aae4f07	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.7		D98B5A1F-DF34-43E7-826F-BCB45DEC582D	1.8	39639797-675b-4f3c-9959-7e3344bea0d1			0.14	22	released	291f0c92-b34d-46af-9e0e-ee2d904c8924	RNA	R	0.14	UV Spec	released	False	85aed4dc-34aa-4917-945a-6c2e78dbe37e	01	0.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	TOP	5ee23474-2d31-4fb3-b0cd-5c105aa8e6d9	released	0.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	BOTTOM	244e6637-9bcf-4aea-ac10-8564d480884a	released	released	175.0						95bc63bd-436a-4ee4-91dd-95c5188fe261	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-25-1877_demographic	81	-29615	730	b10665a5-1955-5d79-92f4-5917a33bfa22	not hispanic or latino	female	white	released	Dead	1912	1995	TCGA-25-1877_exposure	Not Reported	f0e00b3f-8239-54f9-8ff2-5bb244e86ece	released	TCGA-25-1877_diagnosis	29615	not reported	0	549	96598802-b58e-538b-a149-13802533384c	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1993	TCGA-25-1877_treatment_1	TCGA-25-1877_treatment	released	12b032b5-b535-5415-b63c-b1dde48f1c0b	yes	Pharmaceutical Therapy, NOS	released	db1814cc-564c-5d6c-b21d-ce6dc60a5b57	no	Radiation Therapy, NOS	5ab29210-930e-4f81-b9d0-49b934e54e89
ce9deae0-fdae-4c71-baee-d9054fdd0f77.htseq.counts.gz	2566bd4b-ec4f-497a-b8d3-f7081339395f	TCGA-13-0766-01A-02R-1564-13	TCGA-13-0766-01A-02R	TCGA-13-0766-01A-01-BS1	TCGA-13-0766-01A-02-BS2	TCGA-13-0766-01A-02		TCGA-13-0766-01A	TCGA-13-0766	8fe44099-b313-4bfd-a94a-27e72f2a818c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.7		7F283E4B-70F9-4834-866C-B91024C74EA3	1.8	30be1179-7922-4af7-b234-270fd88a2965			0.18	22	released	91d2c998-e7df-4e3d-a0b3-6276fac8ebfb	RNA	R	0.18	UV Spec	released	False	4c4dc5a6-0ff3-4007-9328-e6db1995cc16	02			5.0		20.0		75.0	80.0	TOP	50c7234c-9da1-4c26-8ef8-137c0c0c07e8	released			1.0		20.0		79.0	80.0	BOTTOM	3710a5cd-90f0-4d8a-9b23-a85b0640f834	released	released	180.0						03e8c3f2-99b6-40da-862a-e8263475c434	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-0766_demographic	42	-15571	1725	e30ceb01-2a0d-5f44-bc94-3364ba25f4fc	not hispanic or latino	female	white	released	Dead	1964		TCGA-13-0766_exposure	Not Reported	826d1560-dc45-59e8-998d-937c05f08c8d	released	TCGA-13-0766_diagnosis	15571	not reported	0	651	f8151830-32c5-5123-9995-74276a780df0	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-13-0766_treatment	TCGA-13-0766_treatment_1	released	a2a52632-1831-541a-9c2c-efc2cc36edfa	no	Radiation Therapy, NOS	released	aaebe960-6cc1-52f7-bd16-1aa761773474	yes	Pharmaceutical Therapy, NOS	2566bd4b-ec4f-497a-b8d3-f7081339395f
7570289f-debf-40f9-9e2e-c5acf19626f4.htseq.counts.gz	55bc25ed-d04d-4240-bc10-1262d10944ff	TCGA-23-1029-01B-01R-1567-13	TCGA-23-1029-01B-01R	TCGA-23-1029-01B-01-BS1	TCGA-23-1029-01B-01-TS1	TCGA-23-1029-01B-01		TCGA-23-1029-01B	TCGA-23-1029	4d71dd15-cd01-4dae-ad70-6dc325140207	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	0.8		89E1F403-12CB-442A-9588-CF5C0AC0E0A6	1.8	9a54d0fe-f998-4866-bb1f-92be472d843a			0.15	22	released	1abd427f-c397-4243-9fbb-fe94870d4b56	RNA	R	0.15	UV Spec	released	False	a5987ed4-7e26-40ee-af60-8fd77fec4c6c	01			5.0		0.0	20.0	75.0	80.0	BOTTOM	f0bd82cb-50ca-4cf3-bd28-c28ff2a7cde8	released			0.0		0.0	20.0	80.0	80.0	TOP	cd4d75b5-bc4f-448a-84a3-f34c172f8d61	released	released	115.0						5e13d3ce-ac89-4316-94a1-8395bd56fbfa	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-23-1029_demographic	46	-16889		47da8915-429e-5f86-a3b6-e4843fb7c2fb	not hispanic or latino	female	white	released	Alive	1961		TCGA-23-1029_exposure	Not Reported	8d9fa592-447b-5441-a202-910327c0d927	released	TCGA-23-1029_diagnosis	16889	not reported	0	268	d9297888-91e7-5eb6-9a85-03216ab39514	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-23-1029_treatment	TCGA-23-1029_treatment_1	released	06f0f0d2-b145-53d0-92bf-9bac4e55328c	no	Radiation Therapy, NOS	released	724db254-9d33-5bf4-a86f-b383abab3430	yes	Pharmaceutical Therapy, NOS	55bc25ed-d04d-4240-bc10-1262d10944ff
4b63696f-c8f8-4601-8751-d8efda9224a3.htseq.counts.gz	3d9c2046-d2b1-4a09-b92d-273bacf9da6c	TCGA-59-2350-01A-01R-1569-13	TCGA-59-2350-01A-01R	TCGA-59-2350-01A-01-BS1	TCGA-59-2350-01A-01-TS1	TCGA-59-2350-01A-01		TCGA-59-2350-01A	TCGA-59-2350	e978a457-92ff-4eab-b759-ec6e74d973e8	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.4		6bd3f7a6-bb9c-42ea-8f20-94db43b51bde	1.8	e05f2e2a-77d2-4f86-8e21-27cdd93b88b0			0.15	22	released	db204de9-4c43-4801-bebe-33eaff5bd7e5	RNA	R	0.15	UV Spec	released	False	568ebc92-bbac-4c06-ab2e-55e34b0f1c2f	01			1.0		1.0	19.0	79.0	80.0	BOTTOM	d023d22a-2e51-4f61-8cd6-b45d4cfdc006	released			5.0		1.0	19.0	75.0	80.0	TOP	57e502c7-e6b8-4ccc-9ff7-6719c58f48e0	released	released	158.0						d10b7299-8788-4800-b0a4-e836a18d5def	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-59-2350_demographic	44		679	acbb0dbd-a668-5906-9c1c-4d880389bda6	not reported	female	not reported	released	Dead	1951	1996	TCGA-59-2350_exposure	Not Reported	04e692ec-ebec-5678-b3d6-a2dad6d16c07	released	TCGA-59-2350_diagnosis		not reported	0		ad6e91d2-df71-5fea-b6c5-59d3ea208c19	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1995	TCGA-59-2350_treatment_1	TCGA-59-2350_treatment	released	3394a77b-3154-553d-90d0-66854cebfe11	not reported	Pharmaceutical Therapy, NOS	released	ebdcc39f-1e19-5139-bc18-9fb31e737393	not reported	Radiation Therapy, NOS	3d9c2046-d2b1-4a09-b92d-273bacf9da6c
73ed989a-7f6a-4cff-a7f7-f99157535c7b.htseq.counts.gz	e15cbbfd-bf51-41da-847d-cd75da5a59a4	TCGA-30-1714-01A-02R-1567-13	TCGA-30-1714-01A-02R	TCGA-30-1714-01A-01-BS1	TCGA-30-1714-01A-02-BS2	TCGA-30-1714-01A-02		TCGA-30-1714-01A	TCGA-30-1714	09820a33-80b1-42d0-8366-a0ddaf94b122	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.6		7bec7160-e40c-4b47-b0d6-93652c5e27f2	1.8	c990f93e-c4e1-4192-b948-31a5bda0ff72			0.15	22	released	4d91c2c6-6d27-461a-9e73-17051a1ede6f	RNA	R	0.15	UV Spec	released	False	bebcb16b-0070-47cc-b184-b6d0bdd05d08	02			2.0		0.0	38.0	60.0	85.0	TOP	d9272491-1098-49d2-9bec-c1dfa452548d	released			2.0		0.0	23.0	75.0	85.0	BOTTOM	d261005c-31b3-4a48-9530-3e24454a3d98	released	released	140.0						44b8b591-5dd6-4b93-bd8f-d1c3284af41f	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-30-1714_demographic	68	-25032	1158	490023f5-f2f1-5600-b594-3718d8334148	not hispanic or latino	female	white	released	Dead	1933	2004	TCGA-30-1714_exposure	Not Reported	be9daf86-84d7-564c-bff7-01df2898eed6	released	TCGA-30-1714_diagnosis	25032	not reported	0	1158	8d5d54a4-1e71-57dd-aac3-36c47e241a56	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-30-1714_treatment	TCGA-30-1714_treatment_1	released	b1df4a94-84bb-5f56-9709-b3580d2dcb0c	yes	Radiation Therapy, NOS	released	eac0617c-c23d-5ffa-8e20-613de44326a3	yes	Pharmaceutical Therapy, NOS	e15cbbfd-bf51-41da-847d-cd75da5a59a4
a1c4f19e-079e-47e7-8939-3122c56bbb98.htseq.counts.gz	bc6dab72-dc5a-4ca6-aef3-f7242fa8e329	TCGA-13-0795-01A-01R-1564-13	TCGA-13-0795-01A-01R	TCGA-13-0795-01A-01-TS1	TCGA-13-0795-01A-01-BS1	TCGA-13-0795-01A-01		TCGA-13-0795-01A	TCGA-13-0795	b1e11e94-646b-4c44-9d33-1ca67d8356fb	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	1.4		B98206EC-73D1-404F-B497-BAD6C817D9B7	1.8	5345eef4-ee81-4128-96fb-85c29750cc96			0.19	22	released	8db456cc-e692-40fe-9e86-a28751867bdd	RNA	R	0.19	UV Spec	released	False	81fe814f-4faa-42eb-98f0-f0aac99849bc	01	75.0		0.0		0.0	15.0	85.0	95.0	TOP	715a85bd-eb61-468f-8e17-dc8088b4af18	released			0.0		0.0	5.0	95.0	98.0	BOTTOM	2f633977-70d5-4b3b-878e-64cef7142c05	released	released	135.0						61ef4d54-bfa5-4d62-89bc-2717eabc741b	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-0795_demographic	66	-24403	619	765b568d-c940-5239-92dc-26c4c0431db1	not hispanic or latino	female	white	released	Dead	1941		TCGA-13-0795_exposure	Not Reported	5c96b656-ef31-56c7-afc2-7005e37d12d4	released	TCGA-13-0795_diagnosis	24403	not reported	0	596	049f6c9e-4b02-5c39-ad7f-5f357c226bc5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-13-0795_treatment_1	TCGA-13-0795_treatment	released	01ba7818-7a54-5fcd-ae9a-7961d01adc18	yes	Pharmaceutical Therapy, NOS	released	61f9e645-1126-57fe-8301-cdfbba84acac	no	Radiation Therapy, NOS	bc6dab72-dc5a-4ca6-aef3-f7242fa8e329
dabdc0ac-e436-4140-ba66-52a7d7c50ee0.htseq.counts.gz	1ac7e64a-05ad-49cd-afad-c96415618475	TCGA-13-0765-01A-01R-1564-13	TCGA-13-0765-01A-01R	TCGA-13-0765-01A-01-BS1	TCGA-13-0765-01A-01-TS1	TCGA-13-0765-01A-01		TCGA-13-0765-01A	TCGA-13-0765	774ce281-96b2-467a-9170-079797ee10f7	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.2		96588189-C273-4095-88C5-9E22368813C0	1.8	d5c33d85-54da-455b-aa65-aaec79af99b0			0.18	22	released	777a4691-563e-448e-8204-8ad28b267eca	RNA	R	0.18	UV Spec	released	False	980df042-9548-4789-abde-4fa640e3e76e	01			1.0		1.0		98.0	99.0	BOTTOM	8f9bff9c-ecb0-4f82-aef3-6b55da5dc88c	released			0.0		0.0	5.0	95.0	90.0	TOP	9d588c3d-dc12-4984-a9d6-c5d048ab5f47	released	released	83.0						1fa2d0a4-26a3-4b7b-818b-e20cc200a0ed	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-0765_demographic	50	-18574	1389	7d9699a9-4ea0-5b30-bcda-46dac07eac0a	not hispanic or latino	female	white	released	Dead	1956		TCGA-13-0765_exposure	Not Reported	4297e867-0a1b-5f52-975c-941e707f3ca9	released	TCGA-13-0765_diagnosis	18574	not reported	0	869	15b1a19f-09af-5637-a630-135ff926fb81	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-13-0765_treatment_1	TCGA-13-0765_treatment	released	7b21ae69-fdd3-5060-9019-18a7a9f5434b	yes	Pharmaceutical Therapy, NOS	released	e85c2b74-e4ec-55fd-b9e6-2edf90f5a946	no	Radiation Therapy, NOS	1ac7e64a-05ad-49cd-afad-c96415618475
cf926727-8d8a-4dea-87cb-18aeb4ab216d.htseq.counts.gz	5a38be76-b217-4ee2-9eee-b97683d5d8b2	TCGA-23-1030-01A-02R-1564-13	TCGA-23-1030-01A-02R	TCGA-23-1030-01A-02-BS2	TCGA-23-1030-01A-01-BS1	TCGA-23-1030-01A-02		TCGA-23-1030-01A	TCGA-23-1030	cbcf6922-a3c0-43a1-826e-642918b0a635	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.5		E44D825F-89EE-4FF7-B6D6-B0B17E305B2C	1.8	0cdd0255-c7b2-4cbc-8306-37e74d295324			0.17	22	released	cbf5bc94-6673-4420-b0bd-ed89eac96e4f	RNA	R	0.17	UV Spec	released	False	a4b56e1a-ec0f-497e-aaee-d4615bd78f32	02			5.0		5.0	5.0	85.0	95.0	BOTTOM	b0ce8e47-ce2c-430e-82d7-dbb75c3d373c	released			0.0		5.0	0.0	95.0	95.0	TOP	d3ebeb41-5e90-4826-bda8-8a48f3669622	released	released	52.0						b3716b9c-af9c-41cd-9ceb-f45fcda4a2d5	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-23-1030_demographic	64	-23416		e8dc4dd7-3263-5e49-bcf9-65c4e263a04f	not hispanic or latino	female	white	released	Alive	1942		TCGA-23-1030_exposure	Not Reported	4a09b799-e2b2-5082-b435-b1759a2b2c5e	released	TCGA-23-1030_diagnosis	23416	not reported	0	886	c428661a-76b6-5998-8f9e-3de1a5441bc1	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-23-1030_treatment	TCGA-23-1030_treatment_1	released	595cde23-d937-59f1-b3f6-4237faf481bc	no	Radiation Therapy, NOS	released	c0ddbd31-036a-593f-9d7b-923bfb50a303	yes	Pharmaceutical Therapy, NOS	5a38be76-b217-4ee2-9eee-b97683d5d8b2
590b183e-6bd5-4e23-b41c-7301575c4aa6.htseq.counts.gz	64b2ee7c-f463-4775-9584-63c4aa8297ee	TCGA-13-1506-01A-01R-1565-13	TCGA-13-1506-01A-01R	TCGA-13-1506-01A-01-TS1	TCGA-13-1506-01A-01-BS1	TCGA-13-1506-01A-01		TCGA-13-1506-01A	TCGA-13-1506	1cc02c64-a34e-46ae-9bc7-5d50f2fefb31	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.1		88E423FF-4070-4F01-A0B0-41B45443E762	1.8	927c7b6d-3997-453b-81b1-b947341d5819			0.16	22	released	459d797e-5c4b-4192-8e2c-1a9c6346f14a	RNA	R	0.16	UV Spec	released	False	97ee27ec-0863-4a67-b5af-e6cd6a82428d	01			1.0		0.0	1.0	98.0	99.0	TOP	d6daf712-ccb4-4ecd-859f-c24b37baee13	released			1.0		0.0	1.0	98.0	99.0	BOTTOM	790a38ba-47d7-4ac4-a25e-50a17f9a2a87	released	released	148.0						4725c6d3-c67d-4ce8-a4c1-68c242183ce3	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-13-1506_demographic	45	-16734	1039	75bc4385-e9df-5793-a283-7c3a014c1c85	not hispanic or latino	female	white	released	Dead	1963		TCGA-13-1506_exposure	Not Reported	ec4237fb-49d3-5915-9899-d90b86e7f653	released	TCGA-13-1506_diagnosis	16734	not reported	0	134	b7b88b39-5b78-5c15-a1fb-100e200d6917	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1506_treatment_1	TCGA-13-1506_treatment	released	db9278d6-ee30-5338-8a6c-1569ddb8322f	yes	Pharmaceutical Therapy, NOS	released	dccd01fd-9917-5b2c-8e65-030281a82c81	no	Radiation Therapy, NOS	64b2ee7c-f463-4775-9584-63c4aa8297ee
e47d5da5-4752-46d0-846f-f626be1793ed.htseq.counts.gz	9c2d4394-411d-4f12-b033-7d9b4c8ea430	TCGA-29-1769-01A-01R-1567-13	TCGA-29-1769-01A-01R	TCGA-29-1769-01A-01-TS1	TCGA-29-1769-01A-01-BS1	TCGA-29-1769-01A-01		TCGA-29-1769-01A	TCGA-29-1769	94769f2c-b6fd-48ec-af34-b41165340b7c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.1		67f144b3-c10b-4f96-a70b-6794d817170f	1.8	f2ac7109-1071-47f7-af2a-2d655c475427			0.15	22	released	e5df11e5-e496-4e14-bace-42cbaeacad9b	RNA	R	0.15	UV Spec	released	False	96c2d0a0-6bf3-4cf0-a68b-c114d1720a58	01	2.0		0.0		10.0	5.0	85.0	90.0	TOP	11d4cb8d-65cc-466b-b776-9488e40cbd13	released	2.0		0.0		0.0	15.0	85.0	80.0	BOTTOM	2138180e-d18f-41c7-b87d-25a179a17229	released	released	113.0						cbfe2502-c3d1-44a5-bd1a-4a775c86d27f	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1769_demographic	40	-14754		c864bf04-f19e-53ae-98dc-29cf75ba37fe	not reported	female	white	released	Alive	1967		TCGA-29-1769_exposure	Not Reported	10ac90b2-2cf6-58cd-9678-5ceab7af4401	released	TCGA-29-1769_diagnosis	14754	not reported	0	699	4a6c3210-bd6e-5fed-aa66-cd78f1e21390	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-29-1769_treatment	TCGA-29-1769_treatment_1	released	11936ff0-0e52-5af1-a590-7c1e25af2352	no	Radiation Therapy, NOS	released	e1cdf72d-d1a7-520d-966e-76314f890772	yes	Pharmaceutical Therapy, NOS	9c2d4394-411d-4f12-b033-7d9b4c8ea430
517d7f3f-2ea0-4452-a743-8d0e3083a1bb.htseq.counts.gz	f0b11cc5-bc69-4e05-931b-444e4c01db2f	TCGA-24-1616-01A-01R-1566-13	TCGA-24-1616-01A-01R	TCGA-24-1616-01A-01-BS1	TCGA-24-1616-01A-01-TS1	TCGA-24-1616-01A-01		TCGA-24-1616-01A	TCGA-24-1616	5d7027f5-60a0-47ab-a79d-667c9acc0e54	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	0.9		d8c764d9-0fe8-488e-8aa1-da73a8c10b01	1.8	c334b353-0652-49fb-8cd6-5bcf8485e5d0			0.17	22	released	ba4cc7ff-3f7e-414b-90bc-6c35a3f50dc8	RNA	R	0.17	UV Spec	released	False	8506679e-5ddf-4185-a99e-5f2a923ee70f	01			0.0		0.0	30.0	70.0	80.0	BOTTOM	88f13167-f84b-47af-9e96-c9e2750a70e3	released			5.0		0.0	35.0	60.0	70.0	TOP	8b605a9a-3f71-4af6-b7eb-1bb33efa45ed	released	released	106.0						20d8a43d-e1a7-4e85-8da2-2e9b5f1d3a9a	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-1616_demographic	56	-20785	1163	b5a2d23a-7e9e-5ce2-bf23-c98e8e04a0a6	not reported	female	white	released	Dead	1945	2004	TCGA-24-1616_exposure	Not Reported	07d64dfb-f638-534f-9c67-4ae276c6bbfc	released	TCGA-24-1616_diagnosis	20785	not reported	0	1163	661d13d0-4961-5a39-bd67-d1665dda7bc5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-24-1616_treatment	TCGA-24-1616_treatment_1	released	e6ea5986-200c-5661-801e-6fd1cda8c46f	no	Radiation Therapy, NOS	released	9ff9ebb1-ef7b-5e0f-9c89-bf21ed15c2d7	yes	Pharmaceutical Therapy, NOS	f0b11cc5-bc69-4e05-931b-444e4c01db2f
fb4b490a-de40-4f75-919d-4fb180647eca.htseq.counts.gz	ec9d45db-4cd7-47d9-8762-1a73ddac872f	TCGA-25-2396-01A-01R-1569-13	TCGA-25-2396-01A-01R	TCGA-25-2396-01A-01-TS1	TCGA-25-2396-01A-01-BS1	TCGA-25-2396-01A-01		TCGA-25-2396-01A	TCGA-25-2396	6264e699-d40b-4ebc-b443-0a0edcb220dc	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.0		5AD36576-BDCD-4DE8-9D8C-CD8BE71E4FCF	1.8	43352a4d-f866-4ed7-81f5-5dc478c10992			0.14	22	released	d4e2dc59-69d1-4a1d-8c43-f7d3a077e27d	RNA	R	0.14	UV Spec	released	False	ff9883df-d839-4b72-8cbc-846238c86523	01			0.0		0.0	10.0	90.0	90.0	TOP	80e91a24-243b-410c-a9dc-790aa3b8f6ca	released			1.0		1.0	10.0	88.0	90.0	BOTTOM	cfdcc756-47ed-4f58-a6b5-825c9eba0da5	released	released	144.0						96d1655d-0a5e-4e2e-b9eb-f422ced79483	Primary Tumor	01	1.0	released	Not Reported	released	TCGA-25-2396_demographic	71	-26145	92	abae41c1-1b5e-5262-b644-b8d7fc00fabd	not hispanic or latino	female	white	released	Dead	1933	2004	TCGA-25-2396_exposure	Not Reported	b667f658-306e-5fe3-ae98-507e47096106	released	TCGA-25-2396_diagnosis	26145	not reported	0	92	962f2f69-2e79-50fc-ba72-03bf96cc0d4b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-25-2396_treatment	TCGA-25-2396_treatment_1	released	8f8e49d6-d0fd-5c94-8001-0861b70d6517	no	Radiation Therapy, NOS	released	55f59db7-7aa3-5f4c-83d3-faa02f15135e	not reported	Pharmaceutical Therapy, NOS	ec9d45db-4cd7-47d9-8762-1a73ddac872f
a6542a39-6092-4a62-aa6d-51bfba48ef10.htseq.counts.gz	98d68a27-7017-4b56-859c-5009aaaae371	TCGA-13-0804-01A-01R-1564-13	TCGA-13-0804-01A-01R	TCGA-13-0804-01A-01-BS1	TCGA-13-0804-01A-01-TS1	TCGA-13-0804-01A-01		TCGA-13-0804-01A	TCGA-13-0804	7e34d3c1-1fab-4326-9a69-4260d2bac558	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.3	False	1.5		34870541-DEE9-4B39-A292-117E443B1CBF	1.8	220b144c-9f9c-459a-b332-5d6e5dedb686			0.17	22	released	5c6e4cf9-b03b-4ea6-96dc-8101d6de5edb	RNA	R	0.17	UV Spec	released	False	503d11a0-88cd-4d99-b1f6-23380ea51de9	01			1.0		0.0	4.0	95.0	98.0	BOTTOM	bc23d958-ae94-4d3f-ad5c-2a42dbc98154	released			0.0		0.0	5.0	95.0	98.0	TOP	b9fae803-f9dd-47ee-8417-3f7af1bbf123	released	released	146.0						7432f954-a16f-4053-bedd-aa776f939f71	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-0804_demographic	73	-27021	1073	8b22ed63-d399-5745-b49d-e471cc2b44b8	not hispanic or latino	female	white	released	Dead	1930	2005	TCGA-13-0804_exposure	Not Reported	bb6447ea-4585-5551-8f49-941909778071	released	TCGA-13-0804_diagnosis	27021	not reported	0	1073	f43741dc-837f-5308-a339-6bfc823b87e7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-13-0804_treatment_1	TCGA-13-0804_treatment	released	8446b149-1794-5c7f-8f49-0b5393962b3b	yes	Pharmaceutical Therapy, NOS	released	275af04f-ee9a-5d95-94a0-05805c337d99	no	Radiation Therapy, NOS	98d68a27-7017-4b56-859c-5009aaaae371
d15fbebd-39c7-4714-b6f3-fe920cdd8bef.htseq.counts.gz	4e37723e-008b-4397-8287-e95bf5f8c04a	TCGA-13-0920-01A-01R-1564-13	TCGA-13-0920-01A-01R	TCGA-13-0920-01A-01-TS1	TCGA-13-0920-01A-01-BS1	TCGA-13-0920-01A-01		TCGA-13-0920-01A	TCGA-13-0920	85a85a11-7200-4e96-97af-6ba26d680d59	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.0		6880B406-08B2-43CE-9274-5826B1BE9114	1.8	2d8e1b4d-85d0-4bfd-99f7-59559dabe978			0.14	22	released	26a45072-a0b6-4f68-8548-4da1cc6e866a	RNA	R	0.14	UV Spec	released	False	98846f4e-19c8-46fd-97a8-bfa90e1c62c5	01			0.0		0.0	20.0	80.0	90.0	TOP	865199e6-7b94-40ef-82e8-e65aa9377818	released			0.0		0.0	20.0	80.0	90.0	BOTTOM	b7b9daea-d790-433c-93b2-db5e26827f30	released	released	113.0						a2530fac-9d42-4fbe-881b-e9bad5a2d793	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0920_demographic	65	-24064	1484	4d9e60db-29bf-55a5-b771-45b205a0536b	not hispanic or latino	female	white	released	Dead	1942		TCGA-13-0920_exposure	Not Reported	bde5cd78-5a04-548a-b5fa-e39faebbba77	released	TCGA-13-0920_diagnosis	24064	not reported	0	420	aa92074b-b296-596b-a4d9-ceb3ab1e0160	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-13-0920_treatment	TCGA-13-0920_treatment_1	released	2ef54a76-92fa-5238-a468-e54efb2cf108	no	Radiation Therapy, NOS	released	a926e02c-6113-55e4-b8c3-da5be8ab487a	yes	Pharmaceutical Therapy, NOS	4e37723e-008b-4397-8287-e95bf5f8c04a
65ce7190-f1ef-496a-8e47-bcedd8dce223.htseq.counts.gz	feb4ff14-7dcb-41a5-80d6-2df76d05e529	TCGA-29-1710-01A-02R-1567-13	TCGA-29-1710-01A-02R	TCGA-29-1710-01A-01-BS1	TCGA-29-1710-01A-02-BS2	TCGA-29-1710-01A-02		TCGA-29-1710-01A	TCGA-29-1710	4261267c-7042-4c6e-83ed-12fb401003fc	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.8		52a0d2ae-7467-40f0-b8f3-59812cfac52a	1.8	3bf24456-4b70-4313-a04d-19aba239108d			0.15	22	released	26734927-d929-4a61-a124-9fd5fd63d2c5	RNA	R	0.15	UV Spec	released	False	7349f9ec-43fe-460d-adc1-9a76e38c2e49	02	10.0		10.0		0.0	0.0	90.0	80.0	TOP	3c2c042d-eb31-43f1-96e2-206e9ddd3a64	released	15.0		15.0		0.0	0.0	85.0	75.0	BOTTOM	8ed645cf-dd4b-4bff-b4c3-db614586760f	released	released	133.0						61513da0-4eb3-4cae-bfff-7b05f3362488	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1710_demographic	54	-19969	951	9a82b4e9-f427-5855-bbf0-dc8473c619e0	not reported	female	white	released	Dead	1952	2008	TCGA-29-1710_exposure	Not Reported	12101d8f-0865-5a68-a52b-8789ae4cff64	released	TCGA-29-1710_diagnosis	19969	not reported	0	889	fcbce65c-5e58-502e-bbc5-5dce69cd809f	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-29-1710_treatment	TCGA-29-1710_treatment_1	released	29cda261-919a-51bc-a091-536c588f2ac4	no	Radiation Therapy, NOS	released	1878574a-c55c-5561-8f05-b6b244c9295e	yes	Pharmaceutical Therapy, NOS	feb4ff14-7dcb-41a5-80d6-2df76d05e529
f8397fad-30b3-41a1-8d44-52d939e77a06.htseq.counts.gz	b920a03b-c2b0-4f87-b185-5ac7fbfe2573	TCGA-13-0905-01B-01R-1565-13	TCGA-13-0905-01B-01R	TCGA-13-0905-01B-01-TS1	TCGA-13-0905-01B-01-BS1	TCGA-13-0905-01B-01		TCGA-13-0905-01B	TCGA-13-0905	2038fd65-d8f1-4b16-af90-b1c8f9a379a7	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		4EC6E47F-60BD-413E-9371-D70E1E89D0CA	1.8	6deb1bf0-273a-47ba-9698-3d38ab05f02c			0.14	22	released	edddf635-c923-46e8-914d-d42d860679ad	RNA	R	0.14	UV Spec	released	False	9698c708-d181-4426-b424-fb8d6067454e	01			1.0		0.0	5.0	94.0	95.0	TOP	375bb21d-bdbb-43d2-81f7-2c63c90229fd	released			1.0		0.0	5.0	94.0	95.0	BOTTOM	bff74514-98ec-4d1e-88af-a00aeabd9686	released	released	141.0						3590ce4c-2c63-42f8-ac73-8d813301ef2d	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-0905_demographic	51	-18757		48698460-7bda-5e2d-bc8b-c4314044aaca	not hispanic or latino	female	white	released	Alive	1954		TCGA-13-0905_exposure	Not Reported	d6368bb1-317f-59b9-be18-4a0dfe71f5a7	released	TCGA-13-0905_diagnosis	18757	not reported	0	3746	f00a9a54-c99b-5b21-acd3-6fae35b74a82	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-13-0905_treatment_1	TCGA-13-0905_treatment	released	d9d98a1a-d1ad-5957-8603-ecde648983d5	yes	Pharmaceutical Therapy, NOS	released	bd53d914-bb52-5fcd-aa09-68d4e03edab9	no	Radiation Therapy, NOS	b920a03b-c2b0-4f87-b185-5ac7fbfe2573
9facd5d5-33cc-485f-b80a-b613f936f2d5.htseq.counts.gz	842def11-251c-4dfa-a87c-d49869f4b99d	TCGA-24-1467-01A-01R-1566-13	TCGA-24-1467-01A-01R	TCGA-24-1467-01A-01-TS1	TCGA-24-1467-01A-01-BS1	TCGA-24-1467-01A-01		TCGA-24-1467-01A	TCGA-24-1467	34f545ab-d420-4dd2-8db4-3159896efd23	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.2	False	1.3		6949EFBE-C2EA-4767-B194-2343254F2752	1.8	22902cdb-69f7-4bfc-a5c3-a56229ee501d			0.13	22	released	9e3575f4-6cc6-409d-a9f1-10210699b4d7	RNA	R	0.13	UV Spec	released	False	ae599a24-fb3d-4e78-9123-e93435c3fd7e	01			1.0		0.0	4.0	95.0	95.0	TOP	8d52fd5c-4233-4756-9250-e1e9da4cd119	released			1.0		0.0	19.0	80.0	80.0	BOTTOM	2a7d2b3c-a015-48eb-9ca7-da9e52c29a19	released	released	106.0						b0b13b63-cf9d-4cb9-a3fa-217d499763f8	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-24-1467_demographic	51	-18652	3224	6a7e579e-29e7-5428-ae75-1909d32d4438	not reported	female	white	released	Dead	1947	2006	TCGA-24-1467_exposure	Not Reported	d575ea43-29eb-5509-ad8e-c3b089f014c7	released	TCGA-24-1467_diagnosis	18652	not reported	0	3224	e3e76f36-15de-5e61-98f3-e52149f98d4a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-24-1467_treatment	TCGA-24-1467_treatment_1	released	aca9b339-bbca-5160-a750-2a740c69e77d	no	Radiation Therapy, NOS	released	2703680d-ff7d-582d-a8af-9aab3269991e	yes	Pharmaceutical Therapy, NOS	842def11-251c-4dfa-a87c-d49869f4b99d
1475a657-0f90-4308-a59f-f6c51f60216c.htseq.counts.gz	870f8b40-9a34-4024-b40e-f76c27d42ee6	TCGA-24-2023-01A-01R-1567-13	TCGA-24-2023-01A-01R	TCGA-24-2023-01A-01-TS1	TCGA-24-2023-01A-01-BS1	TCGA-24-2023-01A-01		TCGA-24-2023-01A	TCGA-24-2023	5201ee13-2aed-4641-9169-4d5ee07a23da	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		2a255fa6-65cd-4fb7-9d08-1b6aadd6682b	1.8	11fd4bb1-0f8d-4830-a7f0-83897a5df11d			0.15	22	released	5c9eb981-8a09-4fec-af22-fecd769e031f	RNA	R	0.15	UV Spec	released	False	b0409915-e519-4534-b8fd-c16d55007d96	01	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	86bdd454-e8a5-4343-a6b9-85c9f0b4c291	released	5.0	0.0	0.0	0.0	0.0	20.0	80.0	85.0	BOTTOM	c8d44f47-325c-41b4-99be-a9383fe47b08	released	released	151.0						3ab5e7ea-fc93-4a73-b43d-c3c74ad48bdb	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-24-2023_demographic	54	-19901	1364	324846aa-8368-59b7-8d95-4373adb15ded	not reported	female	white	released	Dead	1940	1997	TCGA-24-2023_exposure	Not Reported	7f93c034-f85d-5aff-9113-a93103553e8f	released	TCGA-24-2023_diagnosis	19901	not reported	0	1364	04bf3f6d-f3c0-510b-a8eb-a46860525c7f	Stage IIIA	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1994	TCGA-24-2023_treatment_1	TCGA-24-2023_treatment	released	1b23f056-de17-5da8-b84a-de4ad174a154	yes	Pharmaceutical Therapy, NOS	released	13f840e8-656a-5562-86e9-db457e4e02ca	no	Radiation Therapy, NOS	870f8b40-9a34-4024-b40e-f76c27d42ee6
47ecef21-f50f-4da1-a267-4466eca80b28.htseq.counts.gz	af6d5688-bd48-452a-8be7-3b90b0d85c25	TCGA-61-2098-01A-01R-1568-13	TCGA-61-2098-01A-01R	TCGA-61-2098-01A-01-TS1	TCGA-61-2098-01A-01-BS1	TCGA-61-2098-01A-01		TCGA-61-2098-01A	TCGA-61-2098	eb7c3b35-7a5e-4621-b31f-9775c51f9a23	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	2		d1c8ab49-5ba0-46c3-8205-53b4e39808b3	1.8	d855f86a-f302-47fb-aa9f-5977632c695a	3.2	20	0.16	22	released	8d77e92b-0e3c-4cce-934e-894e441a8d72	RNA	R	0.16	UV Spec	released	False	2e38f9d2-8051-4cf6-879b-9e5f56bd945c	01			0		0	30	70	70	TOP	a353a944-d562-4992-bea2-6c23d01c685a	released			0		0	20	80	80	BOTTOM	7640aaad-f469-464d-a0cd-efee54d913b9	released	released	133						60b275ef-91db-4572-a187-74fea2507bb8	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-61-2098_demographic	62	-22876		cf4091c2-42a1-5de2-ae37-e74fa4824373	not reported	female	white	released	Alive	1941		TCGA-61-2098_exposure	Not Reported	6375653f-0d84-5775-957c-d9de85ea49c4	released	TCGA-61-2098_diagnosis	22876	not reported	0	1993	00f8ee1c-618f-530e-8d64-954aff8478aa	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-61-2098_treatment_1	TCGA-61-2098_treatment	released	dfbb734a-d2ad-560d-b43e-8330d2ef01da	yes	Pharmaceutical Therapy, NOS	released	2988bc18-b975-53a3-b1b9-338cb73f5f51	no	Radiation Therapy, NOS	af6d5688-bd48-452a-8be7-3b90b0d85c25
caa50267-cc68-4ccc-b506-49a89b163510.htseq.counts.gz	2e5423de-4c4c-4b74-a476-9071c4e046d8	TCGA-31-1944-01A-01R-1568-13	TCGA-31-1944-01A-01R	TCGA-31-1944-01A-01-TS1	TCGA-31-1944-01A-01-BS1	TCGA-31-1944-01A-01		TCGA-31-1944-01A	TCGA-31-1944	6fee41dc-b8a9-4347-8085-b7e05f813ad0	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.0		bd7361f7-07c1-4be8-92c6-4f0a3dea99b2	1.8	c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2			0.16	22	released	f48d33b4-83e7-41f2-adb4-44b7427dd2df	RNA	R	0.16	UV Spec	released	False	196b5edd-12b5-404e-9256-1f721a059fe0	01			5.0		0.0	20.0	70.0	90.0	TOP	b8440d12-6207-4950-9b2f-4b6c007c6220	released			3.0		0.0	27.0	70.0	95.0	BOTTOM	1a8b04f1-bcc9-49fc-931d-c973e12f26f6	released	released	124.0						69617aa2-3b7b-47b5-9f34-2051339dfd34	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-31-1944_demographic	47	-17207		1846915b-b3b0-5629-bb73-f78bf2081edf	not hispanic or latino	female	white	released	Alive	1958		TCGA-31-1944_exposure	Not Reported	c36c4285-bcd1-5470-a3c1-e7d39443a0f3	released	TCGA-31-1944_diagnosis	17207	not reported	0	1386	b0da2290-ee62-5e0f-a177-72bc672062ec	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-31-1944_treatment_1	TCGA-31-1944_treatment	released	0b80d8c7-fdc1-5f6d-95ab-261e779fea6a	yes	Pharmaceutical Therapy, NOS	released	b53485cf-2228-50ab-a344-6deb35087b3f	no	Radiation Therapy, NOS	2e5423de-4c4c-4b74-a476-9071c4e046d8
2e01d725-ae04-49e8-9a45-52634cde5662.htseq.counts.gz	7294abba-fc68-4799-94fd-f46fc3852cb6	TCGA-57-1583-01A-01R-1566-13	TCGA-57-1583-01A-01R	TCGA-57-1583-01A-01-TS1	TCGA-57-1583-01A-01-BS1	TCGA-57-1583-01A-01		TCGA-57-1583-01A	TCGA-57-1583	76cc2d21-eebc-4f09-9bc7-dbf7af0aafa8	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.4		b899b485-621f-46df-8bda-97b0fbe10b6d	1.8	3a37e320-0301-4f2b-bf09-f102c12502b1			0.15	22	released	61f9f252-6319-4970-8720-9fd4bca79e74	RNA	R	0.15	UV Spec	released	False	153b158f-4ca0-4607-ba28-74e15ed4be10	01			1.0		0.0	10.0	94.0	95.0	TOP	cef6fee1-8770-4bb4-938d-7f620a481a6a	released			1.0		0.0	10.0	94.0	95.0	BOTTOM	77fcc4ab-f8e0-4afd-b935-28aafb05feda	released	released	98.0						04b379ac-220b-4582-84c8-be370d5ad619	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-57-1583_demographic	57	-21167	346	65d45d68-52f7-5bf9-83b6-a053ab03eef7	not reported	female	black or african american	released	Dead	1949	2006	TCGA-57-1583_exposure	Not Reported	41253661-d91a-5eca-9047-dd94251c5c8f	released	TCGA-57-1583_diagnosis	21167	not reported	0	346	03a569c0-4d70-554f-9b61-b414ecfffa8e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-57-1583_treatment_1	TCGA-57-1583_treatment	released	b57ddf1e-2be0-521d-a39c-11c1232ed0cc	yes	Pharmaceutical Therapy, NOS	released	34e4a5f6-22af-59c9-9dd1-e4c91dff74c6	no	Radiation Therapy, NOS	7294abba-fc68-4799-94fd-f46fc3852cb6
d1245eee-b6b7-42aa-856c-79148869cb2b.htseq.counts.gz	793878b7-cdbc-4492-a3fb-b5de9dadeddd	TCGA-24-1928-01A-01R-1567-13	TCGA-24-1928-01A-01R	TCGA-24-1928-01A-01-BS1	TCGA-24-1928-01A-01-TS1	TCGA-24-1928-01A-01		TCGA-24-1928-01A	TCGA-24-1928	b45c543a-40d9-423a-a7fa-98e4b325b487	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.5		dc4407fb-d15b-44d5-9c3b-129cca67d8f1	1.8	433d642a-06fe-454f-a2bf-3e0afb3dd23b			0.15	22	released	78594f1f-b1e6-4768-aaf2-9de8f8646ebd	RNA	R	0.15	UV Spec	released	False	dc0a6dfd-2a03-44d3-b841-d17384be596f	01	0.0	0.0	10.0	10.0	0.0	10.0	80.0	80.0	BOTTOM	909bd06c-69c4-4de3-a83f-8f84522e9594	released	0.0	0.0	5.0	5.0	0.0	15.0	80.0	80.0	TOP	590660da-409a-4caf-891f-c804870b37ef	released	released	108.0						595af317-cf8b-4f25-b005-426b078ffc4a	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-1928_demographic	77	-28126	336	e160398a-2b94-5d6a-88dc-1950614fd97d	not reported	female	white	released	Dead	1921	1998	TCGA-24-1928_exposure	Not Reported	0e05d363-f279-572a-9703-bb3a1b08d067	released	TCGA-24-1928_diagnosis	28126	not reported	0	336	20d832c5-76d1-5895-aa49-3794d469aede	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-24-1928_treatment_1	TCGA-24-1928_treatment	released	1ea782c0-b22b-5722-836b-01c2b64cdb96	yes	Pharmaceutical Therapy, NOS	released	60b47769-537d-536e-bfc4-e058ffe51a16	no	Radiation Therapy, NOS	793878b7-cdbc-4492-a3fb-b5de9dadeddd
84e6af70-0c66-410c-9fad-6188151ef356.htseq.counts.gz	f06ab7ae-7352-44e0-a4f8-32a3ae2096ca	TCGA-30-1718-01A-01R-1567-13	TCGA-30-1718-01A-01R	TCGA-30-1718-01A-01-TS1	TCGA-30-1718-01A-01-BS1	TCGA-30-1718-01A-01		TCGA-30-1718-01A	TCGA-30-1718	ad2939e6-b8b8-475a-90e2-6a369c3d3167	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.3		078da76a-b9f5-40d0-9a57-04c306ade36a	1.8	5abce979-686d-40c4-acd7-ef9cc5acf26f			0.15	22	released	2c1a1cdb-4132-4ee9-9824-6136d728cc76	RNA	R	0.15	UV Spec	released	False	2faa70f5-02fb-418a-8cc3-9f80845adab5	01			0.0		0.0	40.0	60.0	90.0	TOP	882c0856-601e-4428-b950-0d13f28e8da0	released			2.0		0.0	18.0	80.0	90.0	BOTTOM	1442d515-ab98-42d8-ac97-9a823ef7f0f9	released	released	101.0						9ea630a2-1412-4f40-897a-38a52600a1cb	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-30-1718_demographic	44	-16400	1579	af0f012e-4f9b-5984-9ca8-278a4b50c0ce	not hispanic or latino	female	white	released	Dead	1958	2006	TCGA-30-1718_exposure	Not Reported	f159c1d9-3b62-5086-9842-8ab1ebb37ef4	released	TCGA-30-1718_diagnosis	16400	not reported	0	1579	a8f15bcc-2d2b-58da-adf9-fe2277971d9e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-30-1718_treatment_1	TCGA-30-1718_treatment	released	6a280956-284d-5474-ac31-9ef9c3d056b6	yes	Pharmaceutical Therapy, NOS	released	17cbc288-edde-54bb-a604-7b7421ba7b73	no	Radiation Therapy, NOS	f06ab7ae-7352-44e0-a4f8-32a3ae2096ca
20c77d79-6934-40ce-b490-54221196a090.htseq.counts.gz	7fb590f3-2504-435f-b18b-c46c3de83181	TCGA-29-1707-02A-01R-1567-13	TCGA-29-1707-02A-01R	TCGA-29-1707-02A-01-TS1	TCGA-29-1707-02A-01-BS1	TCGA-29-1707-02A-01		TCGA-29-1707-02A	TCGA-29-1707	7fd6ab8a-201e-431d-a886-6ab553b6ca36	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		264DFD3E-7413-4DEA-A115-14887718139D	1.8	5a1abe99-6d9f-4534-a32c-30672353ee04			0.15	22	released	65b5f9e2-4887-4358-a9bf-4aa3bcaf363a	RNA	R	0.15	UV Spec	released	False	1b04fc12-fae5-4495-9ba3-0f6e2c5d5d75	01			0.0		0.0	10.0	90.0	95.0	TOP	38223c59-9e68-497a-ad88-5cafaaf27191	released			0.0		0.0	10.0	90.0	95.0	BOTTOM	6b3cfbf5-060f-42a5-9887-e6fe885ee8d9	released	released	145.0						f2a14f3d-6181-48d6-8f44-48b36ab1f246	Recurrent Tumor	02	0.5	released	Not Reported	released	TCGA-29-1707_demographic	41	-15017		fe01d20e-05e0-5be5-89e4-ddd1074b6831	not reported	female	white	released	Alive	1965		TCGA-29-1707_exposure	Not Reported	8c8f3b31-ebdc-5fcb-9955-e6cbbb032f52	released	TCGA-29-1707_diagnosis	15017	not reported	0	1277	4c54de9f-0492-581d-9ba1-398bd16c52c8	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-29-1707_treatment_1	TCGA-29-1707_treatment	released	6b23da8a-2d43-521f-8719-dad6ebcd1c37	yes	Pharmaceutical Therapy, NOS	released	49206d4a-5ccc-5b1d-99ac-32b9bfa5c296	no	Radiation Therapy, NOS	7fb590f3-2504-435f-b18b-c46c3de83181
bb94288a-d4c4-4811-bcd5-7306891779fd.htseq.counts.gz	bbb4e8fd-bc98-457f-b9d6-2ecaf870145b	TCGA-23-1111-01A-01R-1567-13	TCGA-23-1111-01A-01R	TCGA-23-1111-01A-01-TS1	TCGA-23-1111-01A-01-BS1	TCGA-23-1111-01A-01		TCGA-23-1111-01A	TCGA-23-1111	6b2a9f9a-fe96-4311-a330-925c4ad36fe7	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.9	False	0.9		ba3ae03c-74d4-4b5f-849f-71466bae7c0e	1.8	f38e46dc-67b9-448a-8d24-507291e55bca			0.16	22	released	83ccfe48-f941-4126-89df-199321869406	RNA	R	0.16	UV Spec	released	False	eba72607-0bcc-48c5-8c9b-68d0ebc00365	01			5.0					95.0	TOP	2a2f4620-789a-400f-bf1a-10b72d876ef7	released			5.0					95.0	BOTTOM	9949d5f1-ef9c-493a-b04e-3b617d2b30c6	released	released	131.0						2dc30180-9f69-4dd5-914c-1a27fcf170bd	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-23-1111_demographic	63	-23171		c6a9c1d3-b55e-5ef9-a771-a2a379aa9539	not reported	female	white	released	Alive	1945		TCGA-23-1111_exposure	Not Reported	fe565ed8-73d8-59a7-a26a-5a07a70eeea9	released	TCGA-23-1111_diagnosis	23171	not reported	0	98	b706f41e-b852-562e-b355-bba9f964e38a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-23-1111_treatment_1	TCGA-23-1111_treatment	released	7dedcf7e-956d-5de6-9a9e-602cecb93694	yes	Pharmaceutical Therapy, NOS	released	a3567e3c-4b84-5146-9bd0-d18a0d6f2496	no	Radiation Therapy, NOS	bbb4e8fd-bc98-457f-b9d6-2ecaf870145b
4e63ba56-ce7b-4f2a-9b87-aee011ad13e8.htseq.counts.gz	b24f3c34-beb3-47be-b52c-d8d4dc285999	TCGA-13-0916-01A-01R-1564-13	TCGA-13-0916-01A-01R	TCGA-13-0916-01A-01-BS1	TCGA-13-0916-01A-01-TS1	TCGA-13-0916-01A-01		TCGA-13-0916-01A	TCGA-13-0916	5f60bc2d-738f-43fc-a3fb-61ec6e80e3d4	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		28A2A65C-70A2-40D2-A03A-F68884457C14	1.8	63c52e46-68cf-4dac-9bd7-37081daa4474			0.15	22	released	b2481956-64c2-45d9-a6dc-797138dd40d5	RNA	R	0.15	UV Spec	released	False	1f453407-36f2-4871-b353-33d91d5dccf4	01			0.0		0.0	5.0	95.0	98.0	BOTTOM	1f9f945b-dbd0-4bec-99c7-350d23343b9c	released			0.0		0.0	5.0	95.0	98.0	TOP	af6a32f4-c8f5-42fb-aaed-6d40c9076a1e	released	released	99.0						4a2528c7-eaba-46da-b1e5-431a17bff9c7	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-13-0916_demographic	49	-18189		eb66def4-8b14-5b5c-9c01-bd60707a8e18	not hispanic or latino	female	white	released	Alive	1957		TCGA-13-0916_exposure	Not Reported	56cd5a0d-e1cd-5922-97f2-46b9770797a0	released	TCGA-13-0916_diagnosis	18189	not reported	0	1785	013ba4e2-f2d0-5a07-a02e-5293a1da0678	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-13-0916_treatment_1	TCGA-13-0916_treatment	released	38872606-1093-5fcb-b1a1-76e279776111	yes	Pharmaceutical Therapy, NOS	released	0f6be681-a693-5dbc-88d9-01ab2afb79d0	no	Radiation Therapy, NOS	b24f3c34-beb3-47be-b52c-d8d4dc285999
06884e47-0650-4748-9f4e-b8cd9f24795c.htseq.counts.gz	57b7e54d-d9ee-4a6c-a906-c3b8b41f02a3	TCGA-23-1120-01A-02R-1565-13	TCGA-23-1120-01A-02R	TCGA-23-1120-01A-02-BS2	TCGA-23-1120-01A-01-BS1	TCGA-23-1120-01A-02		TCGA-23-1120-01A	TCGA-23-1120	fdf83fdf-dfbb-4306-9a1b-b4487d18b402	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.8		e12ef7d5-6fa8-46fa-bedc-da6ddbbecc37	1.8	9b64998e-eed9-428b-97ac-4de398caaf81			0.16	22	released	50c2ca86-3411-4ba0-b4e0-5a80b227f072	RNA	R	0.16	UV Spec	released	False	af06629a-5506-4bac-9698-421c3bb1af58	02			10.0		0.0	0.0	0.0	95.0	BOTTOM	4cbf84a4-9b8f-4448-a066-3978b5fca0aa	released			10.0		0.0	0.0	0.0	95.0	TOP	7a9f0eb0-59d5-46ee-ae3e-4c9c21218ded	released	released	105.0						6fc497cb-41c0-487c-b527-b33a9af83ef2	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-23-1120_demographic	60	-22148		46d2a0a9-20fb-5a03-b80b-113e9217d392	not hispanic or latino	female	white	released	Alive	1948		TCGA-23-1120_exposure	Not Reported	96b82cca-c110-5109-9608-7aeb2bbd8ffd	released	TCGA-23-1120_diagnosis	22148	not reported	0	130	efacf32e-acbf-5aa1-bc08-b71cd624aea2	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-23-1120_treatment	TCGA-23-1120_treatment_1	released	b15fe942-b529-546b-a2da-c3bc718654e9	no	Radiation Therapy, NOS	released	c2d64e2a-549e-59b0-bd9c-131ab8244dc0	yes	Pharmaceutical Therapy, NOS	57b7e54d-d9ee-4a6c-a906-c3b8b41f02a3
48297930-d22a-463d-80ac-52214964f067.htseq.counts.gz	2ca8f455-9f97-4742-9263-ac902600042e	TCGA-24-1474-01A-01R-1566-13	TCGA-24-1474-01A-01R	TCGA-24-1474-01A-01-BS1	TCGA-24-1474-01A-01-TS1	TCGA-24-1474-01A-01		TCGA-24-1474-01A	TCGA-24-1474	d7b3156d-672a-4a55-868d-9ca6a09fcb0f	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.0		c4d49a95-0478-4399-a5eb-224ca6d16cd7	1.8	4da3ccd5-53e1-46f5-874d-e5d131dbfc52			0.15	22	released	2e1ef287-ce35-4fc7-895c-a50b38928f36	RNA	R	0.15	UV Spec	released	False	fb049b83-5907-44b5-8182-34d38511a0a9	01			1.0		0.0	1.0	98.0	99.0	BOTTOM	c53d2d22-c2c3-4620-91f7-42162f8ba3d5	released			1.0		0.0	1.0	98.0	99.0	TOP	8b1c59c3-2589-42bc-b824-90b082f1e893	released	released	106.0						216c9136-673a-4e87-8537-daf1e4fbf394	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-24-1474_demographic	57	-20902	676	4812aee4-fa81-5936-a941-fc0d01dba26d	not reported	female	black or african american	released	Dead	1943	2001	TCGA-24-1474_exposure	Not Reported	3c5f03fe-cd6e-5bb2-b7c8-d4581c1b022c	released	TCGA-24-1474_diagnosis	20902	not reported	0	676	ed25dede-8f3b-53e0-b342-842614bc07b4	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-24-1474_treatment_1	TCGA-24-1474_treatment	released	f6aaf3da-9287-5e7c-97bf-151deadd4fb4	yes	Pharmaceutical Therapy, NOS	released	3e543b09-92f6-5b4d-874c-2a0176cd2714	no	Radiation Therapy, NOS	2ca8f455-9f97-4742-9263-ac902600042e
7fb4f0f7-027f-4cf8-b8bc-43ca398c46e8.htseq.counts.gz	ae0eca41-64be-4feb-9ad9-20386f39a66d	TCGA-24-2261-01A-01R-1568-13	TCGA-24-2261-01A-01R	TCGA-24-2261-01A-01-BS1	TCGA-24-2261-01A-01-TS1	TCGA-24-2261-01A-01		TCGA-24-2261-01A	TCGA-24-2261	eec69ea9-ceb8-456a-aff4-41fb8a261e36	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.4	False	1.7		6145afd6-e7d7-47bc-a659-ac84c3434e86	1.8	75e9506a-d007-4fb2-8bdd-7e7780653a63			0.15	22	released	eaa2f5c6-40bd-4b73-af56-aaf174197f93	RNA	R	0.15	UV Spec	released	False	82116a0d-70ab-4f58-9172-094937eb01a7	01			5.0		1.0	9.0	85.0	90.0	BOTTOM	f82e1a66-2764-4fc1-8a91-3b907c7f54ad	released			5.0		1.0	9.0	85.0	90.0	TOP	be1df9a9-9cb9-43e5-a447-56368f965041	released	released	137.0						7bcd356d-7031-44b1-b1d7-8d8f60f0caff	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-2261_demographic	76	-27897	24	ff97c3b6-41e4-5f1e-a06b-1dfb04a62127	not reported	female	white	released	Dead	1916	1992	TCGA-24-2261_exposure	Not Reported	12aeecf9-f969-5c5b-ac8a-6c3b1cbfbcd9	released	TCGA-24-2261_diagnosis	27897	not reported	0	24	98810cc1-7704-5e6c-8b7c-fbd3eaa7803b	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1992	TCGA-24-2261_treatment	TCGA-24-2261_treatment_1	released	be9eddb1-e95e-5731-90c8-be143d3f79d6	no	Radiation Therapy, NOS	released	78480514-75d6-5620-9f2a-89250266c0ac	no	Pharmaceutical Therapy, NOS	ae0eca41-64be-4feb-9ad9-20386f39a66d
29d09b58-3cc2-47c0-b78e-18743eed2c2f.htseq.counts.gz	680d5d0b-6e57-4f84-b388-7f9b0838a776	TCGA-61-1736-01B-01R-1568-13	TCGA-61-1736-01B-01R	TCGA-61-1736-01B-01-BS1	TCGA-61-1736-01B-01-TS1	TCGA-61-1736-01B-01		TCGA-61-1736-01B	TCGA-61-1736	0a2d29de-869a-4dc8-ad11-6ee0d0a3a895	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.0		c034e484-683b-463c-999d-eb1fd9741292	1.8	89f1ae39-c387-4dff-be38-e3b7265222bb			0.14	22	released	0756e41a-96ad-4994-b725-e505b0f66b19	RNA	R	0.14	UV Spec	released	False	3cd8c690-4247-4186-9dc2-a49b25e1e0a7	01			1.0		0.0	39.0	60.0	95.0	BOTTOM	e4d5faf5-250e-4f99-bf5e-72d87d5ee298	released			0.0		0.0	30.0	70.0	95.0	TOP	c1c6008e-be3b-453c-8182-6392ee9a02a3	released	released	111.0						8a5f3650-3bfa-48f9-80c3-270b05daa00c	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-1736_demographic	45	-16613	1484	939d1efe-bdfb-577a-94ee-c8c9e51b5fe6	not hispanic or latino	female	white	released	Dead	1960	2009	TCGA-61-1736_exposure	Not Reported	8a4e9f98-dbcb-5d79-834f-ddc219fa1bdf	released	TCGA-61-1736_diagnosis	16613	not reported	0	1484	06cbb2ff-f89f-5c49-a700-1241cb4fa9f8	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-61-1736_treatment	TCGA-61-1736_treatment_1	released	26cdbde5-ebec-5818-8d7a-29010209e452	no	Radiation Therapy, NOS	released	97a8780e-aec4-5b2b-8f13-6a9961f862f4	yes	Pharmaceutical Therapy, NOS	680d5d0b-6e57-4f84-b388-7f9b0838a776
a6c5d247-364e-41c4-8a89-dda2410dd3af.htseq.counts.gz	68bbdba2-5999-430c-9474-7a71b91f98a9	TCGA-13-0911-01A-01R-1564-13	TCGA-13-0911-01A-01R	TCGA-13-0911-01A-01-BS1	TCGA-13-0911-01A-01-TS1	TCGA-13-0911-01A-01		TCGA-13-0911-01A	TCGA-13-0911	8cad4217-5699-4735-9be3-fc0015a8d262	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		0DE80BC5-8AA8-423A-B99B-9CD9883F27C2	1.8	d47147ed-fdb1-4921-9db7-1e0aae32aacb			0.16	22	released	da0644e1-e1d4-4b4d-920c-d676e9a8d6a0	RNA	R	0.16	UV Spec	released	False	69f5001e-8cca-4ef7-a687-0f806a76decb	01	10.0		9.0		0.0	1.0	90.0	99.0	BOTTOM	fbd48661-17fb-44b5-be12-fe788a09667c	released	100.0		5.0		0.0	20.0	75.0	85.0	TOP	d038ca6a-0465-4047-a2a9-46ad58627c2e	released	released	129.0						b4fb23b6-d4a0-409a-9728-174c871270e3	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-13-0911_demographic	55	-20276	1355	d9f04340-86d7-54c3-9770-ba6f4a98c85b	not hispanic or latino	female	white	released	Dead	1950		TCGA-13-0911_exposure	Not Reported	5b7f9ccc-2dc7-56c4-9bfb-459510e20e9f	released	TCGA-13-0911_diagnosis	20276	not reported	0	843	37459c7e-8694-5ed7-8555-422cb0f653b7	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-13-0911_treatment_1	TCGA-13-0911_treatment	released	0121b003-6399-5996-a097-7828e8afec11	yes	Pharmaceutical Therapy, NOS	released	3842c585-4b74-5358-baef-56414520a21b	no	Radiation Therapy, NOS	68bbdba2-5999-430c-9474-7a71b91f98a9
65d87c44-cb1f-4889-bdfa-4788f7183ae1.htseq.counts.gz	644e21d7-13c5-4239-bacd-ccdca695d7c4	TCGA-29-1766-01A-01R-1567-13	TCGA-29-1766-01A-01R	TCGA-29-1766-01A-01-TS1	TCGA-29-1766-01A-01-BS1	TCGA-29-1766-01A-01		TCGA-29-1766-01A	TCGA-29-1766	01ea6354-137b-47f3-9021-a01a382b1147	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.3		fc0a444e-3618-459a-a3ee-58ec9e7e1084	1.8	fb381f7f-a327-49e1-a13a-bca5a06047d3			0.13	22	released	e2bb7dda-497f-49ce-9b78-6692a004f7db	RNA	R	0.13	UV Spec	released	False	6f41211d-0473-42b4-af68-67bae746ec31	01	2.0		5.0		0.0	40.0	55.0	90.0	TOP	b06eb26c-0803-4278-b5bb-8a23e94145e0	released			10.0		0.0	50.0	40.0	90.0	BOTTOM	6edc8a3d-a3a8-44b5-8c3e-ed9021de767b	released	released	104.0						d3a81bab-cce2-48b3-8eb8-9ef9766af108	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1766_demographic	74	-27359	1199	e3cac892-2a78-5c30-b392-1ef7da8a05b6	not reported	female	white	released	Dead	1932	2009	TCGA-29-1766_exposure	Not Reported	aeae204c-2a27-5464-92c6-767b7b9d15ac	released	TCGA-29-1766_diagnosis	27359	not reported	0	1190	c3f472b3-884c-5a6a-b8ef-99c8a29a6b21	Stage IIIC	C48.2	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-29-1766_treatment	TCGA-29-1766_treatment_1	released	cf6cb64c-8c40-5221-a2f2-68d7d527e0e5	no	Radiation Therapy, NOS	released	4d137057-b2a6-52a8-bce7-590cf2bd92e8	yes	Pharmaceutical Therapy, NOS	644e21d7-13c5-4239-bacd-ccdca695d7c4
bea1858a-5de7-48ee-9fc3-f9abdd4b0ded.htseq.counts.gz	73d0bedb-e27b-47c3-bd1d-ce984f2fa430	TCGA-13-1489-02A-01R-1565-13	TCGA-13-1489-02A-01R	TCGA-13-1489-02A-01-BS1	TCGA-13-1489-02A-01-TS1	TCGA-13-1489-02A-01		TCGA-13-1489-02A	TCGA-13-1489	7248cd60-be22-44bc-bc58-f644db0940a2	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.0		639712E8-5C63-433C-8F23-4C78FF37D8FC	1.8	d8cd1ca1-dc00-4a48-ab81-5d23daed6fce			0.15	22	released	58ffa935-a8c9-43b2-85bf-5b2227dea9b8	RNA	R	0.15	UV Spec	released	False	653bd22c-b4a4-4dcf-92cb-9386592db3b6	01			5.0		0.0	5.0	90.0	95.0	BOTTOM	a3a8a1e6-ffaa-4156-b54f-0fadcd0371aa	released			5.0		0.0	5.0	90.0	95.0	TOP	acc6b322-9319-4b2b-b0e5-4d54d649a56d	released	released	134.0						cba94907-4590-492b-88db-613d97208ccf	Recurrent Tumor	02	0.4	released	Not Reported	released	TCGA-13-1489_demographic	70	-25768	2553	39bca6ab-f7fe-59fd-b376-b16f300c341d	not hispanic or latino	female	white	released	Dead	1932		TCGA-13-1489_exposure	Not Reported	888ccf70-daf2-573f-986b-b9a6a79b4635	released	TCGA-13-1489_diagnosis	25768	not reported	0	2521	f903544f-b690-54a3-b3e5-faa412f474d7	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-13-1489_treatment_1	TCGA-13-1489_treatment	released	4d28d2af-7102-5e8b-bb3a-2861f9a5d09b	yes	Pharmaceutical Therapy, NOS	released	ad9e7582-766f-591a-8ef5-78df3f6d07be	no	Radiation Therapy, NOS	73d0bedb-e27b-47c3-bd1d-ce984f2fa430
e4a4badf-b4f9-4729-bec7-191867c7c229.htseq.counts.gz	6a32a1a2-2b31-4cb1-b8ce-032d4cbad587	TCGA-09-0369-01A-01R-1564-13	TCGA-09-0369-01A-01R	TCGA-09-0369-01A-01-TS1	TCGA-09-0369-01A-01-BS1	TCGA-09-0369-01A-01		TCGA-09-0369-01A	TCGA-09-0369	1d9893c8-0de3-4b07-b0ba-a53019b23eb4	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV					False			c052e190-b5c2-44bf-b5b0-2b37cde18cee	1.8	1f972766-2f58-4d41-b84c-3493ef2dd0c4			0.19	22	released	41982e47-9e0f-4cda-bc47-01fbe6d07906	RNA	R	0.19	UV Spec	released	False	48aab2c5-1ac0-42c5-84c8-97fd245bf6e2	01			0.0		0.0	5.0	95.0	98.0	TOP	a1c0652a-fca9-4ae7-8df7-a7e37d1c9d7d	released			0.0		0.0	5.0	95.0	98.0	BOTTOM	98dcd946-275e-4aab-ba34-62443d4dfc1c	released	released							effbbc75-67d0-4d2b-bef5-00ed066b0885	Primary Tumor	01		released	Not Reported	released	TCGA-09-0369_demographic	56	-20705	1082	91435668-d5f8-5c6b-8afd-e3e973f0a0aa	not hispanic or latino	female	white	released	Dead	1947	2005	TCGA-09-0369_exposure	Not Reported	e1c94ae2-ead5-5fe5-a89a-94962f15c34c	released	TCGA-09-0369_diagnosis	20705	not reported	0		2ccc9ded-6131-5138-ac74-27f15e75a761	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-09-0369_treatment	TCGA-09-0369_treatment_1	released	702913e1-f549-5908-ba73-05f3a66fc72e	no	Radiation Therapy, NOS	released	4bb5e72c-1a93-5335-9bfa-1f27904b1fe9	yes	Pharmaceutical Therapy, NOS	6a32a1a2-2b31-4cb1-b8ce-032d4cbad587
95ce6307-6006-4b0e-9fa7-942551eaf05a.htseq.counts.gz	861c25e4-022f-4e03-919d-cbb5fa26d4d3	TCGA-13-1496-01A-01R-1565-13	TCGA-13-1496-01A-01R	TCGA-13-1496-01A-01-TS1	TCGA-13-1496-01A-01-BS1	TCGA-13-1496-01A-01		TCGA-13-1496-01A	TCGA-13-1496	e5a329ec-e50e-4786-901d-b58474f8ea65	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.1		BCDD1BDE-689B-455D-81A7-C2522417E055	1.8	cbdfb183-b1af-42ed-a47a-5fee3ac1059e			0.16	22	released	2f5e2202-8b25-4e84-a5d2-1783e0b69da0	RNA	R	0.16	UV Spec	released	False	b9957398-3765-423b-88c5-022c62fb2389	01			5.0		0.0	1.0	94.0	99.0	TOP	6e8bc620-4631-48ed-8bf8-866854ef6500	released			5.0		0.0	1.0	94.0	99.0	BOTTOM	b3b8a7eb-c3a4-406b-8725-ffe82e1427c3	released	released	141.0						7423b7ef-05e4-4b6c-bad0-bb815d6cfa9a	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-1496_demographic	65	-23993	129	4d5dbb4c-1d7f-5cdf-b9db-1585b9627eb6	not hispanic or latino	female	white	released	Dead	1939	2004	TCGA-13-1496_exposure	Not Reported	d1424f06-73df-5586-b468-53795552fe56	released	TCGA-13-1496_diagnosis	23993	not reported	0	129	7a1b6225-2e8d-59d5-a142-bc7ed5306fb5	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2004	TCGA-13-1496_treatment_1	TCGA-13-1496_treatment	released	027168c1-e434-5b10-80d8-ef81c327376b	yes	Pharmaceutical Therapy, NOS	released	1339ccd3-c639-5b24-b8b2-186a748b9abb	no	Radiation Therapy, NOS	861c25e4-022f-4e03-919d-cbb5fa26d4d3
7093a0f5-822d-4f61-9adb-fe9adbbff769.htseq.counts.gz	b9238220-b705-4009-b730-cca59803728d	TCGA-25-1318-01A-01R-1565-13	TCGA-25-1318-01A-01R	TCGA-25-1318-01A-01-TS1	TCGA-25-1318-01A-01-BS1	TCGA-25-1318-01A-01		TCGA-25-1318-01A	TCGA-25-1318	13319c20-02f6-4b5f-b24f-3d8f4084094c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				2.0	False	4.5		D9B9F69A-265C-42F4-BCD2-4B136A7FE935	1.8	4d3e0164-1346-4e8e-b478-29bd8b1f1ce5			0.15	22	released	1a921841-2049-4c49-b094-d67dbd5f683b	RNA	R	0.15	UV Spec	released	False	6651de6b-f254-4b61-ac6c-14c1f9f65e4b	01			5.0			15.0	80.0	98.0	TOP	328597ad-7246-4ca7-a534-1d265e9c9a59	released			5.0			10.0	85.0	95.0	BOTTOM	71909c29-59a7-45ec-945b-d7965aeec9a5	released	released	177.0						ced18b90-cbcc-4593-9eaf-2d91daa9d756	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-25-1318_demographic	54	-19755	1064	f25e1764-8f69-5eb1-824e-789ac5a8ff24	not hispanic or latino	female	white	released	Dead	1946	2002	TCGA-25-1318_exposure	Not Reported	9b873d69-d172-5649-9537-ef193ac42329	released	TCGA-25-1318_diagnosis	19755	not reported	0	1064	2e841bcd-46c2-5c16-95cc-6d40414476b3	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-25-1318_treatment	TCGA-25-1318_treatment_1	released	a8dead29-cdfb-544f-a4fd-7ffb3c12f56b	no	Radiation Therapy, NOS	released	e1390e5e-6445-57c6-aa1c-e6176fa03ee6	yes	Pharmaceutical Therapy, NOS	b9238220-b705-4009-b730-cca59803728d
cebba8db-616b-49a5-ac4c-c3bee701e48a.htseq.counts.gz	55e3c546-cc91-4032-bd2d-dfd44e6e93fe	TCGA-36-1577-01A-01R-1566-13	TCGA-36-1577-01A-01R	TCGA-36-1577-01A-01-TS1	TCGA-36-1577-01A-01-BS1	TCGA-36-1577-01A-01		TCGA-36-1577-01A	TCGA-36-1577	e294b940-2828-499c-be24-47ef6c2e9035	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.7		0c55b26c-ccf8-4223-9f5e-157bbdf6e5dc	1.8	9ec93bbd-5c62-4974-984f-f86301f0d27e			0.14	22	released	c4abdc22-3c39-41ae-ac3e-a37132dba82f	RNA	R	0.14	UV Spec	released	False	5638e5b1-d2bd-490f-bc95-a61f10c56dd5	01			5.0		0.0	50.0	45.0	70.0	TOP	ef2d27c9-2651-483e-916d-bd0f0f9b8cc9	released			10.0		0.0	40.0	50.0	70.0	BOTTOM	68b0e766-085f-40d9-a3ba-2163f81f8af5	released	released	104.0						73a2a82b-c87c-4c04-8cfe-cc679379b28d	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-36-1577_demographic	43	-15804		0aeca69b-62e8-51ea-b312-dc3e2ba3237c	not reported	female	asian	released	Alive	1964		TCGA-36-1577_exposure	Not Reported	8ec631f8-71a6-5955-9e59-8fcb72cf417c	released	TCGA-36-1577_diagnosis	15804	not reported	0	783	e3059d66-192a-578d-8167-ccefae83a110	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-36-1577_treatment	TCGA-36-1577_treatment_1	released	cfd3536f-c38b-5edf-a9c8-7361ace4c9f7	yes	Radiation Therapy, NOS	released	c5535bfe-1eee-5ce2-9511-6c6f8fd253b6	yes	Pharmaceutical Therapy, NOS	55e3c546-cc91-4032-bd2d-dfd44e6e93fe
6b9a94e7-144b-4a17-97ed-75f7cd311baa.htseq.counts.gz	6fd7d5c0-54d3-430f-8371-5a8ad9a17340	TCGA-29-1711-01A-01R-1567-13	TCGA-29-1711-01A-01R	TCGA-29-1711-01A-01-BS1	TCGA-29-1711-01A-01-TS1	TCGA-29-1711-01A-01		TCGA-29-1711-01A	TCGA-29-1711	f58e49fc-9641-4b46-be4c-766445ec70a3	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.1	False	1.2		e0e207a0-c3c2-4bfc-9d7d-d00c5c953d3d	1.8	c512a6e3-8bc8-4188-b264-89b2fe02baa8			0.16	22	released	fa811206-1b28-4221-bc5c-4bf30564acf1	RNA	R	0.16	UV Spec	released	False	5543b859-960d-4c3d-9079-f0b66ce73d8d	01	2.0	3.0	2.0		0.0	0.0	98.0	90.0	BOTTOM	cee261be-39be-457f-8b61-31eca4d7e795	released			2.0		0.0	0.0	98.0	90.0	TOP	abf41830-7901-443a-a734-4696c4bc7893	released	released	126.0						f0f721b2-edab-49c9-b271-2204878c2ae5	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1711_demographic	45	-16485		8281281b-4e5e-598a-b5f4-68ff6e315138	not reported	female	black or african american	released	Alive	1961		TCGA-29-1711_exposure	Not Reported	0dac7ec5-37a3-57e2-bb74-ff0193549a2a	released	TCGA-29-1711_diagnosis	16485	not reported	0	1053	eda2964c-ca2e-5949-a47e-bde81da98557	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-29-1711_treatment	TCGA-29-1711_treatment_1	released	440d246c-0fd0-58e7-be8a-18e0015a9589	no	Radiation Therapy, NOS	released	6cbb4220-f366-52c2-9c24-c9b55118b6f3	yes	Pharmaceutical Therapy, NOS	6fd7d5c0-54d3-430f-8371-5a8ad9a17340
6aa7225b-3d10-4b19-a472-0adeb21c26cf.htseq.counts.gz	3b82236e-b055-4d10-acb4-b5a5992a1261	TCGA-29-1770-01A-01R-1567-13	TCGA-29-1770-01A-01R	TCGA-29-1770-01A-01-TS1	TCGA-29-1770-01A-01-BS1	TCGA-29-1770-01A-01		TCGA-29-1770-01A	TCGA-29-1770	5abb6d80-fc39-49a4-8db5-3db24543feb6	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.2		05816aac-55d2-4604-9300-e268f73338fe	1.8	5ba75bb8-6229-4d6a-80e5-9a79a548e167			0.17	22	released	ba3844ed-001a-4397-8fd4-82fb24803e75	RNA	R	0.17	UV Spec	released	False	fb6159a5-f237-4544-bc25-81867a34c21d	01			0.0		0.0	20.0	80.0	90.0	TOP	ee73a932-fda4-4c43-b713-155de66a089c	released			5.0		0.0	35.0	60.0	90.0	BOTTOM	60fcddf8-3637-40ae-8ab1-135c28d702e2	released	released	115.0						e14eecdb-9843-4549-917b-ee1e3d77025d	Primary Tumor	01	0.5	released	Not Reported	released	TCGA-29-1770_demographic	54	-20015		08af8cb4-296c-5a4f-b5fc-951011920166	not reported	female	white	released	Alive	1953		TCGA-29-1770_exposure	Not Reported	84d5a4ba-43c1-57a8-9dfd-10ba90d03001	released	TCGA-29-1770_diagnosis	20015	not reported	0	741	05b7bdb6-00fc-573b-88b0-3985a0a97199	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-29-1770_treatment_1	TCGA-29-1770_treatment	released	80e3875e-0d80-5cc2-b131-f7c4b97d7b7a	yes	Pharmaceutical Therapy, NOS	released	bafb4da9-41ca-51be-92f7-f757fdb708d4	no	Radiation Therapy, NOS	3b82236e-b055-4d10-acb4-b5a5992a1261
297978f4-9907-482f-89db-3a0a2a0f19a8.htseq.counts.gz	21cefa4e-6d67-4d9e-a74b-6239a18679d7	TCGA-24-1550-01A-01R-1566-13	TCGA-24-1550-01A-01R	TCGA-24-1550-01A-01-BS1	TCGA-24-1550-01A-01-TS1	TCGA-24-1550-01A-01		TCGA-24-1550-01A	TCGA-24-1550	1858b58f-fdf4-413c-9c29-96ae85b88a74	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		7ebd8d19-0a81-4623-8127-f225ad650d46	1.8	648cb96f-df1c-48c1-bb15-c37a2784a9db			0.15	22	released	2791c102-57d5-4fd3-b297-04c760c0300f	RNA	R	0.15	UV Spec	released	False	d557693c-3269-431f-86b1-07922a125630	01			10.0		0.0	10.0	80.0	85.0	BOTTOM	d3dfc107-2dd1-412c-9649-239b2f3d9970	released			5.0		0.0	25.0	70.0	80.0	TOP	3c468906-1fe3-4438-af83-46db12f8a8cc	released	released	123.0						2726ed05-ac38-41d6-85f3-35ab0bcbc47a	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-24-1550_demographic	49	-18049	1249	398a8019-dc37-529c-a1ed-c9dd8bc38628	not reported	female	white	released	Dead	1948	2000	TCGA-24-1550_exposure	Not Reported	52aab6ee-cfa2-570d-a46d-6c9c325394bc	released	TCGA-24-1550_diagnosis	18049	not reported	0	1249	128ce7b5-2666-568d-8370-bd8ce225cb6a	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1997	TCGA-24-1550_treatment	TCGA-24-1550_treatment_1	released	4a777e8f-38d3-5b9a-9567-7ece5a98878f	no	Radiation Therapy, NOS	released	317e0356-3961-509b-9cc2-c5b1293453d0	yes	Pharmaceutical Therapy, NOS	21cefa4e-6d67-4d9e-a74b-6239a18679d7
5784a937-f090-4866-8d8f-e7cbbb3e327d.htseq.counts.gz	27c2f6c6-68a5-40dc-b649-70e8ac9352c7	TCGA-23-1023-01A-02R-1564-13	TCGA-23-1023-01A-02R	TCGA-23-1023-01A-01-BS1	TCGA-23-1023-01A-02-BS2	TCGA-23-1023-01A-02		TCGA-23-1023-01A	TCGA-23-1023	9e18238f-ae85-4b75-ae87-d92da9731a40	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	0.8		98EBC356-C54E-4C1E-9726-BA61397DDA38	1.8	69bec2db-02c3-46ca-b17b-60eae9a1e0bf			0.16	22	released	ada8eaa7-ff36-47e0-8b42-2a6e4edf59f3	RNA	R	0.16	UV Spec	released	False	98bbc8e1-81f4-4f16-9d23-0257059041d3	02			20.0		5.0	5.0	70.0	80.0	TOP	f2260f08-0126-4fe9-bbb0-09e4fc2fb30e	released			0.0		20.0	10.0	70.0	70.0	BOTTOM	1a4fa055-18ac-4c34-aa07-3e6fbba79d49	released	released	127.0						a6fdfc35-a178-4d5a-8e07-346b55dd936d	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-23-1023_demographic	65	-23826		5401c2e3-25c5-547a-a9df-fce704e3b3f4	not hispanic or latino	female	white	released	Alive	1940		TCGA-23-1023_exposure	Not Reported	903c184b-df15-5a62-a9b6-db964a4c935c	released	TCGA-23-1023_diagnosis	23826	not reported	0	1233	e6fb200e-161a-5533-9fea-45b491af50d2	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2005	TCGA-23-1023_treatment	TCGA-23-1023_treatment_1	released	df39fb19-a55b-5390-b5b6-15c45b5892f4	no	Radiation Therapy, NOS	released	8532d69d-318f-56e7-a207-3b65012cba0c	yes	Pharmaceutical Therapy, NOS	27c2f6c6-68a5-40dc-b649-70e8ac9352c7
8822cd66-d592-4601-a81a-caf939cb8882.htseq.counts.gz	f07bad1a-30b7-4abc-8c39-14052edd0384	TCGA-25-1632-01A-01R-1566-13	TCGA-25-1632-01A-01R	TCGA-25-1632-01A-01-TS1	TCGA-25-1632-01A-01-BS1	TCGA-25-1632-01A-01		TCGA-25-1632-01A	TCGA-25-1632	c435627c-159d-4a6d-a819-30abac24bf4d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.4		F083C2B4-20DE-440F-B6A8-2F332346CECA	1.8	12c78d62-6045-4f77-bd84-9ab5a38f4635			0.15	22	released	a46581ab-424d-4286-adc1-b4df1125c6ea	RNA	R	0.15	UV Spec	released	False	a7b83361-c888-4181-95d4-b5b44545e010	01			1.0		0.0	5.0	94.0	95.0	TOP	441ffc0c-d1a4-4154-ac77-a247fdd66727	released			1.0		0.0	5.0	94.0	95.0	BOTTOM	150d6173-6bb4-4d09-9da1-e8898c0e50cc	released	released	128.0						ed9c97d8-4df2-4ed3-b455-4955d72901a8	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-25-1632_demographic	68	-24993	1799	ecf4f54b-a69f-5931-8dc3-82641be4e4f4	not hispanic or latino	female	white	released	Dead	1934	2006	TCGA-25-1632_exposure	Not Reported	99d4f472-0e0f-5c65-ba70-a3fa8b4fefa5	released	TCGA-25-1632_diagnosis	24993	not reported	0	1732	c8695a7a-bbd7-5587-abe6-4896e3db73ba	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-25-1632_treatment	TCGA-25-1632_treatment_1	released	76150ff8-715c-502e-b0a0-483aadf886d4	no	Radiation Therapy, NOS	released	7db4c2b2-2da1-5438-95c4-41adfbdf83b1	yes	Pharmaceutical Therapy, NOS	f07bad1a-30b7-4abc-8c39-14052edd0384
f562a9d0-39fb-4062-b535-87a96ad3212a.htseq.counts.gz	432b9546-2211-4769-bd8d-fd8fde45f9cd	TCGA-13-1488-01A-01R-1565-13	TCGA-13-1488-01A-01R	TCGA-13-1488-01A-01-TS1	TCGA-13-1488-01A-01-BS1	TCGA-13-1488-01A-01		TCGA-13-1488-01A	TCGA-13-1488	a85f6f9c-1e1d-44fc-85eb-3b2d96cfbc61	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	2.3		79A91E41-0B59-4328-B7BB-2B4EEAD46A89	1.8	fbd513d6-46e8-48f7-9dc3-f7369ad0f3c7			0.14	22	released	e8ef3c13-4826-4c45-b759-cd3ce898b1f2	RNA	R	0.14	UV Spec	released	False	a215dab2-86d3-4338-89f2-f8540ac64c58	01	95.0		5.0	5.0	0.0	15.0	80.0	95.0	TOP	3972462a-d30c-473e-a62b-dae7de1ef2bd	released			0.0		0.0	30.0	70.0	85.0	BOTTOM	783d5d20-6ac1-4777-9bf8-dc82d203c7d6	released	released	134.0						22461884-5fdb-4188-a469-5dfa55a2823e	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1488_demographic	59	-21726	2154	b6bd947a-dae0-5ef3-905e-02630b777a39	not hispanic or latino	female	white	released	Dead	1943	2007	TCGA-13-1488_exposure	Not Reported	b8f30501-ee11-50c5-9c79-09cb051735e2	released	TCGA-13-1488_diagnosis	21726	not reported	0	2154	04ce8f92-1262-5b87-9371-5b7f0e7d3f5f	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-13-1488_treatment	TCGA-13-1488_treatment_1	released	1773f89d-ed73-5734-a705-e5272bf0c60c	no	Radiation Therapy, NOS	released	9d27a61d-dd9a-5c4c-96a4-dc0e2b4215ef	yes	Pharmaceutical Therapy, NOS	432b9546-2211-4769-bd8d-fd8fde45f9cd
c6287ac6-570d-4431-87b3-290db2dbe58b.htseq.counts.gz	1529e2b7-8203-48d8-9b9a-f22af739e83a	TCGA-13-0724-01A-01R-1564-13	TCGA-13-0724-01A-01R	TCGA-13-0724-01A-01-TS1	TCGA-13-0724-01A-01-BS1	TCGA-13-0724-01A-01		TCGA-13-0724-01A	TCGA-13-0724	a9abe7a7-4126-414b-87d2-a6d25abcf1fa	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	1.3		1EC7581B-E7B6-41B9-B96C-DCAF37912D3F	1.8	fc6df206-8c77-486c-bc38-06b6cf20139d			0.19	22	released	201b8a36-94fb-4ba8-9bef-47e92bc01a03	RNA	R	0.19	UV Spec	released	False	89083700-8720-4128-aae6-c21175e3ddae	01			0.0		0.0	5.0	95.0	98.0	TOP	bb70ca78-9511-406f-b555-917d69bbdddf	released			0.0		0.0	10.0	90.0	95.0	BOTTOM	d39fed4b-f145-4c60-8fd1-81541b8bbbd1	released	released	84.0						30abe357-43d0-434c-99d1-affe0fd047d8	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-0724_demographic	72	-26342	83	f7209024-2212-57c6-a911-814f868dded7	hispanic or latino	female	white	released	Dead	1930	2002	TCGA-13-0724_exposure	Not Reported	f28e3a0f-47c2-5c42-8265-33fceb122cf5	released	TCGA-13-0724_diagnosis	26342	not reported	0	83	b91001a3-8a3f-5dfc-8ec8-33576a6f86c7	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-13-0724_treatment	TCGA-13-0724_treatment_1	released	18f395e7-41cf-5bc5-ae77-985e648fbed5	no	Radiation Therapy, NOS	released	ec4590d3-a156-5c9e-847f-275057b683a6	yes	Pharmaceutical Therapy, NOS	1529e2b7-8203-48d8-9b9a-f22af739e83a
d94e4aa8-366d-4330-a08c-b543fc0bd18e.htseq.counts.gz	818f08fc-f7a3-418e-9554-468fd246a916	TCGA-59-2355-01A-01R-1569-13	TCGA-59-2355-01A-01R	TCGA-59-2355-01A-01-BS1	TCGA-59-2355-01A-01-TS1	TCGA-59-2355-01A-01		TCGA-59-2355-01A	TCGA-59-2355	708eec28-2348-4e15-b98c-8c6f9d057b1e	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.6		322bedf6-e6b5-4275-a186-0075a2ec271e	1.8	866c7355-e2ec-4816-953f-7bf791033283			0.14	22	released	03b3f308-19f6-4113-b44b-18c18b63b7d1	RNA	R	0.14	UV Spec	released	False	9b78ac7c-f6ad-4841-acc7-8c03b73e532b	01			20.0		0.0	20.0	60.0	80.0	BOTTOM	d33e6280-0dad-46b2-bb0f-397d05a2f7da	released			0.0		0.0	15.0	85.0	85.0	TOP	07a67953-f1fe-4440-9bc3-a51e2a4a8ab7	released	released	125.0						fc1a6b07-e91e-47c5-bf00-80be3c167605	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-59-2355_demographic	58		65	ea0a2db7-aa6f-51d6-b99f-2e20666781ef	not hispanic or latino	female	white	released	Dead	1948	2006	TCGA-59-2355_exposure	Not Reported	fe87a81d-611f-5261-974b-4bb9c63b427e	released	TCGA-59-2355_diagnosis		not reported	0		399bd74f-6959-50b6-9977-29d7ab3b4588	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-59-2355_treatment_1	TCGA-59-2355_treatment	released	9257b8a0-dca7-5d1f-8427-8287dc8789fa	yes	Pharmaceutical Therapy, NOS	released	c74b03d1-9ee4-5d0f-a5d0-39b066358ffd	not reported	Radiation Therapy, NOS	818f08fc-f7a3-418e-9554-468fd246a916
60deafcb-603b-4eb8-92b1-28656a674581.htseq.counts.gz	8ad5f01a-8870-4997-8ce4-c9eec4747112	TCGA-29-1696-01A-01R-1567-13	TCGA-29-1696-01A-01R	TCGA-29-1696-01A-01-TS1	TCGA-29-1696-01A-01-BS1	TCGA-29-1696-01A-01		TCGA-29-1696-01A	TCGA-29-1696	8a98a6e6-b763-4824-858b-fd2738e6c9a3	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	0.8		5e817943-3108-4838-bf8c-85c4507eb873	1.8	23c4ab1a-f8ce-47be-ab03-abfc66ea70ef			0.14	22	released	67da1a33-39e9-4660-bc6d-91e796b8f9bc	RNA	R	0.14	UV Spec	released	False	a123453e-4d3f-4c37-b577-73c2ea6174be	01			0.0		0.0	0.0	100.0	95.0	TOP	9f136ba5-516c-439d-8e2d-a9061cce1191	released			0.0		0.0	0.0	100.0	70.0	BOTTOM	5ba62db5-014b-4d13-89d9-10a481d6a10b	released	released	126.0						75d36397-75e8-4925-bf1e-6f73bd9293ba	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-29-1696_demographic	43	-15818	1032	c51e54e0-2edf-5cdc-8ca8-6d6d57b1a6fc	not reported	female	white	released	Dead	1960	2005	TCGA-29-1696_exposure	Not Reported	afe7e355-e3f0-5bff-ad31-cd161439faeb	released	TCGA-29-1696_diagnosis	15818	not reported	0	1025	f5ff0990-b997-5fdd-801b-60df58027c40	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-29-1696_treatment	TCGA-29-1696_treatment_1	released	69800ea4-51dd-5371-ae98-68bd783855f1	no	Radiation Therapy, NOS	released	a88f0d1c-1f0c-5a1e-a176-067d9863e393	yes	Pharmaceutical Therapy, NOS	8ad5f01a-8870-4997-8ce4-c9eec4747112
36a15497-1f35-446d-886f-ea34196a5fdd.htseq.counts.gz	690313b2-1a61-4afe-90f7-5ea96a84ebab	TCGA-61-2003-01A-01R-1568-13	TCGA-61-2003-01A-01R	TCGA-61-2003-01A-01-TS1	TCGA-61-2003-01A-01-BS1	TCGA-61-2003-01A-01		TCGA-61-2003-01A	TCGA-61-2003	33dc48d8-2e01-482b-944c-ac10da727ec9	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.4	False	1.5		79c66510-6e38-470f-9e91-d774665d39a6	1.8	bc200f3a-6d31-4480-8785-987f14cfa319			0.14	22	released	81528da3-2c99-4867-92a6-1de2bab7d84a	RNA	R	0.14	UV Spec	released	False	44425f5b-5bc1-49eb-82a9-62d70f2d62cb	01			3.0		7.0	5.0	85.0	95.0	TOP	4a075378-e3da-4b3b-abea-c75c6acfd895	released			3.0		7.0	5.0	85.0	95.0	BOTTOM	a8771b76-02b4-418e-b9a6-2282807606e4	released	released	120.0						74826da0-ddc4-49b0-bcb5-591691f4f8d6	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-61-2003_demographic	53	-19605		08fce3da-3c8e-5e7f-9af4-734444e2919c	not hispanic or latino	female	white	released	Alive	1955		TCGA-61-2003_exposure	Not Reported	ece39e17-c89f-5d1e-af91-deed3a6767b7	released	TCGA-61-2003_diagnosis	19605	not reported	0	122	ad8f87df-db51-56a1-840d-89f7e394ab23	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-61-2003_treatment	TCGA-61-2003_treatment_1	released	82bf33a9-33b0-5f3c-a260-0f9e0bc340ec	no	Radiation Therapy, NOS	released	f4a5805b-6e26-533f-a733-2e5838e3111d	yes	Pharmaceutical Therapy, NOS	690313b2-1a61-4afe-90f7-5ea96a84ebab
81830d92-01c0-4607-888e-be947ccae6e2.htseq.counts.gz	f9cf4c73-e8e6-4992-9dbd-88ba9f049ffc	TCGA-20-1682-01A-01R-1564-13	TCGA-20-1682-01A-01R	TCGA-20-1682-01A-01-TS1	TCGA-20-1682-01A-01-BS1	TCGA-20-1682-01A-01		TCGA-20-1682-01A	TCGA-20-1682	94bd4c68-4bfc-4db3-9365-97c867747133	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	1.0		cf49ea4d-478c-469d-ace2-7ef52b66a332	1.8	f03d023b-cba8-413d-a88d-0378ee7b7748			0.15	22	released	0995338b-45fe-488d-8606-2c2e994a6a21	RNA	R	0.15	UV Spec	released	False	7a3529ad-24c3-4531-a62a-18fdfbe70e99	01	5.0		2.0		0.0	38.0	60.0	80.0	TOP	8c825440-843e-42d1-bd0e-dd91a64b5d69	released	5.0		1.0		0.0	14.0	85.0	80.0	BOTTOM	c4f1280c-1e62-4d03-9237-35a4ce37f578	released	released	125.0						3c3da068-a62f-43c9-91c7-41ead1ca7f75	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-20-1682_demographic	56	-20583		785a428f-fce0-5477-84d9-dc65a0af2908	not hispanic or latino	female	white	released	Alive	1951		TCGA-20-1682_exposure	Not Reported	09f30327-5602-5f1f-af5e-023c2324a934	released	TCGA-20-1682_diagnosis	20583	not reported	0	837	72df9e88-9c14-5df0-820e-182c1459f906	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-20-1682_treatment_1	TCGA-20-1682_treatment	released	d17f7953-84dd-5a23-8a1d-18aaf633f217	yes	Pharmaceutical Therapy, NOS	released	fae81cac-35fa-5817-832b-5b69dac21bfc	no	Radiation Therapy, NOS	f9cf4c73-e8e6-4992-9dbd-88ba9f049ffc
43b0eb35-8278-440a-a743-fd91ca544b1b.htseq.counts.gz	31831810-0208-41bb-bb5a-4cc6d5661f2d	TCGA-13-1511-01A-01R-1565-13	TCGA-13-1511-01A-01R	TCGA-13-1511-01A-01-TS1	TCGA-13-1511-01A-01-BS1	TCGA-13-1511-01A-01		TCGA-13-1511-01A	TCGA-13-1511	756f6768-e69a-4fe9-aa41-7c58aabe4577	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.6	False	2.2		CD73F0B8-0B90-40D1-B6FE-6046F84E9AB0	1.8	ccd83080-7a51-4952-b4af-d13e9c182bc0			0.15	22	released	4bed8faa-e912-457b-a001-b1f09bfe8660	RNA	R	0.15	UV Spec	released	False	974b608d-c669-47bb-af1f-29980272dbe6	01			5.0		0.0	5.0	90.0	95.0	TOP	4fb08454-15fa-40f8-9d21-d7b75fa68fbe	released			5.0		0.0	5.0	90.0	95.0	BOTTOM	1db24a7e-5116-4fad-a830-8ffa5736985b	released	released	165.0						c24a2f48-af41-4e1b-9e23-fbac94d02da4	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1511_demographic	52	-19258	1650	e28453c8-ec26-52b0-ab4d-a347b02c3a2f	not hispanic or latino	female	asian	released	Dead	1956		TCGA-13-1511_exposure	Not Reported	3d20aecd-ddf6-52f9-8e56-7db9884dde3c	released	TCGA-13-1511_diagnosis	19258	not reported	0	119	46631da2-f6dd-5b78-8999-4f18d5131f9c	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1511_treatment_1	TCGA-13-1511_treatment	released	4191796a-4223-5b44-abae-5eb94ade0d45	yes	Pharmaceutical Therapy, NOS	released	d7c83c4a-d7b2-5205-8dc3-85c3c56af640	no	Radiation Therapy, NOS	31831810-0208-41bb-bb5a-4cc6d5661f2d
61b6a3de-8bb2-4fc1-85d9-849c823d8fd5.htseq.counts.gz	a522b6f3-0869-4568-977d-11e283e3a6dd	TCGA-61-2101-01A-01R-1568-13	TCGA-61-2101-01A-01R	TCGA-61-2101-01A-01-TS1	TCGA-61-2101-01A-01-BS1	TCGA-61-2101-01A-01		TCGA-61-2101-01A	TCGA-61-2101	5d1a54fe-e0df-4c17-b623-b649a136dc82	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	1.5		b9d85995-85dd-4b00-b93f-3387cd018475	1.8	95970bdb-e1f2-49dc-903b-c30088cef71d	3	20	0.15	22	released	7b3b08e4-7b60-4606-b530-85ab3384efa5	RNA	R	0.15	UV Spec	released	False	3fb8aedd-61a1-4169-b4b1-753f4104c09e	01			0		0	10	90	90	TOP	d5aab1ba-183b-4f16-8f4c-5902e34d5ea3	released			0		0	10	90	90	BOTTOM	ea43cb3b-f8d4-4869-bf64-ce0af7638a57	released	released	141						46d32513-dc68-4261-8e1b-26d407b6546a	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-2101_demographic	55	-20287	1688	b7c5d9f0-7661-5b83-b542-63db349c7ce3	not hispanic or latino	female	white	released	Dead	1944	2003	TCGA-61-2101_exposure	Not Reported	3db319a4-0177-59e2-905c-936040312204	released	TCGA-61-2101_diagnosis	20287	not reported	0		bcf6dd1a-9c55-5d62-950c-9c3e804897d1	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1999	TCGA-61-2101_treatment	TCGA-61-2101_treatment_1	released	420624e8-613c-5017-8e58-2363bfb58d49	no	Radiation Therapy, NOS	released	d065efab-899d-546e-a625-3fdb7f0840ae	yes	Pharmaceutical Therapy, NOS	a522b6f3-0869-4568-977d-11e283e3a6dd
4e4b6800-a128-4daf-a9f9-803b24e04742.htseq.counts.gz	95149472-6ca4-43a0-b543-e9996c42f723	TCGA-29-1695-01A-01R-1567-13	TCGA-29-1695-01A-01R	TCGA-29-1695-01A-01-TS1	TCGA-29-1695-01A-01-BS1	TCGA-29-1695-01A-01		TCGA-29-1695-01A	TCGA-29-1695	33d36b64-4688-40a7-9a4f-7cd3d4cc683d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.1		136a4380-2a2a-489f-8675-886e876f17f7	1.8	33f1dda6-7601-48c6-b46d-f0ba759e4048			0.15	22	released	dd5d2660-13c3-416f-8a07-fe77accd6b78	RNA	R	0.15	UV Spec	released	False	8afbcc19-d83a-4a21-b86d-ad40ae810dce	01			0.0		0.0	0.0	100.0	85.0	TOP	7fd5b824-6a98-4ed3-b6e9-6564b12229a6	released			2.0		0.0	0.0	98.0	85.0	BOTTOM	06ff1b46-dadd-4aa2-a606-8ef843d8374e	released	released	105.0						7a1db005-662a-4df4-886a-ec3319bde99a	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1695_demographic	62	-22895	1229	dce94daf-399a-5bdc-9190-563469a5a908	not reported	female	white	released	Dead	1941	2006	TCGA-29-1695_exposure	Not Reported	d05c7fd0-0c7b-523b-b508-242d1b7072e9	released	TCGA-29-1695_diagnosis	22895	not reported	0	24	545dae36-7e9c-574c-81a8-71ad91172902	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-29-1695_treatment_1	TCGA-29-1695_treatment	released	2c5e64aa-357e-5a64-9acc-d50e76d3155e	not reported	Pharmaceutical Therapy, NOS	released	5e98915f-9215-5b0f-a8d2-af86dff4b291	no	Radiation Therapy, NOS	95149472-6ca4-43a0-b543-e9996c42f723
2ad549b2-56d8-4047-a398-cbe1f6295722.htseq.counts.gz	e0e57a01-9217-402c-95c8-09843fd2585e	TCGA-24-1105-01A-01R-1565-13	TCGA-24-1105-01A-01R	TCGA-24-1105-01A-01-BS1	TCGA-24-1105-01A-01-TS1	TCGA-24-1105-01A-01		TCGA-24-1105-01A	TCGA-24-1105	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.4		DE593AFC-BC21-4183-94A6-B8BA9931B70F	1.8	fd57adc4-669c-4916-a2f5-e5f92cb0adb6			0.15	22	released	c75d7ff8-f0b7-4084-a2fd-bb843cfa7a7a	RNA	R	0.15	UV Spec	released	False	c73cc52e-7d80-4c6c-9687-02d63adf0835	01			5.0					90.0	BOTTOM	6aefaf25-f9ca-4d2e-8fe1-c76af069cfb9	released			1.0					90.0	TOP	b1eba572-c739-453d-8612-b5e33a50bbac	released	released	130.0						ae4aa065-8b1d-42a3-98ef-357e19c1f1e1	Primary Tumor	01	0.8	released	Not Reported	released	TCGA-24-1105_demographic	36	-13187	1442	8580420d-47dd-59ce-8343-b6d4b53415e6	not reported	female	white	released	Dead	1965	2004	TCGA-24-1105_exposure	Not Reported	eeb2cd91-bb70-5ff5-819c-f3d2d01c37d7	released	TCGA-24-1105_diagnosis	13187	not reported	0	1442	fe611014-c242-5d62-9a13-f3b96ce70bc3	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-24-1105_treatment_1	TCGA-24-1105_treatment	released	6c551a0e-c8a3-5b6f-b3be-59fd2658b60b	yes	Pharmaceutical Therapy, NOS	released	6193e8fc-9c24-5bb3-8826-fda7e5d90222	yes	Radiation Therapy, NOS	e0e57a01-9217-402c-95c8-09843fd2585e
0ffb5d54-6522-4074-9c41-8371f284d1dc.htseq.counts.gz	31ec16d9-c67b-4521-b020-6970103f90af	TCGA-23-1024-01A-02R-1564-13	TCGA-23-1024-01A-02R	TCGA-23-1024-01A-01-BS1	TCGA-23-1024-01A-02-BS2	TCGA-23-1024-01A-02		TCGA-23-1024-01A	TCGA-23-1024	8ac6ce06-ab50-4ab4-a469-9f8bf01be963	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.8		1CCE5978-6A4D-427A-9875-47617F6A4258	1.8	467ceace-18c4-436b-a8f6-842794c5dfa5			0.16	22	released	b14b716b-4d12-4490-90a5-c9ad648cfa11	RNA	R	0.16	UV Spec	released	False	ea0fd884-e677-4f95-b02d-2abda1ba9efb	02			0.0		5.0	5.0	90.0	90.0	TOP	7c5c688d-74e7-470a-95c5-115c73451c0d	released			0.0		10.0	5.0	85.0	80.0	BOTTOM	abbe97b3-ccf4-417e-b838-715a487e2595	released	released	85.0						96430cd1-1f32-4d4e-ae16-e39df6405739	Primary Tumor	01	0.2	released	Not Reported	released	TCGA-23-1024_demographic	52	-19052		83b2a085-d35c-5c1c-a5a5-d0125b3fc24d	not hispanic or latino	female	white	released	Alive	1955		TCGA-23-1024_exposure	Not Reported	bd3701f2-12a5-5597-8403-3a4dbdadcc0b	released	TCGA-23-1024_diagnosis	19052	not reported	0	468	4daaa455-5886-55af-9373-8912838020b3	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2007	TCGA-23-1024_treatment	TCGA-23-1024_treatment_1	released	1ede6ca5-3de4-56d3-913b-e27419c8b222	no	Radiation Therapy, NOS	released	93045d7b-bc7d-5b62-9f76-349a96159585	yes	Pharmaceutical Therapy, NOS	31ec16d9-c67b-4521-b020-6970103f90af
bf4058ee-ed0b-43e4-bc4e-3343239f187b.htseq.counts.gz	1bd104aa-80a0-43fc-bbdf-c0341c0279f5	TCGA-29-1761-01A-01R-1567-13	TCGA-29-1761-01A-01R	TCGA-29-1761-01A-01-TS1	TCGA-29-1761-01A-01-BS1	TCGA-29-1761-01A-01		TCGA-29-1761-01A	TCGA-29-1761	374ea8df-ecc4-44b0-b519-33efa5078018	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	0.9		63defa27-e729-4514-bdd2-d887c4100854	1.8	c4446f6f-fae9-414c-8bae-7c78bb894982			0.15	22	released	8b2dc648-c2a0-47bf-9944-2867e802b8e4	RNA	R	0.15	UV Spec	released	False	355336f6-9d16-4d8d-86b9-6912c5f996ef	01	10.0		5.0		0.0	10.0	85.0	80.0	TOP	26b76609-e133-4641-93f1-5497015975a4	released	15.0		5.0		0.0	5.0	90.0	75.0	BOTTOM	4a648bd9-d950-4516-baa1-0ee2937785ef	released	released	127.0						d9939f44-f5d7-469f-b256-4af851190454	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1761_demographic	80	-29337	528	5707415c-114a-55b6-9c7a-ffe492bcd227	not reported	female	asian	released	Dead	1918	1999	TCGA-29-1761_exposure	Not Reported	f62ba290-9835-599e-8b42-225af2890583	released	TCGA-29-1761_diagnosis	29337	not reported	0	517	d4e1d5f5-41cc-55eb-b085-39c793219da6	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1998	TCGA-29-1761_treatment	TCGA-29-1761_treatment_1	released	8228dadd-a42b-5674-90c3-3f343a60fdae	no	Radiation Therapy, NOS	released	19262f6f-eb0c-55de-b05a-0cbb36bd2af2	yes	Pharmaceutical Therapy, NOS	1bd104aa-80a0-43fc-bbdf-c0341c0279f5
3788684a-b405-44fe-8d09-4e40a46d5214.htseq.counts.gz	4551bd05-feb3-44d8-97c6-5523391bbfc2	TCGA-29-1691-01A-01R-1566-13	TCGA-29-1691-01A-01R	TCGA-29-1691-01A-01-BS1	TCGA-29-1691-01A-01-TS1	TCGA-29-1691-01A-01		TCGA-29-1691-01A	TCGA-29-1691	b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.5		74e45220-b3ac-4404-8bb6-811f3d4ba611	1.8	f83833b8-8cb2-44d8-8ac7-c4d2d2463053			0.15	22	released	64a43887-2a36-4edc-a931-ea5f053be2f0	RNA	R	0.15	UV Spec	released	False	74a297b6-b3e1-4692-8856-eb9693bd534b	01			2.0		0.0	0.0	98.0	95.0	BOTTOM	eec0bed3-fe05-4128-9bac-92a84c021875	released		1.0	2.0		0.0	0.0	98.0	90.0	TOP	cd851d1b-0bd5-4564-bbe0-4dc4aa293b37	released	released	127.0						5dbb6c5e-be66-47ca-9bb4-1845b8004286	Primary Tumor	01	0.05	released	Not Reported	released	TCGA-29-1691_demographic	51	-18664	1470	3e0c0748-6430-57d2-81fa-e74f67bba190	not reported	female	white	released	Dead	1944	1999	TCGA-29-1691_exposure	Not Reported	bd75dbc2-7e8d-5ea6-a30d-6313f032e662	released	TCGA-29-1691_diagnosis	18664	not reported	0	1435	462c9b3c-1b04-5e25-bdd0-cb23c26c7256	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1995	TCGA-29-1691_treatment_1	TCGA-29-1691_treatment	released	a320aea5-1e21-5769-89c6-86337bc081ee	yes	Pharmaceutical Therapy, NOS	released	ab9e8288-c148-5fc9-8502-54b6d560c9a5	no	Radiation Therapy, NOS	4551bd05-feb3-44d8-97c6-5523391bbfc2
a6bbe2d8-2f21-4eaa-b2ed-4da1ff48054a.htseq.counts.gz	e0235689-b4c0-4e36-b3ba-34488d2b10cf	TCGA-09-1665-01B-01R-1566-13	TCGA-09-1665-01B-01R	TCGA-09-1665-01B-01-TS1	TCGA-09-1665-01B-01-BS1	TCGA-09-1665-01B-01		TCGA-09-1665-01B	TCGA-09-1665	9d25cd0e-0a3e-4ee0-b1a3-58ffab348c9d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.5		0e311879-9b25-453d-b41a-7cc3048bb05e	1.8	c06f72e0-e59f-4cbb-8233-1eb6637ea23f			0.16	22	released	c2c10b2c-7ae8-47af-b988-4f8dfb76b6bb	RNA	R	0.16	UV Spec	released	False	713fda59-e947-4dd7-aa2c-71f58b085342	01			5.0		10.0	0.0	85.0	90.0	TOP	34964afd-a82c-411c-9e7e-c3cffa29f204	released			2.0		25.0	5.0	68.0	90.0	BOTTOM	5a6cb79c-8270-4d29-89f5-ccf0a2192634	released	released	105.0						d66fb62f-8483-459c-999e-d5b64b835e11	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-09-1665_demographic	73	-27010	1266	4b2e1ed3-d88a-581c-a432-bcfc88178a7a	not hispanic or latino	female	white	released	Dead	1929	2005	TCGA-09-1665_exposure	Not Reported	0652f2fe-f64a-5f13-9f13-9fb18d5940ac	released	TCGA-09-1665_diagnosis	27010	not reported	0		36ea240f-5e4c-59a4-858e-ff2127a15b98	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2002	TCGA-09-1665_treatment_1	TCGA-09-1665_treatment	released	fc10b85e-eee3-537f-a765-9e95abbb8d6e	yes	Pharmaceutical Therapy, NOS	released	259ed336-fe51-5bcd-8647-917135d01f8f	yes	Radiation Therapy, NOS	e0235689-b4c0-4e36-b3ba-34488d2b10cf
5dbeb062-22ba-4057-afd6-8627f1ac9500.htseq.counts.gz	a5da29f5-78d7-4fbe-a771-5ecde4a7d201	TCGA-24-1426-01A-01R-1565-13	TCGA-24-1426-01A-01R	TCGA-24-1426-01A-01-BS1	TCGA-24-1426-01A-01-TS1	TCGA-24-1426-01A-01		TCGA-24-1426-01A	TCGA-24-1426	c8acee1b-6854-409b-86ab-bf69dbe22ab6	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	1.2		72914511-b2f7-484f-a7ab-3f4f1868f2cb	1.8	8cd9abeb-c09e-4281-a8c8-1b426796d51e			0.17	22	released	026fa03c-22ae-4f0a-869a-fa3489c9473a	RNA	R	0.17	UV Spec	released	False	38765edc-6bd6-49fb-b289-79d3cb35c679	01			0.0		0.0	10.0	90.0	90.0	BOTTOM	df3cb40f-130c-42db-886a-10e298f9a0ce	released			1.0		0.0	10.0	89.0	90.0	TOP	365230f5-c1b1-4124-9ba5-1b86ae87e12b	released	released	90.0						4a4ec9eb-d594-449b-adfb-703ac1f25bb5	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-24-1426_demographic	43	-15949		13753562-152d-554c-9562-f22a3fcf89f7	not reported	female	white	released	Alive	1965		TCGA-24-1426_exposure	Not Reported	2a888d25-0ddb-58b4-8192-cd164c6801a8	released	TCGA-24-1426_diagnosis	15949	not reported	0	163	73d04d1d-d04a-5882-9b7c-26f5a22bf03e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-24-1426_treatment_1	TCGA-24-1426_treatment	released	f2ca52ae-b640-5569-8b74-adb710d973bd	yes	Pharmaceutical Therapy, NOS	released	4e62a9f2-3ff9-53b6-bc81-449ddbcee8a9	no	Radiation Therapy, NOS	a5da29f5-78d7-4fbe-a771-5ecde4a7d201
ade137ec-8b83-48d0-9162-4a2f52db5b0f.htseq.counts.gz	eec66dfc-7b0d-43b1-9695-4720830641f9	TCGA-24-2038-01A-01R-1568-13	TCGA-24-2038-01A-01R	TCGA-24-2038-01A-01-BS1	TCGA-24-2038-01A-01-TS1	TCGA-24-2038-01A-01		TCGA-24-2038-01A	TCGA-24-2038	17181157-c9e2-4bd6-8653-f5dce56f9053	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	1.0		82958234-9de0-429f-8e63-3e8891f1df81	1.8	372a8471-dff3-44c0-9393-94ad511a7374			0.15	22	released	9d213069-5360-466d-8188-4c916373b9f0	RNA	R	0.15	UV Spec	released	False	61dd04b3-7185-43f0-9811-02dcd6d18b0d	01	2.0	0.0	0.0	0.0	0.0	40.0	60.0	90.0	BOTTOM	bfb2b2d1-9854-418f-b254-834554b1f0aa	released	0.0	0.0	0.0	0.0	0.0	5.0	95.0	90.0	TOP	a774211b-82e3-4362-a5bd-7a7f8367fc3a	released	released	129.0						cb5c8591-15ab-46b3-a819-57cbf71c6bce	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-2038_demographic	68	-24957	1354	3ea04b59-4837-5855-9da9-a7e5b46b7e10	not reported	female	white	released	Dead	1932	2003	TCGA-24-2038_exposure	Not Reported	ae71bd83-8d1b-506b-9a9b-2cc13e01a223	released	TCGA-24-2038_diagnosis	24957	not reported	0	1354	82ae2a62-aea4-5d85-9136-e3403b28b06c	Stage IIIA	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-24-2038_treatment_1	TCGA-24-2038_treatment	released	4da6c04a-d1b4-56fd-a6ec-86cbf3a6ad42	yes	Pharmaceutical Therapy, NOS	released	69152569-be83-508b-94fb-050e944616a9	no	Radiation Therapy, NOS	eec66dfc-7b0d-43b1-9695-4720830641f9
fda19653-d2d3-41f2-9122-72e892fd2853.htseq.counts.gz	c479c96a-d88e-463a-9d8c-06059378cf38	TCGA-09-1661-01B-01R-1566-13	TCGA-09-1661-01B-01R	TCGA-09-1661-01B-01-TS1	TCGA-09-1661-01B-01-BS1	TCGA-09-1661-01B-01		TCGA-09-1661-01B	TCGA-09-1661	f8e9d538-7291-4fe7-b3f2-d01676a027f9	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.4	False	0.6		1910251f-8c5c-4067-91dc-87bfdaf77283	1.8	582e6ac5-273a-423d-9169-6393e1b79393			0.17	22	released	1561f73e-d3f2-4866-a590-4a3d2bbfaa95	RNA	R	0.17	UV Spec	released	False	980c9e88-6f3d-4fb1-b609-70303f84bac8	01			5.0		20.0	0.0	75.0	80.0	TOP	54e51666-b7bb-4bc7-b043-1ce3f71a0d85	released			2.0		28.0	0.0	70.0	80.0	BOTTOM	0f6d83b1-1a23-4b61-b9c7-6b73071f3d24	released	released	50.0						a7e17e91-e9d2-4118-8215-86546f8e2feb	Primary Tumor	01	0.1	released	Not Reported	released	TCGA-09-1661_demographic	75	-27486	1169	7d5dcebc-ff09-52ee-aedc-34d4ec8683e2	not hispanic or latino	female	white	released	Dead	1925	2003	TCGA-09-1661_exposure	Not Reported	964cb08a-da14-56b3-bcb2-45fae5472e90	released	TCGA-09-1661_diagnosis	27486	not reported	0		28f74326-0db8-5d53-bab2-b64acfa0aa64	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2000	TCGA-09-1661_treatment	TCGA-09-1661_treatment_1	released	3b4c753c-2b7c-5f2d-8b7d-751e0bc8d35e	no	Radiation Therapy, NOS	released	e0aca0af-8d2d-5891-b240-77e81e3d97f7	yes	Pharmaceutical Therapy, NOS	c479c96a-d88e-463a-9d8c-06059378cf38
5fa4dd02-be02-480e-a8ad-ae89bddc17b9.htseq.counts.gz	1a9eb55c-2725-4357-a8b2-97515418c60d	TCGA-23-1809-01A-01R-1566-13	TCGA-23-1809-01A-01R	TCGA-23-1809-01A-01-TS1	TCGA-23-1809-01A-01-BS1	TCGA-23-1809-01A-01		TCGA-23-1809-01A	TCGA-23-1809	bc3e0b74-ea09-46a5-9f61-16bd15ffd883	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	0.9		f69b3aba-61df-4fd8-94d7-9bb80692464c	1.8	ac764277-4d48-489a-8625-f27541b11258			0.14	22	released	cab2de48-ce3b-4a9b-abf7-95094d6f3cfb	RNA	R	0.14	UV Spec	released	False	59b97da2-8e0d-4bb3-8508-4d5d0cf0c11e	01			10.0		0.0	20.0	70.0	80.0	TOP	ee5e78ba-2887-4eab-ad57-edb5efb61942	released			10.0		0.0	20.0	70.0	80.0	BOTTOM	ae9b5dd9-e156-4990-b851-7a63b4f39e60	released	released	111.0						ef7f3a0d-b620-4355-8212-4bad381fe29c	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-23-1809_demographic	63	-23111		8cd7c35b-a01a-52cd-b6fe-c23edb79cfc4	not hispanic or latino	female	white	released	Alive	1946		TCGA-23-1809_exposure	Not Reported	9ed411a9-4d25-539c-8c7b-3becaa425144	released	TCGA-23-1809_diagnosis	23111	not reported	0	16	ba8c7f10-02ed-5863-a63b-881397fd3c13	Stage IIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-23-1809_treatment	TCGA-23-1809_treatment_1	released	5825fcbd-3f5b-5845-8028-b80430d579ff	no	Radiation Therapy, NOS	released	ddad4156-7e80-500d-8c51-fde3dc1cd16e	yes	Pharmaceutical Therapy, NOS	1a9eb55c-2725-4357-a8b2-97515418c60d
7a7e4b6b-de2d-4e49-bcbf-c705164477b9.htseq.counts.gz	d541dcaf-c368-4e9e-9cf1-9c34309654cb	TCGA-61-1919-01A-01R-1568-13	TCGA-61-1919-01A-01R	TCGA-61-1919-01A-01-BS1	TCGA-61-1919-01A-01-TS1	TCGA-61-1919-01A-01		TCGA-61-1919-01A	TCGA-61-1919	ce871097-a6e9-4139-897e-642ee24ee123	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.8	False	1.5		240a49a3-b611-4949-b3b9-3799d8c0dc46	1.8	056cca38-92df-42ff-b064-b0c243f8a82f			0.14	22	released	10f39a65-ccb0-419f-8885-15dce96cbc85	RNA	R	0.14	UV Spec	released	False	2cdd6ba6-9589-485a-9272-bb6c02d16c6a	01			5.0		0.0	20.0	75.0	80.0	BOTTOM	6e069202-dc06-4418-bb6f-6f36113ce7b4	released			10.0		0.0	20.0	70.0	80.0	TOP	a2bfef73-10d7-4593-9c5b-4b93eddd160b	released	released	104.0						207be628-ffc8-4eb6-88b3-1705a3ee2ab5	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-1919_demographic	58	-21199	1161	23c0b61b-61e7-5f1e-8ed1-2e01f6ec1a56	not hispanic or latino	female	white	released	Dead	1943	2004	TCGA-61-1919_exposure	Not Reported	a6ac790d-e915-51c9-a97f-5237815da52b	released	TCGA-61-1919_diagnosis	21199	not reported	0	1161	41c9c74c-e5f7-5f95-b067-21508c7d5999	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-61-1919_treatment_1	TCGA-61-1919_treatment	released	4b5ca461-c626-5fd4-a3e5-251ab4be9dda	yes	Pharmaceutical Therapy, NOS	released	03223c84-530f-518f-ad2f-990a1386e1b2	no	Radiation Therapy, NOS	d541dcaf-c368-4e9e-9cf1-9c34309654cb
fa3553e7-0255-4d60-b8c9-3caba0d945cd.htseq.counts.gz	d34f8892-6ddb-4f10-b2f7-e81a8482bd30	TCGA-13-1498-01A-01R-1565-13	TCGA-13-1498-01A-01R	TCGA-13-1498-01A-01-BS1	TCGA-13-1498-01A-01-TS1	TCGA-13-1498-01A-01		TCGA-13-1498-01A	TCGA-13-1498	56a30462-2819-4c18-95be-8e73880a4921	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.1		0B03A4B9-61B9-43EA-9E7A-8EE1FF3B31F1	1.8	176d1ca2-eb1d-4f49-9b10-c129c822fa5a			0.16	22	released	00a3f8c5-119b-46f7-a6b5-6fe40ccc35ba	RNA	R	0.16	UV Spec	released	False	3c71ab8d-314b-4e10-aec8-6d4ce4127e4e	01			1.0		0.0	5.0	94.0	95.0	BOTTOM	860b1710-d464-4027-b6be-02694c7027a3	released			10.0		0.0	10.0	80.0	90.0	TOP	c1a533e4-aaec-4ffe-aa78-2f5d3887d768	released	released	131.0						b38f209a-000b-4cbf-a4bd-0bc6f027fce3	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-13-1498_demographic	73	-26820	2012	28950168-4541-54cc-bdd4-8a03516ad698	not hispanic or latino	female	white	released	Dead	1933		TCGA-13-1498_exposure	Not Reported	d0c40a01-dad8-5477-9f5b-962ac1e560d8	released	TCGA-13-1498_diagnosis	26820	not reported	0	1144	7014b3d8-1e77-5bd5-963a-cc54ff5b2d8f	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-13-1498_treatment	TCGA-13-1498_treatment_1	released	c5f54909-dc1a-531f-bce2-b9e66054c35d	no	Radiation Therapy, NOS	released	1251b50a-2183-527d-955f-fbb24c37f2f7	yes	Pharmaceutical Therapy, NOS	d34f8892-6ddb-4f10-b2f7-e81a8482bd30
1e0f7f1f-e4aa-43e6-a6c1-bc4a0439d3af.htseq.counts.gz	3c254d85-ac52-455c-8821-8ddb920a8765	TCGA-31-1953-01A-01R-1568-13	TCGA-31-1953-01A-01R	TCGA-31-1953-01A-01-BS1	TCGA-31-1953-01A-01-TS1	TCGA-31-1953-01A-01		TCGA-31-1953-01A	TCGA-31-1953	61feee94-3ac9-42fe-aaa3-dc6a3efe563c	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.5	False	1.0		c824400d-b062-4a04-b805-f717426d688e	1.8	7b31fc47-0299-4449-aa5b-622ba549371f			0.17	22	released	95633b3d-6d4b-4c20-88a0-4d910ed9b751	RNA	R	0.17	UV Spec	released	False	f8b5f9fa-5d33-422b-bd71-75d1cfcbbe32	01	3.0		0.0		0.0	10.0	90.0	95.0	BOTTOM	f0a27d64-d7c9-438e-9ef0-636ee0881eb0	released	1.0		2.0		0.0	8.0	90.0	95.0	TOP	d23dcd07-a0b5-4eb2-9773-4ab7ffb396ff	released	released	133.0						0918328b-5726-4429-a7dc-bb4d4869575b	Primary Tumor	01	0.1	released	Not Reported	released	TCGA-31-1953_demographic	52	-19064		3bd53964-0f52-57a9-8645-6b78d6e3b5ce	not hispanic or latino	female	asian	released	Alive	1956		TCGA-31-1953_exposure	Not Reported	d0d19a74-8777-500d-8754-0464b95d299d	released	TCGA-31-1953_diagnosis	19064	not reported	0	204	afe49009-fc98-5b1d-9903-ccc3d9c5d4fb	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-31-1953_treatment_1	TCGA-31-1953_treatment	released	5bb29169-014c-5dbd-8698-218bc2f766f4	yes	Pharmaceutical Therapy, NOS	released	17c4216b-0dbb-576d-bec5-8806fd89f076	no	Radiation Therapy, NOS	3c254d85-ac52-455c-8821-8ddb920a8765
4b4d6cbb-92b0-4c40-8338-5acdf5f3f2a9.htseq.counts.gz	f49bf2a4-f988-474c-a229-c0b25b18470a	TCGA-29-1784-01A-02R-1567-13	TCGA-29-1784-01A-02R	TCGA-29-1784-01A-02-BS2	TCGA-29-1784-01A-01-BS1	TCGA-29-1784-01A-02		TCGA-29-1784-01A	TCGA-29-1784	23d32627-9fd2-4312-bcda-ee7409e3983f	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		e4614e5d-eb1f-4ac7-a17f-105936745e80	1.9	c72e442b-36f5-4ea6-a893-505b5ccd8c4f			0.17	22	released	6553e196-3e0e-4ac1-962a-57a03238f376	RNA	R	0.17	UV Spec	released	False	5424263c-4ee7-4e09-b079-e5d5de5f427e	02	15.0		0.0		0.0	5.0	95.0	80.0	BOTTOM	b8defa82-cc0f-44ec-9032-9cd4030304a7	released	20.0		0.0		0.0	10.0	90.0	75.0	TOP	5eb21daa-2637-47ca-ada9-b987cd1621ee	released	released	116.0						90c52b7a-a0fb-4e5f-9c80-ee94516ab8d9	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-29-1784_demographic	55	-20210		331533e8-2b22-538a-bb92-3ba7f81c58a2	not reported	female	white	released	Alive	1954		TCGA-29-1784_exposure	Not Reported	24233ecc-1634-54fa-8dfe-128ea3baaf64	released	TCGA-29-1784_diagnosis	20210	not reported	0	163	3e3aadeb-f781-5f50-86b3-d49f1aa93c4f	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2009	TCGA-29-1784_treatment	TCGA-29-1784_treatment_1	released	23d48b9a-e5f7-5aee-bb22-0a3c67d096a5	no	Radiation Therapy, NOS	released	6a88d265-dee4-595b-a659-1e0f1f844c16	yes	Pharmaceutical Therapy, NOS	f49bf2a4-f988-474c-a229-c0b25b18470a
d7191f19-150b-4175-83a7-21052fefc488.htseq.counts.gz	43d99dae-a1da-4dfb-8eb1-59a3917d069e	TCGA-23-1118-01A-01R-1564-13	TCGA-23-1118-01A-01R	TCGA-23-1118-01A-01-BS1	TCGA-23-1118-01A-01-TS1	TCGA-23-1118-01A-01		TCGA-23-1118-01A	TCGA-23-1118	700e91bb-d675-41b2-bbbd-935767c7b447	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	0.8		2f53a2c6-b67a-4966-b300-5e00968b15f3	1.8	9e73d9f4-dd7c-439f-a8c5-236311e3facf			0.15	22	released	d902eb23-c35d-400a-81ac-17728b2e2876	RNA	R	0.15	UV Spec	released	False	e5b2d2fd-d455-41cb-bf7c-0a5f77deafc1	01			10.0					90.0	BOTTOM	8d624207-a194-492d-b84f-da0a617d2fc2	released			0.0					95.0	TOP	fbcfe18d-548d-4c26-8ed8-c13545b48e49	released	released	101.0						e1be8ad9-1a52-4677-8436-3da22ad12e9a	Primary Tumor	01	0.7	released	Not Reported	released	TCGA-23-1118_demographic	45	-16471		9365e233-5048-5e21-8118-2106e29f75eb	not hispanic or latino	female	white	released	Alive	1956		TCGA-23-1118_exposure	Not Reported	aeb2b56a-2e5d-5a27-841d-227b2f274594	released	TCGA-23-1118_diagnosis	16471	not reported	0	2616	3e654e05-d3e9-57f4-9bda-b31211ca6a22	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-23-1118_treatment_1	TCGA-23-1118_treatment	released	cf2634d6-1817-5f74-8912-3f103b4d42a6	yes	Pharmaceutical Therapy, NOS	released	85cb3d17-bf01-575b-b9f6-6a789b2f494f	no	Radiation Therapy, NOS	43d99dae-a1da-4dfb-8eb1-59a3917d069e
ce515bac-2166-4e01-a3f7-fa822fe8b7d5.htseq.counts.gz	0433e32a-ab20-4fa2-ab3d-556c7891e6d5	TCGA-04-1341-01A-01R-1564-13	TCGA-04-1341-01A-01R	TCGA-04-1341-01A-01-BS1	TCGA-04-1341-01A-01-TS1	TCGA-04-1341-01A-01		TCGA-04-1341-01A	TCGA-04-1341	92badeb5-a50e-4a62-a67e-6a8a59c948ab	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		9DB095E5-19F0-4ECE-9E54-2F030190FDB5	1.7	d525e6af-f667-4891-97ee-856e6052982f			0.17	22	released	c994cc41-caff-4a87-b7e8-0be34282ba82	RNA	R	0.17	UV Spec	released	False	582d08e8-91e2-42a0-9254-3f255c8481dd	01			17.0			28.0	55.0	80.0	BOTTOM	85fe6a7e-fd57-4f26-a84e-f1688df637b3	released			3.0			22.0	75.0	80.0	TOP	c8420eb8-4f42-4b9a-a00e-2e18e43303f8	released	released	107.0						8873baff-198d-4e4c-9d6d-18ee9d164f0d	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-04-1341_demographic	85	-31215		a6a82dbe-deda-5ed3-81b8-4300e0617345	not hispanic or latino	female	white	released	Alive	1921		TCGA-04-1341_exposure	Not Reported	9f6617ca-3fc8-55bb-85a6-baee8f1cbdfb	released	TCGA-04-1341_diagnosis	31215	not reported	0	33	20316fd4-aca7-57fa-9966-4076874a372f		C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2006	TCGA-04-1341_treatment	TCGA-04-1341_treatment_1	released	0d68a73c-3842-5432-bb95-10b03c23f67f	no	Radiation Therapy, NOS	released	ced1f214-4d41-574b-988f-22ffefd1b5eb	not reported	Pharmaceutical Therapy, NOS	0433e32a-ab20-4fa2-ab3d-556c7891e6d5
25577d95-744c-45a8-b84a-a9c1b51c2baf.htseq.counts.gz	1707cf82-ab14-42eb-8230-3fe385ebb513	TCGA-13-1404-01A-01R-1565-13	TCGA-13-1404-01A-01R	TCGA-13-1404-01A-01-BS1	TCGA-13-1404-01A-01-TS1	TCGA-13-1404-01A-01		TCGA-13-1404-01A	TCGA-13-1404	8e107f4b-1912-4d3e-814a-b863e2d65ed7	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.5		39B73962-A374-4521-BFBB-F10D117979F9	1.8	5a24a912-7e38-4d60-a1b9-56023d2a321a			0.17	22	released	3e2d516d-582f-4642-bdb5-25e64723e1a9	RNA	R	0.17	UV Spec	released	False	2d6cb29e-9bd9-434d-8075-806072277d4b	01			1.0		0.0	20.0	79.0	80.0	BOTTOM	04e6176f-aca9-4874-b3d5-baecd5fc11e7	released			5.0		0.0	20.0	75.0	80.0	TOP	cecf7044-1d29-4d14-b137-821f8d48881e	released	released	122.0						f3cea00c-bc4a-450f-ae7b-cd97ab7369be	Primary Tumor	01	0.3	released	Not Reported	released	TCGA-13-1404_demographic	48	-17784		edf28ac0-2fef-5d14-9ecd-ff8a593fa717	not hispanic or latino	female	white	released	Alive	1960		TCGA-13-1404_exposure	Not Reported	d579c7c7-7f54-5792-b79e-94cda4fb5ca0	released	TCGA-13-1404_diagnosis	17784	not reported	0	2469	7b7eb1ba-bb1d-57b4-89e6-1c838f2f540e	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2008	TCGA-13-1404_treatment	TCGA-13-1404_treatment_1	released	4997ac35-df51-529f-91be-802f4bedd7d2	no	Radiation Therapy, NOS	released	aac98e34-c803-5cd3-a685-bd3e8556f567	yes	Pharmaceutical Therapy, NOS	1707cf82-ab14-42eb-8230-3fe385ebb513
8beaeffb-5e9b-4589-8999-52c3d736aea7.htseq.counts.gz	0ce7805a-f215-4470-869a-021b77fe10cc	TCGA-30-1857-01A-02R-1569-13	TCGA-30-1857-01A-02R	TCGA-30-1857-01A-01-BS1	TCGA-30-1857-01A-02-BS2	TCGA-30-1857-01A-02		TCGA-30-1857-01A	TCGA-30-1857	45baebac-32ae-4093-9eba-488b95c1a58d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.7	False	0.8		e3d84909-0149-4691-a398-1a6b272dde60	1.8	7fc46368-c523-4936-84e3-bb3f77db7c48			0.15	22	released	ba18152f-72f2-4ca2-8536-f68bb6a0e1bc	RNA	R	0.15	UV Spec	released	False	ed7637fe-3bc8-4c1c-83dc-6dbbb89f91a7	02			0.0		0.0	15.0	85.0	90.0	TOP	392b4bb4-7991-4797-b75c-ffe3d94a4599	released			0.0		0.0	20.0	80.0	90.0	BOTTOM	c7ade19c-60eb-4fee-b487-879801460374	released	released	111.0						9aae154c-ffe9-4e86-9111-903b55de9228	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-30-1857_demographic	64	-23689	8	053eda72-806d-5ada-932d-fc4e667f34f0	not hispanic or latino	female	white	released	Dead	1937	2001	TCGA-30-1857_exposure	Not Reported	ca2d637c-2147-5e07-a88f-14d3152a629a	released	TCGA-30-1857_diagnosis	23689	not reported	0	8	d43fe037-2d6d-5cea-b640-8656fb0ccd5c	Stage IV	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-30-1857_treatment	TCGA-30-1857_treatment_1	released	eda9659e-b534-500a-957b-cc01c9763139	no	Radiation Therapy, NOS	released	589205cb-2d7c-518a-8425-e574d4da3e39	no	Pharmaceutical Therapy, NOS	0ce7805a-f215-4470-869a-021b77fe10cc
5112a69c-c9ec-4c72-b93d-31f110d74eb1.htseq.counts.gz	c475e830-8cfe-4083-b019-9f6035d5c1fe	TCGA-25-1323-01A-01R-1565-13	TCGA-25-1323-01A-01R	TCGA-25-1323-01A-01-BS1	TCGA-25-1323-01A-01-TS1	TCGA-25-1323-01A-01		TCGA-25-1323-01A	TCGA-25-1323	2ee36d9d-128b-4761-aa1a-a637da106f3d	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				2.0	False	2.5		AFE55BB2-F0FC-4B39-A61A-2287B62354AD	1.8	cd401b89-ae05-4775-94b0-6800f88652b0			0.15	22	released	b34cf67c-f650-448b-885c-63fcb2fdc8b1	RNA	R	0.15	UV Spec	released	False	5d5e4f4d-42bb-4e25-b49f-f8ec56373dde	01			10.0		0.0	25.0	65.0	75.0	BOTTOM	a400c51c-77e2-41e2-be66-b1c4cd67cf7a	released			10.0		20.0	0.0	70.0	80.0	TOP	a8ee5dae-63b9-4972-be8b-e1ad21e2d3c4	released	released	153.0						b1d85c32-1698-44ed-a4e2-707611a3889c	Primary Tumor	01	0.6	released	Not Reported	released	TCGA-25-1323_demographic	72	-26602	395	b7f1ad25-47b4-5bb3-8f7d-332afedb0764	not hispanic or latino	female	white	released	Dead	1929	2002	TCGA-25-1323_exposure	Not Reported	c8fdb513-7409-5227-81ed-665c0f824b66	released	TCGA-25-1323_diagnosis	26602	not reported	0	365	b3861530-7540-5dbb-af8a-d27f40d5b8d0	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2001	TCGA-25-1323_treatment_1	TCGA-25-1323_treatment	released	4d2d67d0-a816-58bf-996d-4a0f7bf9f898	yes	Pharmaceutical Therapy, NOS	released	74ed6bfb-fdc9-586d-aa2b-cfb506e7dcff	no	Radiation Therapy, NOS	c475e830-8cfe-4083-b019-9f6035d5c1fe
fb9c5a20-75cd-49f4-b75f-09a054e72267.htseq.counts.gz	e6cf743a-97c4-4aaf-b825-bde4980d6d0a	TCGA-24-1549-01A-01R-1566-13	TCGA-24-1549-01A-01R	TCGA-24-1549-01A-01-BS1	TCGA-24-1549-01A-01-TS1	TCGA-24-1549-01A-01		TCGA-24-1549-01A	TCGA-24-1549	3b81ec7c-0934-4649-9231-9919dd26dd15	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				0.6	False	0.6		6431416b-d089-442d-9db8-32118eed41de	1.8	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f			0.15	22	released	f105c9a1-d162-4643-af16-32b90b4b2ab6	RNA	R	0.15	UV Spec	released	False	d330ec1f-4010-4899-be2d-e33487e82044	01			5.0		0.0	15.0	80.0	95.0	BOTTOM	9d2f28ad-f2d5-491d-8df7-54afaf3133cc	released			5.0		0.0	10.0	85.0	95.0	TOP	e8282ab7-a954-4aaf-80fb-ca80fc8891c8	released	released	112.0						cd81e8c8-2526-4427-a1db-6ce6bff105e6	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-24-1549_demographic	58	-21432	1721	c55541b5-4687-5f7e-ad06-df8ce619bf84	not reported	female	white	released	Dead	1939	2001	TCGA-24-1549_exposure	Not Reported	aec82ef8-de34-5016-8057-5f4f19d1df9a	released	TCGA-24-1549_diagnosis	21432	not reported	0	1721	f36f2c46-02cd-5d38-a399-09fd46cbb94d	Stage IIIB	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	1997	TCGA-24-1549_treatment	TCGA-24-1549_treatment_1	released	ad5ea13e-3382-5f99-a511-54945c4d6605	no	Radiation Therapy, NOS	released	547ba88d-16c1-53c2-99f6-d770140673ae	yes	Pharmaceutical Therapy, NOS	e6cf743a-97c4-4aaf-b825-bde4980d6d0a
af11caa0-a20b-4c17-8207-0a1142edd9a9.htseq.counts.gz	cc2594ae-895e-4e1d-acf7-82f344672107	TCGA-61-1914-01A-01R-1567-13	TCGA-61-1914-01A-01R	TCGA-61-1914-01A-01-BS1	TCGA-61-1914-01A-01-TS1	TCGA-61-1914-01A-01		TCGA-61-1914-01A	TCGA-61-1914	8e1b8811-1eb2-4337-852c-c19eaa0ee418	Cystic, Mucinous and Serous Neoplasms	Ovary	TCGA-OV				1.0	False	1.2		b634b2cf-9e8d-4dd4-8442-337c22522a43	1.8	0d75483f-eab3-41c8-b2cc-453af29b6f44			0.14	22	released	affa6441-08b8-4a3c-af15-b81f6b24af90	RNA	R	0.14	UV Spec	released	False	5d864b1f-cbda-4f7c-aba8-318da921ab54	01			5.0		0.0	10.0	85.0	90.0	BOTTOM	740aedb0-ca44-4218-8601-cc068d1cac21	released			1.0		0.0	10.0	89.0	90.0	TOP	ac6aa78e-762f-4ded-ab0f-7c528cd199e5	released	released	119.0						98f6fcfd-df24-422f-a14d-144fd1a02849	Primary Tumor	01	0.4	released	Not Reported	released	TCGA-61-1914_demographic	65	-23850		2133f718-5c09-5c22-a386-00330e432c86	not reported	female	not reported	released	Alive	1938		TCGA-61-1914_exposure	Not Reported	5d4f75e6-495a-5b81-8a8a-723a1f7ed1ae	released	TCGA-61-1914_diagnosis	23850	not reported	0	1722	d601544b-eacc-5b79-b206-68fa1be8c0ac	Stage IIIC	C56.9	not reported	8441/3	Serous cystadenocarcinoma, NOS	not reported	No	not reported	Ovary	released	Not Reported	Ovary	not reported	not reported	2003	TCGA-61-1914_treatment_1	TCGA-61-1914_treatment	released	139fde31-e567-55f5-bee3-5c66aa2adf47	yes	Pharmaceutical Therapy, NOS	released	cdfd6ed8-89d3-5764-93ec-e05ccd6b4d7d	no	Radiation Therapy, NOS	cc2594ae-895e-4e1d-acf7-82f344672107